<html lang="en"><head><!-- Shady DOM styles for custom-style --><!-- Shady DOM styles for dom-template --><!-- Shady DOM styles for dom-repeat --><!-- Shady DOM styles for array-selector --><!-- Shady DOM styles for dom-if --><!-- Shady DOM styles for state-modifier --><style scope="state-modifier">a[inherit].state-modifier {
  color: inherit;
}</style><!-- Shady DOM styles for browser-ui --><!-- Shady DOM styles for outlined-text-field --><style scope="outlined-text-field">outlined-text-field {
  display: flex;
  font-family: "Google Sans", Roboto, Arial, sans-serif;
  font-weight: 500;
  flex-direction: column;
}

outlined-text-field span.outlined-text-field {
  display: flex;
  flex-direction: row;
  align-items: center;
}

outlined-text-field input.outlined-text-field {
  height: 40px;
  padding: 0 33px 0 16px;
  
  border-color: #b0b3b6;
  border-width: 1px;
  border-style: solid;
  
  border-radius: 8px;
  caret-color: #3c78e0;
  color: #6a6c71;
  font-size: 14px;
  flex-grow: 1;
}

outlined-text-field[orig] input.outlined-text-field {
  border-color: #e5e5e5;
  
  border-radius: 0;
}

outlined-text-field[dense] input.outlined-text-field {
  height: 32px;
}

outlined-text-field[uppercase] input.outlined-text-field {
  text-transform: uppercase;
}

outlined-text-field:not([wizard-focused]):hover input.outlined-text-field {
  border-color: #737375;
  color: #414447;
}

outlined-text-field:not([wizard-focused]):focus-within input.outlined-text-field,outlined-text-field[wizard-focused] input.outlined-text-field {
  border-color: #3574e0;
  caret-color: #80a5f1;
}

outlined-text-field[wizard-focused] input.outlined-text-field {
  border-width: 2px;
}

outlined-text-field input.outlined-text-field::placeholder {
  color: #65686c;
}

outlined-text-field[uppercase] input.outlined-text-field::placeholder {
  text-transform: none;
}</style><!-- Shady DOM styles for mat-keyword-editor --><!-- Shady DOM styles for mat-chips-input --><!-- Shady DOM styles for mat-input-chip --><!-- Shady DOM styles for pat-dialog --><style scope="pat-dialog">pat-dialog {
  background: white;
  position: absolute;
  border-radius: 8px;
  
  box-shadow: 0 24px 38px 3px rgb(0 0 0 / 14%),
              0 9px 46px 8px rgb(0 0 0 / 12%),
              0 11px 15px -7px rgb(0 0 0 / 20%);
  z-index: 1;
  display: flex;
  flex-direction: column;
}

pat-dialog:not([open]) {
  display: none;
}</style><!-- Shady DOM styles for mat-tabs --><!-- Shady DOM styles for filter-chip --><style scope="filter-chip">filter-chip {
  align-items: center;
  background-color: #fff;
  border-color: #dadce0;
  border-radius: 8px;
  border-style: solid;
  border-width: 1px;
  color: #606368;
  cursor: pointer;
  font-family: "Google Sans", Roboto, Arial, sans-serif;
  font-size: 14px;
  font-weight: 500;
  height: 32px;
  letter-spacing: 0.2px;
  padding: 0 16px;
  user-select: none;
  display: inline-flex;
  white-space: nowrap;
}

filter-chip[disabled] {
  background-color: #e8e8e8;
  border-color: #e8e8e8;
  color: #a9abad;
  cursor: auto;
}

filter-chip svg.filter-chip {
  visibility: collapse;
  font-size: 18px;
  width: 0;
  height: 18px;
}

filter-chip[selected] svg.filter-chip {
  visibility: visible;
  margin: 0 8px;
  width: 18px;
}

filter-chip[selected] svg.filter-chip path.filter-chip {
  fill: #4577d1;
}

filter-chip:not([disabled]):hover {
  background-color: #f7f8f8;
  border-color: #d7d9dc;
  color: #454649;
}

filter-chip:not([disabled]):hover:active {
  background-color: #eff0f0;
  border-color: #d2d5d8;
  color: #222326;
}

filter-chip:not([disabled]):focus {
  background-color: #e7e8e8;
  border-color: #232528;
  color: #202124;
}

filter-chip:not([disabled])[selected] {
  background-color: #e9f0fd;
  border-color: #e9f0fd;
  color: #4577d1;
  padding-left: 0;
}

filter-chip:not([disabled]):focus[selected] {
  background-color: #d5e1fb;
  border-color: #d5e1fb;
  color: #2550a0;
}

filter-chip:not([disabled]):hover[selected] {
  box-shadow: rgba(0, 0, 0, 0.2) 0px 3px 1px -2px,
    rgba(0, 0, 0, 0.14) 0px 2px 2px 0px, rgba(0, 0, 0, 0.12) 0px 1px 5px 0px;
}

filter-chip:not([disabled]):hover:active[selected] {
  background-color: #abc8f2;
  border-color: #abc8f2;
  color: #2a54a3;
}</style><!-- Shady DOM styles for figure-callout --><style scope="figure-callout">figure-callout:not([filenames=""]) a.figure-callout {
  cursor: zoom-in;
  text-decoration: underline;
  text-decoration-color: #ddd;
}</style><!-- Shady DOM styles for mat-button --><style scope="mat-button-0">.mat-button-0 {
  ;
  align-items: center;
  border-radius: 4px;
  color: hsl(217 4% 39%); 
  cursor: pointer;
  font-family: "Google Sans", Roboto, Arial, sans-serif;
  font-size: 14px;
  font-weight: 500;
  height: 36px;
  letter-spacing: 0.2px;
  padding: 0 8px;
  user-select: none;
  display: inline-flex;
  white-space: nowrap;
}

.mat-button-0[filled] {
  background-color: hsl(217 73% 54%); 
  color: white;
}

.mat-button-0[filled]:hover {
  background-color: hsl(217 60% 47%);
}

.mat-button-0[filled]:focus {
  background-color: hsl(217 59% 44%);
}

.mat-button-0[filled]:active {
  background-color: hsl(217 59% 45%);
}

.mat-button-0[filled][disabled] {
  background-color: hsl(217 2% 90%); 
  color: hsl(217 1% 65%);
}</style><!-- Shady DOM styles for search-term-wizard --><style scope="search-term-wizard">search-term-wizard:not([open]) {
  display: none;
}

search-term-wizard .header.search-term-wizard {
  border-bottom: 1px solid #e5e5e5;
  padding: 24px;
  padding-bottom: 0;
}

search-term-wizard .title.search-term-wizard {
  color: #3c4043;
  font-family: Google Sans,Roboto,Arial,sans-serif;
  font-size: 22px;
  user-select: none;
  margin: 0 48px;
}

search-term-wizard #panels.search-term-wizard > *.search-term-wizard:not([selected]) {
  display: none;
}</style><!-- Shady DOM styles for outlined-textarea --><style scope="outlined-textarea">outlined-textarea {
  display: flex;
  font-family: "Google Sans", Roboto, Arial, sans-serif;
  font-weight: 500;
  flex-direction: row;
  
  position: relative;
}

outlined-textarea span.outlined-textarea {
  display: flex;
  flex-direction: column;
  flex-grow: 1;
  justify-content: center;
}

outlined-textarea span.right-button-container.outlined-textarea {
  position: absolute;
  right: 0;
  height: 100%;
}

outlined-textarea textarea.outlined-textarea {
  padding: 16px 16px 0 16px;
  border-color: #b0b3b6;
  border-width: 1px;
  border-style: solid;
  border-radius: 8px;
  caret-color: #3c78e0;
  color: #6a6c71;
  font-size: 14px;
  font-family: "Google Sans", Roboto, Arial, sans-serif;
  font-weight: 500;
  resize: none;
}

outlined-textarea[dense] textarea.outlined-textarea {
  padding: 8px;
}

outlined-textarea[has-icon] textarea.outlined-textarea {
  padding-right: 38px;
}

outlined-textarea[orig] textarea.outlined-textarea {
  border-color: #e5e5e5;
  
  border-radius: 0;
}

outlined-textarea:not([rows]) textarea.outlined-textarea {
  height: 40px;
}

outlined-textarea textarea.resizable.outlined-textarea {
  resize: vertical;
}

outlined-textarea textarea.outlined-textarea:focus,outlined-textarea[wizard-focused] textarea.outlined-textarea,outlined-textarea textarea.outlined-textarea:focus:hover {
  border-color: #3574e0 !important;
  
  outline: none !important;
}

outlined-textarea textarea.outlined-textarea:hover {
  border-color: #202124;
  color: #414447;
}

outlined-textarea.hasValue textarea.outlined-textarea {
  border-color: #888d91;
  color: #45474a;
}

outlined-textarea #helperText.outlined-textarea {
  color: #6a6c71;
  font-size: 12px;
  letter-spacing: 0.3px;
  margin-left: 17px;
  margin-top: 6px;
  user-select: none;
}

outlined-textarea:not([helper-text]) #helperText.outlined-textarea {
  display: none;
}

outlined-textarea[error] textarea.outlined-textarea {
  border-color: #cb4b3d;
  caret-color: #ca493a;
  color: #3d4043;
}

outlined-textarea textarea.outlined-textarea::placeholder {
  font-size: 14px;
  font-weight: 400;
}

outlined-textarea:not([error]):not([disabled]) textarea.outlined-textarea::placeholder {
  color: #6a6c71;
}

outlined-textarea[error] textarea.outlined-textarea::placeholder {
  color: #c84132;
}

outlined-textarea[error] #helperText.outlined-textarea {
  color: #cd5648;
}

outlined-textarea[error] textarea.outlined-textarea:focus {
  border-color: #c84031;
  border-width: 2px;
  outline: none !important;
}

outlined-textarea[error]:not([disabled]) textarea.outlined-textarea:hover {
  border-color: #97231b;
}

outlined-textarea[error]:not([disabled]) textarea.outlined-textarea:hover::placeholder,outlined-textarea[error]:not([disabled]) textarea.outlined-textarea:hover + #helperText.outlined-textarea {
  color: #a94945;
}

outlined-textarea[disabled] textarea.outlined-textarea {
  border-color: #e9e9e9;
  color: #b5b6b8;
}

outlined-textarea[disabled] #helperText.outlined-textarea {
  color: #c4c6c7;
}

outlined-textarea[error][disabled] {
  opacity: 50%;
}

outlined-textarea[error][disabled] textarea.outlined-textarea {
  border-color: #cb4b3d;
  caret-color: #ca493a;
}

outlined-textarea[error][disabled] #helperText.outlined-textarea,outlined-textarea[error][disabled] textarea.outlined-textarea {
  color: #a94945;
}

outlined-textarea[error][disabled] textarea.outlined-textarea::placeholder {
  color: #c84132;
}</style><!-- Shady DOM styles for chemistry-search-term-wizard --><style scope="chemistry-search-term-wizard">chemistry-search-term-wizard {
  display: flex;
  flex-direction: column;
  padding: 24px;
  padding-top: 0;
}

chemistry-search-term-wizard > span.chemistry-search-term-wizard {
  display: flex;
  flex-direction: row;
  align-items: center;
  flex-wrap: wrap;
  margin-top: 16px;
}

chemistry-search-term-wizard .suggestions.chemistry-search-term-wizard {
  margin-top: 4px;
}

chemistry-search-term-wizard > span.chemistry-search-term-wizard svg.chemistry-search-term-wizard {
  margin-right: 24px;
}

chemistry-search-term-wizard path.chemistry-search-term-wizard {
  fill: #5f6368;
}

chemistry-search-term-wizard .help.chemistry-search-term-wizard {
  margin-left: 12px;
  margin-right: 0;
  cursor: pointer;
}

chemistry-search-term-wizard outlined-text-field.chemistry-search-term-wizard {
  flex-grow: 1;
}

chemistry-search-term-wizard mat-button.chemistry-search-term-wizard {
  margin-left: 48px;
}

chemistry-search-term-wizard filter-chip.chemistry-search-term-wizard {
  margin-right: 4px;
}

chemistry-search-term-wizard outlined-textarea.chemistry-search-term-wizard {
  flex-grow: 1;
}

chemistry-search-term-wizard outlined-text-field[batchMode].chemistry-search-term-wizard {
  display: none;
}

chemistry-search-term-wizard outlined-textarea.chemistry-search-term-wizard:not([batchMode]) {
  display: none;
}</style><!-- Shady DOM styles for text-search-term-wizard --><style scope="text-search-term-wizard">text-search-term-wizard {
  display: flex;
  flex-direction: column;
  padding: 24px;
  padding-top: 0;
}

text-search-term-wizard > span.text-search-term-wizard {
  display: flex;
  flex-direction: row;
  align-items: center;
  flex-wrap: wrap;
  margin-top: 16px;
}

text-search-term-wizard > span.text-search-term-wizard svg.text-search-term-wizard {
  margin-right: 24px;
}

text-search-term-wizard path.text-search-term-wizard {
  fill: #5f6368;
}

text-search-term-wizard outlined-text-field.text-search-term-wizard {
  flex-grow: 1;
}

text-search-term-wizard mat-button.text-search-term-wizard {
  margin-left: 48px;
}

text-search-term-wizard filter-chip.text-search-term-wizard {
  margin-right: 4px;
}</style><!-- Shady DOM styles for classification-wizard --><style scope="classification-wizard">classification-wizard {
  display: flex;
  flex-direction: column;
  padding: 24px;
  padding-top: 0;
  max-width: 674px;
}

classification-wizard > span.classification-wizard {
  display: flex;
  flex-direction: row;
  align-items: center;
  flex-wrap: wrap;
  margin-top: 16px;
}

classification-wizard .suggestions.classification-wizard {
  margin-top: 4px;
}

classification-wizard > span.classification-wizard svg.classification-wizard {
  margin-right: 24px;
}

classification-wizard path.classification-wizard {
  fill: #5f6368;
}

classification-wizard outlined-text-field.classification-wizard {
  flex-grow: 1;
}

classification-wizard mat-button.classification-wizard {
  margin-left: 48px;
}

classification-wizard filter-chip.classification-wizard {
  margin-right: 4px;
}

classification-wizard .no-matches.classification-wizard {
  margin-left: 64px;
}

classification-wizard .table-container.classification-wizard {
  max-height: 300px;
  overflow: scroll;
  margin-top: 8px;
}

classification-wizard .table-container.classification-wizard::-webkit-scrollbar {
  -webkit-appearance: none;
  width: 10px;
}

classification-wizard .table-container.classification-wizard::-webkit-scrollbar-thumb {
  border-radius: 5px;
  background-color: #5f636880;
  -webkit-box-shadow: 0 0 1px rgba(255,255,255,.5);
}

classification-wizard table.classification-wizard {
  margin-left: 51px;
  max-width: 575px;
}

classification-wizard tr.classification-wizard {
  margin-top: 4px;
}

classification-wizard tr.classification-wizard suggestive-chip.classification-wizard {
  margin-right: 8px;
}

classification-wizard #spinner.classification-wizard {
  justify-content: space-around;
  margin-left: 48px;
  transform: scale(0.5);
}</style><!-- Shady DOM styles for suggestive-chip --><!-- Shady DOM styles for mat-checkbox --><!-- Shady DOM styles for measure-search-term-wizard --><style scope="measure-search-term-wizard">measure-search-term-wizard {
  display: flex;
  flex-direction: column;
  padding: 24px;
  padding-top: 0;
  max-width: 674px;
}

measure-search-term-wizard > span.measure-search-term-wizard {
  display: flex;
  flex-direction: row;
  align-items: center;
  flex-wrap: wrap;
  margin-top: 16px;
}

measure-search-term-wizard .suggestions.measure-search-term-wizard {
  margin-top: 4px;
}

measure-search-term-wizard > span.measure-search-term-wizard svg.measure-search-term-wizard {
  margin-right: 24px;
}

measure-search-term-wizard path.measure-search-term-wizard {
  fill: #5f6368;
}

measure-search-term-wizard outlined-text-field.measure-search-term-wizard {
  flex-grow: 1;
}

measure-search-term-wizard mat-button.measure-search-term-wizard {
  margin-left: 48px;
}

measure-search-term-wizard filter-chip.measure-search-term-wizard {
  margin-right: 4px;
}</style><!-- Shady DOM styles for numerical-search-term-wizard --><style scope="numerical-search-term-wizard">numerical-search-term-wizard {
  display: flex;
  flex-direction: column;
  padding: 24px;
  padding-top: 0;
  max-width: 674px;
}

numerical-search-term-wizard > span.numerical-search-term-wizard {
  display: flex;
  flex-direction: row;
  align-items: center;
  flex-wrap: wrap;
  margin-top: 16px;
}

numerical-search-term-wizard .suggestions.numerical-search-term-wizard {
  margin-top: 4px;
}

numerical-search-term-wizard > span.numerical-search-term-wizard svg.numerical-search-term-wizard {
  margin-right: 24px;
}

numerical-search-term-wizard path.numerical-search-term-wizard {
  fill: #5f6368;
}

numerical-search-term-wizard outlined-text-field.numerical-search-term-wizard,numerical-search-term-wizard outlined-textarea.numerical-search-term-wizard {
  flex-grow: 1;
}

numerical-search-term-wizard mat-button.numerical-search-term-wizard {
  margin-left: 48px;
}

numerical-search-term-wizard filter-chip.numerical-search-term-wizard {
  margin-right: 4px;
}

numerical-search-term-wizard #spinner.numerical-search-term-wizard {
  justify-content: space-around;
  margin-left: 48px;
  transform: scale(0.5);
}

numerical-search-term-wizard #suggestions.numerical-search-term-wizard {
  margin-left: 58px;
  display: flex;
  flex-direction: column;
  align-items: flex-start;
}

numerical-search-term-wizard .suggestion.numerical-search-term-wizard {
  display: flex;
  flex-direction: row;
  align-items: center;
}

numerical-search-term-wizard .suggestion.numerical-search-term-wizard mat-checkbox.numerical-search-term-wizard {
  margin-right: 8px;
}</style><!-- Shady DOM styles for text-button --><style scope="text-button">text-button {
  align-items: center;
  border-radius: 4px;
  cursor: pointer;
  font-family: "Google Sans", Roboto, Arial, sans-serif;
  font-size: 14px;
  font-weight: 500;
  height: 36px;
  letter-spacing: .25px;
  margin: 6px 0;
  padding: 0 8px;
  user-select: none;
  display: inline-flex;
  white-space: nowrap;
  line-height: 36px;
  text-decoration: none;
  text-transform: none;
  color: #5f6368;
}

text-button:hover {
  background-color: #f8f9fa;
}

text-button:active {
  background-color: #d5e2fa;
}

text-button[selected] {
  background-color: #e8f0fe;
  color: #1967d2;
}

text-button[selected]:active {
  background-color: #d2e3fc;
}</style><!-- Shady DOM styles for mat-spinner --><!-- Shady DOM styles for requery-tile --><style scope="requery-tile">requery-tile {
  display: flex;
  justify-content: space-between;
  align-items: center;
  box-sizing: border-box;
  min-height: 40px;
  padding: 8px 12px 8px 8px;
  gap: 8px;

  border-radius: 16px;
  background: #f7f8f9;
  color: #1f1f1f;
}

requery-tile:hover {
  background: #d7d8d9;
}

requery-tile > [slot="image"] {
  flex-shrink: 0;

  border-radius: 8px;

  background: #fff;
}

.label.requery-tile {
  flex-grow: 999;

  font: 16px/20px "Google Sans", Roboto, Arial, sans-serif;
  font-weight: 500;
}

.search-icon.requery-tile {
  flex-shrink: 0;

  width: 24px;
  height: 24px;
  background-image: url('https://fonts.gstatic.com/s/i/short-term/release/googlesymbols/search/default/24px.svg');
}</style><!-- Shady DOM styles for s-more-inline --><style scope="s-more-inline">s-more-inline {
  display: block;
  margin-top: 24px;
  padding: 16px;
  padding-top: 0;
  position: relative;

  line-height: 18px;
  text-overflow: ellipsis;
  white-space: nowrap;
  cursor: pointer;
}

hr.s-more-inline {
  background-color: #dadce0;
  margin-top: 18px;
  position: absolute;
  border: 0;
  height: 1px;
  left: 0;
  width: 100%;
}

.button.s-more-inline {
  display: flex;
  align-items: center;
  justify-content: center;

  position: relative; 
  margin: 0 auto;

  font: 400 14px Roboto, arial, sans-serif;
  height: 36px;
  width: 300px;
  border-radius: 18px;
  background-color: #f1f3f4;
}

.button.s-more-inline:hover {
  background-color: #d8d7dc;
}

.button.s-more-inline > [slot] {
  padding-right: 8px;
}

.expand.s-more-inline {
  display: inline-block;
  width: 20px;
  height: 20px;
}

.expand.less.s-more-inline {
  background-image: url('https://fonts.gstatic.com/s/i/short-term/release/googlesymbols/expand_less/default/20px.svg');
}

.expand.more.s-more-inline {
  background-image: url('https://fonts.gstatic.com/s/i/short-term/release/googlesymbols/expand_more/default/20px.svg');
}</style><!-- Shady DOM styles for workspace-ui-search --><!-- Shady DOM styles for keyword-wizard --><style scope="keyword-wizard">keyword-wizard {
  display: inline-block;
}

iron-icon.keyword-wizard {
  height: 20px;
    width: 20px;
    color: #999;
    cursor: pointer;
}

iron-icon[active].keyword-wizard {
  color: #4285f4 !important;
}

iron-icon.keyword-wizard:hover {
  color: #ccc;
}

#wizardIcon.keyword-wizard {
  padding-left: 1px;
    height: 16px;
    width: 16px;
    margin: 4px 1px 1px 1px;
}

#wizard.keyword-wizard {
  padding: 0;
    left: 0;
    top: 37px;
    position: absolute;
    background-color: white;
    z-index: 2;
    overflow: hidden;
}

.wizard-header.keyword-wizard {
  display: block;
    width: 100%;
    color: #737373;
    text-transform: uppercase;
    font-size: 13px;
    margin: 16px 0 6px 12px;
}

.filter-chips.keyword-wizard {
  margin-left: 20px;
}

.chip.keyword-wizard {
  background-color: #ebebeb;
    color: #6a6a6a;
    display: inline-block;
    font-size: 13px;
    font-family: inherit;
    border-radius: 12px;
    padding: 6px 12px;
}

.chip.keyword-wizard:hover {
  cursor: pointer;
}

.chip[selected].keyword-wizard {
  background-color: #4285f4;
    color: white;
}

.input-label.keyword-wizard {
  display: inline-block;
    font-size: 13px;
    font-family: inherit;
}

.keyword-input.keyword-wizard {
  display: inline-block;
    border-top: 0;
    border-left: 0;
    border-right: 0;
    border-bottom: 1px solid #dfe1e5;
    padding: 3px;
}

.keyword-input.keyword-wizard::placeholder {
  font-style: italic;
}

.keyword-input.keyword-wizard:hover,.keyword-input.keyword-wizard:focus {
  border-color: #4284f4;
    border-width: 1px;
    outline: none;
}

.cpc-field.keyword-wizard {
  display: inline-block;
    margin: 6px 0 0 24px;
}

#checkboxCPC.keyword-wizard:hover {
  cursor: pointer;
}

.checkbox-label.keyword-wizard {
  font-size: 13px;
    font-style: italic;
    color: #737373;
}

.chemistry-field.keyword-wizard {
  display: block;
}

#inputChem.input-batch.keyword-wizard {
  height: 150px;
    border: 1px solid #dfe1e5;
    padding: 6px;
}

#inputChem.keyword-wizard {
  resize: none;
    height: 15px;
    vertical-align: text-top;
    font-size: 13px;
    font-family: inherit;
    padding: 2px;
}

.chem-type-label.keyword-wizard {
  display: inline;
    font-size: 13px;
    margin-left: 12px;
    margin-right: 4px;
}

#chemType.keyword-wizard {
  border-top: 0;
    border-left: 0;
    border-right: 0;
    border-bottom: 1px solid #dfe1e5;
    margin: 6px;
    padding: 2px;
    outline: none;
    font-family: inherit;
    font-size: 13px;
}

.import.keyword-wizard {
  font-size: 13px;
    font-family: inherit;
}

.import-text.keyword-wizard {
  vertical-align: middle;
    display: inline-block;
}

.import-button.keyword-wizard {
  margin: 6px 0 0 24px;
}

.import-button.keyword-wizard button.keyword-wizard {
  border: 0;
    border-radius: 4px;
    padding: 6px 12px;
    font-family: inherit;
    background-color: #4284f4;
    color: white;
}

.import-button.keyword-wizard button.keyword-wizard:hover {
  cursor: pointer;
    background-color: #4284f4;
    color: white;
}

.wizard-buttons.keyword-wizard {
  float: right;
    padding: 12px;
}

.wizard-buttons.keyword-wizard button.keyword-wizard {
  border: 0;
    border-radius: 4px;
    padding: 6px 12px;
    margin: 2px;
    font-family: inherit;
    background-color: #4284f4;
    color: white;
}

.wizard-buttons.keyword-wizard button.keyword-wizard:hover {
  cursor: pointer;
}

@media screen and (max-width: 700px) {
#wizard.keyword-wizard {
  width: 275px;
}

.chip.keyword-wizard {
  margin: 4px 2px;
}

.keyword-input.keyword-wizard {
  width: 82%;
      margin: 4px 12px 12px 24px;
}

.search-within.keyword-wizard .input-label.keyword-wizard {
  display: none;
}

.cpc-field.keyword-wizard .keyword-input.keyword-wizard {
  width: 225px;
      margin: 12px 0 6px 0;
}

.find-patents.keyword-wizard .input-label.keyword-wizard {
  display: none;
}

.search-by.keyword-wizard .input-label.keyword-wizard {
  width: 55px;
      margin-left: 24px;
}

.search-by.keyword-wizard .keyword-input.keyword-wizard {
  margin-top: 6px;
}

#inputChem.keyword-wizard {
  width: 82%;
      padding: 2px;
      margin: 8px 12px 12px 24px;
}

#inputChem.input-batch.keyword-wizard {
  width: 220px;
      padding: 4px;
}

#chemType.keyword-wizard {
  width: 150px;
}

.import-text.keyword-wizard {
  margin: 6px 12px 6px 24px;
      width: 220px;
}

iron-icon.help-header.keyword-wizard {
  display: none;
}

}

@media screen and (min-width: 700px) {
#wizard.keyword-wizard {
  width: 540px;
}

.chip.keyword-wizard {
  margin: 0 2px;
}

.cpc-field.keyword-wizard .keyword-input.keyword-wizard {
  width: 240px;
      margin: 12px 16px 6px 6px;
}

.cpc-inputs.keyword-wizard {
  display: inline;
}

.find-patents.keyword-wizard .keyword-input.keyword-wizard {
  width: 53%;
      margin: 4px 10px;
}

.cpc-field.keyword-wizard .keyword-input.keyword-wizard::placeholder,#inputAnd.keyword-wizard::placeholder,#inputExact.keyword-wizard::placeholder,#inputOr.keyword-wizard::placeholder,#inputMinus.keyword-wizard::placeholder {
  color: white;
}

.find-patents.keyword-wizard .input-label.keyword-wizard {
  width: 35%;
      margin-left: 24px;
}

.search-by.keyword-wizard .keyword-input.keyword-wizard {
  width: 42%;
      margin: 6px 4px;
}

.search-by.keyword-wizard .input-label.keyword-wizard {
  width: 55px;
      margin-left: 24px;
}

#inputChem.keyword-wizard {
  width: 290px;
      margin: 2px 12px 2px 6px;
}

#inputChem.input-batch.keyword-wizard {
  width: 280px;
      padding: 6px;
}

.import-text.keyword-wizard {
  margin: 6px 12px;
      width: 415px;
}

#chemType.keyword-wizard {
  width: 105px;
}

iron-icon.keyword-wizard:hover.help-header {
  cursor: default;
}

iron-icon.help-header.keyword-wizard {
  height: 16px;
      padding: 0 2px 2px 2px;
      color: #a3a3a3;
}

.help.keyword-wizard p.keyword-wizard {
  margin: 0 0 8px 0
}

.help.keyword-wizard .q.keyword-wizard {
  font-family: monospace;
      color: #0b8043;
      white-space: nowrap;
}

.help.keyword-wizard {
  z-index: 4;
      position: absolute;
      right: 10px;
      padding: 12px;
      border-radius: 2px;
      border: 1px solid #e0e0e0;
      box-shadow: 0 2px 2px 0 rgba(0, 0, 0, 0.2), 0 6px 10px 0 rgba(0, 0, 0, 0.3);
      background: white;
      font-size: 13px;
      line-height: 20px;
      width: 450px;
      max-height: 400px;
      overflow: auto;
}

#withinHelp.keyword-wizard {
  top: 75px;
}

#chemHelp.keyword-wizard {
  top: 0;
}

#searchBooleanHelp.keyword-wizard {
  top: 140px;
}

}</style><!-- Shady DOM styles for bottom-bar --><style scope="bottom-bar">.fixed.bottom-bar {
  display: block;
  position: fixed;
  height: 46px;
  bottom: 0;
}

.fixed[medium].bottom-bar {
  height: 280px;
}

.fixed[large].bottom-bar {
  height: 480px;
}

.shadow.bottom-bar {
  background: white;
  padding: 16px;
  border-radius: 8px 8px 0px 0px;
  box-shadow: 0px 8px 10px 1px rgba(0,0,0,.14), 0px 3px 14px 2px rgba(0,0,0,.12), 0px 5px 5px -3px rgba(0,0,0,.2);
}

.oneline.bottom-bar {
  white-space: nowrap;
  overflow: hidden;
  text-overflow: ellipsis;
  cursor: pointer;
}

.button.bottom-bar {
  cursor: pointer;
}

.buttonAlign.bottom-bar {
  margin-top: -4px;
}

.header.bottom-bar {
  height: 30px;
  font-family: 'Google Sans';
  font-size: 18px;
  padding-bottom: 8px;
}

.list.bottom-bar {
  overflow-y: auto;
  line-height: 20px;
}

.definition.bottom-bar {
  padding: 0px 0px 4px 0px;
  cursor: pointer;
}

[medium].bottom-bar .content.bottom-bar {
  height: 230px;
}

[large].bottom-bar .content.bottom-bar {
  height: 430px;
}

[medium].bottom-bar .content.bottom-bar .list.bottom-bar {
  height: 200px;
}

[large].bottom-bar .content.bottom-bar .list.bottom-bar {
  height: 400px;
}

[hidden].bottom-bar {
  display: none;
}

.label.bottom-bar {
  font-family: 'Google Sans';
  font-size: 12px;
  line-height: 16px;
  font-weight: 400;
  padding: 6px 0px 4px 0px;
  color: #1f1f1f;
}

[pad].bottom-bar {
  margin-left: 16px;
}

.layout.vertical.bottom-bar {
  display: flex;
  flex-direction: column;
}

.layout.horizontal.bottom-bar {
  display: flex;
  flex-direction: row;
}

.flex.bottom-bar {
  flex: 1;
  flex-basis: 0.000000001px;
}

.layout.start.bottom-bar {
  align-items: flex-start;
}

.layout.center.bottom-bar {
  align-items: center;
}

.layout.end.bottom-bar {
  align-items: flex-end;
}

.flex-2.bottom-bar {
  flex: 2;
}

.flex-3.bottom-bar {
  flex: 3;
}

.flex-4.bottom-bar {
  flex: 4;
}

.flex-5.bottom-bar {
  flex: 5;
}

.flex-6.bottom-bar {
  flex: 6;
}

.flex-7.bottom-bar {
  flex: 7;
}

.flex-8.bottom-bar {
  flex: 8;
}

.flex-9.bottom-bar {
  flex: 9;
}

.flex-10.bottom-bar {
  flex: 10;
}

.flex-11.bottom-bar {
  flex: 11;
}

.flex-12.bottom-bar {
  flex: 12;
}</style><!-- Shady DOM styles for landscape-link --><!-- Shady DOM styles for landscape-summary-box --><!-- Shady DOM styles for search-state --><!-- Shady DOM styles for iron-overlay-backdrop --><!-- Shady DOM styles for opaque-animation --><!-- Shady DOM styles for iron-dropdown --><style scope="iron-dropdown">iron-dropdown {
  position: fixed;
}

#contentWrapper.iron-dropdown  > * {
  overflow: auto;
}

#contentWrapper.animating.iron-dropdown  > * {
  overflow: hidden;
}</style><!-- Shady DOM styles for iron-meta --><!-- Shady DOM styles for iron-icon --><style scope="iron-icon-0">.iron-icon-0 {
  display: -ms-inline-flexbox;
        display: -webkit-inline-flex;
        display: inline-flex;-ms-flex-align: center;
        -webkit-align-items: center;
        align-items: center;-ms-flex-pack: center;
        -webkit-justify-content: center;
        justify-content: center;
        position: relative;

        vertical-align: middle;

        fill: currentcolor;
        stroke: none;

        width: 24px;
        height: 24px;;
}

.iron-icon-0[hidden] {
  display: none;
}</style><!-- Shady DOM styles for iron-iconset-svg --><!-- Shady DOM styles for iron-list --><!-- Shady DOM styles for paper-icon-item --><!-- Shady DOM styles for paper-item-body --><!-- Shady DOM styles for paper-item --><!-- Shady DOM styles for dropdown-menu --><style scope="dropdown-menu">dropdown-menu {
  display: inline-block;
        line-height: 24px;
}

.label.dropdown-menu {
  cursor: pointer;
        color: #666;
        align-items: center;
        margin-right: 8px;
        display: inline-block;
        padding: 2px 0;
}

#selected.dropdown-menu {
  color: #212121;
}

.label[open].dropdown-menu {
  border-color: #e0e0e0;
}

iron-dropdown.dropdown-menu {
  margin-top: 26px;
}

iron-icon.dropdown-menu {
  height: 15px;
        width: 15px;
}

#menu.dropdown-menu {
  max-height: 300px;
        padding: 8px 0;
        background: white;
        display: block;
        border-radius: 2px;
        box-shadow: 0 0 2px rgba(0,0,0,0.12), 0 2px 2px rgba(0,0,0,0.24);
}

.item.dropdown-menu {
  cursor: pointer;
        color: rgba(0,0,0,.87);
        font-size: 13px;
        line-height: 18px;
        padding: 6px 18px;
}

.item.dropdown-menu:hover {
  background-color: #e0e0e0;
}

.item[selected].dropdown-menu {
  background-color: #e0e0e0;
}

[multi].dropdown-menu .item.dropdown-menu {
  padding: 6px 18px 6px 34px;
}

[multi].dropdown-menu .item[selected].dropdown-menu {
  background-image: url('https://www.gstatic.com/images/icons/material/system/2x/done_grey600_24dp.png');
        background-position: 8px center;
        background-size: 16px;
        background-repeat: no-repeat;
}</style><!-- Shady DOM styles for chips-input --><!-- Shady DOM styles for input-chip --><!-- Shady DOM styles for keyword-editor --><!-- Shady DOM styles for paper-ripple --><!-- Shady DOM styles for paper-button --><!-- Shady DOM styles for date-editor --><!-- Shady DOM styles for metadata-editor --><!-- Shady DOM styles for restrict-editor --><!-- Shady DOM styles for overlay-tooltip --><style scope="overlay-tooltip">overlay-tooltip {
  display: none;
        color: #fff;
        background-color: #000;
        padding: 10px 12px;
        border-radius: 3px;
        font-size: 13px;
        font-weight: normal;
        line-height: normal;
        position: fixed;
        z-index: 100;
}

#arrow.overlay-tooltip {
  width: 0;
        height: 0;
        border-style: solid;
        border-width: 0 6px 8px 6px;
        border-color: transparent transparent #000 transparent;
        position: absolute;
        top: -8px;
        left: calc(50% - 6px);
}</style><!-- Shady DOM styles for query-renderer --><!-- Shady DOM styles for result-nav --><style scope="result-nav">result-nav {
  display: block;
        white-space: nowrap;
        padding: 0 30px;
        line-height: 30px;
        height: 30px;
        margin-top: 17px;
        font-weight: 500;
        font-size: 15px;
}

state-modifier.result-nav {
  color: #333;
}

state-modifier[disabled].result-nav {
  pointer-events: none;
        color: #ccc;
}</style><!-- Shady DOM styles for raw-html --><!-- Shady DOM styles for paper-material --><style scope="paper-material-0">.paper-material-0 {
  display: block;
        position: relative;
}

.paper-material-0[elevation="1"] {
  box-shadow: 0 2px 2px 0 rgba(0, 0, 0, 0.14),
                    0 1px 5px 0 rgba(0, 0, 0, 0.12),
                    0 3px 1px -2px rgba(0, 0, 0, 0.2);
}

.paper-material-0[elevation="2"] {
  box-shadow: 0 4px 5px 0 rgba(0, 0, 0, 0.14),
                    0 1px 10px 0 rgba(0, 0, 0, 0.12),
                    0 2px 4px -1px rgba(0, 0, 0, 0.4);
}

.paper-material-0[elevation="3"] {
  box-shadow: 0 6px 10px 0 rgba(0, 0, 0, 0.14),
                    0 1px 18px 0 rgba(0, 0, 0, 0.12),
                    0 3px 5px -1px rgba(0, 0, 0, 0.4);
}

.paper-material-0[elevation="4"] {
  box-shadow: 0 8px 10px 1px rgba(0, 0, 0, 0.14),
                    0 3px 14px 2px rgba(0, 0, 0, 0.12),
                    0 5px 5px -3px rgba(0, 0, 0, 0.4);
}

.paper-material-0[elevation="5"] {
  box-shadow: 0 16px 24px 2px rgba(0, 0, 0, 0.14),
                    0  6px 30px 5px rgba(0, 0, 0, 0.12),
                    0  8px 10px -5px rgba(0, 0, 0, 0.4);
}

.paper-material-0[animated] {
  transition: box-shadow 0.28s cubic-bezier(0.4, 0, 0.2, 1);
}

.paper-material-0 {
  ;
}</style><!-- Shady DOM styles for search-box --><style scope="search-box">.layout.horizontal.search-box,.layout.vertical.search-box {
  display: -ms-flexbox;
        display: -webkit-flex;
        display: flex;
}

.layout.inline.search-box {
  display: -ms-inline-flexbox;
        display: -webkit-inline-flex;
        display: inline-flex;
}

.layout.horizontal.search-box {
  -ms-flex-direction: row;
        -webkit-flex-direction: row;
        flex-direction: row;
}

.layout.vertical.search-box {
  -ms-flex-direction: column;
        -webkit-flex-direction: column;
        flex-direction: column;
}

.layout.wrap.search-box {
  -ms-flex-wrap: wrap;
        -webkit-flex-wrap: wrap;
        flex-wrap: wrap;
}

.layout.no-wrap.search-box {
  -ms-flex-wrap: nowrap;
        -webkit-flex-wrap: nowrap;
        flex-wrap: nowrap;
}

.layout.center.search-box,.layout.center-center.search-box {
  -ms-flex-align: center;
        -webkit-align-items: center;
        align-items: center;
}

.layout.center-justified.search-box,.layout.center-center.search-box {
  -ms-flex-pack: center;
        -webkit-justify-content: center;
        justify-content: center;
}

.flex.search-box {
  -ms-flex: 1 1 0.000000001px;
        -webkit-flex: 1;
        flex: 1;
        -webkit-flex-basis: 0.000000001px;
        flex-basis: 0.000000001px;
}

.flex-auto.search-box {
  -ms-flex: 1 1 auto;
        -webkit-flex: 1 1 auto;
        flex: 1 1 auto;
}

.flex-none.search-box {
  -ms-flex: none;
        -webkit-flex: none;
        flex: none;
}

.inputbox.search-box {
  border: 1px solid #ccc;
        padding: 0 12px;
        background: white;
}

.inputbox[focused].search-box {
  border: 1px solid #4285f4 !important;
}

.inputbox.search-box:hover {
  border: 1px solid #999;
}

#searchInput.search-box {
  font-family: inherit;
        font-size: 16px;
        padding: 8px 0;
        outline: none;
        border-right: none;
        width: 100%;
        margin-right: 0;
        border: 0;
}

#searchButton.search-box {
  cursor: pointer;
        background-color: #4285f4;
        border: none;
        color: #fff;
        vertical-align: top;
        width: 70px;
        height: 37px;
        outline: none;
}

.suggest-bg.search-box {
  display: inline-block;
        min-width: 0;
        white-space: nowrap;
}

#suggestMenu.search-box {
  position: absolute;
        margin-top: 38px;
        width: 100%;
        background: white;
        z-index: 1;
}

#suggestMenu.search-box .row.search-box {
  font-size: 13px;
        line-height: 28px;
        white-space: nowrap;
        overflow: hidden;
        text-overflow: ellipsis;
        padding: 4px 2px;
        cursor: pointer;
}

.row[selected].search-box {
  background: rgba(0, 0, 0, 0.05);
}

.suggest-icon.search-box {
  height: 20px;
        width: 20px;
        padding: 0 12px 0 6px;
        transition: transform .15s linear;
        transform: scale(1);
}

.suggest-icon[hide].search-box {
  transform: scale(0);
}

#corpora.search-box {
  padding: 6px 0;
        user-select: none;
}

#corpora.search-box iron-icon.search-box {
  height: 20px;
        width: 20px;
        color: #ccc;
        cursor: pointer;
}

#corpora.search-box iron-icon[active].search-box {
  color: #4285f4 !important;
}

#corpora.search-box iron-icon.search-box:hover {
  color: #999;
}</style><!-- Shady DOM styles for iron-media-query --><!-- Shady DOM styles for paper-header-panel --><!-- Shady DOM styles for iron-a11y-announcer --><style scope="iron-a11y-announcer">iron-a11y-announcer {
  display: inline-block;
        position: fixed;
        clip: rect(0px,0px,0px,0px);
}</style><!-- Shady DOM styles for iron-autogrow-textarea --><!-- Shady DOM styles for iron-input --><!-- Shady DOM styles for paper-input-char-counter --><!-- Shady DOM styles for paper-input-container --><!-- Shady DOM styles for paper-input-error --><!-- Shady DOM styles for paper-input --><!-- Shady DOM styles for paper-textarea --><!-- Shady DOM styles for paper-toast --><style scope="paper-toast-0">.paper-toast-0 {
  display: block;
        position: fixed;
        background-color: #323232;
        color: #f1f1f1;
        min-height: 48px;
        min-width: 288px;
        padding: 16px 24px;
        box-sizing: border-box;
        box-shadow: 0 2px 5px 0 rgba(0, 0, 0, 0.26);
        border-radius: 2px;
        margin: 12px;
        font-size: 14px;
        cursor: default;
        -webkit-transition: -webkit-transform 0.3s, opacity 0.3s;
        transition: transform 0.3s, opacity 0.3s;
        opacity: 0;
        -webkit-transform: translateY(100px);
        transform: translateY(100px);font-family: 'Roboto', 'Noto', sans-serif;
        -webkit-font-smoothing: antialiased;
}

.paper-toast-0.capsule {
  border-radius: 24px;
}

.paper-toast-0.fit-bottom {
  width: 100%;
        min-width: 0;
        border-radius: 0;
        margin: 0;
}

.paper-toast-0.paper-toast-open {
  opacity: 1;
        -webkit-transform: translateY(0px);
        transform: translateY(0px);
}</style><!-- Shady DOM styles for paper-toolbar --><!-- Shady DOM styles for search-footer --><style scope="search-footer">#footer.search-footer {
  font-size: 13px;
        margin-top: 10px;
        background: #fafafa;
        padding: 20px 10px;
        align-items: center;
        border-top: 1px solid #ebebeb;
}

#footer.search-footer .links.search-footer > *.search-footer {
  display: inline-block;
        margin: 0 12px;
}

.layout.horizontal.search-footer,.layout.vertical.search-footer {
  display: -ms-flexbox;
        display: -webkit-flex;
        display: flex;
}

.layout.inline.search-footer {
  display: -ms-inline-flexbox;
        display: -webkit-inline-flex;
        display: inline-flex;
}

.layout.horizontal.search-footer {
  -ms-flex-direction: row;
        -webkit-flex-direction: row;
        flex-direction: row;
}

.layout.vertical.search-footer {
  -ms-flex-direction: column;
        -webkit-flex-direction: column;
        flex-direction: column;
}

.layout.wrap.search-footer {
  -ms-flex-wrap: wrap;
        -webkit-flex-wrap: wrap;
        flex-wrap: wrap;
}

.layout.no-wrap.search-footer {
  -ms-flex-wrap: nowrap;
        -webkit-flex-wrap: nowrap;
        flex-wrap: nowrap;
}

.layout.center.search-footer,.layout.center-center.search-footer {
  -ms-flex-align: center;
        -webkit-align-items: center;
        align-items: center;
}

.layout.center-justified.search-footer,.layout.center-center.search-footer {
  -ms-flex-pack: center;
        -webkit-justify-content: center;
        justify-content: center;
}

.flex.search-footer {
  -ms-flex: 1 1 0.000000001px;
        -webkit-flex: 1;
        flex: 1;
        -webkit-flex-basis: 0.000000001px;
        flex-basis: 0.000000001px;
}

.flex-auto.search-footer {
  -ms-flex: 1 1 auto;
        -webkit-flex: 1 1 auto;
        flex: 1 1 auto;
}

.flex-none.search-footer {
  -ms-flex: none;
        -webkit-flex: none;
        flex: none;
}

.layout.start.search-footer {
  -ms-flex-align: start;
        -webkit-align-items: flex-start;
        align-items: flex-start;
}

.layout.center.search-footer,.layout.center-center.search-footer {
  -ms-flex-align: center;
        -webkit-align-items: center;
        align-items: center;
}

.layout.end.search-footer {
  -ms-flex-align: end;
        -webkit-align-items: flex-end;
        align-items: flex-end;
}

.layout.baseline.search-footer {
  -ms-flex-align: baseline;
        -webkit-align-items: baseline;
        align-items: baseline;
}

.layout.start-justified.search-footer {
  -ms-flex-pack: start;
        -webkit-justify-content: flex-start;
        justify-content: flex-start;
}

.layout.center-justified.search-footer,.layout.center-center.search-footer {
  -ms-flex-pack: center;
        -webkit-justify-content: center;
        justify-content: center;
}

.layout.end-justified.search-footer {
  -ms-flex-pack: end;
        -webkit-justify-content: flex-end;
        justify-content: flex-end;
}

.layout.around-justified.search-footer {
  -ms-flex-pack: distribute;
        -webkit-justify-content: space-around;
        justify-content: space-around;
}

.layout.justified.search-footer {
  -ms-flex-pack: justify;
        -webkit-justify-content: space-between;
        justify-content: space-between;
}

.self-start.search-footer {
  -ms-align-self: flex-start;
        -webkit-align-self: flex-start;
        align-self: flex-start;
}

.self-center.search-footer {
  -ms-align-self: center;
        -webkit-align-self: center;
        align-self: center;
}

.self-end.search-footer {
  -ms-align-self: flex-end;
        -webkit-align-self: flex-end;
        align-self: flex-end;
}

.self-stretch.search-footer {
  -ms-align-self: stretch;
        -webkit-align-self: stretch;
        align-self: stretch;
}

.self-baseline.search-footer {
  -ms-align-self: baseline;
        -webkit-align-self: baseline;
        align-self: baseline;
}

.layout.start-aligned.search-footer {
  -ms-flex-line-pack: start;  
        -ms-align-content: flex-start;
        -webkit-align-content: flex-start;
        align-content: flex-start;
}

.layout.end-aligned.search-footer {
  -ms-flex-line-pack: end;  
        -ms-align-content: flex-end;
        -webkit-align-content: flex-end;
        align-content: flex-end;
}

.layout.center-aligned.search-footer {
  -ms-flex-line-pack: center;  
        -ms-align-content: center;
        -webkit-align-content: center;
        align-content: center;
}

.layout.between-aligned.search-footer {
  -ms-flex-line-pack: justify;  
        -ms-align-content: space-between;
        -webkit-align-content: space-between;
        align-content: space-between;
}

.layout.around-aligned.search-footer {
  -ms-flex-line-pack: distribute;  
        -ms-align-content: space-around;
        -webkit-align-content: space-around;
        align-content: space-around;
}</style><!-- Shady DOM styles for search-header --><style scope="search-header">search-header {
  display: block;
}

.lockup-logo.search-header,.lockup-text.search-header {
  display: inline-block;
}

.lockup-logo.search-header {
  width: 74px;
        height: 24px;
        background-image: url('https://www.gstatic.com/images/branding/googlelogo/1x/googlelogo_color_74x24dp.png');
        background-size: 74px 24px;
}

.lockup-text.search-header {
  font-family: "Product Sans", Arial, Helvetica, sans-serif;

        
        font-size: 22.1px;

        
        text-rendering: optimizeLegibility;

        
        position: relative;
        top: -6px;
        left: -5px;

        
        -webkit-font-smoothing: antialiased;
        -moz-osx-font-smoothing: grayscale;
}

.lockup-brand.search-header {
  opacity: 0.54;
}

@media (-webkit-min-device-pixel-ratio: 1.5), (min-resolution: 144dpi) {
.lockup-logo.search-header {
  background-image: url('https://www.gstatic.com/images/branding/googlelogo/2x/googlelogo_color_74x24dp.png');
}

.lockup-text.search-header {
  font-size: 21.3px;
          left: -7px;
}

}

header.search-header {
  background-color: #fafafa;
        border-bottom: 1px solid #ebebeb;
        color: #333;
        height: 60px;
        width: 100%;
        z-index: 1;
        display: block;
}

[latestStyle].search-header header.search-header {
  background-color: transparent;
}

.headerpad.search-header {
  margin-left: 16px;
}

[wide].search-header .headerpad.search-header {
  margin-left: 32px;
}

.leftheader.search-header {
  width: 322px;
}

header.search-header h1.search-header {
  display: none;
}

header.search-header h1.search-header state-modifier.search-header {
  color: #777;
        text-decoration: none;
        display: inline-block;
}

[wide].search-header header.search-header h1.search-header {
  box-sizing: border-box;
        margin: 0;
        padding: 20px 0 10px;
        font-size: 20px;
        font-weight: 400;
        white-space: nowrap;
        display: block;
}

search-box.search-header {
  height: 37px;
        padding: 0 16px;
        width: 900px;
        align-self: center;
}

.layout.horizontal.search-header,.layout.vertical.search-header {
  display: -ms-flexbox;
        display: -webkit-flex;
        display: flex;
}

.layout.inline.search-header {
  display: -ms-inline-flexbox;
        display: -webkit-inline-flex;
        display: inline-flex;
}

.layout.horizontal.search-header {
  -ms-flex-direction: row;
        -webkit-flex-direction: row;
        flex-direction: row;
}

.layout.vertical.search-header {
  -ms-flex-direction: column;
        -webkit-flex-direction: column;
        flex-direction: column;
}

.layout.wrap.search-header {
  -ms-flex-wrap: wrap;
        -webkit-flex-wrap: wrap;
        flex-wrap: wrap;
}

.layout.no-wrap.search-header {
  -ms-flex-wrap: nowrap;
        -webkit-flex-wrap: nowrap;
        flex-wrap: nowrap;
}

.layout.center.search-header,.layout.center-center.search-header {
  -ms-flex-align: center;
        -webkit-align-items: center;
        align-items: center;
}

.layout.center-justified.search-header,.layout.center-center.search-header {
  -ms-flex-pack: center;
        -webkit-justify-content: center;
        justify-content: center;
}

.flex.search-header {
  -ms-flex: 1 1 0.000000001px;
        -webkit-flex: 1;
        flex: 1;
        -webkit-flex-basis: 0.000000001px;
        flex-basis: 0.000000001px;
}

.flex-auto.search-header {
  -ms-flex: 1 1 auto;
        -webkit-flex: 1 1 auto;
        flex: 1 1 auto;
}

.flex-none.search-header {
  -ms-flex: none;
        -webkit-flex: none;
        flex: none;
}

.layout.start.search-header {
  -ms-flex-align: start;
        -webkit-align-items: flex-start;
        align-items: flex-start;
}

.layout.center.search-header,.layout.center-center.search-header {
  -ms-flex-align: center;
        -webkit-align-items: center;
        align-items: center;
}

.layout.end.search-header {
  -ms-flex-align: end;
        -webkit-align-items: flex-end;
        align-items: flex-end;
}

.layout.baseline.search-header {
  -ms-flex-align: baseline;
        -webkit-align-items: baseline;
        align-items: baseline;
}

.layout.start-justified.search-header {
  -ms-flex-pack: start;
        -webkit-justify-content: flex-start;
        justify-content: flex-start;
}

.layout.center-justified.search-header,.layout.center-center.search-header {
  -ms-flex-pack: center;
        -webkit-justify-content: center;
        justify-content: center;
}

.layout.end-justified.search-header {
  -ms-flex-pack: end;
        -webkit-justify-content: flex-end;
        justify-content: flex-end;
}

.layout.around-justified.search-header {
  -ms-flex-pack: distribute;
        -webkit-justify-content: space-around;
        justify-content: space-around;
}

.layout.justified.search-header {
  -ms-flex-pack: justify;
        -webkit-justify-content: space-between;
        justify-content: space-between;
}

.self-start.search-header {
  -ms-align-self: flex-start;
        -webkit-align-self: flex-start;
        align-self: flex-start;
}

.self-center.search-header {
  -ms-align-self: center;
        -webkit-align-self: center;
        align-self: center;
}

.self-end.search-header {
  -ms-align-self: flex-end;
        -webkit-align-self: flex-end;
        align-self: flex-end;
}

.self-stretch.search-header {
  -ms-align-self: stretch;
        -webkit-align-self: stretch;
        align-self: stretch;
}

.self-baseline.search-header {
  -ms-align-self: baseline;
        -webkit-align-self: baseline;
        align-self: baseline;
}

.layout.start-aligned.search-header {
  -ms-flex-line-pack: start;  
        -ms-align-content: flex-start;
        -webkit-align-content: flex-start;
        align-content: flex-start;
}

.layout.end-aligned.search-header {
  -ms-flex-line-pack: end;  
        -ms-align-content: flex-end;
        -webkit-align-content: flex-end;
        align-content: flex-end;
}

.layout.center-aligned.search-header {
  -ms-flex-line-pack: center;  
        -ms-align-content: center;
        -webkit-align-content: center;
        align-content: center;
}

.layout.between-aligned.search-header {
  -ms-flex-line-pack: justify;  
        -ms-align-content: space-between;
        -webkit-align-content: space-between;
        align-content: space-between;
}

.layout.around-aligned.search-header {
  -ms-flex-line-pack: distribute;  
        -ms-align-content: space-around;
        -webkit-align-content: space-around;
        align-content: space-around;
}</style><!-- Shady DOM styles for search-ui --><style scope="search-ui-0">.search-ui-0 paper-button.search-ui {
  display: inline-block;
        text-align: center;
        font-family: inherit;
}

.search-ui-0 .layout.horizontal.search-ui,.search-ui-0 .layout.vertical.search-ui {
  display: -ms-flexbox;
        display: -webkit-flex;
        display: flex;
}

.search-ui-0 .layout.inline.search-ui {
  display: -ms-inline-flexbox;
        display: -webkit-inline-flex;
        display: inline-flex;
}

.search-ui-0 .layout.horizontal.search-ui {
  -ms-flex-direction: row;
        -webkit-flex-direction: row;
        flex-direction: row;
}

.search-ui-0 .layout.vertical.search-ui {
  -ms-flex-direction: column;
        -webkit-flex-direction: column;
        flex-direction: column;
}

.search-ui-0 .layout.wrap.search-ui {
  -ms-flex-wrap: wrap;
        -webkit-flex-wrap: wrap;
        flex-wrap: wrap;
}

.search-ui-0 .layout.no-wrap.search-ui {
  -ms-flex-wrap: nowrap;
        -webkit-flex-wrap: nowrap;
        flex-wrap: nowrap;
}

.search-ui-0 .layout.center.search-ui,.search-ui-0 .layout.center-center.search-ui {
  -ms-flex-align: center;
        -webkit-align-items: center;
        align-items: center;
}

.search-ui-0 .layout.center-justified.search-ui,.search-ui-0 .layout.center-center.search-ui {
  -ms-flex-pack: center;
        -webkit-justify-content: center;
        justify-content: center;
}

.search-ui-0 .flex.search-ui {
  -ms-flex: 1 1 0.000000001px;
        -webkit-flex: 1;
        flex: 1;
        -webkit-flex-basis: 0.000000001px;
        flex-basis: 0.000000001px;
}

.search-ui-0 .flex-auto.search-ui {
  -ms-flex: 1 1 auto;
        -webkit-flex: 1 1 auto;
        flex: 1 1 auto;
}

.search-ui-0 .flex-none.search-ui {
  -ms-flex: none;
        -webkit-flex: none;
        flex: none;
}

.search-ui-0 .layout.start.search-ui {
  -ms-flex-align: start;
        -webkit-align-items: flex-start;
        align-items: flex-start;
}

.search-ui-0 .layout.center.search-ui,.search-ui-0 .layout.center-center.search-ui {
  -ms-flex-align: center;
        -webkit-align-items: center;
        align-items: center;
}

.search-ui-0 .layout.end.search-ui {
  -ms-flex-align: end;
        -webkit-align-items: flex-end;
        align-items: flex-end;
}

.search-ui-0 .layout.baseline.search-ui {
  -ms-flex-align: baseline;
        -webkit-align-items: baseline;
        align-items: baseline;
}

.search-ui-0 .layout.start-justified.search-ui {
  -ms-flex-pack: start;
        -webkit-justify-content: flex-start;
        justify-content: flex-start;
}

.search-ui-0 .layout.center-justified.search-ui,.search-ui-0 .layout.center-center.search-ui {
  -ms-flex-pack: center;
        -webkit-justify-content: center;
        justify-content: center;
}

.search-ui-0 .layout.end-justified.search-ui {
  -ms-flex-pack: end;
        -webkit-justify-content: flex-end;
        justify-content: flex-end;
}

.search-ui-0 .layout.around-justified.search-ui {
  -ms-flex-pack: distribute;
        -webkit-justify-content: space-around;
        justify-content: space-around;
}

.search-ui-0 .layout.justified.search-ui {
  -ms-flex-pack: justify;
        -webkit-justify-content: space-between;
        justify-content: space-between;
}

.search-ui-0 .self-start.search-ui {
  -ms-align-self: flex-start;
        -webkit-align-self: flex-start;
        align-self: flex-start;
}

.search-ui-0 .self-center.search-ui {
  -ms-align-self: center;
        -webkit-align-self: center;
        align-self: center;
}

.search-ui-0 .self-end.search-ui {
  -ms-align-self: flex-end;
        -webkit-align-self: flex-end;
        align-self: flex-end;
}

.search-ui-0 .self-stretch.search-ui {
  -ms-align-self: stretch;
        -webkit-align-self: stretch;
        align-self: stretch;
}

.search-ui-0 .self-baseline.search-ui {
  -ms-align-self: baseline;
        -webkit-align-self: baseline;
        align-self: baseline;
}

.search-ui-0 .layout.start-aligned.search-ui {
  -ms-flex-line-pack: start;  
        -ms-align-content: flex-start;
        -webkit-align-content: flex-start;
        align-content: flex-start;
}

.search-ui-0 .layout.end-aligned.search-ui {
  -ms-flex-line-pack: end;  
        -ms-align-content: flex-end;
        -webkit-align-content: flex-end;
        align-content: flex-end;
}

.search-ui-0 .layout.center-aligned.search-ui {
  -ms-flex-line-pack: center;  
        -ms-align-content: center;
        -webkit-align-content: center;
        align-content: center;
}

.search-ui-0 .layout.between-aligned.search-ui {
  -ms-flex-line-pack: justify;  
        -ms-align-content: space-between;
        -webkit-align-content: space-between;
        align-content: space-between;
}

.search-ui-0 .layout.around-aligned.search-ui {
  -ms-flex-line-pack: distribute;  
        -ms-align-content: space-around;
        -webkit-align-content: space-around;
        align-content: space-around;
}

.search-ui-0 {
  display: block;
        min-width: 350px;
        height: 100%;
}

.search-ui-0 #content.search-ui {
  height: 100%;
}

.search-ui-0 #leftBarOverflow.search-ui {
  padding-right: 16px;
}

.search-ui-0 [wide].search-ui #leftBarOverflow.search-ui {
  overflow: auto;
}

.search-ui-0 #leftBar.search-ui {
  box-sizing: border-box;
        color: #666;
        font-size: 13px;
        padding: 16px 0 16px 16px;
        border-bottom: 1px solid #e5e5e5;
}

.search-ui-0 [wide].search-ui #leftBar.search-ui {
  display: -ms-flexbox;
        display: -webkit-flex;
        display: flex;

        -ms-flex-direction: column;
        -webkit-flex-direction: column;
        flex-direction: column;
        position: relative;
        width: 350px;
        margin-bottom: 0;
        padding-bottom: 0;
        border-bottom: none;
}

@media print {
.search-ui-0 #leftBar.search-ui {
  display: none !important;
}

}

.search-ui-0 #leftBar.search-ui h3.search-ui {
  text-transform: uppercase;
        font-size: 13px;
        font-weight: normal;
        margin-top: 6px;
        margin-bottom: 6px;
        cursor: default;
        display: inline-block;
        color: #a3a3a3;
}

.search-ui-0 #closeButton.search-ui {
  position: absolute;
        right: 0;
}

.search-ui-0 #searchTermsHeader.search-ui {
  position: relative;
}

.search-ui-0 #searchTermsQ.search-ui iron-icon.search-ui {
  height: 16px;
        padding: 0 2px 2px 2px;
        color: #a3a3a3;
}

.search-ui-0 #searchTermsHeader.search-ui:hover iron-icon.search-ui {
  color: #4285f4;
}

.search-ui-0 #closeLeftBar.search-ui {
  height: 16px;
        width: 16px;
        padding: 0 0 8px 0;
        cursor: pointer;
}

.search-ui-0 #compactQuery.search-ui iron-icon.search-ui {
  height: 20px;
}

.search-ui-0 #backToResultsButton.search-ui {
  color: #fff;
        background: #4285f4;
        margin-top: 20px;
        text-align: center;
}

.search-ui-0 #main.search-ui {
  display: block;
        min-height: calc(100vh - 127px);
}

@media print {
.search-ui-0 [wide].search-ui main.search-ui {
  margin-left: 0;
}

}</style><!-- Shady DOM styles for import-list --><!-- Shady DOM styles for iron-request --><!-- Shady DOM styles for iron-ajax --><!-- Shady DOM styles for paper-dialog --><!-- Shady DOM styles for coverage-stats --><!-- Shady DOM styles for iron-image --><!-- Shady DOM styles for iron-selector --><!-- Shady DOM styles for paper-card --><!-- Shady DOM styles for paper-checkbox --><!-- Shady DOM styles for landing-page --><!-- Shady DOM styles for remote-fetch --><!-- Shady DOM styles for paper-spinner --><style scope="paper-spinner-0">.paper-spinner-0 {
  display: inline-block;
        position: relative;
        width: 28px;
        height: 28px;
}

.paper-spinner-0 #spinnerContainer.paper-spinner {
  width: 100%;
        height: 100%;

        
        direction: ltr;
}

.paper-spinner-0 #spinnerContainer.active.paper-spinner {
  -webkit-animation: container-rotate-paper-spinner-0 1568ms linear infinite;
        animation: container-rotate-paper-spinner-0 1568ms linear infinite;
}

@-webkit-keyframes container-rotate-paper-spinner-0 {
to {
  -webkit-transform: rotate(360deg)
}

}

@keyframes container-rotate-paper-spinner-0 {
to {
  transform: rotate(360deg)
}

}

.paper-spinner-0 .spinner-layer.paper-spinner {
  position: absolute;
        width: 100%;
        height: 100%;
        opacity: 0;
        white-space: nowrap;
        color: #4285f4;
}

.paper-spinner-0 .layer-1.paper-spinner {
  color: #4285f4;
}

.paper-spinner-0 .layer-2.paper-spinner {
  color: #db4437;
}

.paper-spinner-0 .layer-3.paper-spinner {
  color: #f4b400;
}

.paper-spinner-0 .layer-4.paper-spinner {
  color: #0f9d58;
}

.paper-spinner-0 .active.paper-spinner .spinner-layer.paper-spinner {
  -webkit-animation-name: fill-unfill-rotate-paper-spinner-0;
        -webkit-animation-duration: 5332ms;
        -webkit-animation-timing-function: cubic-bezier(0.4, 0.0, 0.2, 1);
        -webkit-animation-iteration-count: infinite;
        animation-name: fill-unfill-rotate-paper-spinner-0;
        animation-duration: 5332ms;
        animation-timing-function: cubic-bezier(0.4, 0.0, 0.2, 1);
        animation-iteration-count: infinite;
        opacity: 1;
}

.paper-spinner-0 .active.paper-spinner .spinner-layer.layer-1.paper-spinner {
  -webkit-animation-name: fill-unfill-rotate-paper-spinner-0, layer-1-fade-in-out-paper-spinner-0;
        animation-name: fill-unfill-rotate-paper-spinner-0, layer-1-fade-in-out-paper-spinner-0;
}

.paper-spinner-0 .active.paper-spinner .spinner-layer.layer-2.paper-spinner {
  -webkit-animation-name: fill-unfill-rotate-paper-spinner-0, layer-2-fade-in-out-paper-spinner-0;
        animation-name: fill-unfill-rotate-paper-spinner-0, layer-2-fade-in-out-paper-spinner-0;
}

.paper-spinner-0 .active.paper-spinner .spinner-layer.layer-3.paper-spinner {
  -webkit-animation-name: fill-unfill-rotate-paper-spinner-0, layer-3-fade-in-out-paper-spinner-0;
        animation-name: fill-unfill-rotate-paper-spinner-0, layer-3-fade-in-out-paper-spinner-0;
}

.paper-spinner-0 .active.paper-spinner .spinner-layer.layer-4.paper-spinner {
  -webkit-animation-name: fill-unfill-rotate-paper-spinner-0, layer-4-fade-in-out-paper-spinner-0;
        animation-name: fill-unfill-rotate-paper-spinner-0, layer-4-fade-in-out-paper-spinner-0;
}

@-webkit-keyframes fill-unfill-rotate-paper-spinner-0 {
12.5% {
  -webkit-transform: rotate(135deg)
}

25% {
  -webkit-transform: rotate(270deg)
}

37.5% {
  -webkit-transform: rotate(405deg)
}

50% {
  -webkit-transform: rotate(540deg)
}

62.5% {
  -webkit-transform: rotate(675deg)
}

75% {
  -webkit-transform: rotate(810deg)
}

87.5% {
  -webkit-transform: rotate(945deg)
}

to {
  -webkit-transform: rotate(1080deg)
}

}

@keyframes fill-unfill-rotate-paper-spinner-0 {
12.5% {
  transform: rotate(135deg)
}

25% {
  transform: rotate(270deg)
}

37.5% {
  transform: rotate(405deg)
}

50% {
  transform: rotate(540deg)
}

62.5% {
  transform: rotate(675deg)
}

75% {
  transform: rotate(810deg)
}

87.5% {
  transform: rotate(945deg)
}

to {
  transform: rotate(1080deg)
}

}

@-webkit-keyframes layer-1-fade-in-out-paper-spinner-0 {
0% {
  opacity: 1
}

25% {
  opacity: 1
}

26% {
  opacity: 0
}

89% {
  opacity: 0
}

90% {
  opacity: 1
}

to {
  opacity: 1
}

}

@keyframes layer-1-fade-in-out-paper-spinner-0 {
0% {
  opacity: 1
}

25% {
  opacity: 1
}

26% {
  opacity: 0
}

89% {
  opacity: 0
}

90% {
  opacity: 1
}

to {
  opacity: 1
}

}

@-webkit-keyframes layer-2-fade-in-out-paper-spinner-0 {
0% {
  opacity: 0
}

15% {
  opacity: 0
}

25% {
  opacity: 1
}

50% {
  opacity: 1
}

51% {
  opacity: 0
}

to {
  opacity: 0
}

}

@keyframes layer-2-fade-in-out-paper-spinner-0 {
0% {
  opacity: 0
}

15% {
  opacity: 0
}

25% {
  opacity: 1
}

50% {
  opacity: 1
}

51% {
  opacity: 0
}

to {
  opacity: 0
}

}

@-webkit-keyframes layer-3-fade-in-out-paper-spinner-0 {
0% {
  opacity: 0
}

40% {
  opacity: 0
}

50% {
  opacity: 1
}

75% {
  opacity: 1
}

76% {
  opacity: 0
}

to {
  opacity: 0
}

}

@keyframes layer-3-fade-in-out-paper-spinner-0 {
0% {
  opacity: 0
}

40% {
  opacity: 0
}

50% {
  opacity: 1
}

75% {
  opacity: 1
}

76% {
  opacity: 0
}

to {
  opacity: 0
}

}

@-webkit-keyframes layer-4-fade-in-out-paper-spinner-0 {
0% {
  opacity: 0
}

65% {
  opacity: 0
}

75% {
  opacity: 1
}

90% {
  opacity: 1
}

to {
  opacity: 0
}

}

@keyframes layer-4-fade-in-out-paper-spinner-0 {
0% {
  opacity: 0
}

65% {
  opacity: 0
}

75% {
  opacity: 1
}

90% {
  opacity: 1
}

to {
  opacity: 0
}

}

.paper-spinner-0 .circle-clipper.paper-spinner {
  display: inline-block;
        position: relative;
        width: 50%;
        height: 100%;
        overflow: hidden;
}

.paper-spinner-0 .spinner-layer.paper-spinner::after {
  left: 45%;
        width: 10%;
        border-top-style: solid;
}

.paper-spinner-0 .spinner-layer.paper-spinner::after,.paper-spinner-0 .circle-clipper.paper-spinner::after {
  content: '';
        box-sizing: border-box;
        position: absolute;
        top: 0;
        border-width: 3px;
        border-radius: 50%;
}

.paper-spinner-0 .circle-clipper.paper-spinner::after {
  bottom: 0;
        width: 200%;
        border-style: solid;
        border-bottom-color: transparent !important;
}

.paper-spinner-0 .circle-clipper.left.paper-spinner::after {
  left: 0;
        border-right-color: transparent !important;
        -webkit-transform: rotate(129deg);
        transform: rotate(129deg);
}

.paper-spinner-0 .circle-clipper.right.paper-spinner::after {
  left: -100%;
        border-left-color: transparent !important;
        -webkit-transform: rotate(-129deg);
        transform: rotate(-129deg);
}

.paper-spinner-0 .active.paper-spinner .gap-patch.paper-spinner::after,.paper-spinner-0 .active.paper-spinner .circle-clipper.paper-spinner::after {
  -webkit-animation-duration: 1333ms;
        -webkit-animation-timing-function: cubic-bezier(0.4, 0.0, 0.2, 1);
        -webkit-animation-iteration-count: infinite;
        animation-duration: 1333ms;
        animation-timing-function: cubic-bezier(0.4, 0.0, 0.2, 1);
        animation-iteration-count: infinite;
}

.paper-spinner-0 .active.paper-spinner .circle-clipper.left.paper-spinner::after {
  -webkit-animation-name: left-spin-paper-spinner-0;
        animation-name: left-spin-paper-spinner-0;
}

.paper-spinner-0 .active.paper-spinner .circle-clipper.right.paper-spinner::after {
  -webkit-animation-name: right-spin-paper-spinner-0;
        animation-name: right-spin-paper-spinner-0;
}

@-webkit-keyframes left-spin-paper-spinner-0 {
0% {
  -webkit-transform: rotate(130deg)
}

50% {
  -webkit-transform: rotate(-5deg)
}

to {
  -webkit-transform: rotate(130deg)
}

}

@keyframes left-spin-paper-spinner-0 {
0% {
  transform: rotate(130deg)
}

50% {
  transform: rotate(-5deg)
}

to {
  transform: rotate(130deg)
}

}

@-webkit-keyframes right-spin-paper-spinner-0 {
0% {
  -webkit-transform: rotate(-130deg)
}

50% {
  -webkit-transform: rotate(5deg)
}

to {
  -webkit-transform: rotate(-130deg)
}

}

@keyframes right-spin-paper-spinner-0 {
0% {
  transform: rotate(-130deg)
}

50% {
  transform: rotate(5deg)
}

to {
  transform: rotate(-130deg)
}

}

.paper-spinner-0 #spinnerContainer.cooldown.paper-spinner {
  -webkit-animation: container-rotate-paper-spinner-0 1568ms linear infinite, fade-out-paper-spinner-0 400ms cubic-bezier(0.4, 0.0, 0.2, 1);
        animation: container-rotate-paper-spinner-0 1568ms linear infinite, fade-out-paper-spinner-0 400ms cubic-bezier(0.4, 0.0, 0.2, 1);
}

@-webkit-keyframes fade-out-paper-spinner-0 {
0% {
  opacity: 1
}

to {
  opacity: 0
}

}

@keyframes fade-out-paper-spinner-0 {
0% {
  opacity: 1
}

to {
  opacity: 0
}

}</style><!-- Shady DOM styles for paper-spinner-lite --><!-- Shady DOM styles for concept-card --><!-- Shady DOM styles for concept-mention --><style scope="concept-mention">.block.concept-mention {
  display: block;
}

[hidden].concept-mention {
  display: none !important;
}

.invisible.concept-mention {
  visibility: hidden !important;
}

.relative.concept-mention {
  position: relative;
}

.fit.concept-mention {
  position: absolute;
        top: 0;
        right: 0;
        bottom: 0;
        left: 0;
}

body.fullbleed.concept-mention {
  margin: 0;
        height: 100vh;
}

.scroll.concept-mention {
  -webkit-overflow-scrolling: touch;
        overflow: auto;
}

.fixed-bottom.concept-mention,.fixed-left.concept-mention,.fixed-right.concept-mention,.fixed-top.concept-mention {
  position: fixed;
}

.fixed-top.concept-mention {
  top: 0;
        left: 0;
        right: 0;
}

.fixed-right.concept-mention {
  top: 0;
        right: 0;
        bottom: 0;
}

.fixed-bottom.concept-mention {
  right: 0;
        bottom: 0;
        left: 0;
}

.fixed-left.concept-mention {
  top: 0;
        bottom: 0;
        left: 0;
}

#target.concept-mention:hover {
  background-color: #e8f0fe;
}

#target[noicon].concept-mention {
  padding: 1px;
}

#target.concept-mention:hover[noicon] {
  border: 1px solid #e8f0fe;
        padding: 0;
}

#target.concept-mention {
  display: inline-block;
}

.inline-icon.concept-mention {
  cursor: pointer;
        height: 12px;
        width: 12px;
        padding-left: 4px;
        color: #5e6368;
}

concept-card.concept-mention {
  z-index: 1;
        position: absolute;
}</style><!-- Shady DOM styles for fterm-concept-card --><!-- Shady DOM styles for fterm-concept-mention --><!-- Shady DOM styles for paper-fab --><!-- Shady DOM styles for paper-icon-button --><!-- Shady DOM styles for paper-icon-button-light --><!-- Shady DOM styles for classification-tree --><style scope="classification-tree">.layout.horizontal.classification-tree,.layout.vertical.classification-tree {
  display: -ms-flexbox;
        display: -webkit-flex;
        display: flex;
}

.layout.inline.classification-tree {
  display: -ms-inline-flexbox;
        display: -webkit-inline-flex;
        display: inline-flex;
}

.layout.horizontal.classification-tree {
  -ms-flex-direction: row;
        -webkit-flex-direction: row;
        flex-direction: row;
}

.layout.vertical.classification-tree {
  -ms-flex-direction: column;
        -webkit-flex-direction: column;
        flex-direction: column;
}

.layout.wrap.classification-tree {
  -ms-flex-wrap: wrap;
        -webkit-flex-wrap: wrap;
        flex-wrap: wrap;
}

.layout.no-wrap.classification-tree {
  -ms-flex-wrap: nowrap;
        -webkit-flex-wrap: nowrap;
        flex-wrap: nowrap;
}

.layout.center.classification-tree,.layout.center-center.classification-tree {
  -ms-flex-align: center;
        -webkit-align-items: center;
        align-items: center;
}

.layout.center-justified.classification-tree,.layout.center-center.classification-tree {
  -ms-flex-pack: center;
        -webkit-justify-content: center;
        justify-content: center;
}

.flex.classification-tree {
  -ms-flex: 1 1 0.000000001px;
        -webkit-flex: 1;
        flex: 1;
        -webkit-flex-basis: 0.000000001px;
        flex-basis: 0.000000001px;
}

.flex-auto.classification-tree {
  -ms-flex: 1 1 auto;
        -webkit-flex: 1 1 auto;
        flex: 1 1 auto;
}

.flex-none.classification-tree {
  -ms-flex: none;
        -webkit-flex: none;
        flex: none;
}

classification-tree {
  display: block;
        line-height: 20px;
}

.wrap.classification-tree {
  padding: 6px 12px;
}

.wrap.classification-tree:hover {
  background: #fafafa;
}

.description.classification-tree {
  padding-left: 4px;
}

iron-icon.classification-tree {
  color: #eaeaea;
}

.code[first].classification-tree {
  font-weight: 500;
}

.code[additional].classification-tree {
  font-style: italic;
}</style><!-- Shady DOM styles for classification-viewer --><style scope="classification-viewer">.table.classification-viewer {
  border: 1px solid #eaeaea;
        display: block;
}

.more.classification-viewer {
  padding: 6px 12px;
        cursor: pointer;
        font-style: italic;
        color: #aaa;
}

.more.classification-viewer:hover {
  background: #fafafa;
}

.chip.classification-viewer {
  display: inline-block;
        padding: 4px 6px;
        border-radius: 2px;
}

.chip[additional].classification-viewer {
  font-style: italic;
}</style><!-- Shady DOM styles for image-carousel --><style scope="image-carousel">image-carousel {
  display: block;
}

.thumbnails.image-carousel {
  display: block;
        background-color: transparent;
        padding: 7px;
        white-space: nowrap;
        overflow: auto;
        font-size: 0;
}

.thumbnails.image-carousel img.image-carousel {
  margin-right: 7px;
        cursor: zoom-in;
}

.thumbnails.image-carousel img[selected].image-carousel {
  outline: solid 3px #4285f4;
}

.thumbnails.image-carousel img.image-carousel:last-of-type {
  margin-right: 0;
}</style><!-- Shady DOM styles for image-viewer --><!-- Shady DOM styles for patent-result --><style scope="patent-result">#wrapper.patent-result {
  padding: 20px;
        max-width: 1050px;
        outline: 0;
}

.scroll-target.patent-result:before {
  display: block;
        content: '';
        visibility: hidden;
}

h1.patent-result {
  font-weight: 500;
        font-size: 20px;
        margin: 0 0 20px 0;
}

h3.patent-result {
  font-size: 15px;
        font-weight: 500;
        margin: 28px 0 18px 0;
}

dl.patent-result {
  line-height: 1.5;
        font-size: 0;
}

dt.patent-result,dd.patent-result {
  display: inline;
        font-size: 13px;
        margin: 0;
}

dt.patent-result {
  font-weight: 500;
        color: #000;
}

dt.patent-result::after {
  content: ': ';
}

dd.patent-result {
  color: #aaa;
}

dd.patent-result ~ dd.patent-result::before {
  content: ', ';
}

dt.patent-result + dd.patent-result::before {
  content: '';
}

dd.patent-result ~ dt.patent-result::before {
  display: block;
        content: '';
        margin-top: 8px;
}

dd.patent-result core-icon.patent-result {
  width: 14px;
        height: 14px;
        vertical-align: top;
        color: inherit;
}

.table.patent-result {
  display: table;
        border-collapse: collapse;
        border-spacing: 0;
        border: 1px solid #eaeaea;
        width: 100%;
        box-sizing: border-box;
}

.tr.patent-result {
  display: table-row;
        border-bottom: 1px solid #eaeaea;
}

.th.patent-result,.td.patent-result {
  display: table-cell;
        padding: 10px 12px;
}

.thead.patent-result {
  display: table-header-group;
}

.tbody.patent-result {
  display: table-row-group;
}

.th.patent-result {
  text-align: left;
        white-space: nowrap;
        background-color: #fafafa;
        color: #757575;
}

.td.patent-result {
  vertical-align: top;
}

.td.patent-result > p.patent-result {
  margin-top: 0;
}

.nowrap.patent-result {
  white-space: nowrap;
}

.knowledge-card.patent-result {
  border: 1px solid #e5e5e5;
        border-radius: 2px;
}

.knowledge-card.patent-result > header.patent-result {
  -webkit-font-smoothing: antialiased;
        -moz-osx-font-smoothing: grayscale;
        background: #4285f4;
        color: #fff;
        padding: 20px 12px;
}

.knowledge-card.patent-result > header.patent-result state-modifier.patent-result,.knowledge-card.patent-result > header.patent-result a.patent-result {
  color: inherit;
        margin: 0 12px 0 0;
        display: inline-block;
}

.knowledge-card.patent-result > header.patent-result h2.patent-result,.knowledge-card.patent-result > header.patent-result .tagline.patent-result {
  margin: 0;
        font-weight: normal;
        padding-top: 4px;
}

.knowledge-card.patent-result > header.patent-result h2.patent-result {
  font-size: 20px;
}

.knowledge-card.patent-result .knowledge-card-action-bar.patent-result {
  background: #3367d6;
        padding: 10px 12px;
        margin: 20px -12px -20px;
}

.knowledge-card.patent-result .knowledge-card-action-bar.patent-result core-icon.patent-result {
  margin-right: 12px;
        width: 24px;
        height: 24px;
}

.knowledge-card.patent-result dl.patent-result {
  padding: 16px 12px;
}

.knowledge-card.patent-result hr.patent-result {
  border: none;
        height: 1px;
        background: #e5e5e5;
        margin: 0;
}

.main-link.patent-result {
  margin: 14px;
        font-weight: 500;
}

.footer.patent-result h3.patent-result state-modifier.patent-result,.footer.patent-result h3.patent-result a.patent-result {
  float: right;
        font-weight: 400;
        font-size: 13px;
        line-height: 24px;
}

.footer.patent-result dl.patent-result {
  margin-left: 30px;
}

.footer.patent-result > ul.patent-result > li.patent-result {
  margin-bottom: 8px;
}

h3.patent-result .righthead.patent-result {
  color: #aaa;
        font-weight: 400;
        font-size: 13px;
        cursor: help;
}

.tooltip-hint.patent-result {
  border-bottom: 1px dotted #ccc;
}

[marginRight].patent-result {
  margin-right: 60px;
}

.flex-width.patent-result {
  min-width: 0;
        word-break: break-word;
}

.responsive-table.patent-result {
  width: 100%;
        overflow-x: auto;
        overflow-y: hidden;
}

.layout.horizontal.patent-result,.layout.vertical.patent-result {
  display: -ms-flexbox;
        display: -webkit-flex;
        display: flex;
}

.layout.inline.patent-result {
  display: -ms-inline-flexbox;
        display: -webkit-inline-flex;
        display: inline-flex;
}

.layout.horizontal.patent-result {
  -ms-flex-direction: row;
        -webkit-flex-direction: row;
        flex-direction: row;
}

.layout.vertical.patent-result {
  -ms-flex-direction: column;
        -webkit-flex-direction: column;
        flex-direction: column;
}

.layout.wrap.patent-result {
  -ms-flex-wrap: wrap;
        -webkit-flex-wrap: wrap;
        flex-wrap: wrap;
}

.layout.no-wrap.patent-result {
  -ms-flex-wrap: nowrap;
        -webkit-flex-wrap: nowrap;
        flex-wrap: nowrap;
}

.layout.center.patent-result,.layout.center-center.patent-result {
  -ms-flex-align: center;
        -webkit-align-items: center;
        align-items: center;
}

.layout.center-justified.patent-result,.layout.center-center.patent-result {
  -ms-flex-pack: center;
        -webkit-justify-content: center;
        justify-content: center;
}

.flex.patent-result {
  -ms-flex: 1 1 0.000000001px;
        -webkit-flex: 1;
        flex: 1;
        -webkit-flex-basis: 0.000000001px;
        flex-basis: 0.000000001px;
}

.flex-auto.patent-result {
  -ms-flex: 1 1 auto;
        -webkit-flex: 1 1 auto;
        flex: 1 1 auto;
}

.flex-none.patent-result {
  -ms-flex: none;
        -webkit-flex: none;
        flex: none;
}

.layout.start.patent-result {
  -ms-flex-align: start;
        -webkit-align-items: flex-start;
        align-items: flex-start;
}

.layout.center.patent-result,.layout.center-center.patent-result {
  -ms-flex-align: center;
        -webkit-align-items: center;
        align-items: center;
}

.layout.end.patent-result {
  -ms-flex-align: end;
        -webkit-align-items: flex-end;
        align-items: flex-end;
}

.layout.baseline.patent-result {
  -ms-flex-align: baseline;
        -webkit-align-items: baseline;
        align-items: baseline;
}

.layout.start-justified.patent-result {
  -ms-flex-pack: start;
        -webkit-justify-content: flex-start;
        justify-content: flex-start;
}

.layout.center-justified.patent-result,.layout.center-center.patent-result {
  -ms-flex-pack: center;
        -webkit-justify-content: center;
        justify-content: center;
}

.layout.end-justified.patent-result {
  -ms-flex-pack: end;
        -webkit-justify-content: flex-end;
        justify-content: flex-end;
}

.layout.around-justified.patent-result {
  -ms-flex-pack: distribute;
        -webkit-justify-content: space-around;
        justify-content: space-around;
}

.layout.justified.patent-result {
  -ms-flex-pack: justify;
        -webkit-justify-content: space-between;
        justify-content: space-between;
}

.self-start.patent-result {
  -ms-align-self: flex-start;
        -webkit-align-self: flex-start;
        align-self: flex-start;
}

.self-center.patent-result {
  -ms-align-self: center;
        -webkit-align-self: center;
        align-self: center;
}

.self-end.patent-result {
  -ms-align-self: flex-end;
        -webkit-align-self: flex-end;
        align-self: flex-end;
}

.self-stretch.patent-result {
  -ms-align-self: stretch;
        -webkit-align-self: stretch;
        align-self: stretch;
}

.self-baseline.patent-result {
  -ms-align-self: baseline;
        -webkit-align-self: baseline;
        align-self: baseline;
}

.layout.start-aligned.patent-result {
  -ms-flex-line-pack: start;  
        -ms-align-content: flex-start;
        -webkit-align-content: flex-start;
        align-content: flex-start;
}

.layout.end-aligned.patent-result {
  -ms-flex-line-pack: end;  
        -ms-align-content: flex-end;
        -webkit-align-content: flex-end;
        align-content: flex-end;
}

.layout.center-aligned.patent-result {
  -ms-flex-line-pack: center;  
        -ms-align-content: center;
        -webkit-align-content: center;
        align-content: center;
}

.layout.between-aligned.patent-result {
  -ms-flex-line-pack: justify;  
        -ms-align-content: space-between;
        -webkit-align-content: space-between;
        align-content: space-between;
}

.layout.around-aligned.patent-result {
  -ms-flex-line-pack: distribute;  
        -ms-align-content: space-around;
        -webkit-align-content: space-around;
        align-content: space-around;
}

.flex.patent-result,.flex-1.patent-result {
  -ms-flex: 1 1 0.000000001px;
        -webkit-flex: 1;
        flex: 1;
        -webkit-flex-basis: 0.000000001px;
        flex-basis: 0.000000001px;
}

.flex-2.patent-result {
  -ms-flex: 2;
        -webkit-flex: 2;
        flex: 2;
}

.flex-3.patent-result {
  -ms-flex: 3;
        -webkit-flex: 3;
        flex: 3;
}

.flex-4.patent-result {
  -ms-flex: 4;
        -webkit-flex: 4;
        flex: 4;
}

.flex-5.patent-result {
  -ms-flex: 5;
        -webkit-flex: 5;
        flex: 5;
}

.flex-6.patent-result {
  -ms-flex: 6;
        -webkit-flex: 6;
        flex: 6;
}

.flex-7.patent-result {
  -ms-flex: 7;
        -webkit-flex: 7;
        flex: 7;
}

.flex-8.patent-result {
  -ms-flex: 8;
        -webkit-flex: 8;
        flex: 8;
}

.flex-9.patent-result {
  -ms-flex: 9;
        -webkit-flex: 9;
        flex: 9;
}

.flex-10.patent-result {
  -ms-flex: 10;
        -webkit-flex: 10;
        flex: 10;
}

.flex-11.patent-result {
  -ms-flex: 11;
        -webkit-flex: 11;
        flex: 11;
}

.flex-12.patent-result {
  -ms-flex: 12;
        -webkit-flex: 12;
        flex: 12;
}

@media print {
#text.patent-result {
  flex-direction: column-reverse !important;
}

}

patent-result-ref-list.patent-result {
  width: 100%;
}

patent-result-ref-list.patent-result + patent-result-ref-list.patent-result {
  margin-left: 10px;
}

[narrow].patent-result {
  flex-direction: column-reverse !important;
}

.famheader.patent-result {
  text-align: left;
        white-space: nowrap;
        background-color: #fafafa;
        color: #757575;
}

.collapse.patent-result {
  color: #616161;
        font-size: 13px;
        cursor: pointer;
}

#imageDrag.patent-result {
  position: fixed;
        cursor: col-resize;
}

#imageDrag.patent-result div.patent-result {
  width: 4px;
        height: 100%;
        margin: 0 4px;
        background: #eee;
}

#imageDrag.patent-result:hover {
  background: #eee;
}

#imageDrag.patent-result:hover div.patent-result {
  background: #ccc;
}

.imageWrapper.patent-result {
  position: fixed;
        top: 60px;
        background: white;
        margin-left: 12px;
}

#notices.patent-result {
  padding: 20px;
}

#figures.patent-result {
  background: #efefef;
}

.headerButton.patent-result {
  color: #3c80f6;
        cursor: pointer;
        display: inline-block;
        padding: 0 14px;
        line-height: 27px;
}

.headerButton.patent-result iron-icon.patent-result {
  width: 16px;
        height: 16px;
}

.tr.conceptDomain.patent-result {
  display: table-row;
}

.responsive-grid.patent-result {
  display: grid;
        gap: 8px;
        grid-template-columns: none;
}</style><!-- Shady DOM styles for family-viewer --><!-- Shady DOM styles for app-row --><!-- Shady DOM styles for application-timeline --><style scope="application-timeline">.layout.horizontal.application-timeline,.layout.vertical.application-timeline {
  display: -ms-flexbox;
        display: -webkit-flex;
        display: flex;
}

.layout.inline.application-timeline {
  display: -ms-inline-flexbox;
        display: -webkit-inline-flex;
        display: inline-flex;
}

.layout.horizontal.application-timeline {
  -ms-flex-direction: row;
        -webkit-flex-direction: row;
        flex-direction: row;
}

.layout.vertical.application-timeline {
  -ms-flex-direction: column;
        -webkit-flex-direction: column;
        flex-direction: column;
}

.layout.wrap.application-timeline {
  -ms-flex-wrap: wrap;
        -webkit-flex-wrap: wrap;
        flex-wrap: wrap;
}

.layout.no-wrap.application-timeline {
  -ms-flex-wrap: nowrap;
        -webkit-flex-wrap: nowrap;
        flex-wrap: nowrap;
}

.layout.center.application-timeline,.layout.center-center.application-timeline {
  -ms-flex-align: center;
        -webkit-align-items: center;
        align-items: center;
}

.layout.center-justified.application-timeline,.layout.center-center.application-timeline {
  -ms-flex-pack: center;
        -webkit-justify-content: center;
        justify-content: center;
}

.flex.application-timeline {
  -ms-flex: 1 1 0.000000001px;
        -webkit-flex: 1;
        flex: 1;
        -webkit-flex-basis: 0.000000001px;
        flex-basis: 0.000000001px;
}

.flex-auto.application-timeline {
  -ms-flex: 1 1 auto;
        -webkit-flex: 1 1 auto;
        flex: 1 1 auto;
}

.flex-none.application-timeline {
  -ms-flex: none;
        -webkit-flex: none;
        flex: none;
}

.wrap.application-timeline {
  padding: 16px 12px;
}

.event.application-timeline {
  padding: 3px 0;
}

[date].application-timeline {
  color: #5f6368;
        font-size: 13px;
        padding: 3px 0;
        width: 70px;
        line-height: 16px;
}

[critical].application-timeline [date].application-timeline {
  color: #202124;
        font-weight: 500;
        line-height: 18px;
}

.line.application-timeline {
  margin: 9px 6px;
        border-radius: 4px;
        background: #dadce0;
        width: 4px;
        height: 4px;
}

.dot.application-timeline {
  margin: 3px 0;
        border-radius: 4px;
        background: #dadce0;
        width: 4px;
        height: 4px;
        display: inline-block;
}

[critical].application-timeline .line.application-timeline {
  background: #4285f4;
}

[current].application-timeline .line.application-timeline {
  background: #81c995;
}

[current][critical].application-timeline .line.application-timeline {
  background: #81c995;
}

.title.application-timeline {
  font-size: 13px;
        padding: 3px 0;
        line-height: 16px;
}

.title-text.application-timeline {
  color: #5f6368;
}

.description-item.application-timeline {
  font-size: 12px;
        padding: 6px 0;
        max-width: 300px;
}

#legal.application-timeline {
  height: 14px;
        width: 14px;
        padding: 0 3px 1px 3px;
        vertical-align: text-bottom;
}

#icon.application-timeline {
  height: 12px;
        width: 12px;
        padding: 0 3px 3px 3px;
        vertical-align: text-bottom;
}

.unknown.application-timeline {
  font-style: italic;
}

.not_active.application-timeline {
  text-decoration: line-through;
}

.active.application-timeline {
  font-weight: 500;
}

#cc[this].application-timeline {
  color: #202124 !important;
        text-decoration: underline;
}

#cc[this].not_active.application-timeline {
  text-decoration: line-through underline;
}

hr.application-timeline {
  border: none;
        height: 1px;
        background: #e5e5e5;
        margin: 10px 0 16px 0;
}

.header.application-timeline {
  font-size: 13px;
        line-height: 20px;
        font-weight: 500;
        color: #202124;
        padding-bottom: 8px;
}

.block.application-timeline {
  padding: 0 6px 0 0;
}

.year.application-timeline {
  color: #5f6368;
        font-size: 13px;
        font-weight: 500;
        padding: 3px 1px;
        width: 70px;
}

.expand.application-timeline {
  cursor: pointer;
        padding: 6px 0 3px 0;
}</style><!-- Shady DOM styles for patent-text --><style scope="patent-text">.layout.horizontal.patent-text,.layout.vertical.patent-text {
  display: -ms-flexbox;
        display: -webkit-flex;
        display: flex;
}

.layout.inline.patent-text {
  display: -ms-inline-flexbox;
        display: -webkit-inline-flex;
        display: inline-flex;
}

.layout.horizontal.patent-text {
  -ms-flex-direction: row;
        -webkit-flex-direction: row;
        flex-direction: row;
}

.layout.vertical.patent-text {
  -ms-flex-direction: column;
        -webkit-flex-direction: column;
        flex-direction: column;
}

.layout.wrap.patent-text {
  -ms-flex-wrap: wrap;
        -webkit-flex-wrap: wrap;
        flex-wrap: wrap;
}

.layout.no-wrap.patent-text {
  -ms-flex-wrap: nowrap;
        -webkit-flex-wrap: nowrap;
        flex-wrap: nowrap;
}

.layout.center.patent-text,.layout.center-center.patent-text {
  -ms-flex-align: center;
        -webkit-align-items: center;
        align-items: center;
}

.layout.center-justified.patent-text,.layout.center-center.patent-text {
  -ms-flex-pack: center;
        -webkit-justify-content: center;
        justify-content: center;
}

.flex.patent-text {
  -ms-flex: 1 1 0.000000001px;
        -webkit-flex: 1;
        flex: 1;
        -webkit-flex-basis: 0.000000001px;
        flex-basis: 0.000000001px;
}

.flex-auto.patent-text {
  -ms-flex: 1 1 auto;
        -webkit-flex: 1 1 auto;
        flex: 1 1 auto;
}

.flex-none.patent-text {
  -ms-flex: none;
        -webkit-flex: none;
        flex: none;
}

.layout.start.patent-text {
  -ms-flex-align: start;
        -webkit-align-items: flex-start;
        align-items: flex-start;
}

.layout.center.patent-text,.layout.center-center.patent-text {
  -ms-flex-align: center;
        -webkit-align-items: center;
        align-items: center;
}

.layout.end.patent-text {
  -ms-flex-align: end;
        -webkit-align-items: flex-end;
        align-items: flex-end;
}

.layout.baseline.patent-text {
  -ms-flex-align: baseline;
        -webkit-align-items: baseline;
        align-items: baseline;
}

.layout.start-justified.patent-text {
  -ms-flex-pack: start;
        -webkit-justify-content: flex-start;
        justify-content: flex-start;
}

.layout.center-justified.patent-text,.layout.center-center.patent-text {
  -ms-flex-pack: center;
        -webkit-justify-content: center;
        justify-content: center;
}

.layout.end-justified.patent-text {
  -ms-flex-pack: end;
        -webkit-justify-content: flex-end;
        justify-content: flex-end;
}

.layout.around-justified.patent-text {
  -ms-flex-pack: distribute;
        -webkit-justify-content: space-around;
        justify-content: space-around;
}

.layout.justified.patent-text {
  -ms-flex-pack: justify;
        -webkit-justify-content: space-between;
        justify-content: space-between;
}

.self-start.patent-text {
  -ms-align-self: flex-start;
        -webkit-align-self: flex-start;
        align-self: flex-start;
}

.self-center.patent-text {
  -ms-align-self: center;
        -webkit-align-self: center;
        align-self: center;
}

.self-end.patent-text {
  -ms-align-self: flex-end;
        -webkit-align-self: flex-end;
        align-self: flex-end;
}

.self-stretch.patent-text {
  -ms-align-self: stretch;
        -webkit-align-self: stretch;
        align-self: stretch;
}

.self-baseline.patent-text {
  -ms-align-self: baseline;
        -webkit-align-self: baseline;
        align-self: baseline;
}

.layout.start-aligned.patent-text {
  -ms-flex-line-pack: start;  
        -ms-align-content: flex-start;
        -webkit-align-content: flex-start;
        align-content: flex-start;
}

.layout.end-aligned.patent-text {
  -ms-flex-line-pack: end;  
        -ms-align-content: flex-end;
        -webkit-align-content: flex-end;
        align-content: flex-end;
}

.layout.center-aligned.patent-text {
  -ms-flex-line-pack: center;  
        -ms-align-content: center;
        -webkit-align-content: center;
        align-content: center;
}

.layout.between-aligned.patent-text {
  -ms-flex-line-pack: justify;  
        -ms-align-content: space-between;
        -webkit-align-content: space-between;
        align-content: space-between;
}

.layout.around-aligned.patent-text {
  -ms-flex-line-pack: distribute;  
        -ms-align-content: space-around;
        -webkit-align-content: space-around;
        align-content: space-around;
}

patent-text {
  display: block;
}

#text.patent-text {
  line-height: 20px;
        min-width: 0;
}

#margin.patent-text {
  width: 16px;
}

#createHighlight.patent-text {
  position: relative;
        width: 16px;
        height: 16px;
        cursor: pointer;
}

.notranslate.patent-text > .google-src-text.patent-text {
  display: none;
}

.notranslate.patent-text:hover,mark.patent-text {
  background-color: #fbfcae;
}

.description-paragraph.patent-text {
  margin-block-start: 1em;
        margin-block-end: 1em;
}

.claim-text.patent-text {
  margin: 14px 0 0 20px;
}

.claim-dependent.patent-text {
  margin-left: 40px;
        color: #888;
}

[hide-claims].patent-text .claim-dependent.patent-text .claim-text.patent-text {
  height: 0;
        width: 0;
        visibility: hidden;
}

[hide-claims].patent-text .claim-dependent.patent-text .claim.patent-text:after {
  content: ""
}

.patent-full-image.patent-text {
  max-width: 100%;
        height: auto;
}

.small-patent-image.patent-text {
  display: inline;
}

ul.patent-text {
  padding: 0 0 0 50px;
}

li.patent-text {
  list-style-type: none;
        position: relative;
}

ol.claims.patent-text li.patent-text {
  list-style-type: decimal;
        font-weight: bold;
}

ol.claims.patent-text li.patent-text > *.patent-text {
  font-weight: normal;
}

li.patent-text > para-num.patent-text {
  position: absolute;
        left: -45px;
        color: #888;
}

mark.patent-text {
  background: #fff59d;
}

mark.searchText.patent-text {
  background: #80deea;
}

.searchTextHeader.patent-text {
  font-weight: 500;
}

pre.patent-text {
  white-space: pre-wrap;
}

heading.patent-text {
  display: block;
        font-weight: 500;
        font-size: 13px;
}

#comment.patent-text {
  width: 16px;
        height: 16px;
}

[has-search][no-results].patent-text {
  display: none;
}

.highlight.patent-text {
  background-color: #fef7e0;
}</style><!-- Shady DOM styles for para-num --><style scope="para-num">para-num {
  display: block;
}</style><!-- Shady DOM styles for result-container --><style scope="result-container">paper-spinner.result-container {
  position: absolute;
        
        top: calc(50%  + 56px - 16px);
        left: calc(50% + 175px - 16px);
}</style><!-- Shady DOM styles for scholar-result --><!-- Shady DOM styles for search-result --><style scope="search-result">.layout.horizontal.search-result,.layout.vertical.search-result {
  display: -ms-flexbox;
        display: -webkit-flex;
        display: flex;
}

.layout.inline.search-result {
  display: -ms-inline-flexbox;
        display: -webkit-inline-flex;
        display: inline-flex;
}

.layout.horizontal.search-result {
  -ms-flex-direction: row;
        -webkit-flex-direction: row;
        flex-direction: row;
}

.layout.vertical.search-result {
  -ms-flex-direction: column;
        -webkit-flex-direction: column;
        flex-direction: column;
}

.layout.wrap.search-result {
  -ms-flex-wrap: wrap;
        -webkit-flex-wrap: wrap;
        flex-wrap: wrap;
}

.layout.no-wrap.search-result {
  -ms-flex-wrap: nowrap;
        -webkit-flex-wrap: nowrap;
        flex-wrap: nowrap;
}

.layout.center.search-result,.layout.center-center.search-result {
  -ms-flex-align: center;
        -webkit-align-items: center;
        align-items: center;
}

.layout.center-justified.search-result,.layout.center-center.search-result {
  -ms-flex-pack: center;
        -webkit-justify-content: center;
        justify-content: center;
}

.flex.search-result {
  -ms-flex: 1 1 0.000000001px;
        -webkit-flex: 1;
        flex: 1;
        -webkit-flex-basis: 0.000000001px;
        flex-basis: 0.000000001px;
}

.flex-auto.search-result {
  -ms-flex: 1 1 auto;
        -webkit-flex: 1 1 auto;
        flex: 1 1 auto;
}

.flex-none.search-result {
  -ms-flex: none;
        -webkit-flex: none;
        flex: none;
}

.layout.start.search-result {
  -ms-flex-align: start;
        -webkit-align-items: flex-start;
        align-items: flex-start;
}

.layout.center.search-result,.layout.center-center.search-result {
  -ms-flex-align: center;
        -webkit-align-items: center;
        align-items: center;
}

.layout.end.search-result {
  -ms-flex-align: end;
        -webkit-align-items: flex-end;
        align-items: flex-end;
}

.layout.baseline.search-result {
  -ms-flex-align: baseline;
        -webkit-align-items: baseline;
        align-items: baseline;
}

.layout.start-justified.search-result {
  -ms-flex-pack: start;
        -webkit-justify-content: flex-start;
        justify-content: flex-start;
}

.layout.center-justified.search-result,.layout.center-center.search-result {
  -ms-flex-pack: center;
        -webkit-justify-content: center;
        justify-content: center;
}

.layout.end-justified.search-result {
  -ms-flex-pack: end;
        -webkit-justify-content: flex-end;
        justify-content: flex-end;
}

.layout.around-justified.search-result {
  -ms-flex-pack: distribute;
        -webkit-justify-content: space-around;
        justify-content: space-around;
}

.layout.justified.search-result {
  -ms-flex-pack: justify;
        -webkit-justify-content: space-between;
        justify-content: space-between;
}

.self-start.search-result {
  -ms-align-self: flex-start;
        -webkit-align-self: flex-start;
        align-self: flex-start;
}

.self-center.search-result {
  -ms-align-self: center;
        -webkit-align-self: center;
        align-self: center;
}

.self-end.search-result {
  -ms-align-self: flex-end;
        -webkit-align-self: flex-end;
        align-self: flex-end;
}

.self-stretch.search-result {
  -ms-align-self: stretch;
        -webkit-align-self: stretch;
        align-self: stretch;
}

.self-baseline.search-result {
  -ms-align-self: baseline;
        -webkit-align-self: baseline;
        align-self: baseline;
}

.layout.start-aligned.search-result {
  -ms-flex-line-pack: start;  
        -ms-align-content: flex-start;
        -webkit-align-content: flex-start;
        align-content: flex-start;
}

.layout.end-aligned.search-result {
  -ms-flex-line-pack: end;  
        -ms-align-content: flex-end;
        -webkit-align-content: flex-end;
        align-content: flex-end;
}

.layout.center-aligned.search-result {
  -ms-flex-line-pack: center;  
        -ms-align-content: center;
        -webkit-align-content: center;
        align-content: center;
}

.layout.between-aligned.search-result {
  -ms-flex-line-pack: justify;  
        -ms-align-content: space-between;
        -webkit-align-content: space-between;
        align-content: space-between;
}

.layout.around-aligned.search-result {
  -ms-flex-line-pack: distribute;  
        -ms-align-content: space-around;
        -webkit-align-content: space-around;
        align-content: space-around;
}

search-result {
  display: block;
        font-size: 13px;
}

#mainContainer.search-result {
  min-height: calc(100vh - 127px);
        color: #333;
}

#compactQuery.search-result {
  padding: 18px 20px 10px 20px;
        cursor: pointer;
}

#compactQuery.search-result > span.search-result {
  padding: 0 14px 0 0;
}

#compactQuery.search-result iron-icon.search-result {
  padding-right: 6px;
        height: 16px;
        width: 16px;
}</style><!-- Shady DOM styles for webdoc-result --><!-- Shady DOM styles for iron-pages --><!-- Shady DOM styles for paper-tab --><!-- Shady DOM styles for paper-tabs --><!-- Shady DOM styles for debug-info --><!-- Shady DOM styles for search-paging --><!-- Shady DOM styles for search-result-item --><!-- Shady DOM styles for search-result-image --><!-- Shady DOM styles for search-result-entities --><!-- Shady DOM styles for search-result-measures --><!-- Shady DOM styles for search-results --><!-- Shady DOM styles for summary-box --><!-- Shady DOM styles for timeline-page --><!-- Shady DOM styles for iron-localstorage --><!-- Shady DOM styles for search-app --><style scope="search-app">search-app {
  display: block;
        height: 100%;
}

#toast.search-app {
  min-height: 64px;
        min-width: 742px;
}</style><style>body {transition: opacity ease-in 0.2s; } 
body[unresolved] {opacity: 0; display: block; overflow: hidden; position: relative; } 
</style>
    <title>EP2891884B1 - IL-8 for predicting or monitoring efficacy of c-MET inhibitor 
        - Google Patents</title>

    <meta name="viewport" content="width=device-width, initial-scale=1">
    <meta charset="UTF-8">
    <meta name="referrer" content="origin-when-crossorigin">
    <link rel="canonical" href="https://patents.google.com/patent/EP2891884B1/en">
    
    <meta name="DC.type" content="patent">
    <meta name="DC.title" content="IL-8 for predicting or monitoring efficacy of c-MET inhibitor 
       ">
    <meta name="DC.date" content="2015-01-07" scheme="dateSubmitted">
    <meta name="DC.description" content="">
    <meta name="citation_patent_application_number" content="EP:15150360.4A">
    <meta name="citation_pdf_url" content="https://patentimages.storage.googleapis.com/32/c0/9c/040e75626587e8/EP2891884B1.pdf">
    <meta name="citation_patent_number" content="EP:2891884:B1">
    <meta name="DC.date" content="2017-10-25" scheme="issue">
    <meta name="DC.contributor" content="Soo Yeon Jung" scheme="inventor">
    <meta name="DC.contributor" content="Seon Hui Shim" scheme="inventor">
    <meta name="DC.contributor" content="Yun Jeong Song" scheme="inventor">
    <meta name="DC.contributor" content="Hyeon-seok Yoo" scheme="inventor">
    <meta name="DC.contributor" content="Samsung Electronics Co Ltd" scheme="assignee">
    <meta name="citation_reference" content="M. MERCHANT ET AL: &quot;Monovalent antibody design and mechanism of action of onartuzumab, a MET antagonist with anti-tumor activity as a therapeutic agent&quot;, PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES, vol. 110, no. 32, 6 August 2013 (2013-08-06), pages E2987 - E2996, ISSN: 0027-8424, DOI: 10.1073/pnas.1302725110" scheme="references">
    <link rel="stylesheet" href="https://fonts.googleapis.com/css?family=Roboto:400,400italic,500,500italic,700">
    <link rel="stylesheet" href="https://fonts.googleapis.com/css?family=Product+Sans">
    <link rel="stylesheet" href="https://fonts.googleapis.com/css2?family=Google+Sans:wght@400;500;700">

    <style>
      body { transition: none; }
    </style>

    <script src="https://apis.google.com/_/scs/abc-static/_/js/k=gapi.lb.en.IKZeRvoAYNY.O/m=client/rt=j/sv=1/d=1/ed=1/am=AAAQ/rs=AHpOoo-SMWTzMRJrTty6iE5dL_aWGYOnuw/cb=gapi.loaded_0?le=scs" async=""></script><script>
      window.version = 'patent-search.search_20240531_RC00';

      function sendFeedback() {
        userfeedback.api.startFeedback({
          'productId': '713680',
          'bucket': 'patent-search-web',
          'productVersion': window.version,
        });
      }

      window.experiments = {};
      window.experiments.patentCountries = "ae,ag,al,am,ao,ap,ar,at,au,aw,az,ba,bb,bd,be,bf,bg,bh,bj,bn,bo,br,bw,bx,by,bz,ca,cf,cg,ch,ci,cl,cm,cn,co,cr,cs,cu,cy,cz,dd,de,dj,dk,dm,do,dz,ea,ec,ee,eg,em,ep,es,fi,fr,ga,gb,gc,gd,ge,gh,gm,gn,gq,gr,gt,gw,hk,hn,hr,hu,ib,id,ie,il,in,ir,is,it,jo,jp,ke,kg,kh,km,kn,kp,kr,kw,kz,la,lc,li,lk,lr,ls,lt,lu,lv,ly,ma,mc,md,me,mg,mk,ml,mn,mo,mr,mt,mw,mx,my,mz,na,ne,ng,ni,nl,no,nz,oa,om,pa,pe,pg,ph,pl,pt,py,qa,ro,rs,ru,rw,sa,sc,sd,se,sg,si,sk,sl,sm,sn,st,su,sv,sy,sz,td,tg,th,tj,tm,tn,tr,tt,tw,tz,ua,ug,us,uy,uz,vc,ve,vn,wo,yu,za,zm,zw";
      
      
      window.experiments.keywordWizard = true;
      
      
      
      window.experiments.definitions = true;

      window.Polymer = {
        dom: 'shady',
        lazyRegister: true,
      };
    </script>

    <script src="//www.gstatic.com/patent-search/frontend/patent-search.search_20240531_RC00/scs/compiled_dir/webcomponentsjs/webcomponents-lite.min.js"></script>
    <style>[hidden]:not([style-scope]):not(.style-scope) {
  display: none !important;
}

</style><style></style><style></style><style></style><style></style><link rel="stylesheet" href="https://fonts.googleapis.com/css?family=Roboto:400,300,300italic,400italic,500,500italic,700,700italic"><link rel="stylesheet" href="https://fonts.googleapis.com/css?family=Roboto+Mono:400,700"><style></style><style></style><style>
  html, body {
    min-width: 100%;
    width: 100%;
    min-height: 100%;
    height: 100%;
  }

  body {
    background-color: #fff;
    font-family: 'Roboto', sans-serif;
    color: #333;
    margin: 0;
    padding: 0;
    /*
     * Turn off https://github.com/WICG/ScrollAnchoring/blob/master/explainer.md
     * https://memegen.googleplex.com/5230756293246976
     */
    overflow-anchor: none;
  }

  body h1, body h2, body h3 {
    -webkit-font-smoothing: antialiased;
    -moz-osx-font-smoothing: grayscale;
  }

  body a:link {
    color: #3c80f6;
    text-decoration: none;
  }

  body a:visited {
    color: #3c80f6;
  }

  body a[open-result]:visited {
    color: #7e57c2;
  }

  /* For Firefox */
  a:link {
    color: #3c80f6;
    text-decoration: none;
  }

  a:visited {
    color: #3c80f6;
  }

  a[open-result]:visited {
    color: #7e57c2;
  }

  ::selection , body ::selection {
    background-color: #c6dafc;
    color: #333;
  }
</style><link rel="import" href="//www.gstatic.com/patent-search/frontend/patent-search.search_20240531_RC00/scs/compiled_dir/search-app-vulcanized.html">
  <style>[hidden] { display: none !important; }</style><script type="text/javascript" charset="UTF-8" src="https://apis.google.com/js/client.js" gapi_processed="true"></script></head>
  <body>
    <script src="//www.gstatic.com/patent-search/frontend/patent-search.search_20240531_RC00/scs/compiled_dir/search-app-vulcanized.js"></script><span style="font-size: 13px; white-space: pre-wrap; display: inline-block; position: absolute; left: -99999px; top: -99999px; max-width: 217px;"></span><span style="font-size: 13px; white-space: pre-wrap; display: inline-block; position: absolute; left: -99999px; top: -99999px; max-width: 217px;"></span>
    <search-app>
    
    <remote-fetch class="style-scope search-app"></remote-fetch>
    <search-state class="style-scope search-app"></search-state>
    <browser-ui class="style-scope search-app"></browser-ui>
    <template is="dom-if" restamp="" class="style-scope search-app"></template>
    <template is="dom-if" restamp="" class="style-scope search-app"></template>
    
      <search-result id="result" class="style-scope search-app">
    
    
    <search-ui mode="result" class="style-scope search-result x-scope search-ui-0">
    
    
    
    <div id="content" class="style-scope search-ui" wide="">
      <search-header show-search="" class="style-scope search-ui">
    
    
    <div class="style-scope search-header" wide="">
      <header class="style-scope search-header">
        <div class="layout horizontal headerpad style-scope search-header">
          <div class="layout horizontal leftheader style-scope search-header">
            <h1 class="style-scope search-header">
              <state-modifier inherit="" act="{&quot;type&quot;: &quot;HOME&quot;}" class="style-scope search-header"><a id="link" href="#" class="style-scope state-modifier" inherit="">
                <div class="lockup style-scope search-header">
                  <span class="lockup-logo style-scope search-header"></span>
                  <span class="lockup-text style-scope search-header">
                    <span class="lockup-brand style-scope search-header">&nbsp;Patents</span>
                  </span>
                </div>
              </a></state-modifier>
            </h1>
          </div>
          
            <search-box class="style-scope search-header">
    
    <div class="layout horizontal style-scope search-box" style="position: relative;">
      <div class="inputbox flex layout horizontal style-scope search-box">
        <div class="suggest-bg flex style-scope search-box">
          <input name="q" id="searchInput" data-proto="SEARCH_INPUT" autocomplete="off" class="style-scope search-box">
        </div>
        <div id="corpora" class="style-scope search-box">
          <iron-icon icon="icons:lightbulb-outline" id="patentIcon" class="style-scope search-box x-scope iron-icon-0" active=""><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M9 21c0 .55.45 1 1 1h4c.55 0 1-.45 1-1v-1H9v1zm3-19C8.14 2 5 5.14 5 9c0 2.38 1.19 4.47 3 5.74V17c0 .55.45 1 1 1h6c.55 0 1-.45 1-1v-2.26c1.81-1.27 3-3.36 3-5.74 0-3.86-3.14-7-7-7zm2.85 11.1l-.85.6V16h-4v-2.3l-.85-.6C7.8 12.16 7 10.63 7 9c0-2.76 2.24-5 5-5s5 2.24 5 5c0 1.63-.8 3.16-2.15 4.1z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
          <overlay-tooltip positioning-target="#patentIcon" direction="bottom" class="style-scope search-box" style="display: none;">
    
    <div id="arrow" class="style-scope overlay-tooltip" hidden=""></div>
    <div class="style-scope overlay-tooltip">
      Include patents
    </div>
  </overlay-tooltip>
          <iron-icon icon="social:school" id="nplIcon" class="style-scope search-box x-scope iron-icon-0"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M5 13.18v4L12 21l7-3.82v-4L12 17l-7-3.82zM12 3L1 9l11 6 9-4.91V17h2V9L12 3z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
          <overlay-tooltip positioning-target="#nplIcon" direction="bottom" class="style-scope search-box" style="display: none;">
    
    <div id="arrow" class="style-scope overlay-tooltip" hidden=""></div>
    <div class="style-scope overlay-tooltip">
      Include non-patent literature
    </div>
  </overlay-tooltip>
          <keyword-wizard id="wizardIcon" class="style-scope search-box">


<div id="wizardContainer" class="style-scope keyword-wizard">
  <iron-icon icon="image:tune" id="wizardIcon" class="style-scope keyword-wizard x-scope iron-icon-0"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M3 17v2h6v-2H3zM3 5v2h10V5H3zm10 16v-2h8v-2h-8v-2h-2v6h2zM7 9v2H3v2h4v2h2V9H7zm14 4v-2H11v2h10zm-6-4h2V7h4V5h-4V3h-2v6z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
  <paper-material elevation="2" id="wizard" class="style-scope keyword-wizard x-scope paper-material-0" hidden="">
    
    

    
    
    <div class="search-within style-scope keyword-wizard">
      <span class="wizard-header style-scope keyword-wizard">
        Search within
        <iron-icon icon="icons:help-outline" class="help-header style-scope keyword-wizard x-scope iron-icon-0" id="within"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M11 18h2v-2h-2v2zm1-16C6.48 2 2 6.48 2 12s4.48 10 10 10 10-4.48 10-10S17.52 2 12 2zm0 18c-4.41 0-8-3.59-8-8s3.59-8 8-8 8 3.59 8 8-3.59 8-8 8zm0-14c-2.21 0-4 1.79-4 4h2c0-1.1.9-2 2-2s2 .9 2 2c0 2-3 1.75-3 5h2c0-2.25 3-2.5 3-5 0-2.21-1.79-4-4-4z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      </span>
      
      <div class="help style-scope keyword-wizard" id="withinHelp" hidden="">
        <p class="style-scope keyword-wizard"><b class="style-scope keyword-wizard">Search within the title, abstract, claims, or full patent document</b>: You can
          restrict your search to a specific field using field names.</p>
        <p class="style-scope keyword-wizard">Use <span class="q style-scope keyword-wizard">TI=</span> to search in the title, <span class="q style-scope keyword-wizard">AB=</span> for the
          abstract, <span class="q style-scope keyword-wizard">CL=</span> for the claims, or <span class="q style-scope keyword-wizard">TAC=</span> for
          all three. For example, <span class="q style-scope keyword-wizard">TI=(safety belt)</span>.
        </p>
        <p class="style-scope keyword-wizard"><b class="style-scope keyword-wizard">Search by Cooperative Patent Classifications (CPCs)</b>: These are commonly used to
          represent ideas in place of keywords, and can also be entered in a search term box. If
          you're searching for<span class="q style-scope keyword-wizard">seat belts</span>, you could also search for
          <span class="q style-scope keyword-wizard">B60R22/00</span> to retrieve documents that mention safety belts or body
          harnesses. <span class="q style-scope keyword-wizard">CPC=B60R22</span> will match documents with exactly this CPC,
          <span class="q style-scope keyword-wizard">CPC=B60R22/low</span> matches documents with this CPC or a child
          classification of this CPC.
        </p>
          <a href="https://support.google.com/faqs/answer/7049475" target="_blank" class="style-scope keyword-wizard">Learn More</a>
      </div>
      <div class="filter-chips style-scope keyword-wizard">
        <span class="chip style-scope keyword-wizard" id="title" selected="">Title</span>
        <span class="chip style-scope keyword-wizard" id="abstract" selected="">Abstract</span>
        <span class="chip style-scope keyword-wizard" id="claims" selected="">Claims</span>
        <span class="chip style-scope keyword-wizard" id="fullDoc" selected="">Full Document</span>
      </div>
      
      <div class="cpc-field style-scope keyword-wizard">
        <span class="input-label style-scope keyword-wizard"><label for="inputCPC" class="style-scope keyword-wizard">or CPC</label></span>
        <div class="cpc-inputs style-scope keyword-wizard">
          <input class="keyword-input style-scope keyword-wizard" id="inputCPC" placeholder="Or search with CPC">
          <input type="checkbox" id="childCPC" checked="" class="style-scope keyword-wizard">
          <label class="checkbox-label style-scope keyword-wizard" for="childCPC">
            Include child classifications
          </label>
        </div>
      </div>
    </div>
    
    <div class="find-patents style-scope keyword-wizard">
      <span class="wizard-header style-scope keyword-wizard">
        Find patents
        <iron-icon class="help-header style-scope keyword-wizard x-scope iron-icon-0" icon="icons:help-outline" id="searchBoolean"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M11 18h2v-2h-2v2zm1-16C6.48 2 2 6.48 2 12s4.48 10 10 10 10-4.48 10-10S17.52 2 12 2zm0 18c-4.41 0-8-3.59-8-8s3.59-8 8-8 8 3.59 8 8-3.59 8-8 8zm0-14c-2.21 0-4 1.79-4 4h2c0-1.1.9-2 2-2s2 .9 2 2c0 2-3 1.75-3 5h2c0-2.25 3-2.5 3-5 0-2.21-1.79-4-4-4z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      </span>
      
      <div class="help style-scope keyword-wizard" id="searchBooleanHelp" hidden="">
        <p class="style-scope keyword-wizard"><b class="style-scope keyword-wizard">Keywords and boolean syntax (USPTO or EPO format)</b>:
          <span class="q style-scope keyword-wizard">seat belt</span> searches these two words, or their plurals and close
          synonyms. <span class="q style-scope keyword-wizard">"seat belt"</span> searches this exact phrase, in order.
          <span class="q style-scope keyword-wizard">-seat -belt</span> searches for documents not containing either word.
        </p>
        <p class="style-scope keyword-wizard"><b class="style-scope keyword-wizard">For searches using boolean logic</b>, the default operator is
          <span class="q style-scope keyword-wizard">AND</span> with left associativity. <i class="style-scope keyword-wizard">Note:</i> this means
          <span class="q style-scope keyword-wizard">safety OR seat belt</span> is searched as <span class="q style-scope keyword-wizard">(safety OR seat)
          AND belt</span>. Each word automatically includes plurals and close synonyms. Adjacent
          words that are implicitly ANDed together, such as <span class="q style-scope keyword-wizard">(safety belt)</span>,
          are treated as a phrase when generating synonyms.
        </p>
        <a href="https://support.google.com/faqs/answer/7049475" target="_blank" class="style-scope keyword-wizard">Learn More</a>
      </div>
      <div class="style-scope keyword-wizard">
        <span class="input-label style-scope keyword-wizard"><label for="inputAnd" class="style-scope keyword-wizard">with ALL of the words</label></span>
        <input class="keyword-input style-scope keyword-wizard" id="inputAnd" placeholder="with ALL of the words">
      </div>
      <div class="style-scope keyword-wizard">
        <span class="input-label style-scope keyword-wizard"><label for="inputExact" class="style-scope keyword-wizard">with the EXACT PHRASE</label></span>
        <input class="keyword-input style-scope keyword-wizard" id="inputExact" placeholder="with the EXACT PHRASE"></div>
      <div class="style-scope keyword-wizard">
        <span class="input-label style-scope keyword-wizard"><label for="inputOr" class="style-scope keyword-wizard">with AT LEAST ONE of the words</label></span>
        <input class="keyword-input style-scope keyword-wizard" id="inputOr" placeholder="with AT LEAST ONE of the words"></div>
      <div class="style-scope keyword-wizard">
        <span class="input-label style-scope keyword-wizard"><label for="inputMinus" class="style-scope keyword-wizard">WITHOUT the words</label></span>
        <input class="keyword-input style-scope keyword-wizard" id="inputMinus" placeholder="WITHOUT the words"></div>
    </div>
    <div class="search-by style-scope keyword-wizard">
      <div class="wizard-header style-scope keyword-wizard">
          Search by
          <iron-icon icon="icons:help-outline" class="help-header style-scope keyword-wizard x-scope iron-icon-0" id="chem"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M11 18h2v-2h-2v2zm1-16C6.48 2 2 6.48 2 12s4.48 10 10 10 10-4.48 10-10S17.52 2 12 2zm0 18c-4.41 0-8-3.59-8-8s3.59-8 8-8 8 3.59 8 8-3.59 8-8 8zm0-14c-2.21 0-4 1.79-4 4h2c0-1.1.9-2 2-2s2 .9 2 2c0 2-3 1.75-3 5h2c0-2.25 3-2.5 3-5 0-2.21-1.79-4-4-4z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      </div>
      
      <div class="help style-scope keyword-wizard" id="chemHelp" hidden="">
        <p class="style-scope keyword-wizard"><b class="style-scope keyword-wizard">Chemistry searches</b> match terms (trade names, IUPAC names, etc.
          extracted from the entire document, and processed from .MOL files.)
        </p>
        <p class="style-scope keyword-wizard">Substructure (use <span class="q style-scope keyword-wizard">SSS=</span>) and similarity (use
          <span class="q style-scope keyword-wizard">~</span>) searches are limited to one per search at the top-level
          <span class="q style-scope keyword-wizard">AND</span> condition. Exact searches can be used multiple times throughout
          the search query.
        </p>
        <p class="style-scope keyword-wizard">Searching by SMILES or InChi key requires no special syntax. To search by SMARTS, use
          <span class="q style-scope keyword-wizard">SMARTS=</span>.
        </p>
        <p class="style-scope keyword-wizard">To search for multiple molecules, select "Batch" in the "Type" menu. Enter multiple
          molecules separated by whitespace or by comma.
        </p>
        <a href="https://support.google.com/faqs/answer/7049475" target="_blank" class="style-scope keyword-wizard">Learn More</a>
      </div>
      
      <div class="chemistry-field style-scope keyword-wizard">
          <span class="input-label style-scope keyword-wizard"><label for="inputChem" class="style-scope keyword-wizard">Chemistry</label></span>
          <span class="chem-type-label style-scope keyword-wizard"><label for="chemType" hidden="" class="style-scope keyword-wizard">Type</label></span>
          <select id="chemType" class="style-scope keyword-wizard">
            <option value="identical" class="style-scope keyword-wizard">Identical</option>
            <option value="substructure" class="style-scope keyword-wizard">Substructure</option>
            <option value="smarts" class="style-scope keyword-wizard">SMARTS</option>
            <option value="similarity" class="style-scope keyword-wizard">Similarity</option>
            <option value="batch" class="style-scope keyword-wizard">Batch</option>
          </select>
          <textarea class="keyword-input style-scope keyword-wizard" id="inputChem" placeholder="Trade name, SMILES, InChiKey"></textarea>
      </div>
      <div class="import style-scope keyword-wizard">
        <div class="wizard-header style-scope keyword-wizard">
          Patent numbers
        </div>
        <span class="import-button style-scope keyword-wizard">
          <a href="https://patents.google.com/import" class="style-scope keyword-wizard"><button class="style-scope keyword-wizard">Import</button></a>
        </span>
        <p class="import-text style-scope keyword-wizard">
          Search specific patents by importing a CSV or list of patent publication or application numbers.
        </p>
      </div>
    </div>
    
    <div class="wizard-buttons style-scope keyword-wizard">
      <button type="reset" class="style-scope keyword-wizard">Close</button>
      <button type="button" autofocus="" class="style-scope keyword-wizard">Add</button>
    </div>
  
  </paper-material>
</div>
</keyword-wizard>
          <overlay-tooltip positioning-target="#wizardIcon" direction="bottom" class="style-scope search-box" style="display: none;">
    
    <div id="arrow" class="style-scope overlay-tooltip" hidden=""></div>
    <div class="style-scope overlay-tooltip">
      Display advanced search options
    </div>
  </overlay-tooltip>
        </div>
      </div>
      <paper-material id="suggestMenu" class="style-scope search-box x-scope paper-material-0" elevation="1" hidden="">
    
    

    
        <template is="dom-repeat" class="style-scope search-box"></template>
        <div class="row style-scope search-box" hidden="">
          <iron-icon class="suggest-icon style-scope search-box x-scope iron-icon-0" icon="error"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M12 2C6.48 2 2 6.48 2 12s4.48 10 10 10 10-4.48 10-10S17.52 2 12 2zm1 15h-2v-2h2v2zm0-4h-2V7h2v6z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon> Sorry, we couldn't find this patent number.
        </div>
        <div class="row style-scope search-box" hidden="">
          <iron-icon class="suggest-icon style-scope search-box x-scope iron-icon-0" icon="error"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M12 2C6.48 2 2 6.48 2 12s4.48 10 10 10 10-4.48 10-10S17.52 2 12 2zm1 15h-2v-2h2v2zm0-4h-2V7h2v6z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon> 
        </div>
      
  </paper-material>
      <button id="searchButton" class="style-scope search-box"><iron-icon class="style-scope search-box x-scope iron-icon-0" icon="search"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M15.5 14h-.79l-.28-.27C15.41 12.59 16 11.11 16 9.5 16 5.91 13.09 3 9.5 3S3 5.91 3 9.5 5.91 16 9.5 16c1.61 0 3.09-.59 4.23-1.57l.27.28v.79l5 4.99L20.49 19l-4.99-5zm-6 0C7.01 14 5 11.99 5 9.5S7.01 5 9.5 5 14 7.01 14 9.5 11.99 14 9.5 14z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon></button>
    </div>
  </search-box>
          <template is="dom-if" class="style-scope search-header"></template>
          <div class="flex style-scope search-header"></div>
          
            <div id="header-container" class="style-scope search-header">
              <result-nav class="style-scope search-header">
    
    <div class="style-scope result-nav" hidden="">
      <state-modifier id="current" act="{&quot;type&quot;: &quot;BACK_TO_RESULTS&quot;}" inherit="" class="style-scope result-nav"><a id="link" href="#" class="style-scope state-modifier" inherit=""><span class="style-scope result-nav"></span> of
      <template is="dom-if" class="style-scope result-nav"></template>
      0<template is="dom-if" class="style-scope result-nav"></template></a></state-modifier>
      <state-modifier id="prevResult" inherit="" act="{&quot;type&quot;: &quot;NAV_RESULT&quot;, &quot;result&quot;: &quot;$id&quot;, &quot;page&quot;: $page}" class="style-scope result-nav" disabled=""><a id="link" href="#" class="style-scope state-modifier" inherit="">
        <iron-icon icon="chevron-left" class="style-scope result-nav x-scope iron-icon-0"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M15.41 7.41L14 6l-6 6 6 6 1.41-1.41L10.83 12z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      </a></state-modifier><state-modifier id="nextResult" inherit="" act="{&quot;type&quot;: &quot;NAV_RESULT&quot;, &quot;result&quot;: &quot;$id&quot;, &quot;page&quot;: $page}" class="style-scope result-nav" disabled=""><a id="link" href="#" class="style-scope state-modifier" inherit="">
        <iron-icon icon="chevron-right" class="style-scope result-nav x-scope iron-icon-0"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M10 6L8.59 7.41 13.17 12l-4.58 4.59L10 18l6-6z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      </a></state-modifier>
      <overlay-tooltip positioning-target="#prevResult" direction="bottom" arrow="" class="style-scope result-nav" style="display: none;">
    
    <div id="arrow" class="style-scope overlay-tooltip"></div>
    <div class="style-scope overlay-tooltip">
      Previous result
    </div>
  </overlay-tooltip>
      <overlay-tooltip positioning-target="#nextResult" direction="bottom" arrow="" class="style-scope result-nav" style="display: none;">
    
    <div id="arrow" class="style-scope overlay-tooltip"></div>
    <div class="style-scope overlay-tooltip">
      Next result
    </div>
  </overlay-tooltip>
    </div>
  </result-nav>
            </div>
          <template is="dom-if" class="style-scope search-header"></template>
        </div>
      </header>
    </div>
  </search-header>

      <div class="layout horizontal style-scope search-ui">
        <template is="dom-if" class="style-scope search-ui"></template>

        <div id="main" class="style-scope search-ui">
          <search-term-wizard class="style-scope search-ui"><pat-dialog open="" class="style-scope search-term-wizard">
  <span class="header style-scope search-term-wizard">
    <span class="title style-scope search-term-wizard">Search tools</span>
    <span id="language" class="style-scope search-term-wizard">
      <text-button id="textButton" selected="" class="style-scope search-term-wizard">Text
</text-button>
      <text-button id="classificationButton" class="style-scope search-term-wizard">Classification
</text-button>
      <text-button id="chemistryButton" class="style-scope search-term-wizard">Chemistry
</text-button>
      <text-button id="measureButton" class="style-scope search-term-wizard">Measure
</text-button>
      <text-button id="numbersButton" class="style-scope search-term-wizard">Numbers
</text-button>
    </span>
  </span>
  <span id="panels" class="style-scope search-term-wizard">
    <text-search-term-wizard id="textPanel" class="style-scope search-term-wizard" selected=""><span class="style-scope text-search-term-wizard">
  <svg xmlns="http://www.w3.org/2000/svg" height="24" width="24" fill="#041E49" class="style-scope text-search-term-wizard">
    <path d="M3.85 15.275V13h10.3v2.275Zm0-4.275V8.725h16.3V11Z" class="style-scope text-search-term-wizard"></path>
  </svg>
  <outlined-text-field id="textField" placeholder="Type a concept you want to search for here" class="style-scope text-search-term-wizard" value=""><span class="style-scope outlined-text-field">
  <input id="input" spellcheck="false" autocomplete="off" class="style-scope outlined-text-field" aria-disabled="false" placeholder="Type a concept you want to search for here">
  
</span>
</outlined-text-field>
</span>
<span class="style-scope text-search-term-wizard">
  <svg xmlns="http://www.w3.org/2000/svg" height="24" width="24" fill="#041E49" class="style-scope text-search-term-wizard">
    <path d="M8 18.025h8v-2.1H8Zm0-4h8v-2.1H8ZM6.075 22.2q-.95 0-1.612-.662-.663-.663-.663-1.613V4.075q0-.95.663-1.613.662-.662 1.612-.662h8L20.2 7.925v12q0 .95-.662 1.613-.663.662-1.613.662Zm6.85-13.125v-5h-6.85v15.85h11.85V9.075Zm-6.85-5v5-5 15.85-15.85Z" class="style-scope text-search-term-wizard"></path>
  </svg>
  <filter-chip id="fullDocuments" selected="" class="style-scope text-search-term-wizard"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 48 48" preserveAspectRatio="none" class="style-scope filter-chip">
  <path d="M18.9 35.7 7.7 24.5 9.85 22.35 18.9 31.4 38.1 12.2 40.25 14.35Z" class="style-scope filter-chip"></path>
</svg>
Full documents</filter-chip>
  <filter-chip id="title" class="style-scope text-search-term-wizard"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 48 48" preserveAspectRatio="none" class="style-scope filter-chip">
  <path d="M18.9 35.7 7.7 24.5 9.85 22.35 18.9 31.4 38.1 12.2 40.25 14.35Z" class="style-scope filter-chip"></path>
</svg>
Title</filter-chip>
  <filter-chip id="abstract" class="style-scope text-search-term-wizard"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 48 48" preserveAspectRatio="none" class="style-scope filter-chip">
  <path d="M18.9 35.7 7.7 24.5 9.85 22.35 18.9 31.4 38.1 12.2 40.25 14.35Z" class="style-scope filter-chip"></path>
</svg>
Abstract</filter-chip>
  <filter-chip id="claims" class="style-scope text-search-term-wizard"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 48 48" preserveAspectRatio="none" class="style-scope filter-chip">
  <path d="M18.9 35.7 7.7 24.5 9.85 22.35 18.9 31.4 38.1 12.2 40.25 14.35Z" class="style-scope filter-chip"></path>
</svg>
Claims</filter-chip>
</span>
<span class="style-scope text-search-term-wizard">
  <svg xmlns="http://www.w3.org/2000/svg" height="24" width="24" fill="#041E49" class="style-scope text-search-term-wizard">
    <path d="M16 16.925q2.05 0 3.488-1.437Q20.925 14.05 20.925 12t-1.437-3.488Q18.05 7.075 16 7.075q-.625 0-1.2.15t-1.075.425q.7.925 1.087 2.025.388 1.1.388 2.325t-.388 2.325q-.387 1.1-1.087 2.025.5.275 1.075.425.575.15 1.2.15Zm-4-2.075q.45-.575.688-1.313.237-.737.237-1.537 0-.8-.237-1.538Q12.45 9.725 12 9.15q-.45.575-.688 1.312-.237.738-.237 1.538t.237 1.537q.238.738.688 1.313Zm-4 2.075q.625 0 1.2-.15t1.075-.425q-.7-.925-1.087-2.025Q8.8 13.225 8.8 12t.388-2.325q.387-1.1 1.087-2.025-.5-.275-1.075-.425-.575-.15-1.2-.15-2.05 0-3.487 1.437Q3.075 9.95 3.075 12t1.438 3.488Q5.95 16.925 8 16.925ZM8 19.2q-3 0-5.1-2.1Q.8 15 .8 12q0-3 2.1-5.1Q5 4.8 8 4.8q1.125 0 2.137.312 1.013.313 1.863.913.85-.6 1.863-.913Q14.875 4.8 16 4.8q3 0 5.1 2.1Q23.2 9 23.2 12q0 3-2.1 5.1-2.1 2.1-5.1 2.1-1.125 0-2.137-.313-1.013-.312-1.863-.912-.85.6-1.863.912Q9.125 19.2 8 19.2Z" class="style-scope text-search-term-wizard"></path>
  </svg>
  <filter-chip id="all" selected="" class="style-scope text-search-term-wizard"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 48 48" preserveAspectRatio="none" class="style-scope filter-chip">
  <path d="M18.9 35.7 7.7 24.5 9.85 22.35 18.9 31.4 38.1 12.2 40.25 14.35Z" class="style-scope filter-chip"></path>
</svg>
All</filter-chip>
  <filter-chip id="any" class="style-scope text-search-term-wizard"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 48 48" preserveAspectRatio="none" class="style-scope filter-chip">
  <path d="M18.9 35.7 7.7 24.5 9.85 22.35 18.9 31.4 38.1 12.2 40.25 14.35Z" class="style-scope filter-chip"></path>
</svg>
Any</filter-chip>
  <filter-chip id="exact" class="style-scope text-search-term-wizard"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 48 48" preserveAspectRatio="none" class="style-scope filter-chip">
  <path d="M18.9 35.7 7.7 24.5 9.85 22.35 18.9 31.4 38.1 12.2 40.25 14.35Z" class="style-scope filter-chip"></path>
</svg>
Exact</filter-chip>
  <filter-chip id="not" class="style-scope text-search-term-wizard"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 48 48" preserveAspectRatio="none" class="style-scope filter-chip">
  <path d="M18.9 35.7 7.7 24.5 9.85 22.35 18.9 31.4 38.1 12.2 40.25 14.35Z" class="style-scope filter-chip"></path>
</svg>
Not</filter-chip>
</span>
<span class="style-scope text-search-term-wizard">
  <mat-button id="button" filled="" class="style-scope text-search-term-wizard x-scope mat-button-0" disabled=""><span slot="label" class="style-scope text-search-term-wizard">Add AND condition</span></mat-button></span></text-search-term-wizard>
    <classification-wizard id="classificationPanel" class="style-scope search-term-wizard"><span class="style-scope classification-wizard">
  <svg xmlns="http://www.w3.org/2000/svg" height="24" width="24" fill="#041E49" class="style-scope classification-wizard">
    <path d="M3.85 15.275V13h10.3v2.275Zm0-4.275V8.725h16.3V11Z" class="style-scope classification-wizard"></path>
  </svg>
  <outlined-text-field id="textField" placeholder="Enter a CPC here" uppercase="" class="style-scope classification-wizard" value=""><span class="style-scope outlined-text-field">
  <input id="input" spellcheck="false" autocomplete="off" class="style-scope outlined-text-field" aria-disabled="false" placeholder="Enter a CPC here">
  
</span>
</outlined-text-field>
</span>
<template is="dom-if" class="style-scope classification-wizard"></template>
<template is="dom-if" class="style-scope classification-wizard"></template>
<template is="dom-if" class="style-scope classification-wizard"></template>
<span class="style-scope classification-wizard">
  <svg xmlns="http://www.w3.org/2000/svg" height="24" width="24" fill="#041E49" class="style-scope classification-wizard">
    <path d="M16 16.925q2.05 0 3.488-1.437Q20.925 14.05 20.925 12t-1.437-3.488Q18.05 7.075 16 7.075q-.625 0-1.2.15t-1.075.425q.7.925 1.087 2.025.388 1.1.388 2.325t-.388 2.325q-.387 1.1-1.087 2.025.5.275 1.075.425.575.15 1.2.15Zm-4-2.075q.45-.575.688-1.313.237-.737.237-1.537 0-.8-.237-1.538Q12.45 9.725 12 9.15q-.45.575-.688 1.312-.237.738-.237 1.538t.237 1.537q.238.738.688 1.313Zm-4 2.075q.625 0 1.2-.15t1.075-.425q-.7-.925-1.087-2.025Q8.8 13.225 8.8 12t.388-2.325q.387-1.1 1.087-2.025-.5-.275-1.075-.425-.575-.15-1.2-.15-2.05 0-3.487 1.437Q3.075 9.95 3.075 12t1.438 3.488Q5.95 16.925 8 16.925ZM8 19.2q-3 0-5.1-2.1Q.8 15 .8 12q0-3 2.1-5.1Q5 4.8 8 4.8q1.125 0 2.137.312 1.013.313 1.863.913.85-.6 1.863-.913Q14.875 4.8 16 4.8q3 0 5.1 2.1Q23.2 9 23.2 12q0 3-2.1 5.1-2.1 2.1-5.1 2.1-1.125 0-2.137-.313-1.013-.312-1.863-.912-.85.6-1.863.912Q9.125 19.2 8 19.2Z" class="style-scope classification-wizard"></path>
  </svg>
  <filter-chip id="notExact" class="style-scope classification-wizard"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 48 48" preserveAspectRatio="none" class="style-scope filter-chip">
  <path d="M18.9 35.7 7.7 24.5 9.85 22.35 18.9 31.4 38.1 12.2 40.25 14.35Z" class="style-scope filter-chip"></path>
</svg>

    These CPCs and their children
  </filter-chip>
  <filter-chip selected="" id="exact" class="style-scope classification-wizard"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 48 48" preserveAspectRatio="none" class="style-scope filter-chip">
  <path d="M18.9 35.7 7.7 24.5 9.85 22.35 18.9 31.4 38.1 12.2 40.25 14.35Z" class="style-scope filter-chip"></path>
</svg>

    These exact CPCs
  </filter-chip>
</span>
<span class="style-scope classification-wizard">
  <mat-button id="button" filled="" class="style-scope classification-wizard x-scope mat-button-0" disabled=""><span slot="label" class="style-scope classification-wizard">Add AND condition</span></mat-button>
</span></classification-wizard>
    <chemistry-search-term-wizard id="chemistryPanel" class="style-scope search-term-wizard"><span class="style-scope chemistry-search-term-wizard">
  <svg xmlns="http://www.w3.org/2000/svg" height="24" width="24" fill="#041E49" class="style-scope chemistry-search-term-wizard">
    <path d="M3.85 15.275V13h10.3v2.275Zm0-4.275V8.725h16.3V11Z" class="style-scope chemistry-search-term-wizard"></path>
  </svg>
  <outlined-text-field id="textField" placeholder="Trade name, SMILES, InChI Key" class="style-scope chemistry-search-term-wizard" value=""><span class="style-scope outlined-text-field">
  <input id="input" spellcheck="false" autocomplete="off" class="style-scope outlined-text-field" aria-disabled="false" placeholder="Trade name, SMILES, InChI Key">
  
</span>
</outlined-text-field>
  <outlined-textarea id="textArea" placeholder="Enter multiple SMILES or InChI Keys, one per line" rows="4" class="style-scope chemistry-search-term-wizard"><span class="style-scope outlined-textarea">
  <textarea id="textarea" autocomplete="off" autocorrect="off" spellcheck="false" tabindex="0" aria-disabled="false" wrap="soft" class="style-scope outlined-textarea" rows="4" placeholder="Enter multiple SMILES or InChI Keys, one per line">  </textarea>
  <div id="helperText" class="style-scope outlined-textarea"> </div>
</span>
<span class="right-button-container style-scope outlined-textarea">
  
</span>
</outlined-textarea>
  <a href="https://support.google.com/faqs/answer/7049475#zippy=%2Csearching-by-chemistry" target="_blank" class="style-scope chemistry-search-term-wizard">
    <svg class="help style-scope chemistry-search-term-wizard" xmlns="http://www.w3.org/2000/svg" height="24" width="24" fill="#041E49">
      <path d="M11.95 18q.525 0 .888-.363.362-.362.362-.887t-.362-.887q-.363-.363-.888-.363t-.888.363q-.362.362-.362.887t.362.887q.363.363.888.363Zm-.9-3.85h1.85q0-.825.188-1.3.187-.475 1.062-1.3.65-.65 1.025-1.238.375-.587.375-1.412 0-1.4-1.025-2.15T12.1 6q-1.425 0-2.312.75-.888.75-1.238 1.8l1.65.65q.125-.45.563-.975Q11.2 7.7 12.1 7.7q.8 0 1.2.437.4.438.4.963 0 .5-.3.937-.3.438-.75.813-1.1.975-1.35 1.475-.25.5-.25 1.825ZM12 22q-2.075 0-3.9-.788-1.825-.787-3.175-2.137-1.35-1.35-2.137-3.175Q2 14.075 2 12t.788-3.9q.787-1.825 2.137-3.175 1.35-1.35 3.175-2.138Q9.925 2 12 2t3.9.787q1.825.788 3.175 2.138 1.35 1.35 2.137 3.175Q22 9.925 22 12t-.788 3.9q-.787 1.825-2.137 3.175-1.35 1.35-3.175 2.137Q14.075 22 12 22Zm0-2q3.35 0 5.675-2.325Q20 15.35 20 12q0-3.35-2.325-5.675Q15.35 4 12 4 8.65 4 6.325 6.325 4 8.65 4 12q0 3.35 2.325 5.675Q8.65 20 12 20Zm0-8Z" class="style-scope chemistry-search-term-wizard"></path>
    </svg>
  </a>
</span>
<span id="chemQuantifiers" class="style-scope chemistry-search-term-wizard">
  <svg xmlns="http://www.w3.org/2000/svg" height="24" width="24" fill="#041E49" class="style-scope chemistry-search-term-wizard">
    <path d="M5 21.2q-1.4 0-2-1.25-.6-1.25.3-2.325l5.5-6.7V5.15h-.825q-.475 0-.8-.338Q6.85 4.475 6.85 4q0-.475.325-.813.325-.337.8-.337h8.05q.475 0 .8.337.325.338.325.813 0 .475-.325.812-.325.338-.8.338H15.2v5.775l5.5 6.7q.9 1.075.3 2.325-.6 1.25-2 1.25Zm2.15-3.275h9.7l-3.275-3.85h-3.15Zm-2 1h13.7l-5.925-7.2V5.15h-1.85v6.575Zm6.85-6.9Z" class="style-scope chemistry-search-term-wizard"></path>
  </svg>
  <filter-chip id="exact" selected="" class="style-scope chemistry-search-term-wizard"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 48 48" preserveAspectRatio="none" class="style-scope filter-chip">
  <path d="M18.9 35.7 7.7 24.5 9.85 22.35 18.9 31.4 38.1 12.2 40.25 14.35Z" class="style-scope filter-chip"></path>
</svg>
Exact</filter-chip>
  <filter-chip id="exactBatch" class="style-scope chemistry-search-term-wizard"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 48 48" preserveAspectRatio="none" class="style-scope filter-chip">
  <path d="M18.9 35.7 7.7 24.5 9.85 22.35 18.9 31.4 38.1 12.2 40.25 14.35Z" class="style-scope filter-chip"></path>
</svg>
Exact Batch</filter-chip>
  <filter-chip id="similar" class="style-scope chemistry-search-term-wizard"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 48 48" preserveAspectRatio="none" class="style-scope filter-chip">
  <path d="M18.9 35.7 7.7 24.5 9.85 22.35 18.9 31.4 38.1 12.2 40.25 14.35Z" class="style-scope filter-chip"></path>
</svg>
Similar</filter-chip>
  <filter-chip id="substructure" class="style-scope chemistry-search-term-wizard"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 48 48" preserveAspectRatio="none" class="style-scope filter-chip">
  <path d="M18.9 35.7 7.7 24.5 9.85 22.35 18.9 31.4 38.1 12.2 40.25 14.35Z" class="style-scope filter-chip"></path>
</svg>
Substructure</filter-chip>
  <filter-chip id="smarts" class="style-scope chemistry-search-term-wizard"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 48 48" preserveAspectRatio="none" class="style-scope filter-chip">
  <path d="M18.9 35.7 7.7 24.5 9.85 22.35 18.9 31.4 38.1 12.2 40.25 14.35Z" class="style-scope filter-chip"></path>
</svg>
Substructure (SMARTS)</filter-chip>
</span>
<span id="location" class="style-scope chemistry-search-term-wizard">
  <svg xmlns="http://www.w3.org/2000/svg" height="24" width="24" fill="#041E49" class="style-scope chemistry-search-term-wizard">
    <path d="M8 18.025h8v-2.1H8Zm0-4h8v-2.1H8ZM6.075 22.2q-.95 0-1.612-.662-.663-.663-.663-1.613V4.075q0-.95.663-1.613.662-.662 1.612-.662h8L20.2 7.925v12q0 .95-.662 1.613-.663.662-1.613.662Zm6.85-13.125v-5h-6.85v15.85h11.85V9.075Zm-6.85-5v5-5 15.85-15.85Z" class="style-scope chemistry-search-term-wizard"></path>
  </svg>
  <filter-chip id="fullDocuments" selected="" class="style-scope chemistry-search-term-wizard"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 48 48" preserveAspectRatio="none" class="style-scope filter-chip">
  <path d="M18.9 35.7 7.7 24.5 9.85 22.35 18.9 31.4 38.1 12.2 40.25 14.35Z" class="style-scope filter-chip"></path>
</svg>
Full documents</filter-chip>
  <filter-chip id="claims" class="style-scope chemistry-search-term-wizard"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 48 48" preserveAspectRatio="none" class="style-scope filter-chip">
  <path d="M18.9 35.7 7.7 24.5 9.85 22.35 18.9 31.4 38.1 12.2 40.25 14.35Z" class="style-scope filter-chip"></path>
</svg>
Claims only</filter-chip>
</span>
<span class="style-scope chemistry-search-term-wizard">
  <mat-button id="button" filled="" class="style-scope chemistry-search-term-wizard x-scope mat-button-0" disabled=""><span slot="label" class="style-scope chemistry-search-term-wizard">Add AND condition</span></mat-button>
</span>
</chemistry-search-term-wizard>
    <measure-search-term-wizard id="measurePanel" class="style-scope search-term-wizard"><span class="style-scope measure-search-term-wizard">
  <svg xmlns="http://www.w3.org/2000/svg" height="24" width="24" fill="#041E49" class="style-scope measure-search-term-wizard">
    <path d="M4.1 18.15q-.95 0-1.612-.663-.663-.662-.663-1.612v-7.75q0-.95.663-1.613Q3.15 5.85 4.1 5.85h15.8q.95 0 1.613.662.662.663.662 1.613v7.75q0 .95-.662 1.612-.663.663-1.613.663Zm0-2.275h15.8v-7.75H17V12h-2V8.125h-2V12h-2V8.125H9V12H7V8.125H4.1v7.75ZM7 12h2Zm4 0h2Zm4 0h2Zm-3 0Z" class="style-scope measure-search-term-wizard"></path>
  </svg>
  <outlined-text-field id="measureExpression" placeholder="1.5 mm, 20 ft, 400-500 fahrenheit, 800 MHz, 0.01-100 mol" class="style-scope measure-search-term-wizard" value=""><span class="style-scope outlined-text-field">
  <input id="input" spellcheck="false" autocomplete="off" class="style-scope outlined-text-field" aria-disabled="false" placeholder="1.5 mm, 20 ft, 400-500 fahrenheit, 800 MHz, 0.01-100 mol">
  
</span>
</outlined-text-field>
</span>
<span class="style-scope measure-search-term-wizard">
  <svg xmlns="http://www.w3.org/2000/svg" height="24" width="24" fill="#041E49" class="style-scope measure-search-term-wizard">
    <path d="M3.875 20.15V8.85h4.25v11.3Zm6 0V3.85h4.25v16.3Zm6 0v-7.3h4.25v7.3Z" class="style-scope measure-search-term-wizard"></path>
  </svg>
  <outlined-text-field id="context" placeholder="activity, wavelength, embossing depth, absorption" class="style-scope measure-search-term-wizard" value=""><span class="style-scope outlined-text-field">
  <input id="input" spellcheck="false" autocomplete="off" class="style-scope outlined-text-field" aria-disabled="false" placeholder="activity, wavelength, embossing depth, absorption">
  
</span>
</outlined-text-field>
</span>
<span class="style-scope measure-search-term-wizard">
  <mat-button id="button" filled="" class="style-scope measure-search-term-wizard x-scope mat-button-0" disabled=""><span slot="label" class="style-scope measure-search-term-wizard">Add AND condition</span></mat-button>
</span>
</measure-search-term-wizard>
    <numerical-search-term-wizard id="numericalPanel" class="style-scope search-term-wizard"><span class="style-scope numerical-search-term-wizard">
  <svg xmlns="http://www.w3.org/2000/svg" height="24" width="24" fill="#041E49" class="style-scope numerical-search-term-wizard">
    <path d="M3.85 15.275V13h10.3v2.275Zm0-4.275V8.725h16.3V11Z" class="style-scope numerical-search-term-wizard"></path>
  </svg>
  <outlined-textarea id="batch" placeholder="Enter multiple Patent Application and Publication Numbers, one per line" rows="4" class="style-scope numerical-search-term-wizard"><span class="style-scope outlined-textarea">
  <textarea id="textarea" autocomplete="off" autocorrect="off" spellcheck="false" tabindex="0" aria-disabled="false" wrap="soft" class="style-scope outlined-textarea" rows="4" placeholder="Enter multiple Patent Application and Publication Numbers, one per line">  </textarea>
  <div id="helperText" class="style-scope outlined-textarea"> </div>
</span>
<span class="right-button-container style-scope outlined-textarea">
  
</span>
</outlined-textarea>
</span>
<template is="dom-if" class="style-scope numerical-search-term-wizard"></template>
<template is="dom-if" class="style-scope numerical-search-term-wizard"></template>
<span class="style-scope numerical-search-term-wizard">
  <svg xmlns="http://www.w3.org/2000/svg" height="24" width="24" fill="#041E49" class="style-scope numerical-search-term-wizard">
    <path d="m10.825 23.45-1.6-1.625L10.9 20.15H8q-.35.9-1.162 1.488-.813.587-1.838.587-1.35 0-2.287-.937-.938-.938-.938-2.288 0-1.025.588-1.837Q2.95 16.35 3.85 16V8q-.9-.35-1.487-1.163Q1.775 6.025 1.775 5q0-1.35.938-2.288Q3.65 1.775 5 1.775q1.025 0 1.838.587Q7.65 2.95 8 3.85h2.9L9.225 2.175l1.6-1.625L15.275 5l-4.45 4.45-1.6-1.625L10.9 6.15H8q-.25.65-.725 1.125T6.15 8v8q.65.25 1.125.725T8 17.85h2.9l-1.675-1.675 1.6-1.625 4.45 4.45ZM19 22.225q-1.35 0-2.287-.937-.938-.938-.938-2.288 0-1.05.588-1.863.587-.812 1.487-1.137V8q-.9-.325-1.487-1.137-.588-.813-.588-1.863 0-1.35.938-2.288.937-.937 2.287-.937 1.35 0 2.288.937.937.938.937 2.288 0 1.05-.587 1.863Q21.05 7.675 20.15 8v8q.9.35 1.488 1.163.587.812.587 1.837 0 1.35-.937 2.288-.938.937-2.288.937ZM5 19.95q.4 0 .675-.275T5.95 19q0-.4-.275-.675T5 18.05q-.4 0-.675.275T4.05 19q0 .4.275.675T5 19.95Zm14 0q.4 0 .675-.275T19.95 19q0-.4-.275-.675T19 18.05q-.4 0-.675.275T18.05 19q0 .4.275.675t.675.275Zm-14-14q.4 0 .675-.275T5.95 5q0-.4-.275-.675T5 4.05q-.4 0-.675.275T4.05 5q0 .4.275.675T5 5.95Zm14 0q.4 0 .675-.275T19.95 5q0-.4-.275-.675T19 4.05q-.4 0-.675.275T18.05 5q0 .4.275.675T19 5.95ZM5 19Zm14 0ZM5 5Zm14 0Z" class="style-scope numerical-search-term-wizard"></path>
  </svg>
  <filter-chip id="applicationNumbers" class="style-scope numerical-search-term-wizard"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 48 48" preserveAspectRatio="none" class="style-scope filter-chip">
  <path d="M18.9 35.7 7.7 24.5 9.85 22.35 18.9 31.4 38.1 12.2 40.25 14.35Z" class="style-scope filter-chip"></path>
</svg>
Application Numbers</filter-chip>
  <filter-chip id="publicationNumbers" class="style-scope numerical-search-term-wizard"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 48 48" preserveAspectRatio="none" class="style-scope filter-chip">
  <path d="M18.9 35.7 7.7 24.5 9.85 22.35 18.9 31.4 38.1 12.2 40.25 14.35Z" class="style-scope filter-chip"></path>
</svg>
Publication Numbers</filter-chip>
  <filter-chip id="either" selected="" class="style-scope numerical-search-term-wizard"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 48 48" preserveAspectRatio="none" class="style-scope filter-chip">
  <path d="M18.9 35.7 7.7 24.5 9.85 22.35 18.9 31.4 38.1 12.2 40.25 14.35Z" class="style-scope filter-chip"></path>
</svg>
Either</filter-chip>
</span>
<span class="style-scope numerical-search-term-wizard">
  <svg xmlns="http://www.w3.org/2000/svg" height="24" width="24" fill="#041E49" class="style-scope numerical-search-term-wizard">
    <path d="M12 22.2q-2.1 0-3.962-.8-1.863-.8-3.25-2.175Q3.4 17.85 2.6 15.988 1.8 14.125 1.8 12t.8-3.988q.8-1.862 2.188-3.237Q6.175 3.4 8.038 2.6 9.9 1.8 12 1.8q2.125 0 3.988.8 1.862.8 3.237 2.175Q20.6 6.15 21.4 8.012q.8 1.863.8 3.988t-.8 3.988q-.8 1.862-2.175 3.237Q17.85 20.6 15.988 21.4q-1.863.8-3.988.8Zm-1-2.325v-1.95q-.8 0-1.387-.575-.588-.575-.588-1.4v-.975L4.275 10.2q-.075.45-.137.9-.063.45-.063.9 0 3 1.975 5.25T11 19.875Zm6.85-2.525q.5-.55.888-1.175.387-.625.65-1.313.262-.687.4-1.412.137-.725.137-1.45 0-2.425-1.338-4.438-1.337-2.012-3.612-2.887v.375q0 .825-.587 1.4-.588.575-1.388.575h-2v2q0 .4-.287.687-.288.288-.688.288h-2v2h5.95q.425 0 .713.287.287.288.287.688v2.975h1q.65 0 1.163.387.512.388.712 1.013Z" class="style-scope numerical-search-term-wizard"></path>
  </svg>
  <outlined-text-field id="countryFilter" placeholder="Restrict search to these countries" class="style-scope numerical-search-term-wizard" value=""><span class="style-scope outlined-text-field">
  <input id="input" spellcheck="false" autocomplete="off" class="style-scope outlined-text-field" aria-disabled="false" placeholder="Restrict search to these countries">
  
</span>
</outlined-text-field>
</span>
<span class="style-scope numerical-search-term-wizard">
  <svg xmlns="http://www.w3.org/2000/svg" height="24" width="24" fill="#041E49" class="style-scope numerical-search-term-wizard">
    <path d="M2.85 18.225V15.95h6.3v2.275Zm0-5.075v-2.3h12.3v2.3Zm0-5.1V5.775h18.3V8.05Z" class="style-scope numerical-search-term-wizard"></path>
  </svg>
  <outlined-text-field id="countryOrder" placeholder="Prefer results from these countries in this order" class="style-scope numerical-search-term-wizard" value="US, EP, WO, JP, CN"><span class="style-scope outlined-text-field">
  <input id="input" spellcheck="false" autocomplete="off" class="style-scope outlined-text-field" aria-disabled="false" placeholder="Prefer results from these countries in this order">
  
</span>
</outlined-text-field>
</span>
<span class="style-scope numerical-search-term-wizard">
  <mat-button id="button" filled="" class="style-scope numerical-search-term-wizard x-scope mat-button-0" disabled=""><span slot="label" class="style-scope numerical-search-term-wizard">Add AND condition</span></mat-button>
</span>
</numerical-search-term-wizard>
  </span>

</pat-dialog>
</search-term-wizard>
          
      <div content="" class="style-scope search-result">
        <div id="mainContainer" class="vertical layout style-scope search-result">
          <template is="dom-if" class="style-scope search-result"></template>
          <result-container class="style-scope search-result">
    

    <paper-spinner class="style-scope result-container x-scope paper-spinner-0" aria-hidden="true" hidden=""><div id="spinnerContainer" class="  style-scope paper-spinner"><div class="spinner-layer layer-1 style-scope paper-spinner"><div class="circle-clipper left style-scope paper-spinner"></div><div class="circle-clipper right style-scope paper-spinner"></div></div><div class="spinner-layer layer-2 style-scope paper-spinner"><div class="circle-clipper left style-scope paper-spinner"></div><div class="circle-clipper right style-scope paper-spinner"></div></div><div class="spinner-layer layer-3 style-scope paper-spinner"><div class="circle-clipper left style-scope paper-spinner"></div><div class="circle-clipper right style-scope paper-spinner"></div></div><div class="spinner-layer layer-4 style-scope paper-spinner"><div class="circle-clipper left style-scope paper-spinner"></div><div class="circle-clipper right style-scope paper-spinner"></div></div></div></paper-spinner>
    
      <patent-result class="style-scope result-container">
    
    
    <div class="layout horizontal style-scope patent-result">
      <div style="width: 1200px; height: auto; overflow: auto;" class="style-scope patent-result">
        <div id="wrapper" tabindex="0" class="style-scope patent-result">
          <result-tags class="style-scope patent-result"></result-tags>
          <h1 id="title" class="scroll-target style-scope patent-result">
            IL-8 for predicting or monitoring efficacy of c-MET inhibitor 
       </h1>
          <div class="horizontal layout style-scope patent-result">
            
            <div class="flex-3 style-scope patent-result" style="margin-top:-20px;overflow:hidden;" marginright="">
              <section id="abstract" class="style-scope patent-result" hidden="">
                <h3 class="layout horizontal style-scope patent-result">
                  <div class="flex style-scope patent-result">Abstract</div>
                  <div class="righthead style-scope patent-result" hidden="">translated from </div>
                </h3>
                <patent-text name="abstract" class="style-scope patent-result">
    
    
    <template is="dom-if" restamp="" class="style-scope patent-text"></template>
    <overlay-tooltip id="tooltip" class="style-scope patent-text" style="display: none;">
    
    <div id="arrow" class="style-scope overlay-tooltip" hidden=""></div>
    <div class="style-scope overlay-tooltip">
      
    </div>
  </overlay-tooltip>
    <div class="layout horizontal style-scope patent-text">
      <section id="text" class="flex style-scope patent-text"></section>
      <div id="margin" class="style-scope patent-text">
        <div id="createHighlight" style="top: 0px;" class="style-scope patent-text" hidden="">
          <iron-icon id="comment" icon="editor:insert-comment" class="style-scope patent-text x-scope iron-icon-0"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M20 2H4c-1.1 0-2 .9-2 2v12c0 1.1.9 2 2 2h14l4 4V4c0-1.1-.9-2-2-2zm-2 12H6v-2h12v2zm0-3H6V9h12v2zm0-3H6V6h12v2z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
        </div>
      </div>
    </div>
  </patent-text>
              </section>
              
              
                <section id="thumbnails" class="style-scope patent-result">
                  <h3 class="style-scope patent-result">Images (<span class="style-scope patent-result">27</span>)</h3>
                  <image-carousel id="figures" class="style-scope patent-result">
    
    
      <div class="thumbnails style-scope image-carousel">
        
          <img class="style-scope image-carousel" src="https://patentimages.storage.googleapis.com/30/fe/4b/fe0c9af8eb37d4/imgf0001.png">
        
          <img class="style-scope image-carousel" src="https://patentimages.storage.googleapis.com/64/71/52/1de56862a3295e/imgf0002.png">
        
          <img class="style-scope image-carousel" src="https://patentimages.storage.googleapis.com/b1/9c/36/f8cd0b56fb4f10/imgf0003.png">
        
          <img class="style-scope image-carousel" src="https://patentimages.storage.googleapis.com/9b/7c/39/12a63fcd1ce3f7/imgf0004.png">
        
          <img class="style-scope image-carousel" src="https://patentimages.storage.googleapis.com/15/cc/c8/ff02cabcb6ce38/imgf0005.png">
        
          <img class="style-scope image-carousel" src="https://patentimages.storage.googleapis.com/c0/fe/12/cd289088a7b74b/imgf0006.png">
        
          <img class="style-scope image-carousel" src="https://patentimages.storage.googleapis.com/ba/6e/5d/d8c1be21fdb987/imgf0007.png">
        
          <img class="style-scope image-carousel" src="https://patentimages.storage.googleapis.com/31/4a/df/71cd943b95bf28/imgf0008.png">
        
          <img class="style-scope image-carousel" src="https://patentimages.storage.googleapis.com/1c/5b/fb/ce9e51c090d404/imgf0009.png">
        
          <img class="style-scope image-carousel" src="https://patentimages.storage.googleapis.com/f5/e8/bf/c8e52a44a1941e/imgf0010.png">
        
          <img class="style-scope image-carousel" src="https://patentimages.storage.googleapis.com/2f/f2/58/053e389520abc4/imgf0011.png">
        
          <img class="style-scope image-carousel" src="https://patentimages.storage.googleapis.com/c1/90/17/509931a52e79c8/imgf0012.png">
        
          <img class="style-scope image-carousel" src="https://patentimages.storage.googleapis.com/84/5a/34/d2cb91cc9aed6c/imgf0013.png">
        
          <img class="style-scope image-carousel" src="https://patentimages.storage.googleapis.com/a6/30/5e/045660510adc25/imgf0014.png">
        
          <img class="style-scope image-carousel" src="https://patentimages.storage.googleapis.com/6b/eb/09/b17e6ed3105328/imgf0015.png">
        
          <img class="style-scope image-carousel" src="https://patentimages.storage.googleapis.com/ce/b0/ba/7c6ba6e8875001/imgf0016.png">
        
          <img class="style-scope image-carousel" src="https://patentimages.storage.googleapis.com/90/9e/a5/e31a3902d2975f/imgf0017.png">
        
          <img class="style-scope image-carousel" src="https://patentimages.storage.googleapis.com/ac/10/6a/a644349ce1f9a4/imgf0018.png">
        
          <img class="style-scope image-carousel" src="https://patentimages.storage.googleapis.com/72/cb/89/4862d53638ed95/imgf0019.png">
        
          <img class="style-scope image-carousel" src="https://patentimages.storage.googleapis.com/fa/8b/b2/97668c75e45e8d/imgf0020.png">
        
          <img class="style-scope image-carousel" src="https://patentimages.storage.googleapis.com/9e/f5/83/478f864bb10682/imgf0021.png">
        
          <img class="style-scope image-carousel" src="https://patentimages.storage.googleapis.com/a4/6f/46/2796d0aaeb248d/imgf0022.png">
        
          <img class="style-scope image-carousel" src="https://patentimages.storage.googleapis.com/e2/eb/d5/9e26a64dfe68c8/imgf0023.png">
        
          <img class="style-scope image-carousel" src="https://patentimages.storage.googleapis.com/fa/10/38/b1616c65fbf7ec/imgf0024.png">
        
          <img class="style-scope image-carousel" src="https://patentimages.storage.googleapis.com/da/b1/e4/2551641702e9a8/imgf0025.png">
        
          <img class="style-scope image-carousel" src="https://patentimages.storage.googleapis.com/e0/b6/b7/c8c6d28992f8bb/imgf0026.png">
        
          <img class="style-scope image-carousel" src="https://patentimages.storage.googleapis.com/de/d1/5c/8df701488e2456/imgf0027.png">
        <template is="dom-repeat" as="img" class="style-scope image-carousel"></template>
      </div>
    <template is="dom-if" class="style-scope image-carousel"></template>
  </image-carousel>
                </section>
              <template is="dom-if" class="style-scope patent-result"></template>
              
              <section id="classifications" class="style-scope patent-result">
                <h3 class="layout horizontal style-scope patent-result">
                  <div class="flex style-scope patent-result">Classifications</div>
                  <div id="machineClassifiedWarning" class="righthead tooltip-hint style-scope patent-result" hidden="">machine-classified</div>
                  <div id="machineClassifiedCPCWarning" class="righthead tooltip-hint style-scope patent-result" hidden="">cpc-machine-classified</div>
                  <div id="machineClassifiedFtermWarning" class="righthead tooltip-hint style-scope patent-result" hidden="">fterm-machine-classified</div>
                  <div class="style-scope patent-result" hidden="">&nbsp;</div>
                  <div id="familyClassifiedFtermWarning" class="righthead tooltip-hint style-scope patent-result" hidden="">fterm-family-classified</div>
                </h3>
                <overlay-tooltip positioning-target="#machineClassifiedWarning" direction="bottom" class="style-scope patent-result" style="display: none;">
    
    <div id="arrow" class="style-scope overlay-tooltip" hidden=""></div>
    <div class="style-scope overlay-tooltip">
      The classifications are assigned by a computer and are not a legal conclusion. <br class="style-scope patent-result"> Google has not performed a legal analysis and makes no representation as to the accuracy of the classifications listed.
    </div>
  </overlay-tooltip>
                <overlay-tooltip positioning-target="#machineClassifiedCPCWarning" direction="bottom" class="style-scope patent-result" style="display: none;">
    
    <div id="arrow" class="style-scope overlay-tooltip" hidden=""></div>
    <div class="style-scope overlay-tooltip">
      The CPC classifications are assigned by a computer and are not a legal conclusion. <br class="style-scope patent-result"> Google has not performed a legal analysis and makes no representation as to the accuracy of the classifications listed.
    </div>
  </overlay-tooltip>
                <overlay-tooltip positioning-target="#familyClassifiedFtermWarning" direction="bottom" class="style-scope patent-result" style="display: none;">
    
    <div id="arrow" class="style-scope overlay-tooltip" hidden=""></div>
    <div class="style-scope overlay-tooltip">
      The F-term classifications are assigned based on a patent family member containing these classification codes.
    </div>
  </overlay-tooltip>
                <overlay-tooltip positioning-target="#machineClassifiedFtermWarning" direction="bottom" class="style-scope patent-result" style="display: none;">
    
    <div id="arrow" class="style-scope overlay-tooltip" hidden=""></div>
    <div class="style-scope overlay-tooltip">
      The F-term classifications are assigned by a computer and are not a legal conclusion. <br class="style-scope patent-result"> Google has not performed a legal analysis and makes no representation as to the accuracy of the classifications listed.
    </div>
  </overlay-tooltip>
                <classification-viewer class="style-scope patent-result">
    
    <div class="table style-scope classification-viewer">
      
        <classification-tree class="style-scope classification-viewer">
    
    <div class="style-scope classification-tree">
      <div class="layout horizontal wrap style-scope classification-tree">
        <div class="flex style-scope classification-tree">
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="G"><a id="link" href="#" class="style-scope state-modifier">G</a></state-modifier>
                  <span class="description style-scope classification-tree">PHYSICS</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="G01"><a id="link" href="#" class="style-scope state-modifier">G01</a></state-modifier>
                  <span class="description style-scope classification-tree">MEASURING; TESTING</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="G01N"><a id="link" href="#" class="style-scope state-modifier">G01N</a></state-modifier>
                  <span class="description style-scope classification-tree">INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="G01N33/00"><a id="link" href="#" class="style-scope state-modifier">G01N33/00</a></state-modifier>
                  <span class="description style-scope classification-tree">Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="G01N33/48"><a id="link" href="#" class="style-scope state-modifier">G01N33/48</a></state-modifier>
                  <span class="description style-scope classification-tree">Biological material, e.g. blood, urine; Haemocytometers</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="G01N33/50"><a id="link" href="#" class="style-scope state-modifier">G01N33/50</a></state-modifier>
                  <span class="description style-scope classification-tree">Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="G01N33/53"><a id="link" href="#" class="style-scope state-modifier">G01N33/53</a></state-modifier>
                  <span class="description style-scope classification-tree">Immunoassay; Biospecific binding assay; Materials therefor</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="G01N33/574"><a id="link" href="#" class="style-scope state-modifier">G01N33/574</a></state-modifier>
                  <span class="description style-scope classification-tree">Immunoassay; Biospecific binding assay; Materials therefor for cancer</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="G01N33/57484"><a id="link" href="#" class="style-scope state-modifier">G01N33/57484</a></state-modifier>
                  <span class="description style-scope classification-tree">Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumor, cancer, neoplasia, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides, metabolites</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" first="true" data-cpc="G01N33/57488"><a id="link" href="#" class="style-scope state-modifier">G01N33/57488</a></state-modifier>
                  <span class="description style-scope classification-tree">Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumor, cancer, neoplasia, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides, metabolites involving compounds identifable in body fluids</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          <template is="dom-repeat" class="style-scope classification-tree"></template>
        </div>
      </div>
    </div>
  </classification-tree>
      <template is="dom-repeat" class="style-scope classification-viewer"></template>
      
      <div class="style-scope classification-viewer">
        
          <classification-tree class="style-scope classification-viewer">
    
    <div class="style-scope classification-tree">
      <div class="layout horizontal wrap style-scope classification-tree">
        <div class="flex style-scope classification-tree">
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="C"><a id="link" href="#" class="style-scope state-modifier">C</a></state-modifier>
                  <span class="description style-scope classification-tree">CHEMISTRY; METALLURGY</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="C07"><a id="link" href="#" class="style-scope state-modifier">C07</a></state-modifier>
                  <span class="description style-scope classification-tree">ORGANIC CHEMISTRY</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="C07K"><a id="link" href="#" class="style-scope state-modifier">C07K</a></state-modifier>
                  <span class="description style-scope classification-tree">PEPTIDES</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="C07K16/00"><a id="link" href="#" class="style-scope state-modifier">C07K16/00</a></state-modifier>
                  <span class="description style-scope classification-tree">Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="C07K16/40"><a id="link" href="#" class="style-scope state-modifier">C07K16/40</a></state-modifier>
                  <span class="description style-scope classification-tree">Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against enzymes</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          <template is="dom-repeat" class="style-scope classification-tree"></template>
        </div>
      </div>
    </div>
  </classification-tree>
        
          <classification-tree class="style-scope classification-viewer">
    
    <div class="style-scope classification-tree">
      <div class="layout horizontal wrap style-scope classification-tree">
        <div class="flex style-scope classification-tree">
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="C"><a id="link" href="#" class="style-scope state-modifier">C</a></state-modifier>
                  <span class="description style-scope classification-tree">CHEMISTRY; METALLURGY</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="C12"><a id="link" href="#" class="style-scope state-modifier">C12</a></state-modifier>
                  <span class="description style-scope classification-tree">BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="C12Q"><a id="link" href="#" class="style-scope state-modifier">C12Q</a></state-modifier>
                  <span class="description style-scope classification-tree">MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="C12Q1/00"><a id="link" href="#" class="style-scope state-modifier">C12Q1/00</a></state-modifier>
                  <span class="description style-scope classification-tree">Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="C12Q1/68"><a id="link" href="#" class="style-scope state-modifier">C12Q1/68</a></state-modifier>
                  <span class="description style-scope classification-tree">Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="C12Q1/6876"><a id="link" href="#" class="style-scope state-modifier">C12Q1/6876</a></state-modifier>
                  <span class="description style-scope classification-tree">Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="C12Q1/6883"><a id="link" href="#" class="style-scope state-modifier">C12Q1/6883</a></state-modifier>
                  <span class="description style-scope classification-tree">Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="C12Q1/6886"><a id="link" href="#" class="style-scope state-modifier">C12Q1/6886</a></state-modifier>
                  <span class="description style-scope classification-tree">Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          <template is="dom-repeat" class="style-scope classification-tree"></template>
        </div>
      </div>
    </div>
  </classification-tree>
        
          <classification-tree class="style-scope classification-viewer">
    
    <div class="style-scope classification-tree">
      <div class="layout horizontal wrap style-scope classification-tree">
        <div class="flex style-scope classification-tree">
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="G"><a id="link" href="#" class="style-scope state-modifier">G</a></state-modifier>
                  <span class="description style-scope classification-tree">PHYSICS</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="G01"><a id="link" href="#" class="style-scope state-modifier">G01</a></state-modifier>
                  <span class="description style-scope classification-tree">MEASURING; TESTING</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="G01N"><a id="link" href="#" class="style-scope state-modifier">G01N</a></state-modifier>
                  <span class="description style-scope classification-tree">INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="G01N33/00"><a id="link" href="#" class="style-scope state-modifier">G01N33/00</a></state-modifier>
                  <span class="description style-scope classification-tree">Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="G01N33/48"><a id="link" href="#" class="style-scope state-modifier">G01N33/48</a></state-modifier>
                  <span class="description style-scope classification-tree">Biological material, e.g. blood, urine; Haemocytometers</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="G01N33/50"><a id="link" href="#" class="style-scope state-modifier">G01N33/50</a></state-modifier>
                  <span class="description style-scope classification-tree">Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="G01N33/53"><a id="link" href="#" class="style-scope state-modifier">G01N33/53</a></state-modifier>
                  <span class="description style-scope classification-tree">Immunoassay; Biospecific binding assay; Materials therefor</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="G01N33/574"><a id="link" href="#" class="style-scope state-modifier">G01N33/574</a></state-modifier>
                  <span class="description style-scope classification-tree">Immunoassay; Biospecific binding assay; Materials therefor for cancer</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="G01N33/57407"><a id="link" href="#" class="style-scope state-modifier">G01N33/57407</a></state-modifier>
                  <span class="description style-scope classification-tree">Specifically defined cancers</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="G01N33/57419"><a id="link" href="#" class="style-scope state-modifier">G01N33/57419</a></state-modifier>
                  <span class="description style-scope classification-tree">Specifically defined cancers of colon</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          <template is="dom-repeat" class="style-scope classification-tree"></template>
        </div>
      </div>
    </div>
  </classification-tree>
        
          <classification-tree class="style-scope classification-viewer">
    
    <div class="style-scope classification-tree">
      <div class="layout horizontal wrap style-scope classification-tree">
        <div class="flex style-scope classification-tree">
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="G"><a id="link" href="#" class="style-scope state-modifier">G</a></state-modifier>
                  <span class="description style-scope classification-tree">PHYSICS</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="G01"><a id="link" href="#" class="style-scope state-modifier">G01</a></state-modifier>
                  <span class="description style-scope classification-tree">MEASURING; TESTING</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="G01N"><a id="link" href="#" class="style-scope state-modifier">G01N</a></state-modifier>
                  <span class="description style-scope classification-tree">INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="G01N33/00"><a id="link" href="#" class="style-scope state-modifier">G01N33/00</a></state-modifier>
                  <span class="description style-scope classification-tree">Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="G01N33/48"><a id="link" href="#" class="style-scope state-modifier">G01N33/48</a></state-modifier>
                  <span class="description style-scope classification-tree">Biological material, e.g. blood, urine; Haemocytometers</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="G01N33/50"><a id="link" href="#" class="style-scope state-modifier">G01N33/50</a></state-modifier>
                  <span class="description style-scope classification-tree">Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="G01N33/53"><a id="link" href="#" class="style-scope state-modifier">G01N33/53</a></state-modifier>
                  <span class="description style-scope classification-tree">Immunoassay; Biospecific binding assay; Materials therefor</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="G01N33/574"><a id="link" href="#" class="style-scope state-modifier">G01N33/574</a></state-modifier>
                  <span class="description style-scope classification-tree">Immunoassay; Biospecific binding assay; Materials therefor for cancer</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="G01N33/57407"><a id="link" href="#" class="style-scope state-modifier">G01N33/57407</a></state-modifier>
                  <span class="description style-scope classification-tree">Specifically defined cancers</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="G01N33/57423"><a id="link" href="#" class="style-scope state-modifier">G01N33/57423</a></state-modifier>
                  <span class="description style-scope classification-tree">Specifically defined cancers of lung</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          <template is="dom-repeat" class="style-scope classification-tree"></template>
        </div>
      </div>
    </div>
  </classification-tree>
        
          <classification-tree class="style-scope classification-viewer">
    
    <div class="style-scope classification-tree">
      <div class="layout horizontal wrap style-scope classification-tree">
        <div class="flex style-scope classification-tree">
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="G"><a id="link" href="#" class="style-scope state-modifier">G</a></state-modifier>
                  <span class="description style-scope classification-tree">PHYSICS</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="G01"><a id="link" href="#" class="style-scope state-modifier">G01</a></state-modifier>
                  <span class="description style-scope classification-tree">MEASURING; TESTING</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="G01N"><a id="link" href="#" class="style-scope state-modifier">G01N</a></state-modifier>
                  <span class="description style-scope classification-tree">INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="G01N33/00"><a id="link" href="#" class="style-scope state-modifier">G01N33/00</a></state-modifier>
                  <span class="description style-scope classification-tree">Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="G01N33/48"><a id="link" href="#" class="style-scope state-modifier">G01N33/48</a></state-modifier>
                  <span class="description style-scope classification-tree">Biological material, e.g. blood, urine; Haemocytometers</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="G01N33/50"><a id="link" href="#" class="style-scope state-modifier">G01N33/50</a></state-modifier>
                  <span class="description style-scope classification-tree">Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="G01N33/53"><a id="link" href="#" class="style-scope state-modifier">G01N33/53</a></state-modifier>
                  <span class="description style-scope classification-tree">Immunoassay; Biospecific binding assay; Materials therefor</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="G01N33/574"><a id="link" href="#" class="style-scope state-modifier">G01N33/574</a></state-modifier>
                  <span class="description style-scope classification-tree">Immunoassay; Biospecific binding assay; Materials therefor for cancer</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="G01N33/57407"><a id="link" href="#" class="style-scope state-modifier">G01N33/57407</a></state-modifier>
                  <span class="description style-scope classification-tree">Specifically defined cancers</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="G01N33/57446"><a id="link" href="#" class="style-scope state-modifier">G01N33/57446</a></state-modifier>
                  <span class="description style-scope classification-tree">Specifically defined cancers of stomach or intestine</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          <template is="dom-repeat" class="style-scope classification-tree"></template>
        </div>
      </div>
    </div>
  </classification-tree>
        
          <classification-tree class="style-scope classification-viewer">
    
    <div class="style-scope classification-tree">
      <div class="layout horizontal wrap style-scope classification-tree">
        <div class="flex style-scope classification-tree">
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="G"><a id="link" href="#" class="style-scope state-modifier">G</a></state-modifier>
                  <span class="description style-scope classification-tree">PHYSICS</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="G01"><a id="link" href="#" class="style-scope state-modifier">G01</a></state-modifier>
                  <span class="description style-scope classification-tree">MEASURING; TESTING</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="G01N"><a id="link" href="#" class="style-scope state-modifier">G01N</a></state-modifier>
                  <span class="description style-scope classification-tree">INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="G01N33/00"><a id="link" href="#" class="style-scope state-modifier">G01N33/00</a></state-modifier>
                  <span class="description style-scope classification-tree">Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="G01N33/48"><a id="link" href="#" class="style-scope state-modifier">G01N33/48</a></state-modifier>
                  <span class="description style-scope classification-tree">Biological material, e.g. blood, urine; Haemocytometers</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="G01N33/50"><a id="link" href="#" class="style-scope state-modifier">G01N33/50</a></state-modifier>
                  <span class="description style-scope classification-tree">Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="G01N33/68"><a id="link" href="#" class="style-scope state-modifier">G01N33/68</a></state-modifier>
                  <span class="description style-scope classification-tree">Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="G01N33/6863"><a id="link" href="#" class="style-scope state-modifier">G01N33/6863</a></state-modifier>
                  <span class="description style-scope classification-tree">Cytokines, i.e. immune system proteins modifying a biological response such as cell growth proliferation or differentiation, e.g. TNF, CNF, GM-CSF, lymphotoxin, MIF or their receptors</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="G01N33/6869"><a id="link" href="#" class="style-scope state-modifier">G01N33/6869</a></state-modifier>
                  <span class="description style-scope classification-tree">Interleukin</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          <template is="dom-repeat" class="style-scope classification-tree"></template>
        </div>
      </div>
    </div>
  </classification-tree>
        
          <classification-tree class="style-scope classification-viewer">
    
    <div class="style-scope classification-tree">
      <div class="layout horizontal wrap style-scope classification-tree">
        <div class="flex style-scope classification-tree">
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="A"><a id="link" href="#" class="style-scope state-modifier">A</a></state-modifier>
                  <span class="description style-scope classification-tree">HUMAN NECESSITIES</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="A61"><a id="link" href="#" class="style-scope state-modifier">A61</a></state-modifier>
                  <span class="description style-scope classification-tree">MEDICAL OR VETERINARY SCIENCE; HYGIENE</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="A61K"><a id="link" href="#" class="style-scope state-modifier">A61K</a></state-modifier>
                  <span class="description style-scope classification-tree">PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="A61K39/00"><a id="link" href="#" class="style-scope state-modifier">A61K39/00</a></state-modifier>
                  <span class="description style-scope classification-tree">Medicinal preparations containing antigens or antibodies</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" additional="true" data-cpc="A61K2039/505"><a id="link" href="#" class="style-scope state-modifier">A61K2039/505</a></state-modifier>
                  <span class="description style-scope classification-tree">Medicinal preparations containing antigens or antibodies comprising antibodies</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          <template is="dom-repeat" class="style-scope classification-tree"></template>
        </div>
      </div>
    </div>
  </classification-tree>
        
          <classification-tree class="style-scope classification-viewer">
    
    <div class="style-scope classification-tree">
      <div class="layout horizontal wrap style-scope classification-tree">
        <div class="flex style-scope classification-tree">
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="C"><a id="link" href="#" class="style-scope state-modifier">C</a></state-modifier>
                  <span class="description style-scope classification-tree">CHEMISTRY; METALLURGY</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="C07"><a id="link" href="#" class="style-scope state-modifier">C07</a></state-modifier>
                  <span class="description style-scope classification-tree">ORGANIC CHEMISTRY</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="C07K"><a id="link" href="#" class="style-scope state-modifier">C07K</a></state-modifier>
                  <span class="description style-scope classification-tree">PEPTIDES</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="C07K2317/00"><a id="link" href="#" class="style-scope state-modifier">C07K2317/00</a></state-modifier>
                  <span class="description style-scope classification-tree">Immunoglobulins specific features</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="C07K2317/20"><a id="link" href="#" class="style-scope state-modifier">C07K2317/20</a></state-modifier>
                  <span class="description style-scope classification-tree">Immunoglobulins specific features characterized by taxonomic origin</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" additional="true" data-cpc="C07K2317/24"><a id="link" href="#" class="style-scope state-modifier">C07K2317/24</a></state-modifier>
                  <span class="description style-scope classification-tree">Immunoglobulins specific features characterized by taxonomic origin containing regions, domains or residues from different species, e.g. chimeric, humanized or veneered</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          <template is="dom-repeat" class="style-scope classification-tree"></template>
        </div>
      </div>
    </div>
  </classification-tree>
        
          <classification-tree class="style-scope classification-viewer">
    
    <div class="style-scope classification-tree">
      <div class="layout horizontal wrap style-scope classification-tree">
        <div class="flex style-scope classification-tree">
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="C"><a id="link" href="#" class="style-scope state-modifier">C</a></state-modifier>
                  <span class="description style-scope classification-tree">CHEMISTRY; METALLURGY</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="C07"><a id="link" href="#" class="style-scope state-modifier">C07</a></state-modifier>
                  <span class="description style-scope classification-tree">ORGANIC CHEMISTRY</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="C07K"><a id="link" href="#" class="style-scope state-modifier">C07K</a></state-modifier>
                  <span class="description style-scope classification-tree">PEPTIDES</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="C07K2317/00"><a id="link" href="#" class="style-scope state-modifier">C07K2317/00</a></state-modifier>
                  <span class="description style-scope classification-tree">Immunoglobulins specific features</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="C07K2317/50"><a id="link" href="#" class="style-scope state-modifier">C07K2317/50</a></state-modifier>
                  <span class="description style-scope classification-tree">Immunoglobulins specific features characterized by immunoglobulin fragments</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="C07K2317/52"><a id="link" href="#" class="style-scope state-modifier">C07K2317/52</a></state-modifier>
                  <span class="description style-scope classification-tree">Constant or Fc region; Isotype</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" additional="true" data-cpc="C07K2317/53"><a id="link" href="#" class="style-scope state-modifier">C07K2317/53</a></state-modifier>
                  <span class="description style-scope classification-tree">Hinge</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          <template is="dom-repeat" class="style-scope classification-tree"></template>
        </div>
      </div>
    </div>
  </classification-tree>
        
          <classification-tree class="style-scope classification-viewer">
    
    <div class="style-scope classification-tree">
      <div class="layout horizontal wrap style-scope classification-tree">
        <div class="flex style-scope classification-tree">
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="C"><a id="link" href="#" class="style-scope state-modifier">C</a></state-modifier>
                  <span class="description style-scope classification-tree">CHEMISTRY; METALLURGY</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="C07"><a id="link" href="#" class="style-scope state-modifier">C07</a></state-modifier>
                  <span class="description style-scope classification-tree">ORGANIC CHEMISTRY</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="C07K"><a id="link" href="#" class="style-scope state-modifier">C07K</a></state-modifier>
                  <span class="description style-scope classification-tree">PEPTIDES</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="C07K2317/00"><a id="link" href="#" class="style-scope state-modifier">C07K2317/00</a></state-modifier>
                  <span class="description style-scope classification-tree">Immunoglobulins specific features</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="C07K2317/50"><a id="link" href="#" class="style-scope state-modifier">C07K2317/50</a></state-modifier>
                  <span class="description style-scope classification-tree">Immunoglobulins specific features characterized by immunoglobulin fragments</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="C07K2317/56"><a id="link" href="#" class="style-scope state-modifier">C07K2317/56</a></state-modifier>
                  <span class="description style-scope classification-tree">Immunoglobulins specific features characterized by immunoglobulin fragments variable (Fv) region, i.e. VH and/or VL</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" additional="true" data-cpc="C07K2317/565"><a id="link" href="#" class="style-scope state-modifier">C07K2317/565</a></state-modifier>
                  <span class="description style-scope classification-tree">Complementarity determining region [CDR]</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          <template is="dom-repeat" class="style-scope classification-tree"></template>
        </div>
      </div>
    </div>
  </classification-tree>
        
          <classification-tree class="style-scope classification-viewer">
    
    <div class="style-scope classification-tree">
      <div class="layout horizontal wrap style-scope classification-tree">
        <div class="flex style-scope classification-tree">
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="C"><a id="link" href="#" class="style-scope state-modifier">C</a></state-modifier>
                  <span class="description style-scope classification-tree">CHEMISTRY; METALLURGY</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="C07"><a id="link" href="#" class="style-scope state-modifier">C07</a></state-modifier>
                  <span class="description style-scope classification-tree">ORGANIC CHEMISTRY</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="C07K"><a id="link" href="#" class="style-scope state-modifier">C07K</a></state-modifier>
                  <span class="description style-scope classification-tree">PEPTIDES</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="C07K2317/00"><a id="link" href="#" class="style-scope state-modifier">C07K2317/00</a></state-modifier>
                  <span class="description style-scope classification-tree">Immunoglobulins specific features</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="C07K2317/60"><a id="link" href="#" class="style-scope state-modifier">C07K2317/60</a></state-modifier>
                  <span class="description style-scope classification-tree">Immunoglobulins specific features characterized by non-natural combinations of immunoglobulin fragments</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="C07K2317/62"><a id="link" href="#" class="style-scope state-modifier">C07K2317/62</a></state-modifier>
                  <span class="description style-scope classification-tree">Immunoglobulins specific features characterized by non-natural combinations of immunoglobulin fragments comprising only variable region components</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" additional="true" data-cpc="C07K2317/622"><a id="link" href="#" class="style-scope state-modifier">C07K2317/622</a></state-modifier>
                  <span class="description style-scope classification-tree">Single chain antibody (scFv)</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          <template is="dom-repeat" class="style-scope classification-tree"></template>
        </div>
      </div>
    </div>
  </classification-tree>
        
          <classification-tree class="style-scope classification-viewer">
    
    <div class="style-scope classification-tree">
      <div class="layout horizontal wrap style-scope classification-tree">
        <div class="flex style-scope classification-tree">
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="C"><a id="link" href="#" class="style-scope state-modifier">C</a></state-modifier>
                  <span class="description style-scope classification-tree">CHEMISTRY; METALLURGY</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="C07"><a id="link" href="#" class="style-scope state-modifier">C07</a></state-modifier>
                  <span class="description style-scope classification-tree">ORGANIC CHEMISTRY</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="C07K"><a id="link" href="#" class="style-scope state-modifier">C07K</a></state-modifier>
                  <span class="description style-scope classification-tree">PEPTIDES</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="C07K2317/00"><a id="link" href="#" class="style-scope state-modifier">C07K2317/00</a></state-modifier>
                  <span class="description style-scope classification-tree">Immunoglobulins specific features</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="C07K2317/70"><a id="link" href="#" class="style-scope state-modifier">C07K2317/70</a></state-modifier>
                  <span class="description style-scope classification-tree">Immunoglobulins specific features characterized by effect upon binding to a cell or to an antigen</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" additional="true" data-cpc="C07K2317/76"><a id="link" href="#" class="style-scope state-modifier">C07K2317/76</a></state-modifier>
                  <span class="description style-scope classification-tree">Antagonist effect on antigen, e.g. neutralization or inhibition of binding</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          <template is="dom-repeat" class="style-scope classification-tree"></template>
        </div>
      </div>
    </div>
  </classification-tree>
        
          <classification-tree class="style-scope classification-viewer">
    
    <div class="style-scope classification-tree">
      <div class="layout horizontal wrap style-scope classification-tree">
        <div class="flex style-scope classification-tree">
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="C"><a id="link" href="#" class="style-scope state-modifier">C</a></state-modifier>
                  <span class="description style-scope classification-tree">CHEMISTRY; METALLURGY</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="C12"><a id="link" href="#" class="style-scope state-modifier">C12</a></state-modifier>
                  <span class="description style-scope classification-tree">BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="C12Q"><a id="link" href="#" class="style-scope state-modifier">C12Q</a></state-modifier>
                  <span class="description style-scope classification-tree">MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="C12Q2600/00"><a id="link" href="#" class="style-scope state-modifier">C12Q2600/00</a></state-modifier>
                  <span class="description style-scope classification-tree">Oligonucleotides characterized by their use</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" additional="true" data-cpc="C12Q2600/106"><a id="link" href="#" class="style-scope state-modifier">C12Q2600/106</a></state-modifier>
                  <span class="description style-scope classification-tree">Pharmacogenomics, i.e. genetic variability in individual responses to drugs and drug metabolism</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          <template is="dom-repeat" class="style-scope classification-tree"></template>
        </div>
      </div>
    </div>
  </classification-tree>
        
          <classification-tree class="style-scope classification-viewer">
    
    <div class="style-scope classification-tree">
      <div class="layout horizontal wrap style-scope classification-tree">
        <div class="flex style-scope classification-tree">
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="C"><a id="link" href="#" class="style-scope state-modifier">C</a></state-modifier>
                  <span class="description style-scope classification-tree">CHEMISTRY; METALLURGY</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="C12"><a id="link" href="#" class="style-scope state-modifier">C12</a></state-modifier>
                  <span class="description style-scope classification-tree">BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="C12Q"><a id="link" href="#" class="style-scope state-modifier">C12Q</a></state-modifier>
                  <span class="description style-scope classification-tree">MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="C12Q2600/00"><a id="link" href="#" class="style-scope state-modifier">C12Q2600/00</a></state-modifier>
                  <span class="description style-scope classification-tree">Oligonucleotides characterized by their use</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" additional="true" data-cpc="C12Q2600/158"><a id="link" href="#" class="style-scope state-modifier">C12Q2600/158</a></state-modifier>
                  <span class="description style-scope classification-tree">Expression markers</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          <template is="dom-repeat" class="style-scope classification-tree"></template>
        </div>
      </div>
    </div>
  </classification-tree>
        
          <classification-tree class="style-scope classification-viewer">
    
    <div class="style-scope classification-tree">
      <div class="layout horizontal wrap style-scope classification-tree">
        <div class="flex style-scope classification-tree">
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="G"><a id="link" href="#" class="style-scope state-modifier">G</a></state-modifier>
                  <span class="description style-scope classification-tree">PHYSICS</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="G01"><a id="link" href="#" class="style-scope state-modifier">G01</a></state-modifier>
                  <span class="description style-scope classification-tree">MEASURING; TESTING</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="G01N"><a id="link" href="#" class="style-scope state-modifier">G01N</a></state-modifier>
                  <span class="description style-scope classification-tree">INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="G01N2333/00"><a id="link" href="#" class="style-scope state-modifier">G01N2333/00</a></state-modifier>
                  <span class="description style-scope classification-tree">Assays involving biological materials from specific organisms or of a specific nature</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="G01N2333/435"><a id="link" href="#" class="style-scope state-modifier">G01N2333/435</a></state-modifier>
                  <span class="description style-scope classification-tree">Assays involving biological materials from specific organisms or of a specific nature from animals; from humans</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="G01N2333/475"><a id="link" href="#" class="style-scope state-modifier">G01N2333/475</a></state-modifier>
                  <span class="description style-scope classification-tree">Assays involving growth factors</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" additional="true" data-cpc="G01N2333/495"><a id="link" href="#" class="style-scope state-modifier">G01N2333/495</a></state-modifier>
                  <span class="description style-scope classification-tree">Transforming growth factor [TGF]</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          <template is="dom-repeat" class="style-scope classification-tree"></template>
        </div>
      </div>
    </div>
  </classification-tree>
        
          <classification-tree class="style-scope classification-viewer">
    
    <div class="style-scope classification-tree">
      <div class="layout horizontal wrap style-scope classification-tree">
        <div class="flex style-scope classification-tree">
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="G"><a id="link" href="#" class="style-scope state-modifier">G</a></state-modifier>
                  <span class="description style-scope classification-tree">PHYSICS</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="G01"><a id="link" href="#" class="style-scope state-modifier">G01</a></state-modifier>
                  <span class="description style-scope classification-tree">MEASURING; TESTING</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="G01N"><a id="link" href="#" class="style-scope state-modifier">G01N</a></state-modifier>
                  <span class="description style-scope classification-tree">INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="G01N2333/00"><a id="link" href="#" class="style-scope state-modifier">G01N2333/00</a></state-modifier>
                  <span class="description style-scope classification-tree">Assays involving biological materials from specific organisms or of a specific nature</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="G01N2333/435"><a id="link" href="#" class="style-scope state-modifier">G01N2333/435</a></state-modifier>
                  <span class="description style-scope classification-tree">Assays involving biological materials from specific organisms or of a specific nature from animals; from humans</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="G01N2333/52"><a id="link" href="#" class="style-scope state-modifier">G01N2333/52</a></state-modifier>
                  <span class="description style-scope classification-tree">Assays involving cytokines</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="G01N2333/54"><a id="link" href="#" class="style-scope state-modifier">G01N2333/54</a></state-modifier>
                  <span class="description style-scope classification-tree">Interleukins [IL]</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" additional="true" data-cpc="G01N2333/5421"><a id="link" href="#" class="style-scope state-modifier">G01N2333/5421</a></state-modifier>
                  <span class="description style-scope classification-tree">IL-8</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          <template is="dom-repeat" class="style-scope classification-tree"></template>
        </div>
      </div>
    </div>
  </classification-tree>
        
          <classification-tree class="style-scope classification-viewer">
    
    <div class="style-scope classification-tree">
      <div class="layout horizontal wrap style-scope classification-tree">
        <div class="flex style-scope classification-tree">
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="G"><a id="link" href="#" class="style-scope state-modifier">G</a></state-modifier>
                  <span class="description style-scope classification-tree">PHYSICS</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="G01"><a id="link" href="#" class="style-scope state-modifier">G01</a></state-modifier>
                  <span class="description style-scope classification-tree">MEASURING; TESTING</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="G01N"><a id="link" href="#" class="style-scope state-modifier">G01N</a></state-modifier>
                  <span class="description style-scope classification-tree">INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="G01N2333/00"><a id="link" href="#" class="style-scope state-modifier">G01N2333/00</a></state-modifier>
                  <span class="description style-scope classification-tree">Assays involving biological materials from specific organisms or of a specific nature</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="G01N2333/90"><a id="link" href="#" class="style-scope state-modifier">G01N2333/90</a></state-modifier>
                  <span class="description style-scope classification-tree">Enzymes; Proenzymes</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" additional="true" data-cpc="G01N2333/99"><a id="link" href="#" class="style-scope state-modifier">G01N2333/99</a></state-modifier>
                  <span class="description style-scope classification-tree">Isomerases (5.)</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          <template is="dom-repeat" class="style-scope classification-tree"></template>
        </div>
      </div>
    </div>
  </classification-tree>
        
          <classification-tree class="style-scope classification-viewer">
    
    <div class="style-scope classification-tree">
      <div class="layout horizontal wrap style-scope classification-tree">
        <div class="flex style-scope classification-tree">
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="G"><a id="link" href="#" class="style-scope state-modifier">G</a></state-modifier>
                  <span class="description style-scope classification-tree">PHYSICS</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="G01"><a id="link" href="#" class="style-scope state-modifier">G01</a></state-modifier>
                  <span class="description style-scope classification-tree">MEASURING; TESTING</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="G01N"><a id="link" href="#" class="style-scope state-modifier">G01N</a></state-modifier>
                  <span class="description style-scope classification-tree">INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="G01N2800/00"><a id="link" href="#" class="style-scope state-modifier">G01N2800/00</a></state-modifier>
                  <span class="description style-scope classification-tree">Detection or diagnosis of diseases</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" additional="true" data-cpc="G01N2800/52"><a id="link" href="#" class="style-scope state-modifier">G01N2800/52</a></state-modifier>
                  <span class="description style-scope classification-tree">Predicting or monitoring the response to treatment, e.g. for selection of therapy based on assay results in personalised medicine; Prognosis</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          <template is="dom-repeat" class="style-scope classification-tree"></template>
        </div>
      </div>
    </div>
  </classification-tree>
        <template is="dom-repeat" class="style-scope classification-viewer"></template>
        <div class="more style-scope classification-viewer" style="" hidden="">View 18 more classifications</div>
        <div class="more style-scope classification-viewer">Hide more classifications</div>
      </div>
      <template is="dom-if" class="style-scope classification-viewer"></template>
    </div>
  </classification-viewer>
              </section>
              
              <template is="dom-if" class="style-scope patent-result"></template>
              
              <template is="dom-if" class="style-scope patent-result"></template>
              
              
                <section class="style-scope patent-result">
                  <h3 class="layout horizontal style-scope patent-result">
                    <div class="flex style-scope patent-result">Landscapes</div>
                  </h3>
                  <div class="responsive-grid style-scope patent-result">
                    
                      <landscape-link class="style-scope patent-result"><state-modifier act="{&quot;type&quot;:&quot;QUERY_SET_TERM&quot;,&quot;term&quot;:&quot;$term&quot;,&quot;origin&quot;:&quot;LANDSCAPE_LINK&quot;}" class="style-scope landscape-link" data-term="Health &amp; Medical Sciences"><a id="link" href="#" class="style-scope state-modifier">
  <requery-tile class="area style-scope landscape-link">
<span class="label style-scope requery-tile">
    Health &amp; Medical Sciences
  </span>
<span class="search-icon style-scope requery-tile"></span>
</requery-tile>
</a></state-modifier>
</landscape-link>
                    
                      <landscape-link class="style-scope patent-result"><state-modifier act="{&quot;type&quot;:&quot;QUERY_SET_TERM&quot;,&quot;term&quot;:&quot;$term&quot;,&quot;origin&quot;:&quot;LANDSCAPE_LINK&quot;}" class="style-scope landscape-link" data-term="Life Sciences &amp; Earth Sciences"><a id="link" href="#" class="style-scope state-modifier">
  <requery-tile class="area style-scope landscape-link">
<span class="label style-scope requery-tile">
    Life Sciences &amp; Earth Sciences
  </span>
<span class="search-icon style-scope requery-tile"></span>
</requery-tile>
</a></state-modifier>
</landscape-link>
                    <template is="dom-repeat" class="style-scope patent-result"></template>
                  </div>
                  <s-more-inline class="style-scope patent-result"><hr aria-hidden="true" class="style-scope s-more-inline">

<div class="button style-scope s-more-inline">
  <span slot="expand_text" class="style-scope patent-result">Show more</span>
  <span class="expand more style-scope s-more-inline"></span>
</div>
<div class="button style-scope s-more-inline" hidden="">
  <span slot="collapse_text" class="style-scope patent-result">Show less</span>
  <span class="expand less style-scope s-more-inline"></span>
</div>
</s-more-inline>
                </section>
              <template is="dom-if" class="style-scope patent-result"></template>
            </div>
            <div class="flex-2 style-scope patent-result">
              <section class="knowledge-card style-scope patent-result">
                <header class="style-scope patent-result">
                  <h2 id="pubnum" class="style-scope patent-result">EP2891884B1</h2>
                  <p class="tagline style-scope patent-result">European Patent Office</p>
                  <overlay-tooltip positioning-target="#pubnum" direction="bottom" class="style-scope patent-result" style="display: none;">
    
    <div id="arrow" class="style-scope overlay-tooltip" hidden=""></div>
    <div class="style-scope overlay-tooltip">
      
                    <div style="max-width: 300px;" class="style-scope patent-result">Granted patent</div>
                  
    </div>
  </overlay-tooltip>

                  <div class="knowledge-card-action-bar style-scope patent-result">
                    <a target="_blank" class="style-scope patent-result" href="https://patentimages.storage.googleapis.com/32/c0/9c/040e75626587e8/EP2891884B1.pdf"><iron-icon icon="description" class="style-scope patent-result x-scope iron-icon-0"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M14 2H6c-1.1 0-1.99.9-1.99 2L4 20c0 1.1.89 2 1.99 2H18c1.1 0 2-.9 2-2V8l-6-6zm2 16H8v-2h8v2zm0-4H8v-2h8v2zm-3-5V3.5L18.5 9H13z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon> Download PDF</a>
                    <state-modifier inherit="" act="{&quot;type&quot;: &quot;QUERY_FIND_PRIOR_ART&quot;, &quot;keywords&quot;: $keywords, &quot;before&quot;: &quot;$before&quot;}" class="style-scope patent-result" data-keywords="[&quot;met&quot;,&quot;seq&quot;,&quot;antibody&quot;,&quot;met inhibitor&quot;,&quot;efficacy&quot;]" data-before="20140107"><a id="link" href="#" class="style-scope state-modifier" inherit="">
                      <iron-icon icon="find-in-page" class="style-scope patent-result x-scope iron-icon-0"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M20 19.59V8l-6-6H6c-1.1 0-1.99.9-1.99 2L4 20c0 1.1.89 2 1.99 2H18c.45 0 .85-.15 1.19-.4l-4.43-4.43c-.8.52-1.74.83-2.76.83-2.76 0-5-2.24-5-5s2.24-5 5-5 5 2.24 5 5c0 1.02-.31 1.96-.83 2.75L20 19.59zM9 13c0 1.66 1.34 3 3 3s3-1.34 3-3-1.34-3-3-3-3 1.34-3 3z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon> Find Prior Art
                    </a></state-modifier>
                    <state-modifier inherit="" act="{&quot;type&quot;: &quot;QUERY_SIMILAR_DOCUMENTS&quot;, &quot;id&quot;: &quot;$id&quot;}" class="style-scope patent-result" data-id="patent/EP2891884B1"><a id="link" href="#" class="style-scope state-modifier" inherit="">
                      <iron-icon icon="editor:functions" class="style-scope patent-result x-scope iron-icon-0"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M18 4H6v2l6.5 6L6 18v2h12v-3h-7l5-5-5-5h7z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon> Similar
                    </a></state-modifier>
                  </div>
                </header>

                <dl class="important-people style-scope patent-result">
                  
                    <dt class="style-scope patent-result">Other languages</dt>
                    <dd class="style-scope patent-result"><state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/EP2891884B1/de"><a id="link" href="#" class="style-scope state-modifier">German</a></state-modifier></dd><dd class="style-scope patent-result"><state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/EP2891884B1/fr"><a id="link" href="#" class="style-scope state-modifier">French</a></state-modifier></dd><template is="dom-repeat" strip-whitespace="" class="style-scope patent-result"></template>
                  <template is="dom-if" class="style-scope patent-result"></template>
                  
                  <dt class="style-scope patent-result">Inventor</dt>
                  <dd class="style-scope patent-result"><state-modifier act="{&quot;type&quot;: &quot;QUERY_SEARCH_INVENTOR&quot;, &quot;inventor&quot;: &quot;$inventor&quot;}" class="style-scope patent-result" data-inventor="Soo Yeon Jung"><a id="link" href="#" class="style-scope state-modifier">Soo Yeon Jung</a></state-modifier></dd><dd class="style-scope patent-result"><state-modifier act="{&quot;type&quot;: &quot;QUERY_SEARCH_INVENTOR&quot;, &quot;inventor&quot;: &quot;$inventor&quot;}" class="style-scope patent-result" data-inventor="Seon Hui Shim"><a id="link" href="#" class="style-scope state-modifier">Seon Hui Shim</a></state-modifier></dd><dd class="style-scope patent-result"><state-modifier act="{&quot;type&quot;: &quot;QUERY_SEARCH_INVENTOR&quot;, &quot;inventor&quot;: &quot;$inventor&quot;}" class="style-scope patent-result" data-inventor="Yun Jeong Song"><a id="link" href="#" class="style-scope state-modifier">Yun Jeong Song</a></state-modifier></dd><dd class="style-scope patent-result"><state-modifier act="{&quot;type&quot;: &quot;QUERY_SEARCH_INVENTOR&quot;, &quot;inventor&quot;: &quot;$inventor&quot;}" class="style-scope patent-result" data-inventor="Hyeon-seok Yoo"><a id="link" href="#" class="style-scope state-modifier">Hyeon-seok Yoo</a></state-modifier></dd><template is="dom-repeat" strip-whitespace="" class="style-scope patent-result"></template>
                  <template is="dom-if" class="style-scope patent-result"></template>

                  
                  <dt class="style-scope patent-result">
                    <span class="tooltip-hint style-scope patent-result" id="assigneeWarning">Current Assignee</span>
                    <overlay-tooltip positioning-target="#assigneeWarning" direction="bottom" class="style-scope patent-result" style="display: none;">
    
    <div id="arrow" class="style-scope overlay-tooltip" hidden=""></div>
    <div class="style-scope overlay-tooltip">
      
                      The listed assignees may be inaccurate.<br class="style-scope patent-result">
                      Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.
                    
    </div>
  </overlay-tooltip>
                  </dt>
                  <dd class="style-scope patent-result">
                    
    Samsung Electronics Co Ltd
  
                  </dd><template is="dom-repeat" strip-whitespace="" class="style-scope patent-result"></template>
                  <template is="dom-if" class="style-scope patent-result"></template>
                </dl>

                <hr class="style-scope patent-result">

                <application-timeline class="style-scope patent-result">
    
    
    <div class="wrap style-scope application-timeline">
      <div class="header style-scope application-timeline">Worldwide applications</div>
      <div class="event style-scope application-timeline">
        
          <span class="block style-scope application-timeline">
            <span class="year style-scope application-timeline">2015</span>
            <span class="dot style-scope application-timeline"></span>
            
              <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope application-timeline" data-result="patent/US10393748B2/en"><a id="link" href="#" class="style-scope state-modifier">
                <span id="cc" class="active style-scope application-timeline">US</span>
              </a></state-modifier>
              <overlay-tooltip positioning-target="#cc" direction="bottom" class="style-scope application-timeline" style="display: none;">
    
    <div id="arrow" class="style-scope overlay-tooltip" hidden=""></div>
    <div class="style-scope overlay-tooltip">
      
                <div class="style-scope application-timeline">Application number: US14/591,787</div>
                <div class="style-scope application-timeline">Filing date: 2015-01-07</div>
                <div class="style-scope application-timeline">Legal status: Active</div>
              
    </div>
  </overlay-tooltip>
            
              <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope application-timeline" data-result="patent/CN104762371B/en"><a id="link" href="#" class="style-scope state-modifier">
                <span id="cc" class="active style-scope application-timeline">CN</span>
              </a></state-modifier>
              <overlay-tooltip positioning-target="#cc" direction="bottom" class="style-scope application-timeline" style="display: none;">
    
    <div id="arrow" class="style-scope overlay-tooltip" hidden=""></div>
    <div class="style-scope overlay-tooltip">
      
                <div class="style-scope application-timeline">Application number: CN201510008065.5A</div>
                <div class="style-scope application-timeline">Filing date: 2015-01-07</div>
                <div class="style-scope application-timeline">Legal status: Active</div>
              
    </div>
  </overlay-tooltip>
            
              <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope application-timeline" data-result="patent/EP2891884B1/en"><a id="link" href="#" class="style-scope state-modifier">
                <span id="cc" class="active style-scope application-timeline" this="">EP</span>
              </a></state-modifier>
              <overlay-tooltip positioning-target="#cc" direction="bottom" class="style-scope application-timeline" style="display: none;">
    
    <div id="arrow" class="style-scope overlay-tooltip" hidden=""></div>
    <div class="style-scope overlay-tooltip">
      
                <div class="style-scope application-timeline">Application number: EP15150360.4A</div>
                <div class="style-scope application-timeline">Filing date: 2015-01-07</div>
                <div class="style-scope application-timeline">Legal status: Active</div>
              
    </div>
  </overlay-tooltip>
            
              <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope application-timeline" data-result="patent/JP6512828B2/en"><a id="link" href="#" class="style-scope state-modifier">
                <span id="cc" class="active style-scope application-timeline">JP</span>
              </a></state-modifier>
              <overlay-tooltip positioning-target="#cc" direction="bottom" class="style-scope application-timeline" style="display: none;">
    
    <div id="arrow" class="style-scope overlay-tooltip" hidden=""></div>
    <div class="style-scope overlay-tooltip">
      
                <div class="style-scope application-timeline">Application number: JP2015001880A</div>
                <div class="style-scope application-timeline">Filing date: 2015-01-07</div>
                <div class="style-scope application-timeline">Legal status: Active</div>
              
    </div>
  </overlay-tooltip>
            <template is="dom-repeat" class="style-scope application-timeline"></template>
          </span>
        <template is="dom-repeat" class="style-scope application-timeline"></template>
      </div>
      <hr class="style-scope application-timeline">
      <div class="header style-scope application-timeline">Application EP15150360.4A events <iron-icon id="legal" icon="icons:help-outline" class="style-scope application-timeline x-scope iron-icon-0"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M11 18h2v-2h-2v2zm1-16C6.48 2 2 6.48 2 12s4.48 10 10 10 10-4.48 10-10S17.52 2 12 2zm0 18c-4.41 0-8-3.59-8-8s3.59-8 8-8 8 3.59 8 8-3.59 8-8 8zm0-14c-2.21 0-4 1.79-4 4h2c0-1.1.9-2 2-2s2 .9 2 2c0 2-3 1.75-3 5h2c0-2.25 3-2.5 3-5 0-2.21-1.79-4-4-4z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
        <overlay-tooltip positioning-target="#legal" direction="right" class="style-scope application-timeline" style="display: none;">
    
    <div id="arrow" class="style-scope overlay-tooltip" hidden=""></div>
    <div class="style-scope overlay-tooltip">
      
          <div style="max-width: 300px;" class="style-scope application-timeline">
            A timeline of key events for this patent application, including priority claims, publications, legal status, reassignments, and litigation.<br class="style-scope application-timeline"><br class="style-scope application-timeline">
            Google has not performed a legal analysis and makes no representation as to the accuracy or completeness of the events listed.
          </div>
        
    </div>
  </overlay-tooltip>
      </div>
      <div class="event layout horizontal style-scope application-timeline"><div date="" class="external-priority style-scope application-timeline">2015-01-06</div><div class="line style-scope application-timeline"></div><div class="flex title style-scope application-timeline"><template is="dom-if" class="style-scope application-timeline"></template><state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope application-timeline" data-result="patent/KR102272788B1/en"><a id="link" href="#" class="style-scope state-modifier"><span class="title-text style-scope application-timeline">Priority claimed from KR1020150000956A</span></a></state-modifier><template is="dom-if" class="style-scope application-timeline"></template><template is="dom-if" class="style-scope application-timeline"></template><template is="dom-if" class="style-scope application-timeline"></template><template is="dom-if" class="style-scope application-timeline"></template></div></div><div class="event layout horizontal style-scope application-timeline" critical=""><div date="" class="filed style-scope application-timeline">2015-01-07</div><div class="line style-scope application-timeline"></div><div class="flex title style-scope application-timeline"><template is="dom-if" class="style-scope application-timeline"></template><template is="dom-if" class="style-scope application-timeline"></template><state-modifier act="{&quot;type&quot;: &quot;QUERY_SEARCH_ASSIGNEE&quot;, &quot;assignee&quot;: &quot;$assignee&quot;}" class="style-scope application-timeline" data-assignee="Samsung Electronics Co Ltd"><a id="link" href="#" class="style-scope state-modifier"><span class="title-text style-scope application-timeline">Application filed by Samsung Electronics Co Ltd</span></a></state-modifier><template is="dom-if" class="style-scope application-timeline"></template><template is="dom-if" class="style-scope application-timeline"></template><template is="dom-if" class="style-scope application-timeline"></template></div></div><div class="event layout horizontal style-scope application-timeline" critical=""><div date="" class="publication style-scope application-timeline">2015-07-08</div><div class="line style-scope application-timeline"></div><div class="flex title style-scope application-timeline"><template is="dom-if" class="style-scope application-timeline"></template><state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope application-timeline" data-result="patent/EP2891884A2/en"><a id="link" href="#" class="style-scope state-modifier"><span class="title-text style-scope application-timeline">Publication of EP2891884A2</span></a></state-modifier><template is="dom-if" class="style-scope application-timeline"></template><template is="dom-if" class="style-scope application-timeline"></template><template is="dom-if" class="style-scope application-timeline"></template><template is="dom-if" class="style-scope application-timeline"></template></div></div><div class="event layout horizontal style-scope application-timeline" critical=""><div date="" class="publication style-scope application-timeline">2015-10-14</div><div class="line style-scope application-timeline"></div><div class="flex title style-scope application-timeline"><template is="dom-if" class="style-scope application-timeline"></template><state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope application-timeline" data-result="patent/EP2891884A3/en"><a id="link" href="#" class="style-scope state-modifier"><span class="title-text style-scope application-timeline">Publication of EP2891884A3</span></a></state-modifier><template is="dom-if" class="style-scope application-timeline"></template><template is="dom-if" class="style-scope application-timeline"></template><template is="dom-if" class="style-scope application-timeline"></template><template is="dom-if" class="style-scope application-timeline"></template></div></div><div class="event layout horizontal style-scope application-timeline" critical=""><div date="" class="granted style-scope application-timeline">2017-10-25</div><div class="line style-scope application-timeline"></div><div class="flex title style-scope application-timeline"><template is="dom-if" class="style-scope application-timeline"></template><template is="dom-if" class="style-scope application-timeline"></template><template is="dom-if" class="style-scope application-timeline"></template><span class="title-text style-scope application-timeline">Application granted</span><template is="dom-if" class="style-scope application-timeline"></template><template is="dom-if" class="style-scope application-timeline"></template></div></div><div class="event layout horizontal style-scope application-timeline" critical=""><div date="" class="publication style-scope application-timeline">2017-10-25</div><div class="line style-scope application-timeline"></div><div class="flex title style-scope application-timeline"><template is="dom-if" class="style-scope application-timeline"></template><state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope application-timeline" data-result="patent/EP2891884B1/en"><a id="link" href="#" class="style-scope state-modifier"><span class="title-text style-scope application-timeline">Publication of EP2891884B1</span></a></state-modifier><template is="dom-if" class="style-scope application-timeline"></template><template is="dom-if" class="style-scope application-timeline"></template><template is="dom-if" class="style-scope application-timeline"></template><template is="dom-if" class="style-scope application-timeline"></template></div></div><div class="event layout horizontal style-scope application-timeline" current="" critical=""><div date="" class="legal-status style-scope application-timeline">Status</div><div class="line style-scope application-timeline"></div><div class="flex title style-scope application-timeline"><template is="dom-if" class="style-scope application-timeline"></template><template is="dom-if" class="style-scope application-timeline"></template><template is="dom-if" class="style-scope application-timeline"></template><span class="title-text style-scope application-timeline">Active</span><template is="dom-if" class="style-scope application-timeline"></template><template is="dom-if" class="style-scope application-timeline"></template></div></div><div class="event layout horizontal style-scope application-timeline" critical=""><div date="" class="legal-status style-scope application-timeline">2035-01-07</div><div class="line style-scope application-timeline"></div><div class="flex title style-scope application-timeline"><template is="dom-if" class="style-scope application-timeline"></template><template is="dom-if" class="style-scope application-timeline"></template><template is="dom-if" class="style-scope application-timeline"></template><span class="title-text style-scope application-timeline">Anticipated expiration</span><template is="dom-if" class="style-scope application-timeline"></template><template is="dom-if" class="style-scope application-timeline"></template></div></div><template is="dom-repeat" strip-whitespace="" class="style-scope application-timeline"></template>
      <template is="dom-if" class="style-scope application-timeline"></template>
    </div>
  </application-timeline>
                <hr class="style-scope patent-result">

                <dl class="links style-scope patent-result">
                  <dt class="style-scope patent-result">Info</dt>

                  
                  <dd class="style-scope patent-result"><a href="#patentCitations" class="style-scope patent-result">Patent citations (20)</a></dd>
                  <template is="dom-if" restamp="" class="style-scope patent-result"></template>

                  
                  <dd class="style-scope patent-result"><a href="#nplCitations" class="style-scope patent-result">Non-patent citations (1)</a></dd>
                  <template is="dom-if" restamp="" class="style-scope patent-result"></template>

                  
                  <dd class="style-scope patent-result"><a href="#citedBy" class="style-scope patent-result">Cited by (1)</a></dd>
                  <template is="dom-if" restamp="" class="style-scope patent-result"></template>

                  
                  <dd class="style-scope patent-result"><a href="#legalEvents" class="style-scope patent-result">Legal events</a></dd>
                  <template is="dom-if" restamp="" class="style-scope patent-result"></template>

                  
                  <dd class="style-scope patent-result"><a href="#similarDocuments" class="style-scope patent-result">Similar documents</a></dd>
                  <template is="dom-if" restamp="" class="style-scope patent-result"></template>

                  
                  <dd class="style-scope patent-result"><a href="#relatedApplications" class="style-scope patent-result">Priority and Related Applications</a></dd>
                  <template is="dom-if" restamp="" class="style-scope patent-result"></template>

                  <dt class="style-scope patent-result">External links</dt>

                  <dd class="style-scope patent-result"><a target="_blank" class="style-scope patent-result" href="https://worldwide.espacenet.com/publicationDetails/biblio?CC=EP&amp;NR=2891884B1&amp;KC=B1&amp;FT=D">Espacenet</a></dd><dd class="style-scope patent-result"><a target="_blank" class="style-scope patent-result" href="https://data.epo.org/gpi/EP2891884B1">EPO GPI</a></dd><dd class="style-scope patent-result"><a target="_blank" class="style-scope patent-result" href="https://register.epo.org/espacenet/application?number=EP15150360">EP Register</a></dd><dd class="style-scope patent-result"><a target="_blank" class="style-scope patent-result" href="https://globaldossier.uspto.gov/#/result/publication/EP/2891884/1">Global Dossier</a></dd><dd class="style-scope patent-result"><a target="_blank" class="style-scope patent-result" href="https://patents.stackexchange.com/questions/tagged/EP2891884B1">Discuss</a></dd><template is="dom-repeat" strip-whitespace="" class="style-scope patent-result"></template>
                </dl>
              </section>
            </div>
          </div>

          <div id="text" class="horizontal layout style-scope patent-result">
            <div class="flex flex-width style-scope patent-result" marginright="">
              <section id="description" class="style-scope patent-result">
                <h3 class="layout horizontal style-scope patent-result">
                  <div class="flex style-scope patent-result">Description</div>
                  <div class="righthead style-scope patent-result" hidden="">translated from </div>
                </h3>
                <patent-text name="description" id="descriptionText" class="style-scope patent-result" style="padding-top: 0px;">
    
    
    <template is="dom-if" restamp="" class="style-scope patent-text"></template>
    <overlay-tooltip id="tooltip" class="style-scope patent-text" style="display: none;">
    
    <div id="arrow" class="style-scope overlay-tooltip" hidden=""></div>
    <div class="style-scope overlay-tooltip">
      
    </div>
  </overlay-tooltip>
    <div class="layout horizontal style-scope patent-text">
      <section id="text" class="flex style-scope patent-text"><ul mxw-id="PDES122228147" lang="EN" load-source="patent-office" class="description style-scope patent-text">
    
    <heading id="h0001" class="style-scope patent-text">
      <b class="style-scope patent-text">BACKGROUND OF THE <figure-callout id="1" label="INVENTION" filenames="imgf0003.png,imgf0006.png" class="style-scope patent-text"><a title="Show image containing callout" class="style-scope figure-callout">INVENTION</a></figure-callout> </b>
    </heading>
    <heading id="h0002" class="style-scope patent-text">
      <b class="style-scope patent-text">1. Field</b>
    </heading>
    <li class="style-scope patent-text"> <para-num num="[0001]" class="style-scope patent-text">
    
    [0001]
  </para-num> <div id="p0001" num="0001" class="description-line style-scope patent-text">Provided are methods for predicting the effect of an antic-Met antibody by analyzing IL-8, and an anti-c Met antibody for use in a method of treating cancer in a subject having a high level of IL-8.</div>
    </li> <heading id="h0003" class="style-scope patent-text">
      <b class="style-scope patent-text">2. Description of the Related Art</b>
    </heading>
    <li class="style-scope patent-text"> <para-num num="[0002]" class="style-scope patent-text">
    
    [0002]
  </para-num> <div id="p0002" num="0002" class="description-line style-scope patent-text">A biomarker generally refers to a measured characteristic (e.g., a naturally occurring protein) which may be used as an indicator of some change caused in an organism by an external factor (e.g., injury). Active studies have recently been made to apply biomarkers to the diagnosis of various diseases, such as cancer, stroke, dementia, etc., and the prediction or monitoring of therapeutic effects of some agents. Among biomarkers relevant to drug development are pharmacodynamic markers (PD markers) for indicating whether drugs are functionally effective <i class="style-scope patent-text">in vivo,</i> and predictive markers for indicating the most likely response to particular drugs before administration. The use of such markers is helpful in establishing the clinical strategy of drugs. For example, a predictive marker, designed to indicate sensitivity or resistance to drug action, may be applied to the selection of patients to allow for more effective drug therapy while the activity of a drug in individual patients can be monitored with a pharmacodynamic marker, which together can lead to the establishment of effective therapeutic strategies. Further, even in the absence of a predictive marker, a pharmacodynamic marker permits the early monitoring of responses to a drug, thus allowing one to identify drug-effective groups from drug-ineffective groups at an early stage. Consequentially, more effective and successful drug therapies can be developed. In addition, when applied to the monitoring of responses to a drug as a function of concentrations, a pharmacodynamic marker can be an index for calculating suitable doses of the drug.</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0003]" class="style-scope patent-text">
    
    [0003]
  </para-num> <div id="p0003" num="0003" class="description-line style-scope patent-text">To date, cancer is one of the leading causes of death. Although the development of medical techniques has brought about a remarkable progress in cancer therapy, the 5-year survival rate of all cancers has only improved by 10 % over the past two decades. This is because cancer characteristics, such as rapid growth, metastasis, etc., make it difficult to diagnose and treat within a suitable time. The identification of suitable biomarkers that provide information regarding the efficacy of a cancer therapy can greatly impact the ability to provide the most suitable cancer therapies at the most optimal times. For example, patients with lung cancer may differ from each other in cancer classification, genotype, and protein secretion, and thus must be treated with different, proper therapeutics. For chemotherapy using a specific drug, a corresponding biomarker, if present, would reduce the number of erroneous trials and increase possibility of success. In this regard, it is very important to explore biomarkers for predicting or monitoring the effect of anti-cancer therapeutics. A proper biomarker, if successfully exploited, can make a great contribution to the utility and value of anti-cancer drugs and the success rate of treatment with them.</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0004]" class="style-scope patent-text">
    
    [0004]
  </para-num> <div id="p0004" num="0004" class="description-line style-scope patent-text">c-Met is a hepatocyte growth factor (HGF) receptor. Hepatocyte growth factor (HGF) acts as a multi-functional cytokine which binds to the extracellular domain of the c-Met receptor to regulate cell division, cell motility, and morphogenesis in various normal and tumor cells. The c-Met receptor is a membrane receptor that possesses tyrosine kinase activity. c-Met is a proto-oncogene, that encodes the representative receptor tyrosine kinase. Occasionally, it takes part in a variety of mechanisms responsible for the development of cancer such as oncogenesis, metastasis, migration, angiogenesis, and invasion of cancer cells, etc., irrespectively of the ligand HGF, and thus has attracted intensive attention as a target for anti-cancer therapy. Thus targeted therapies, such as antibodies against c-Met, have been developed; see, for example, <a id="pcit0001" dnum="US2011262436A1" class="patcit style-scope patent-text" href="/patent/US20110262436"> <text class="style-scope patent-text">US 2011/262436 A1</text> </a>.</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0005]" class="style-scope patent-text">
    
    [0005]
  </para-num> <div id="p0005" num="0005" class="description-line style-scope patent-text">A therapy with a developed c-Met targeting drug might be more effective treating cancer, with an elevated probability of success if there is a biomarker that is capable of predicting and monitoring the therapeutic effect of the drug to select patients suitable for the drug therapy and to monitor patient responses to the drug. Thus, the use of biomarkers could be applied to the establishment of effective therapeutic strategies.</div>
    </li> <heading id="h0004" class="style-scope patent-text">
      <b class="style-scope patent-text">BRIEF SUMMARY OF THE INVENTION</b>
    </heading>
    <li class="style-scope patent-text"> <para-num num="[0006]" class="style-scope patent-text">
    
    [0006]
  </para-num> <div id="p0006" num="0006" class="description-line style-scope patent-text">The invention relates to the following items:
</div> </li> <ol class="style-scope patent-text"> <li class="style-scope patent-text">1. A method for predicting the antitumor or anticancer efficacy of a c-Met inhibitor in a subject or selecting a subject with cancer suitable for the application of a c-Met inhibitor, comprising:
<ul class="style-scope patent-text"> <li class="style-scope patent-text">measuring, in a serum or blood sample, a level of ; and</li> <li class="style-scope patent-text">comparing the measured level with a reference,</li> <li class="style-scope patent-text">wherein an increase in the measured level of IL-8 in a serum or blood sample obtained from the subject, relative to the reference which is a serum or blood sample where the c-Met inhibitor is not effective, indicates that the c-Met inhibitor would be effective or that the subject is suitable for the application of a c-Met inhibitor, and</li> </ul>
wherein the c-Met inhibitor is an anti-c-Met antibody or an antigen-binding fragment thereof, which recognizes or binds an epitope comprising 5 to 19 contiguous amino acid residues within SEQ ID NO: 71 and wherein the epitope comprises at least SEQ ID NO: 73.</li> <li class="style-scope patent-text">2. The method of <figure-callout id="1" label="item" filenames="imgf0003.png,imgf0006.png" class="style-scope patent-text"><a title="Show image containing callout" class="style-scope figure-callout">item</a></figure-callout> 1, wherein the anti-c-Met antibody or an antigen-binding fragment thereof comprises:
<ol class="style-scope patent-text"> <li class="style-scope patent-text">(i) heavy chain complementarity determining regions (CDRs) comprising (a) a CDR-H1 comprising SEQ ID NO: 4; (b) a CDR-H2 comprising SEQ ID NO: 2, SEQ ID NO: 5, or an amino acid sequence comprising 8-19 consecutive amino acids within SEQ ID NO: 2 including the 3<sup class="style-scope patent-text">rd</sup> to 10<sup class="style-scope patent-text">th</sup> positions of SEQ ID NO: 2; and (c) a CDR-H3 comprising an amino acid sequence comprising 6-13 consecutive amino acids within SEQ ID NO: 85 including the 1<sup class="style-scope patent-text">st</sup> to 6<sup class="style-scope patent-text">th</sup> positions of the amino acid sequence of SEQ ID NO: 85, SEQ ID NO: 85, or SEQ ID NO: 6; and</li> <li class="style-scope patent-text">(ii) light chain CDRs comprising (a) a CDR-L1 comprising SEQ ID NO: 7, (b) a CDR-L2 comprising SEQ ID NO: 8, and (c) a CDR-L3 comprising SEQ ID NO: 9, SEQ ID NO: 15, SEQ ID NO: 86, or 9-17 consecutive amino acids within SEQ ID NO: 89 including the 1<sup class="style-scope patent-text">st</sup> to 9<sup class="style-scope patent-text">th</sup> positions of SEQ ID NO: 89.</li> </ol> </li> <li class="style-scope patent-text">3. A use of at least one interacting material selected from the group consisting of IL-8 binding antibody and an IL-8 binding aptamer in the method of <figure-callout id="1" label="item" filenames="imgf0003.png,imgf0006.png" class="style-scope patent-text"><a title="Show image containing callout" class="style-scope figure-callout"> <figure-callout id="2" label="item" filenames="imgf0012.png,imgf0013.png" class="style-scope patent-text"><a title="Show image containing callout" class="style-scope figure-callout">item</a></figure-callout> </a></figure-callout> 1 or 2.</li> <li class="style-scope patent-text">4. A c-Met inhibitor as defined in <figure-callout id="1" label="item" filenames="imgf0003.png,imgf0006.png" class="style-scope patent-text"><a title="Show image containing callout" class="style-scope figure-callout"> <figure-callout id="2" label="item" filenames="imgf0012.png,imgf0013.png" class="style-scope patent-text"><a title="Show image containing callout" class="style-scope figure-callout">item</a></figure-callout> </a></figure-callout> 1 or 2 for use in a method of treating a cancer in a subject, wherein the subject has been selected by the method of <figure-callout id="1" label="item" filenames="imgf0003.png,imgf0006.png" class="style-scope patent-text"><a title="Show image containing callout" class="style-scope figure-callout">item</a></figure-callout> 1.</li> </ol>
    <heading id="h0005" class="style-scope patent-text">
      <b class="style-scope patent-text">BRIEF DESCRIPTION OF THE DRAWINGS</b>
    </heading>
    
    <li class="style-scope patent-text"> <para-num num="[0007]" class="style-scope patent-text">
    
    [0007]
  </para-num> <div id="p0007" num="0007" class="description-line style-scope patent-text">
      </div> </li> <ul class="style-scope patent-text">
        <li class="style-scope patent-text"> <figref idrefs="f0001" class="style-scope patent-text">FIGS. 1A</figref>, <figref idrefs="f0002" class="style-scope patent-text">1B</figref>, <figref idrefs="f0003" class="style-scope patent-text">1C</figref>, <figref idrefs="f0004" class="style-scope patent-text">1D</figref>, and <figref idrefs="f0005" class="style-scope patent-text">1E</figref> are graphs showing the anticancer activity of an anti-c-Met antibody in terms of changes in tumor size with treatment with the anti-c-Met antibody in mouse models implanted with Lovo cells (<figref idrefs="f0001" class="style-scope patent-text">FIG. 1A</figref>), HT29 cells (<figref idrefs="f0002" class="style-scope patent-text">FIG. 1B</figref>), EBC-1 cells (<figref idrefs="f0003" class="style-scope patent-text">FIG. 1C</figref>), Hs746T cells (<figref idrefs="f0004" class="style-scope patent-text">FIG. 1D</figref>), and MKN45 cells (<figref idrefs="f0005" class="style-scope patent-text">FIG. 1E</figref>).</li>
        <li class="style-scope patent-text"> <figref idrefs="f0006" class="style-scope patent-text">FIG. 2</figref> is a graph of IL-8 levels in cancer cell-implanted mouse models showing relationship between IL-8 level and responsiveness to an anti-c-Met antibody.</li>
        <li class="style-scope patent-text"> <figref idrefs="f0007" class="style-scope patent-text">FIG. 3</figref> contains graphs showing the serum level changes of IL-8 in response to the different doses of the anti-c-Met antibody in responder and non-responder groups of the human cancer cell-implanted mouse models.</li>
        <li class="style-scope patent-text"> <figref idrefs="f0008" class="style-scope patent-text">FIG. 4</figref> is a graph showing IL-8 levels in serum samples from the control (vehicle (PBS) treated) of mouse models implanted with patient-derived tumor tissues.</li>
        <li class="style-scope patent-text"> <figref idrefs="f0009" class="style-scope patent-text">FIG. 5</figref> is a graph of IL-8 levels in serum samples from anti-c-Met antibody-treated and untreated (control PBS treated) groups of mouse models implanted with patient-derived tumor tissues, showing relationship between the anticancer efficacy of the anti-c-Met antibody and the change of IL-8 level after treatment of anti-c-Met antibody.</li>
        <li class="style-scope patent-text"> <figref idrefs="f0010" class="style-scope patent-text">FIG. 6</figref> is a graph showing a change in tumor size after treatment of the anti-c-Met antibody in conventional cancer cell line (EBC-1)-implanted mouse models.</li>
        <li class="style-scope patent-text"> <figref idrefs="f0011" class="style-scope patent-text">FIG. 7</figref> is a graph a graph showing a change in tumor size after treatment of the anti-c-Met antibody in conventional cancer cell line (Hs746T)-implanted mouse models.</li>
        <li class="style-scope patent-text"> <figref idrefs="f0012" class="style-scope patent-text">FIG. 8</figref> is a graph showing a change in IL-8 level with time after treatment of the anti-c-Met antibody in conventional cancer cell line (EBC-1)-implanted mouse models.</li>
        <li class="style-scope patent-text"> <figref idrefs="f0013" class="style-scope patent-text">FIG. 9</figref> is a graph showing a change in IL-8 level with time after treatment of the anti-c-Met antibody in conventional cancer cell line (Hs746T)-implanted mouse models.</li>
        <li class="style-scope patent-text"> <figref idrefs="f0014" class="style-scope patent-text">FIG. 10</figref> is a graph showing a change in tumor size after treatment of the anti-c-Met antibody in U87MG-implanted mouse model.</li>
        <li class="style-scope patent-text"> <figref idrefs="f0015" class="style-scope patent-text">FIG. 11</figref> shows a change in protein expression pattern in U87MG cells, as measured by a chemiluminescence immunoassay using protein array kit.</li>
        <li class="style-scope patent-text"> <figref idrefs="f0016" class="style-scope patent-text">FIG. 12</figref> is a graph showing a change in bIG-H3 level after treatment of the anti-c-Met antibody in serum from mouse models implanted with various cancer cells.</li>
        <li class="style-scope patent-text"> <figref idrefs="f0017" class="style-scope patent-text">FIG. 13</figref> is a graph showing a change in bIG-H3 level after treatment of the anti-c-Met antibody in serum from mouse models implanted with patient-derived tumor tissues.</li>
        <li class="style-scope patent-text"> <figref idrefs="f0018" class="style-scope patent-text">FIG. 14</figref> is a graph showing a change in bIG-H3 level after treatment of the anti-c-Met antibody in cancer tissue lysates from mouse models implanted with patient-derived tumor tissues.</li>
        <li class="style-scope patent-text"> <figref idrefs="f0019" class="style-scope patent-text">FIG. 15</figref> shows a change in protein expression pattern in a patient-derived tumor tissue-implanted mouse model (LXFA623), as measured by a chemiluminescence immunoassay using protein array kit.</li>
        <li class="style-scope patent-text"> <figref idrefs="f0020" class="style-scope patent-text">FIG. 16</figref> is a graph showing a change in MIF level after treatment of the anti-c-Met antibody in serum samples from mouse models implanted with various cancer cell lines.</li>
        <li class="style-scope patent-text"> <figref idrefs="f0021" class="style-scope patent-text">FIG. 17</figref> is a graph showing a change in MIF level after treatment of the anti-c-Met antibody in serum samples from mouse models implanted with patient-derived tumor tissues.</li>
        <li class="style-scope patent-text"> <figref idrefs="f0022" class="style-scope patent-text">FIG. 18</figref> shows c-Met protein expression levels in patient-derived cancer cell-implanted mouse models, as measured by Western blotting.</li>
        <li class="style-scope patent-text"> <figref idrefs="f0023" class="style-scope patent-text">FIG. 19</figref> contains graphs illustrating the change of tumor sizes after treatment of the anti-c-Met antibody in the presence or absence of K-RAS and B-RAF mutations in patient-derived tumor tissue-implanted mouse models.</li>
        <li class="style-scope patent-text"> <figref idrefs="f0024" class="style-scope patent-text">FIG. 20</figref> contains graphs illustrating the responsiveness of anti-c-Met antibody responder cell lines to the treatment of other c-Met inhibitors; crizotinib and PHA665752.</li>
        <li class="style-scope patent-text"> <figref idrefs="f0025" class="style-scope patent-text">FIG. 21</figref> contains graphs illustrating the responsiveness of anti-c-Met antibody non-responder cell lines to the treatment of other c-Met inhibitors; crizotinib and PHA665752.</li>
        <li class="style-scope patent-text"> <figref idrefs="f0026" class="style-scope patent-text">FIG. 22</figref> contains graphs illustrating the relative levels of IL-8 (%) in culture sup of the anti-c-Met antibody responder cell lines after treatment of various c-Met inhibitors, L3-1Y/IgG2, crizotinib and PHA665752.</li>
        <li class="style-scope patent-text"> <figref idrefs="f0027" class="style-scope patent-text">FIG. 23</figref> contains graphs illustrating the relative levels of IL-8(%) in culture sup of the anti-c-Met antibody non-responder cell lines after treatment of various c-Met inhibitors, L3-1Y/IgG2, crizotinib and PHA665752.</li>
      </ul>
    
    <heading id="h0006" class="style-scope patent-text">
      <b class="style-scope patent-text">DETAILED DESCRIPTION OF THE INVENTION AND THE DISCLOSURE</b>
    </heading>
    <li class="style-scope patent-text"> <para-num num="[0008]" class="style-scope patent-text">
    
    [0008]
  </para-num> <div id="p0008" num="0008" class="description-line style-scope patent-text">Described herein is a biomarker for use in predicting and/or monitoring the therapeutic effect of a c-Met inhibitor or selecting a subject suitable for the application of a c-Met inhibitor, wherein the biomarker includes at least one selected from the group consisting of IL-8, b-IG-H3, MIF, KRAS/BRAF, and nucleic acids encoding the proteins.</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0009]" class="style-scope patent-text">
    
    [0009]
  </para-num> <div id="p0009" num="0009" class="description-line style-scope patent-text">Further described is a use of a biomarker for predicting and/or monitoring the therapeutic effect of a c-Met inhibitor or selecting a subject suitable for the application of a c-Met inhibitor, wherein the biomarker includes at least one selected from the group consisting of IL-8, b-IG-H3, MIF, KRAS/BRAF, and nucleic acids encoding the proteins.</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0010]" class="style-scope patent-text">
    
    [0010]
  </para-num> <div id="p0010" num="0010" class="description-line style-scope patent-text">Also described is a composition and a kit for use in predicting and/or monitoring the effect of a c-Met inhibitor or selecting a subject to which a c-Met inhibitor is applicable (i.e., will exhibit efficacy), comprising a material interacting with at least one selected from the group consisting of IL-8, b-IG-H3, MIF, KRAS/BRAF, and nucleic acids encoding the proteins.</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0011]" class="style-scope patent-text">
    
    [0011]
  </para-num> <div id="p0011" num="0011" class="description-line style-scope patent-text">Further described is a use of a composition and a kit comprising a material interacting with at least one selected from the group consisting of IL-8, b-IG-H3, MIF, KRAS/BRAF, and nucleic acids encoding the proteins, for predicting and/or monitoring the effect of a c-Met inhibitor or selecting a subject suitable for the application of a c-Met inhibitor.</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0012]" class="style-scope patent-text">
    
    [0012]
  </para-num> <div id="p0012" num="0012" class="description-line style-scope patent-text">Further described is a material interacting with at least one selected from the group consisting of IL-8, b-IG-H3, MIF, KRAS/BRAF, and nucleic acids encoding the proteins, for use in predicting and/or monitoring the effect of a c-Met inhibitor or selecting a subject suitable for the application of a c-Met inhibitor.</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0013]" class="style-scope patent-text">
    
    [0013]
  </para-num> <div id="p0013" num="0013" class="description-line style-scope patent-text">Further described is a use of a material interacting with at least one selected from the group consisting of IL-8, b-IG-H3, MIF, KRAS/BRAF, and nucleic acids encoding the proteins, for predicting and/or monitoring the effect of a c-Met inhibitor or selecting a subject suitable for the application of a c-Met inhibitor.</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0014]" class="style-scope patent-text">
    
    [0014]
  </para-num> <div id="p0014" num="0014" class="description-line style-scope patent-text">Further described is a method for predicting and/or monitoring the effect of a c-Met inhibitor or selecting a subject to which a c-Met inhibitor is applicable (i.e., will exhibit efficacy), comprising the analysis of at least one biomarker selected from the group consisting of IL-8, b-IG-H3, MIF, KRAS/BRAF, and nucleic acids encoding the proteins.</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0015]" class="style-scope patent-text">
    
    [0015]
  </para-num> <div id="p0015" num="0015" class="description-line style-scope patent-text">Further described is a method for predicting and/or monitoring the efficacy of c-Met inhibitor or for providing information on the prediction and/or monitoring of the efficacy of a c-Met inhibitor, comprising measuring existence, level, and/or mutation of at least one selected from the group consisting of IL-8, b-IG-H3, MIF, KRAS/BRAF, and nucleic acids encoding the proteins, in a biological sample.</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0016]" class="style-scope patent-text">
    
    [0016]
  </para-num> <div id="p0016" num="0016" class="description-line style-scope patent-text">Further described is a method for selecting a subject suitable for the application of a c-Met inhibitor, comprising measuring for existence, level and/or mutation of at least one selected from the group consisting of IL-8, b-IG-H3, MIF, KRAS/BRAF, and nucleic acids encoding the proteins, in a biological sample obtained from a subject.</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0017]" class="style-scope patent-text">
    
    [0017]
  </para-num> <div id="p0017" num="0017" class="description-line style-scope patent-text">Further described is a c-Met inhibitor or a pharmaceutical composition including a c-Met inhibitor, for use in inhibiting c-Met and/or treating a cancer in a subject, wherein the subject has a high level of IL-8 or a nucleic acid encoding IL-8 compared to a reference sample in which a c-Met inhibitor is not effective; shows a decreased level of IL-8, bIG-H3, MIF, and/or nucleic acids encoding them after administering a c-Met inhibitor (compared to that of before the administration); and/or has a mutation of KRAS, BRAF, and/or nucleic acids encoding them.</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0018]" class="style-scope patent-text">
    
    [0018]
  </para-num> <div id="p0018" num="0018" class="description-line style-scope patent-text">Further described is a use of a c-Met inhibitor or a pharmaceutical composition including a c-Met inhibitor, for inhibiting c-Met and/or treating a cancer in a subject or for preparing a pharmaceutical composition for inhibiting c-Met and/or treating a cancer in a subject, wherein the subject has a high level of IL-8 or a nucleic acid encoding IL-8 compared to a reference sample in which a c-Met inhibitor is not effective; shows a decreased level of IL-8, bIG-H3, MIF, and/or nucleic acids encoding them after administering a c-Met inhibitor (compared to that of before the administration); and/or has a mutation of KRAS, BRAF, and/or nucleic acids encoding them.</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0019]" class="style-scope patent-text">
    
    [0019]
  </para-num> <div id="p0019" num="0019" class="description-line style-scope patent-text">Further described is a method for preventing and/or treating cancer, comprising administering a c-Met inhibitor to a subject, wherein the subject has a high level of IL-8 or a nucleic acid encoding IL-8 compared to a reference sample in which a c-Met inhibitor is not effective, as defined below; shows a decreased level of IL-8, bIG-H3, MIF, and/or nucleic acids encoding them after administering a c-Met inhibitor (compared to that of before the administration); and/or has a mutation of KRAS, BRAF, and/or nucleic acids encoding them. For example, the subject may be selected by the above method for selecting a subject suitable for the application of a c-Met inhibitor. This preventing or treating method may further comprise selecting a subject suitable for the application of the c-Met inhibitor, prior to the administration.</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0020]" class="style-scope patent-text">
    
    [0020]
  </para-num> <div id="p0020" num="0020" class="description-line style-scope patent-text">Further described is a method for inhibiting c-Met, comprising administering a c-Met inhibitor to a subject, wherein the subject has a high level of IL-8 or a nucleic acid encoding IL-8 compared to a reference sample in which a c-Met inhibitor is not effective, as defined below; shows a decreased level of IL-8, bIG-H3, MIF, and/or nucleic acids encoding them after administering a c-Met inhibitor (compared to that of before the administration); and/or has a mutation of KRAS, BRAF, and/or nucleic acids encoding them. For example, the subject may be selected by the above method for selecting a subject suitable for the application of a c-Met inhibitor. This inhibiting method may further comprise selecting a subject suitable for the application of the c-Met inhibitor, prior to the administration.</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0021]" class="style-scope patent-text">
    
    [0021]
  </para-num> <div id="p0021" num="0021" class="description-line style-scope patent-text">As used herein, the term "efficacy" of a c-Met inhibitor refers to a c-Met inhibitory effect and/or the pharmaceutical activity of a c-Met inhibitor resulting in the prevention, amelioration, reduction or treatment of a c-Met-related disease, for instance, a cancer. As regards cancer the efficacy refers to an anticancer effect, for example, an ability to induce the reduction or death of cancer cells or tissues, and the suppression of cancer cell migration and/or invasion responsible for cancer metastasis. In other word, the efficacy may refer to responsiveness of a subject, who is administered with a c-Met inhibitor, to the c-Met inhibitor.</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0022]" class="style-scope patent-text">
    
    [0022]
  </para-num> <div id="p0022" num="0022" class="description-line style-scope patent-text">As used herein, the term "predicting an efficacy of a c-Met inhibitor" may refer to determining whether or not or how much the c-Met inhibitor exhibits its desired efficacy (e.g., an antitumor or anticancer efficacy) on a subject who is treated therewith.</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0023]" class="style-scope patent-text">
    
    [0023]
  </para-num> <div id="p0023" num="0023" class="description-line style-scope patent-text">As used herein, the wording "a subject suitable for the application of the c-Met inhibitor" may refer to "a subject suitable for administration or treatment with a c-Met inhibitor" or "a subject with a disease (e.g., cancer) that is likely to respond to a c-Met inhibitor".</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0024]" class="style-scope patent-text">
    
    [0024]
  </para-num> <div id="p0024" num="0024" class="description-line style-scope patent-text">The expression level of a certain protein may be determined by quantitatively analyzing the protein or the gene (nucleic acid) encoding it, such as DNA, cDNA or mRNA. As used herein, the term "gene" refers to any nucleic acid encoding the protein, whether genomic DNA, cDNA, or RNA (mRNA). The determination of KRAS/BRAF mutations may be achieved at a gene level or a protein level.</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0025]" class="style-scope patent-text">
    
    [0025]
  </para-num> <div id="p0025" num="0025" class="description-line style-scope patent-text">IL-8 (Interleukin 8) is a chemokine functioning as an important mediator of immune responses. IL-8, also known as neutrophil chemotactic factor, has two primary functions: it induces chemotaxis in target cells, primarily neutrophils but also other granulocytes, causing them to migrate toward the site of infection; and also phagocytosis once they have arrived. IL-8 is also known to be a potent promoter of angiogenesis contributing to the proliferation and metastasis of tumor cells. In one exemplary embodiment of the present invention, a response to a c-Met inhibitor varies depending on the expression level of IL-8, and a difference in the expression level of IL-8 between biological samples before and after treatment with an c-Met inhibitor is dependent on the response to the c-Met inhibitor (see Example 1). Briefly, a higher level of IL-8 or its gene in a biological sample indicates that a c-Met inhibitor, e.g., an anti-c-Met antibody, more efficiently exerts its function on the biological sample or a patient from which the biological sample is sourced. In addition, a biological sample in which a c-Met inhibitor, for example, an anti-c-Met antibody, functions well (drug response group), a decrease in the level of IL-8 or its gene after the application of the c-Met inhibitor, compared to before the application, is typically observed.</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0026]" class="style-scope patent-text">
    
    [0026]
  </para-num> <div id="p0026" num="0026" class="description-line style-scope patent-text">That is, an expression level of IL-8 can be used to predict the efficacy of an c-Met inhibitor and thus to select a subject suitable for treatment with the c-Met inhibitor, or a change in the expression level of IL-8 according to, or before and after treatment with a c-Met inhibitor allows for the evaluation (identification) or monitoring of the efficacy of the c-Met inhibitor, thereby being useful in determining whether the c-Met inhibitor should continue to be applied, or in establishing the therapeutic strategy of the c-Met inhibitor with regard to dose, dosing interval, and dosing number. Based on this finding, the use of IL-8 as a marker for indicating and/or monitoring the efficacy of a c-Met inhibitor is suggested.</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0027]" class="style-scope patent-text">
    
    [0027]
  </para-num> <div id="p0027" num="0027" class="description-line style-scope patent-text">The IL-8 may originate from vertebrates including mammals, such as rodents, e.g., mice, rat, etc., and primates, e.g., humans, monkeys, etc., birds, reptiles, amphibians, and fishes. For example, the IL-8 may be selected from the group consisting of NP_000575.1, AAH13615.1, AAA59158.1, NP_001028137.1, AAA80141.2, and AAA86711.1. An IL-8-encoding gene (cDNA or mRNA) may be selected from among NM_000584.3, BC013615.1 (from 41 to 340 positions), NC_000004, NG_029889, NC_018915.2, AC_000136, M28130.1, NM_001032965.1, S78555.1, andU19849.1.</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0028]" class="style-scope patent-text">
    
    [0028]
  </para-num> <div id="p0028" num="0028" class="description-line style-scope patent-text">One embodiment described herein is directed to the analysis of a biomarker for the prediction and/or monitoring of the efficacy of a c-Met inhibitor comprising the analysis of (e.g., measuring the level of) at least one selected from the group consisting of IL-8.</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0029]" class="style-scope patent-text">
    
    [0029]
  </para-num> <div id="p0029" num="0029" class="description-line style-scope patent-text">Another embodiment described herein is directed to the analysis of a biomarker for the selection of a subject suitable to the application of a c-Met inhibitor, comprising the analysis of (e.g., measuring the level of) at least one selected from the group consisting of IL-8.</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0030]" class="style-scope patent-text">
    
    [0030]
  </para-num> <div id="p0030" num="0030" class="description-line style-scope patent-text">Also described is a composition and a kit for the prediction and/or monitoring of the efficacy of a c-Met inhibitor, comprising a material capable of interacting with at least one selected from the group consisting of IL-8 and a nucleic acid (e.g., gene) encoding IL-8.</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0031]" class="style-scope patent-text">
    
    [0031]
  </para-num> <div id="p0031" num="0031" class="description-line style-scope patent-text">Further described is a composition and a kit for the selection of a subject suitable to the application of a c-Met inhibitor, comprising a material interacting with at least one selected from the group consisting of IL-8 and a nucleic acid (e.g., gene) encoding IL-8.</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0032]" class="style-scope patent-text">
    
    [0032]
  </para-num> <div id="p0032" num="0032" class="description-line style-scope patent-text">Provided is a method for predicting the efficacy of a c-Met inhibitor, comprising measuring a biological sample for a level of IL-8, as defined in the claims.</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0033]" class="style-scope patent-text">
    
    [0033]
  </para-num> <div id="p0033" num="0033" class="description-line style-scope patent-text">Another embodiment provides a method for selecting a subject suitable to the application of a c-Met inhibitor, comprising measuring a biological sample for a level of IL-8, as defined in the claims. The sample used for performing the invention is limited to serum or blood, the biomarker is limited to IL-8 (i.e. the protein), and the C-Met inhibitor is limited to the antibody specified in <figure-callout id="1" label="claim" filenames="imgf0003.png,imgf0006.png" class="style-scope patent-text"><a title="Show image containing callout" class="style-scope figure-callout">claim</a></figure-callout> 1. Described is a method for predicting the efficacy of a c-Met inhibitor, or for selecting a subject suitable to the application of a c-Met inhibitor, comprising measuring a level of IL-8. In the method for predicting the efficacy of a c-Met inhibitor or for offering information on the efficacy of a c-Met inhibitor, when a biological sample is measured to have a high level of IL-8 , the biological sample or a patient from which the biological sample is originated can be predicted to allow the c-Met inhibitor to effectively exert its activity or may be considered to be suitable for the application of the c-Met inhibitor. Hence, the method for predicting the efficacy of a c-Met inhibitor may further comprise determining that the c-Met inhibitor exhibits its efficacy in the biological sample or the patient when the biological sample is observed to have a high level of IL-8 after the measurement. In addition, the method for selecting a subject suitable to the application of a c-Met inhibitor may further comprise determining the biological sample or the patient as a subject suitable for the application of the c-Met inhibitor when the biological sample is observed to have a high level of IL-8 after the measurement.</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0034]" class="style-scope patent-text">
    
    [0034]
  </para-num> <div id="p0034" num="0034" class="description-line style-scope patent-text">"A high level of at least one selected from the group consisting of IL-8 and a nucleic acid (e.g., gene) encoding IL-8" may refer to a large amount of IL-8 protein and/or a nucleic acid (e.g., gene) encoding IL-8 (DNA, cDNA or mRNA), compared to a biological sample (reference sample) from a patient in which a c-Met inhibitor to be applied does not exert therapeutic activity. For example, when the level of at least one selected from IL-8 and a nucleic acid (e.g., gene) encoding IL-8in a test biological sample from a test patient is at least about 1.5-, about 2-, about 3-, about 4-, or about 5-fold, for example, about 1.5- to about 100-fold, about 2- to about 100-fold, about 3- to about 100-fold, about 4- to about 100-fold, or about 5- to about 100-fold greater in weight than that in a reference biological sample on which the c-Met inhibitor to be applied does not exert its efficacy (e.g., a c-Met inhibitory efficacy or an anticancer efficacy), the c-Met inhibitor is predicted to effectively exert its efficacy (e.g., a c-Met inhibitory efficacy or an anticancer efficacy) in the test biological sample or the test patient, or the test biological sample or the test patient can be considered as a subject suitable to the application of the c-Met inhibitor. The c-Met inhibitor may be, for example, an anti-c-Met antibody. The reference biological sample can be any sample useful for comparing the expression of the c-Met biomarker and/or c-Met inhibitor efficacy, such as a biological sample comprising cells, such as a mammalian cancer cell, in which the c-Met inhibitor does not have its efficacy (e.g., a c-Met inhibitory or anticancer efficacy). Examples of the reference biological sample on which the c-Met inhibitor does not exert its efficacy include, but are not limited to, the Lovo cell line (CCL-229, ATCC), and the HT-29 cell line (HTB-38, ATCC). Therefore, the method for predicting the efficacy of a c-Met inhibitor (or for offering information on the prediction of the efficacy of a c-Met inhibitor) or for selecting a subject suitable to the application of a c-Met inhibitor (or for offering information of the selection of a subject suitable to the application of a c-Met inhibitor) may further comprise a step of measuring a level of at least one selected from the group consisting of IL-8 and a nucleic acid (e.g., gene) encoding IL-8in a reference biological sample. The measurement of the level of IL-8 and/or a nucleic acid (e.g., gene) encoding IL-8 (e.g., quantitative analysis) may be performed by the same method in both the test biological sample and the reference biological sample.</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0035]" class="style-scope patent-text">
    
    [0035]
  </para-num> <div id="p0035" num="0035" class="description-line style-scope patent-text">Measuring the biological sample for a level of at least one selected from among IL-8 and a nucleic acid (e.g., gene) encoding IL-8may comprise i) treating (reacting or contacting) the biological sample with a material interacting with at least one selected from the group consisting of IL-8 and a nucleic acid (e.g., gene) encoding IL-8; and ii) quantitatively analyzing the reaction mixture to determine the level of at least one selected from IL-8 and a nucleic acid (e.g., gene) encoding IL-8. In an aspect described herein, prior to step i), a step of preparing a biological sample may be further performed, wherein the preparation step may comprise obtaining (isolating) a biological sample from a patient or obtaining a biological sample which has been isolated from a patient. In step i), the interacting material may be at least one selected from the group consisting of compounds (a small molecular chemical; including any general label such as a fluorescent, a dye, etc.), proteins (antibodies, aptamers, etc.) nucleic acid (DNA, RNA, etc.), and the like, binding to IL-8 or IL-8 gene, and for example, the interacting material may be a compound (a small molecular chemical; e.g., general label such as a fluorescent, a dye, etc.), an antibody, or an aptamer, all binding (e.g., specifically binding) to IL-8, a polynucleotide (e.g., a primer, a probe, an aptamer) binding to a part or entirety of a nucleic acid (e.g., gene) encoding IL-8, or any combination thereof, and optionally, may be conjugated with a general label, such as a fluorescent, a secondary antibody, a bead (e.g., a magnetic bead or polystyrene bead), a dye, or any combination thereof. The step i) may be configured to form a complex by adding the interacting material to the biological sample. In step ii), the reaction mixture may be the complex resulting from interaction (binding) between at least one selected from the group consisting of IL-8 and a nucleic acid (e.g., gene) encoding IL-8 and the interacting material, which can be obtained in step i). Quantitatively analyzing may comprise quantifying the complex, the label conjugated to the complex, or the IL-8 or nucleic acid (e.g., gene) encoding IL-8 segregated from the complex after the isolation of the complex from the biological sample. Also described herein is a method for monitoring (evaluating or identifying) the efficacy of a c-Met inhibitor or for offering information on the monitoring (evaluation or identification) of the efficacy of a c-Met inhibitor, comprising measuring a level of at least one selected from the group consisting of IL-8 and a nucleic acid (e.g., gene) encoding IL-8in a biological sample. In the method for monitoring the efficacy of a c-Met inhibitor or for offering information on the monitoring of the efficacy of a c-Met inhibitor, levels of at least one selected from the group consisting of IL-8 and a nucleic acid (e.g., gene) encoding IL-8 in biological samples from a patient before and after treatment with the c-Met inhibitor (or in a c-Met inhibitor-untreated biological sample and a c-Met inhibitor-treated biological sample) may be measured and compared to each other. When the post-treatment level of at least one selected from the group consisting of IL-8 and a nucleic acid (e.g., gene) encoding IL-8 is lower (decreased) compared to the pre-treatment level, the c-Met inhibitor is determined to exert its efficacy in the patient from which the biological sample is sourced (obtained), whereas when the post-treatment level of at least one selected from the group consisting of IL-8 and a nucleic acid (e.g., gene) encoding IL-8 is the same with or higher (increase) compared to the pre-treatment level, it is determined that the c-Met inhibitor does not exert its efficacy or a resistance to the c-Met inhibitor occurs in the patient from which the biological sample is sourced (obtained). Therefore, the method for monitoring the efficacy of a c-Met inhibitor or for offering information on the monitoring of the efficacy of a c-Met inhibitor may further comprise 1) comparing the levels of at least one selected from the group consisting of IL-8 and a nucleic acid (e.g., gene) encoding IL-8 in a biological sample from the c-Met inhibitor-treated group with that in a biological sample from the untreated group, and/or 2) determining that the c-Met inhibitor exerts its efficacy in the biological sample-derived patient when the level of at least one selected from the group consisting of IL-8 and a nucleic acid (e.g., gene) encoding IL-8 in the biological sample of the c-Met inhibitor-treated group is reduced, compared to that of the untreated group (in this case, it may be determined to maintain (continue) the administration of a c-Met inhibitor to the subject), and/or 3) determining that the c-Met inhibitor does not exert its efficacy or a resistance to the c-Met inhibitor occurs in the biological sample-derived patient when the level of at least one selected from the group consisting of IL-8 and a nucleic acid (e.g., gene) encoding IL-8 in the biological sample of the c-Met inhibitor-treated group is maintained or increased (in this case, it may be determined to stop the administration of a c-Met inhibitor to the subject). The c-Met inhibitor may be an anti-c-Met antibody.</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0036]" class="style-scope patent-text">
    
    [0036]
  </para-num> <div id="p0036" num="0036" class="description-line style-scope patent-text">As used herein, the c-Met inhibitor-treated group and the untreated group mean the same biological sample after and before treatment with a c-Met inhibitor, respectively, or aliquots of the same biological sample which are treated with and are not treated with a c-Met inhibitor (for example, treated only with a vehicle), respectively. Unless stated otherwise, the terms "c-Met inhibitor-untreated group (or biological sample)" and "biological sample before treatment with a c-Met inhibitor" or "pre-treatment biological sample" are identical to each other while the terms "c-Met inhibitor-treated group (or biological sample)" and "biological sample after treatment with a c-Met inhibitor" or "post-treatment biological sample" share the same meaning. The term "c-Met inhibitor-untreated group (or biological sample)" and "biological sample before treatment with a c-Met inhibitor" or "pre-treatment biological sample" may refer to a biological sample obtained from a subject prior to the administration with a c-Met inhibitor to the subject, and the terms "c-Met inhibitor-treated group (or biological sample)" and "biological sample after treatment with a c-Met inhibitor" or "post-treatment biological sample" may refer to a biological sample obtained from a subject after the administration with a c-Met inhibitor to the subject.</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0037]" class="style-scope patent-text">
    
    [0037]
  </para-num> <div id="p0037" num="0037" class="description-line style-scope patent-text">The level of at least one selected from the group consisting of IL-8 and a nucleic acid (e.g., gene) encoding IL-8 may be measured by quantifying an IL-8 protein and/or a nucleic acid (e.g., gene) encoding IL-8 (DNA, cDNA or mRNA). For example, when the level of at least one selected from the group consisting of IL-8 and a nucleic acid (e.g., gene) encoding IL-8 in the c-Met inhibitor-treated group or in the biological sample after treatment with a c-Met inhibitor is about 0 to about 80 wt %, about 0 to about 70 wt %, about 0 to about 60 wt %, about 0 to about 50 wt %, about 0 to about 40 wt %, about 0 to about 30 wt %, about 0 to about 20 wt %, or about 0 to about 10 wt % compared to that (considering 100 wt%) of the c-Met inhibitor-untreated group or the pre-treatment biological sample, the c-Met inhibitor-treated group, or the post-treatment sample biological, is determined to decrease in the level of at least one selected from the group consisting of IL-8 and a nucleic acid (e.g., gene) encoding IL-8, compared to the c-Met inhibitor-untreated or the pre-treatment biological sample. When the level of IL-8 and a nucleic acid (e.g., gene) encoding IL-8 in the c-Met inhibitor-treated group or the post-treatment biological sample is about 0 wt % of that in the c-Met inhibitor-untreated group or the pre-treatment biological sample there is no detection (absence) of at least one selected from the IL-8 and a nucleic acid (e.g., gene) encoding IL-8 in the c-Met inhibitor-treated group or the post-treatment biological sample. Levels of IL-8 and/or a nucleic acid (e.g., gene) encoding IL-8 in the c-Met inhibitor-untreated group (or pre-treatment) and the c-Met inhibitor-treated group (or post-treatment) may be measured by conducting the same procedure on sample samples from the same patient.</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0038]" class="style-scope patent-text">
    
    [0038]
  </para-num> <div id="p0038" num="0038" class="description-line style-scope patent-text">For monitoring the efficacy of an c-Met inhibitor, IL-8 and/or a nucleic acid (e.g., gene) encoding IL-8may be quantitatively analyzed within a relatively short period of time, for example, a week, 5 days, 3 days, 2 days or 1 day after administration of the c-Met inhibitor, and comparison between levels of the marker before and after administration thereof can evaluate the efficacy of c-Met inhibitor. Henceforth, the advantage of establishing a more effective therapeutic strategy can be achieved, since it is possible to evaluate the efficacy of the c-Met inhibitor in an early stage of therapy. Also described herein, the measuring of a level of at least one selected from the group consisting of IL-8 and a nucleic acid (e.g., gene) encoding IL-8 in a biological sample may comprise 1) determining a level of at least one selected from the group consisting of IL-8 and a nucleic acid (e.g., gene) encoding IL-8 in a biological sample from a patient prior to treatment with a c-Met inhibitor (or a c-Met inhibitor untreated biological sample which is a part of biological sample from a patient) and 2) determining a level of at least one selected from the group consisting of IL-8 and a nucleic acid (e.g., gene) encoding IL-8 in a biological sample from the patient after treatment with a c-Met inhibitor (or a c-Met inhibitor treated biological sample which is the other part of biological sample from a patient). Each of the steps 1) and 2) may comprise i) applying (adding) a material interacting with at least one selected from the group consisting of IL-8 and a nucleic acid (e.g., gene) encoding IL-8 to the biological sample; and ii) quantitatively analyzing the resulting reaction mixture to determine a level of at least one selected from the group consisting of IL-8 and a nucleic acid (e.g., gene) encoding IL-8. In an aspect described herein, prior to the step i), a step of preparing a biological sample may be further performed, wherein the preparation step may comprise obtaining (isolating) a biological sample from the patient or obtaining a biological sample which has been isolated from a patient. In step i), as will be further elucidated below, the interacting material may be at least one selected from the group consisting of compounds (a small molecular chemical; e.g., general label such as a fluorescent, a dye, etc.), proteins (antibodies, aptamers, etc.) nucleic acid (DNA, RNA, etc.), and the like, binding to IL-8 or IL-8 gene, and for example, the interacting material may be at least one selected from the group consisting of a compound, an antibody (e.g., antibodies for intracellular staining (human CXCL8/IL-8 phycoerythrin MAb; #IC208P; R&amp;D systems), etc.), an aptamer, all specifically binding to IL-8, and a polynucleotide (e.g., a primer, such as a primer set used in RT-PCR for IL-8 gene (ACCESSION NO: BC013615.1; forward primer: 5'-ATG ACT TCC AAG CTG GCC GTG GCT-3' (SEQ ID NO: 113) and reverse primer: 5'-TCT CAG CCC TCT TCA AAA ACT TCT-3' (SEQ ID NO: 114) etc.); a probe, an aptamer) binding to a part or entirety of a gene encoding IL-8, and optionally, may be conjugated with a label, such as a fluorescent or a dye. The step i) may be configured to form a complex by applying (adding) the interacting material to the biological sample. In step ii), the reaction mixture may be a complex resulting from interaction (binding) between at least one selected from the group consisting of IL-8 and a nucleic acid (e.g., gene) encoding IL-8 and the interacting material, which can be obtained in step i). The quantitatively analyzing step may comprise quantifying the complex, the marker conjugated to the complex, or the IL-8 or the gene segregated from the complex after the isolation of the complex from the biological sample. The quantitative analysis of IL-8 may be performed by any general quantifying means of proteins, such as immunochromatography, immunohistochemistry, immunohistochemical staining, enzyme linked immunosorbent assay (ELISA; e.g., Platinum ELISA Human IL-8/NAP-1 (#BMS204/3, eBioscience), etc.), radioimmunoassay (RIA), enzyme immunoassay (EIA), fluorescence immunoassay (FIA), luminescence immunoassay (LIA), Western blotting, microarray, surface plasmon resonance (SPR), flow cytometry assay (e.g., Cytometric Bead Array (CBA) assay, such as IL-8 flex set (#558277), human inflammatory cytokine kit (#551811); BD biosciences), intracellular staining (e.g., using antibodies such as human CXCL8/IL-8 phycoerythrin MAb (#IC208P; R&amp;D systems), etc.), Luminex assay, and the like, and the quantitative analysis of IL-8 gene may be performed by any general quantifying means of genes (DNA or RNA), such as PCR, (e.g., qPCR, RT-PCR, etc.)" mRNA microarray, and the like, but not limited thereto.</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0039]" class="style-scope patent-text">
    
    [0039]
  </para-num> <div id="p0039" num="0039" class="description-line style-scope patent-text">The monitoring method may be useful in determining whether the c-Met inhibitor continues to be used, and/or suitable dosing conditions of the c-Met inhibitor (dose, dosing interval, number of doses, etc.). For example, when the level of at least one selected from the group consisting of IL-8 and a nucleic acid (e.g., gene) encoding IL-8 in the c-Met inhibitor-treated group or in the post-treatment biological sample is reduced, compared to the c-Met inhibitor-untreated group or the pre-treatment biological sample, for example, when the level of at least one selected from the group consisting of IL-8 and a nucleic acid (e.g., gene) encoding IL-8 in the c-Met inhibitor-treated group or in the post-treatment biological sample is about 0 to about 80 wt %, about 0 to about 70 wt %, about 0 to about 60 wt %, about 0 to about 50 wt %, about 0 to about 40 wt %, about 0 to about 30 wt %, about 0 to about 20 wt %, or about 0 to about 10 wt % of that of the c-Met inhibitor-untreated group or the pre-treatment biological sample, the use of c-Met inhibitor may be determined to be continued. In addition, when the level of at least one selected from the group consisting of IL-8 and a nucleic acid (e.g., gene) encoding IL-8 in the c-Met inhibitor-treated group or in the post-treatment biological sample is reduced, compared to the c-Met inhibitor-untreated group or the pre-treatment biological sample, for example, when the level of at least one selected from the group consisting of IL-8 and a nucleic acid (e.g., gene) encoding IL-8 in the c-Met inhibitor-treated group or in the post-treatment biological sample is about 0 to about 80 wt %, about 0 to about 70 wt %, about 0 to about 60 wt %, about 0 to about 50 wt %, about 0 to about 40 wt %, about 0 to about 30 wt %, about 0 to about 20 wt %, or about 0 to about 10 wt %, of that of the c-Met inhibitor-untreated group or the pre-treatment biological sample, the dosing condition of the c-Met inhibitor may be determined to be suitable. The dosing condition may be at least one selected from the group consisting of a dose, a dosing interval, and a number of doses.</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0040]" class="style-scope patent-text">
    
    [0040]
  </para-num> <div id="p0040" num="0040" class="description-line style-scope patent-text">Another aspect described herein provides a method for inhibiting c-Met, comprising administering a c-Met inhibitor to a subject who has a high level of IL-8 and/or a nucleic acid encoding IL-8 (wherein the high level is defined above) and/or shows a decreased level of IL-8 and/or a nucleic acid encoding IL-8 after administration of a c-Met inhibitor (compared to before administration of the c-Met inhibitor).. The subject may be 1) selected by the above method for selecting a subject suitable for the application of a c-Met inhibitor or 2) determined by the above method of monitoring efficacy of a c-Met inhibitor as a subject wherein a c-Met inhibitor exert its efficacy thereon.</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0041]" class="style-scope patent-text">
    
    [0041]
  </para-num> <div id="p0041" num="0041" class="description-line style-scope patent-text">Another aspect described herein provides a method for preventing and/or treating cancer, comprising administering a c-Met inhibitor to a subject who has a high level of IL-8 or a nucleic acid encoding IL-8 (wherein the high level is defined above) and/or shows a decreased level of IL-8 and/or a nucleic acid encoding IL-8 after administration of a c-Met inhibitor (compared to before administration of the c-Met inhibitor). The subject may be 1) selected by the above method for selecting a subject suitable for the application of a c-Met inhibitor or 2) determined by the above method of monitoring efficacy of a c-Met inhibitor as a subject wherein a c-Met inhibitor exert its efficacy thereon.</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0042]" class="style-scope patent-text">
    
    [0042]
  </para-num> <div id="p0042" num="0042" class="description-line style-scope patent-text">The method for inhibiting c-Met or the method for preventing and/treating cancer may further comprise selecting a subject to which the c-Met inhibitor is applicable, prior to the administering step. Details of the selection are as described above. The c-Met inhibitor may be an anti-c-Met antibody.</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0043]" class="style-scope patent-text">
    
    [0043]
  </para-num> <div id="p0043" num="0043" class="description-line style-scope patent-text">In an aspect described herein, the method for inhibiting c-Met or for preventing and/or treating cancer may comprise:
</div> </li> <ul class="style-scope patent-text"> <li class="style-scope patent-text">identifying a subject to which a c-Met inhibitor is applicable; and</li> <li class="style-scope patent-text">administering a pharmaceutically effective amount of the c-Met inhibitor to the subject.</li> </ul>
    <li class="style-scope patent-text"> <para-num num="[0044]" class="style-scope patent-text">
    
    [0044]
  </para-num> <div id="p0044" num="0044" class="description-line style-scope patent-text">In another embodiment described herein, the method for inhibiting c-Met or for preventing and/or treating cancer may comprise:
</div> </li> <ul class="style-scope patent-text"> <li class="style-scope patent-text">measuring a level of IL-8 and/or a nucleic acid (e.g., gene) encoding IL-8 in a biological sample to select a c-Met inhibitor-applicable subject; and</li> <li class="style-scope patent-text">administering a pharmaceutically effective amount of the c-Met inhibitor to the subject.</li> </ul>
    <li class="style-scope patent-text"> <para-num num="[0045]" class="style-scope patent-text">
    
    [0045]
  </para-num> <div id="p0045" num="0045" class="description-line style-scope patent-text">With regard to dosing conditions of the c-Met inhibitor, such as doses, dosing intervals and/or number of doses, they may be determined in the method for monitoring a c-Met inhibitor for efficacy.</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0046]" class="style-scope patent-text">
    
    [0046]
  </para-num> <div id="p0046" num="0046" class="description-line style-scope patent-text">Some anti-cancer agents such as sunitinib, cis-platin, paclitaxel, etc. often cannot exert their anticancer effects in individuals with a high level of IL-8 because they provoke resistance. In contrast, c-Met inhibitors, for example, anti-c-Met antibodies, particularly, those described below, can exhibit high anticancer activity in individuals with a high level of IL-8, thereby allowing for the suggestion of more effective therapeutic strategies.</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0047]" class="style-scope patent-text">
    
    [0047]
  </para-num> <div id="p0047" num="0047" class="description-line style-scope patent-text">bIG-H3, also known as TGFBI (transforming growth factor beta-induced), is RGD-containing protein that binds to type I, II and IV collagens. The RGD motif is found in ECM (extracellular matrix). Serves as a ligand binding to a3b1 integrin, bIG-H3 is involved in cell adhesion, and migration. bIG-H3 is a soluble protein and plays a role in cancer metastasis and angiogenesis in the tumor microenvironment. No reports have been made on a relationship between c-Met and bIG-H3, so far.</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0048]" class="style-scope patent-text">
    
    [0048]
  </para-num> <div id="p0048" num="0048" class="description-line style-scope patent-text">MIF (Macrophage migration inhibitory factor) is an important regulator of innate immunity and is classified as an inflammatory cytokine.</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0049]" class="style-scope patent-text">
    
    [0049]
  </para-num> <div id="p0049" num="0049" class="description-line style-scope patent-text">In the Example section of the specification, a difference in the expression level of bIG-H3 and/or MIF between c-Met inhibitor-treated groups and untreated groups or between a post-treatment group and a pre-treatment group was observed to vary depending in response to the c-Met inhibitor (refer to Examples 2 and 3). In detail, when a c-Met inhibitor, e.g., an anti-c-Met antibody functions well (drug responsive group), the level of at least one selected from the group consisting of bIG-H3, MIF and nucleic acids encoding the proteins is lower after application of the c-Met inhibitor than before the application.</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0050]" class="style-scope patent-text">
    
    [0050]
  </para-num> <div id="p0050" num="0050" class="description-line style-scope patent-text">In other words, expression levels of at least one selected from the group consisting of bIG-H3, MIF, and nucleic acids encoding the proteins before or after the application of a c-Met inhibitor are measured to assay (identify) or monitor the effect of the c-Met inhibitor, so that the measurements can be effectively used to determine whether the c-Met inhibitor should continue to be applied or not, or to establish a therapeutic strategy with regard to, for example, doses, dosing intervals, dose numbers of the c-Met inhibitor. Based on this finding, bIG-H3 and/or MIF as appear to be viable pharmacodynamic markers for c-Met inhibitors.</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0051]" class="style-scope patent-text">
    
    [0051]
  </para-num> <div id="p0051" num="0051" class="description-line style-scope patent-text">The bIG-H3 may originate from vertebrates including mammals, such as rodents, e.g., mice, rat, etc., and primates, e.g., humans, monkeys, etc., birds, reptiles, amphibians, and fishes. For example, the bIG-H3 may be selected from the group consisting of, but not limited to, human bIG-H3 (NP_000349.1, AAC24944.1, AAC08449.1, AAH00097.1, etc.), mouse bIG-H3 (NP_033395.1, AAI29901.1, AAI29902.1, etc.), rat bIG-H3 (NP_446254.1, etc.), and zebrafish bIG-H3 (NP_878282.1, etc.). A bIG-H3 encoding gene (cDNA or mRNA) may be selected from the group consisting of, but not limited to, NM_000358.2, NM_009369.4, NM_053802.1, and NM_182862.1.</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0052]" class="style-scope patent-text">
    
    [0052]
  </para-num> <div id="p0052" num="0052" class="description-line style-scope patent-text">MIF may originate from vertebrates including mammals, birds, reptiles, amphibians, and fishes. For example, the MIF may be selected from the group consisting of, but not limited to, human MIF (NP_002406.1, etc.), monkey MIF (e.g., NP_001028087.1, etc.), sheep MIF (e.g., NP_001072123.1), etc.), rodent MIF (e.g., mouse MIF(NP_034928.1, etc.), rat MIF (NP_112313.1, etc.), NP_001266756.1, etc.), cow MIF (NP_001028780.1, etc.), zebrafish MIF (NP_001036786.1, etc.), pig MIF (NP_001070681.1, etc.), frog MIF (NP_001083650.1, NP_001107147.1, etc.), and fish MIF (e.g., NP_001118053.1, NP_001135019.1, NP_001027889.1). An MIF-encoding gene (cDNA or mRNA) may be selected from among, but not limited to, NM_002415.1, NM_001032915.1, NM_001078655.1, NM_010798.2, NM_031051.1, NM_001279827.1, NM_001033608.1, NM_001043321.1, NM_001077213.2, NM_001090181.1, NM_001113675.1, NM_001124581.1, NM_001141547.1, and NM_001032717.1.</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0053]" class="style-scope patent-text">
    
    [0053]
  </para-num> <div id="p0053" num="0053" class="description-line style-scope patent-text">An aspect described herein provides a biomarker for evaluating the effect of a c-Met inhibitor, comprising at least one selected from the group consisting of bIG-H3, MIF, and nucleic acids encoding the proteins.</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0054]" class="style-scope patent-text">
    
    [0054]
  </para-num> <div id="p0054" num="0054" class="description-line style-scope patent-text">Another aspect described herein provides a composition and a kit for evaluating the effect of a c-Met inhibitor, comprising at least one selected from the group consisting of bIG-H3, MIF, and nucleic acids encoding the proteins.</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0055]" class="style-scope patent-text">
    
    [0055]
  </para-num> <div id="p0055" num="0055" class="description-line style-scope patent-text">Another aspect described herein provides a method for evaluating (or identifying or monitoring) the efficacy of a c-Met inhibitor or for offering information on the evaluation (or identifying or monitoring) of the efficacy of a c-Met inhibitor, comprising measuring a level of at least one selected from the group consisting of bIG-H3, MIF, and nucleic acids encoding the proteins in a biological sample.</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0056]" class="style-scope patent-text">
    
    [0056]
  </para-num> <div id="p0056" num="0056" class="description-line style-scope patent-text">In the disclosed method for monitoring the efficacy of a c-Met inhibitor or for offering information on the monitoring of the efficacy of a c-Met inhibitor, levels of at least one selected from the group consisting of bIG-H3, MIF and nucleic acids encoding the proteins in biological samples from a patient before and after treatment with the c-Met inhibitor (or in a c-Met inhibitor treated group biological sample and a c-Met inhibitor untreated biological sample) are measured and compared. When the post-treatment level of at least one selected from the group consisting of bIG-H3, MIF, and nucleic acids encoding the proteins is lower (decreased) compared to the pre-treatment level, the c-Met inhibitor is determined to exert its activity in the patient from which the biological sample is sourced (obtained), whereas when the post-treatment level of at least one selected from the group consisting of bIG-H3, MIF, and nucleic acids encoding the proteins is the same with or higher (increase) compared to the pre-treatment level, it is determined that the c-Met inhibitor does not exert its efficacy or a resistance to the c-Met inhibitor occurs in the patient from which the biological sample is sourced (obtained). Therefore, the method for monitoring the efficacy of a c-Met inhibitor or for offering information on the monitoring of the efficacy of a c-Met inhibitor may further comprise 1) comparing the level of at least one selected from the group consisting of bIG-H3, MIF, and nucleic acids encoding the proteins in a biological sample from the c-Met inhibitor-treated group with that in a biological sample from the untreated group, and/or 2) determining that the c-Met inhibitor exerts its efficacy in the biological sample-derived patient when the level of at least one selected from the group consisting of bIG-H3 or MIF and a nucleic acid (e.g., gene) encoding bIG-H3 or MIF in the biological sample of the c-Met inhibitor-treated group is reduced, compared to that of the untreated group (in this case, it may be determined to maintain (continue) the administration of a c-Met inhibitor to the subject), and/or 3) determining that the c-Met inhibitor does not exert its efficacy or a resistance to the c-Met inhibitor occurs in the biological sample-derived patient when the level of at least one selected from the group consisting of bIG-H3, MIF, and nucleic acids encoding the proteins in the biological sample of the c-Met inhibitor-treated group is maintained or increased (in this case, it may be determined to stop the administration of a c-Met inhibitor to the subject). The c-Met inhibitor may be an anti-c-Met antibody.</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0057]" class="style-scope patent-text">
    
    [0057]
  </para-num> <div id="p0057" num="0057" class="description-line style-scope patent-text">The level of at least one selected from the group consisting of bIG-H3, MIF and nucleic acids encoding the proteins may be measured by quantifying an bIG-H3 protein, an MIF protein and nucleic acids (DNA, cDNA or mRNA) encoding the proteins using the quantification techniques described, above. For example, when the level of at least one selected from the group consisting of bIG-H3, MIF and nucleic acids encoding the proteins in the c-Met inhibitor-treated group or in the biological sample after treatment with a c-Met inhibitor is about 0 to about 80 wt %, about 0 to about 70 wt %, about 0 to about 60 wt %, about 0 to about 50 wt %, about 0 to about 40 wt %, about 0 to about 30 wt %, about 0 to about 20 wt %, or about 0 to about 10 wt % of that of the c-Met inhibitor-untreated group or the pre-treatment biological sample, the c-Met inhibitor-treated group, or the post-treatment sample biological is determined to decrease in the level of at least one selected from the group consisting of bIG-H3, MIF and nucleic acids encoding the proteins, compared to the c-Met inhibitor-untreated or the pre-treatment biological sample. When the level of at least one selected from the group consisting of bIG-H3, MIF and nucleic acids encoding the proteins in the c-Met inhibitor-treated group or the post-treatment biological sample is about 0 wt % of that in the c-Met inhibitor-untreated group or the pre-treatment biological sample, there is no detection (absence) of at least one selected from the bIG-H3, MIF and nucleic acids encoding the proteins in the c-Met inhibitor-treated group or the post-treatment biological sample. Levels of bIG-H3, MIF and nucleic acids encoding the proteins in the c-Met inhibitor-untreated group (or pre-treatment) and the c-Met inhibitor-treated group (or post-treatment) may be measured by conducting the same procedure on sample samples from the same patient.</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0058]" class="style-scope patent-text">
    
    [0058]
  </para-num> <div id="p0058" num="0058" class="description-line style-scope patent-text">bIG-H3, MIF and nucleic acids encoding the proteins may be quantitatively analyzed within a relatively short period of time, for example, one month, two weeks, a week, 5 days, 3 days, 2 days or 1 day after administration of the c-Met inhibitor, and comparison between levels of the marker after and before administration thereof can evaluate the efficacy of c-Met inhibitor. Henceforth, the advantage of establishing a more effective therapeutic strategy can be achieved, since it makes it possible to evaluate the efficacy of the c-Met inhibitor in an early stage of therapy.</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0059]" class="style-scope patent-text">
    
    [0059]
  </para-num> <div id="p0059" num="0059" class="description-line style-scope patent-text">In one aspect described herein, the measuring of a level of at least one selected from the group consisting of bIG-H3, MIF and nucleic acids encoding the proteins in a biological sample may comprise 1) determining a level of at least one selected from the group consisting of bIG-H3, MIF and nucleic acids encoding the proteins in a biological sample from a patient prior to treatment with a c-Met inhibitor (or in a c-Met inhibitor untreated biological sample which is a part of biological sample from a patient) and 2) determining a level of at least one selected from the group consisting of bIG-H3, MIF and nucleic acids encoding the proteins in a biological sample from the patient after treatment with a c-Met inhibitor (or in a c-Met inhibitor treated biological sample which is a part of biological sample from a patient). Each of the steps 1) and 2) may comprise i) applying (adding) a material interacting with at least one selected from the group consisting of bIG-H3, MIF and nucleic acids encoding the proteins to the biological sample; and ii) quantitatively analyzing the resulting reaction mixture to determine a level of at least one selected from the group consisting of bIG-H3, MIF and nucleic acids encoding the proteins. In an aspect described herein, prior to the step i), a step of preparing a biological sample may be further performed, wherein the preparation step may comprise obtaining (isolating) a biological sample from the patient or obtained a biological sample which has been isolated from a patient. In step i), as will be further elucidated below, the interacting material may be at least one selected from the group consisting of compounds (a small molecular chemical; e.g., general label such as a fluorescent, a dye, etc.), proteins (antibodies, aptamers, etc.) nucleic acid (DNA, RNA, etc.), and the like, binding to bIG-H3, MIF, bIG-H3 gene or MIF gene, and for example, the interacting material may be at least one selected from the group consisting of a compound, an antibody, an aptamer, all specifically binding to bIG-H3 or MIF, and a polynucleotide (e.g., a primer, a probe, an aptamer) binding to a part or entirety of a gene encoding bIG-H3 or MIF, and optionally, may be conjugated with a label, such as a fluorescent, a secondary antibody, a bead (e.g., a magnetic or polystyrene bead), or a dye. The step i) may be configured to form a complex by applying (adding) the interacting material to the biological sample. In step ii), the reaction mixture may be a complex resulting from interaction (binding) between at least one selected from the group consisting of bIG-H3, MIF and nucleic acids encoding the proteins and the interacting material, which can be obtained in step i). The quantitative analysis step may comprise quantifying the complex, the label conjugated to the complex, or the bIG-H3 or the MIF, or the nucleic acid encoding same segregated from the complex after the isolation of the complex from the biological sample. The quantitative analysis of bIG-H3 or MIF may be performed by any general quantifying means of proteins, such as immunochromatography, immunohistochemistry, immunohistochemical staining, enzyme linked immunosorbent assay (ELISA), radioimmunoassay (RIA), enzyme immunoassay (EIA), fluorescence immunoassay (FIA), luminescence immunoassay (LIA), Western blotting, microarray, surface plasmon resonance (SPR), flow cytometry assay (e.g., Cytometric Bead Array (CBA) assay, human inflammatory cytokine kit; BD biosciences), intracellular staining, Luminex assay, and the like, and the quantitative analysis of IL-8 gene may be performed by any general quantifying means of genes (DNA or RNA), such as PCR, (e.g., qPCR, RT-PCR, etc.), mRNA microarray, and the like, but not limited thereto.</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0060]" class="style-scope patent-text">
    
    [0060]
  </para-num> <div id="p0060" num="0060" class="description-line style-scope patent-text">The evaluating method may be useful in determining whether the c-Met inhibitor continues to be used, and/or suitable dosing conditions of the c-Met inhibitor (dose, dosing interval, and number of dosing). For example, when the level of at least one selected from the group consisting of bIG-H3, MIF and genes in the c-Met inhibitor-treated group or in the post-treatment biological sample is reduced, compared to the c-Met inhibitor-untreated group or the pre-treatment biological sample, e.g., when the level of at least one selected from the group consisting of bIG-H3, MIF and genes in the c-Met inhibitor-treated group or in the post-treatment biological sample is about 0 to about 80 wt %, about 0 to about 70 wt %, about 0 to about 60 wt %, about 0 to about 50 wt %, about 0 to about 40 wt %, about 0 to about 30 wt %, about 0 to about 20 wt %, or about 0 to about 10 wt % of that of the c-Met inhibitor-untreated group or the pre-treatment biological sample, the use of c-Met inhibitor may be determined to be continued. In addition, when the level of at least one selected from the group consisting of bIG-H3, MIF and genes in the c-Met inhibitor-treated group or in the post-treatment biological sample is reduced, compared to the c-Met inhibitor-untreated group or the pre-treatment biological sample, e.g., when the level of at least one selected from the group consisting of bIG-H3, MIF and genes in the c-Met inhibitor-treated group or in the post-treatment biological sample is about 0 to about 80 wt %, about 0 to about 70 wt %, about 0 to about 60 wt %, about 0 to about 50 wt %, about 0 to about 40 wt %, about 0 to about 30 wt %, about 0 to about 20 wt %, or about 0 to about 10 wt % of that of the c-Met inhibitor-untreated group or the pre-treatment biological sample, the dosing condition of the c-Met inhibitor may be determined to be suitable. The dosing condition may be at least one selected from the group consisting of a dose, a dosing interval, and a number of doses. The dosing condition may be determined using the techniques described, above.</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0061]" class="style-scope patent-text">
    
    [0061]
  </para-num> <div id="p0061" num="0061" class="description-line style-scope patent-text">Another aspect described herein provides a method for inhibiting c-Met, comprising administering a c-Met inhibitor to a subject in need thereof. Another embodiment described herein provides a method for preventing and/or treating cancer, comprising administering a c-Met inhibitor to a subject in need thereof. In the method for inhibiting c-Met or for preventing and/or treating cancer, the subject may be one showing a decreased level of bIG-H3, MIF, and/or nucleic acids encoding them after administering the c-Met inhibitor (compared to before the administration). For example, the subject may be 1) selected by the above method for selecting a subject suitable for the application of a c-Met inhibitor or 2) determined by the above method of monitoring efficacy of a c-Met inhibitor as a subject wherein a c-Met inhibitor exert its efficacy thereon.</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0062]" class="style-scope patent-text">
    
    [0062]
  </para-num> <div id="p0062" num="0062" class="description-line style-scope patent-text">In the method for inhibiting c-Met or for preventing and/or treating cancer, the administration of the c-Met inhibitor may be conducted according to the suitable dosing conditions determined by the evaluating method, such as a dose, a dosing interval, and/or a number of doses.</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0063]" class="style-scope patent-text">
    
    [0063]
  </para-num> <div id="p0063" num="0063" class="description-line style-scope patent-text">Levels of IL-8, bIG-H3, MIF, and nucleic acids (e.g., genes) encoding them can be measured by any general protein or gene assay method using a material interacting with the proteins or the genes. The material interacting with any of the proteins or the genes may be a compound, an antibody, or an aptamer, all specifically binding to IL-8, bIG-H3, or <figure-callout id="8" label="MIF" filenames="imgf0006.png,imgf0007.png" class="style-scope patent-text"><a title="Show image containing callout" class="style-scope figure-callout">MIF</a></figure-callout> 8 proteins, or a polynucleotide (e.g., a primer, a probe, an aptamer) binding to a part or entirety of a gene encoding IL-8, bIG-H3, or MIF proteins. For example, the levels of IL-8, bIG-H3, or MIF protein may be measured by detecting enzymatic reactions, fluorescence, luminescence and/or radioactivity using a compound (a small molecular chemical; e.g., general label such as a fluorescent, a dye, etc.), an antibody and/or an aptamer, which binds (e.g., specifically binds) to IL-8, bIG-H3, or MIF proteins. In detail, the level of the proteins may be determined using an analysis technique selected from among, but not limited to, immunochromatography, immunohistochemistry (IHC), immunohistochemical staining, enzyme linked immunosorbent assay (ELISA), radioimmunoassay (RIA), enzyme immunoassay (EIA), fluorescence immunoassay (FIA), luminescence immunoassay (LIA), Western blotting, microarray, surface plasmon resonance (SPR), flow cytometry assay (e.g., Cytometric Bead Array (CBA) assay (BD biosciences), Intracellular staining, etc.), Luminex assay, and the like. In addition, the level of a gene encoding IL-8, bIG-H3 or MIF may be measured by a typical gene assay method using a primer, probe or aptamer hybridizable with the gene, for example, by polymerase chain reaction (PCR; e.g., qPCR, RT-PCR, etc.), FISH (fluorescent in situ hybridization), or microarray assay. In one embodiment described herein, the primer is designed to detect a fragment of successive base pairs out of the gene encoding IL-8, bIG-H3 or MIF5 (full-length DNA, cDNA or mRNA), for example, a fragment of about 5 to about 2000 bp or about 5 to about 1000 bp , e.g., about 10 to about 1500 bp, about 10 to about 1000 bp, about 10 to about 500 bp, about 20 to about 200 bp, or about 50 to about 200 bp, and may be a pair of primers having nucleotide sequences which are respectively hybridizable with (e.g., complementary to) 3'- and 5'-terminal regions ranging in size from about 5 to about 100 bp, e.g., about 5 to about 50 bp, about 5 to about 30 bp, or about 10 to about 25 bp. The probe or the aptamer hybridizable with the gene may have a nucleotide sequence with a size of from about 5 to about 2000 bp, from about 5 to about 1500 bp, from about 5 to about 1000 bp, from about 5 to about 500 bp, from about 5 to about 100 bp, from about 5 to about 50 bp, from about 5 to about 30 bp, or from about 5 to about 25 bp, which is hybridizable with (or complementary to) a fragment of the IL-8, bIG-H3 or MIF-encoding gene (full-length DNA, cDNA or mRNA). As used herein, the term "hybridizable" means pertaining to complementarily binding to a specific region of the gene, with a sequence complementarity of 80% or higher, e.g., 90% or higher, 95% or higher, 98% or higher, 99% or higher, or 100% between the primer, probe or aptamer and the gene region.</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0064]" class="style-scope patent-text">
    
    [0064]
  </para-num> <div id="p0064" num="0064" class="description-line style-scope patent-text">The RAS-RAF pathway is a representative cell proliferation signaling pathway of which cancer cells take advantage in their growth. For this reason, the RAS-RAF pathway is a main target of anticancer drugs. Hence, a mutation of the RAS-RAF pathway may be an important factor that can affect the efficacy of a drug targeting the pathway. No reports have been made on a relationship between c-Met and RAS-RAF mutation, so far.</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0065]" class="style-scope patent-text">
    
    [0065]
  </para-num> <div id="p0065" num="0065" class="description-line style-scope patent-text">In one exemplary aspect described herein, a response to a c-Met inhibitor varies depending on the mutation of RAS and/or RAF (see Example 4). In greater detail, when a biological sample is observed to have a RAS and/or RAF mutation, a c-Met inhibitor, e.g., an anti-c-Met antibody does not work in the biological sample or the patient from which the biological sample originates.</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0066]" class="style-scope patent-text">
    
    [0066]
  </para-num> <div id="p0066" num="0066" class="description-line style-scope patent-text">In other words, detection of the mutation of RAS and/or RAF may be effectively used to predict the efficacy of a c-Met inhibitor or to select a subject to which a c-Met inhibitor is applicable. Based on this finding, RAS-RAF is first suggested as a predictive maker for c-Met inhibitors.</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0067]" class="style-scope patent-text">
    
    [0067]
  </para-num> <div id="p0067" num="0067" class="description-line style-scope patent-text">RAS, a member of the GTPase superfamily, may be selected from the group consisting of KRAS, NRAS, and HRAS, all of which originate from vertebrates including mammals, such as rodents, e.g., mice, rat, etc., and primates, e.g., humans, monkeys, etc., birds, reptiles, amphibians, and fishes. For example, KRAS may be selected from the group consisting of, but not limited to, human KRAS (NP_004976.2, NP_203524.1, etc.), mouse KRAS (NP_067259.4, etc.), zebrafish KRAS (NP_001003744.1, etc.), frog KRAS (NP_001095209.1), cow KRAS (NP_001103471.1), chicken KRAS (NP_001243091.1), monkey KRAS (NP_001248441.1), NP_001028153.1, NP_113703.1, and NP_001008034.1. A KRAS-encoding gene (cDNA or mRNA) may be selected from among, but not limited to, NM_004985.4, NM_033360.3, NM_021284.6, NM_001003744.1, NM_001101739.1, NM_001110001.1, NM_001256162.1, NM_001261512.2, NM_001032981.2, NM_031515.3, and NM_001008033.1.</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0068]" class="style-scope patent-text">
    
    [0068]
  </para-num> <div id="p0068" num="0068" class="description-line style-scope patent-text">The mutation of KRAS connected with the prediction of the effect of c-Met inhibitors may be a substitution on the <figure-callout id="12" label="codon" filenames="imgf0011.png,imgf0020.png" class="style-scope patent-text"><a title="Show image containing callout" class="style-scope figure-callout">codon</a></figure-callout> 12 GGT (corresponding to Gly at <figure-callout id="12" label="position" filenames="imgf0011.png,imgf0020.png" class="style-scope patent-text"><a title="Show image containing callout" class="style-scope figure-callout">position</a></figure-callout> 12 of the amino acid sequence NP_004976) of wild-type KRAS (accession number: NM_004985) and/or on the <figure-callout id="13" label="codon" filenames="imgf0014.png" class="style-scope patent-text"><a title="Show image containing callout" class="style-scope figure-callout">codon</a></figure-callout> 13 GGC (corresponding to Gly at <figure-callout id="13" label="position" filenames="imgf0014.png" class="style-scope patent-text"><a title="Show image containing callout" class="style-scope figure-callout">position</a></figure-callout> 13 of the amino acid sequence NP_004976), as shown in Table 1, below.
<tables id="tabl0001" num="0001" class="style-scope patent-text"> <patent-tables frame="all" class="style-scope patent-text">TABLE 1<table cols="3" class="description-table style-scope patent-text" width="100%"> <thead class="style-scope patent-text"> <tr class="description-tr style-scope patent-text"> <td namest="col1" nameend="col3" align="center" valign="top" class="description-td style-scope patent-text" colspan="3">Examples of amino acid modification of NP_004976</td> </tr> <tr class="description-tr style-scope patent-text"> <td valign="top" class="description-td style-scope patent-text">Codon #</td> <td valign="top" class="description-td style-scope patent-text">Base substitution</td> <td valign="top" class="description-td style-scope patent-text">Amino acid substitution (in NP_004976)</td> </tr> </thead>  <tbody class="style-scope patent-text"><tr class="description-tr style-scope patent-text"> <td class="description-td style-scope patent-text">12</td> <td class="description-td style-scope patent-text">GGTGCT</td> <td class="description-td style-scope patent-text">GlyAla (G12A)</td> </tr> <tr class="description-tr style-scope patent-text"> <td class="description-td style-scope patent-text">12</td> <td class="description-td style-scope patent-text">GGTGAT</td> <td class="description-td style-scope patent-text">GlyAsp (G12D)</td> </tr> <tr class="description-tr style-scope patent-text"> <td class="description-td style-scope patent-text">12</td> <td class="description-td style-scope patent-text">GGTCGT</td> <td class="description-td style-scope patent-text">GlyArg (G12R)</td> </tr> <tr class="description-tr style-scope patent-text"> <td class="description-td style-scope patent-text">12</td> <td class="description-td style-scope patent-text">GGTTGT</td> <td class="description-td style-scope patent-text">GlyCys (G12C)</td> </tr> <tr class="description-tr style-scope patent-text"> <td class="description-td style-scope patent-text">12</td> <td class="description-td style-scope patent-text">GGTAGT</td> <td class="description-td style-scope patent-text">GlySer (G12S)</td> </tr> <tr class="description-tr style-scope patent-text"> <td class="description-td style-scope patent-text">12</td> <td class="description-td style-scope patent-text">GGTGTT</td> <td class="description-td style-scope patent-text">GlyVal (G12V)</td> </tr> <tr class="description-tr style-scope patent-text"> <td class="description-td style-scope patent-text">13</td> <td class="description-td style-scope patent-text">GGCGAC</td> <td class="description-td style-scope patent-text">GlyAsp (G13D)</td> </tr> <tr class="description-tr style-scope patent-text"> <td class="description-td style-scope patent-text">13</td> <td class="description-td style-scope patent-text"> </td> <td class="description-td style-scope patent-text">GlyAsn (G13N)</td> </tr> <tr class="description-tr style-scope patent-text"> <td class="description-td style-scope patent-text">13</td> <td class="description-td style-scope patent-text"> </td> <td class="description-td style-scope patent-text">GlyCys (G13C)</td> </tr> <tr class="description-tr style-scope patent-text"> <td class="description-td style-scope patent-text">23</td> <td class="description-td style-scope patent-text"> </td> <td class="description-td style-scope patent-text">LeuArg (L23R)</td> </tr> <tr class="description-tr style-scope patent-text"> <td class="description-td style-scope patent-text">24</td> <td class="description-td style-scope patent-text"> </td> <td class="description-td style-scope patent-text">IlePhe (I24F)</td> </tr> <tr class="description-tr style-scope patent-text"> <td class="description-td style-scope patent-text">59</td> <td class="description-td style-scope patent-text"> </td> <td class="description-td style-scope patent-text">AlaThr (A59T)</td> </tr> <tr class="description-tr style-scope patent-text"> <td class="description-td style-scope patent-text">61</td> <td class="description-td style-scope patent-text"> </td> <td class="description-td style-scope patent-text">GlnLeu (Q61L)</td> </tr> <tr class="description-tr style-scope patent-text"> <td class="description-td style-scope patent-text">61</td> <td class="description-td style-scope patent-text"> </td> <td class="description-td style-scope patent-text">GlnHis (Q61H)</td> </tr> <tr class="description-tr style-scope patent-text"> <td class="description-td style-scope patent-text">61</td> <td class="description-td style-scope patent-text"> </td> <td class="description-td style-scope patent-text">GlnLys (Q61K)</td> </tr> <tr class="description-tr style-scope patent-text"> <td class="description-td style-scope patent-text">146</td> <td class="description-td style-scope patent-text"> </td> <td class="description-td style-scope patent-text">AlaThr (A146T)</td> </tr>  </tbody></table> </patent-tables> </tables> </div>
    </li> <li class="style-scope patent-text"> <para-num num="[0069]" class="style-scope patent-text">
    
    [0069]
  </para-num> <div id="p0069" num="0069" class="description-line style-scope patent-text">In addition, the mutation may be a substitution for at least one amino acid residue selected from the group consisting of Gly at <figure-callout id="13" label="position" filenames="imgf0014.png" class="style-scope patent-text"><a title="Show image containing callout" class="style-scope figure-callout">position</a></figure-callout> 13, Ile at <figure-callout id="24" label="position" filenames="imgf0005.png,imgf0014.png" class="style-scope patent-text"><a title="Show image containing callout" class="style-scope figure-callout">position</a></figure-callout> 24, Ala at position 59, Gln at position 61, and Ala at position 146 on the amino acid sequence of NP_004976, and/or a mutation in a KRAS coding nucleic acid inducing the amino acid mutation described above. For example, the mutation of KRAS may comprise at least one selected from the group consisting of G12A, G12D, G12R, G12C, G12S, G12V, A146T, A59T, L23R, G13N, G13D, I24F, Q61L, Q61H, G13C, and Q61K on the amino acid sequence of NP_004976, mutations in a KRAS coding nucleic acid inducing the amino acid mutation described above, or a combination thereof.</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0070]" class="style-scope patent-text">
    
    [0070]
  </para-num> <div id="p0070" num="0070" class="description-line style-scope patent-text">Amino acid sequence of NP_004976 (188 a.a.: SEQ ID NO: 109)
<div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/31/7c/0c/d1c6734ff9fc78/imgb0001.png" class="style-scope patent-text"><img id="ib0001" file="imgb0001.tif" wi="141" he="26" img-content="dna" img-format="tif" width="564" height="104" alt="Figure imgb0001" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/31/7c/0c/d1c6734ff9fc78/imgb0001.png"></a></div> </div>
    </li> <li class="style-scope patent-text"> <para-num num="[0071]" class="style-scope patent-text">
    
    [0071]
  </para-num> <div id="p0071" num="0071" class="description-line style-scope patent-text">RAF may be selected from the group consisting of BRAF, c-RAF A-RAF, V-RAF, KSR1, and KSR2, all of which originate from vertebrates including mammals, such as rodents, e.g., mice, rats, etc., and primates, e.g., humans, monkeys, etc., birds, reptiles, amphibians, and fishes. For example, BRAF may be selected from the group consisting of, but not limited to, human BRAF (NP_004324.2, etc.), mouse BRAF (NP_647455.3, etc.), frog BRAF (NP_001083526.1, etc.), zebrafish BRAF (NP_991307.2, etc.), rat BRAF (NP_579817.1, etc.), and chicken BRAF (NP_990633.1, etc.). The BRAF-encoding gene (cDNA or mRNA) may be selected from the group consisting of, but not limited to, NM_004333.4, NM_139294.5, NM_001090057.1, NM_205744.3, NM_133283.1, and NM_205302.1.</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0072]" class="style-scope patent-text">
    
    [0072]
  </para-num> <div id="p0072" num="0072" class="description-line style-scope patent-text">The mutation of BRAF connected with the prediction of the effect of c-Met inhibitors may be a substitution of at least one selected from the group consisting of the amino acids at positions 596 (G), 600 (V), 601 (K), 469 (G), 466 (G), 581 (N), 597 (L), 464 (G), and the like. For example, the mutation of BRAF connected with the prediction of the effect of c-Met inhibitors may comprise at least one following mutation on the basis of wild-type BRAF (accession number NP_004324): G596R (base G at position 596 substituted by R), V600E, V600K, V600R, K601E, K601E, G469A, V600M, G469A, V600L, G466V, V600D, G469V, D594G, D594N, N581S, L597V, L597S, L597Q, K601N, G466V, G466E, G464V, G469E, etc.; mutations in a BRAF coding nucleic acid inducing the amino acid mutation described above; or a combination thereof.</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0073]" class="style-scope patent-text">
    
    [0073]
  </para-num> <div id="p0073" num="0073" class="description-line style-scope patent-text">Amino Acid Sequence of NP_004324 (766 a.a.: SEQ ID NO: 110)
<div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/3d/09/11/0c847cc744df68/imgb0002.png" class="style-scope patent-text"><img id="ib0002" file="imgb0002.tif" wi="153" he="49" img-content="dna" img-format="tif" width="612" height="196" alt="Figure imgb0002" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/3d/09/11/0c847cc744df68/imgb0002.png"></a></div>
<div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/a2/06/93/563d51c7ef78a3/imgb0003.png" class="style-scope patent-text"><img id="ib0003" file="imgb0003.tif" wi="153" he="57" img-content="dna" img-format="tif" width="612" height="228" alt="Figure imgb0003" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/a2/06/93/563d51c7ef78a3/imgb0003.png"></a></div> </div>
    </li> <li class="style-scope patent-text"> <para-num num="[0074]" class="style-scope patent-text">
    
    [0074]
  </para-num> <div id="p0074" num="0074" class="description-line style-scope patent-text">An aspect described herein provides a composition and a kit for the prediction of the efficacy of a c-Met inhibitor, comprising a material detecting a mutation of at least one selected from the group consisting of KRAS protein, BRAF protein and nucleic acids encoding the proteins.</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0075]" class="style-scope patent-text">
    
    [0075]
  </para-num> <div id="p0075" num="0075" class="description-line style-scope patent-text">Another aspect described herein provides a composition and a kit for the selection of a subject suitable to the application of a c-Met inhibitor, comprising a material detecting a mutation of at least one selected from the group consisting of KRAS protein, BRAF protein and nucleic acids encoding the proteins.</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0076]" class="style-scope patent-text">
    
    [0076]
  </para-num> <div id="p0076" num="0076" class="description-line style-scope patent-text">Also, provided according to another aspect described herein is a method for predicting the efficacy of a c-Met inhibitor, for offering information on the prediction of the efficacy of a c-Met inhibitor, for selecting a subject suitable to the application of a c-Met inhibitor, or for offering information of the selection of a subject suitable to the application of a c-Met inhibitor, comprising detecting a mutation of at least one selected from the group consisting of KRAS protein, BRAF protein and nucleic acids encoding the proteins in a biological sample. In the method for predicting the efficacy of a c-Met inhibitor or for offering information on the efficacy of a c-Met inhibitor, when a mutation of at least one selected from the group consisting of KRAS protein, BRAF protein and nucleic acids encoding the proteins is not detected in a biological sample, the biological sample or a patient from which the biological sample is originated can be predicted to allow the c-Met inhibitor to effectively exert its activity or may be considered to be suitable for the application of the c-Met inhibitor. Hence, the method for predicting the efficacy of a c-Met inhibitor or for offering information on the efficacy of a c-Met inhibitor may further comprise estimating that when a mutation of at least one selected from the group consisting of KRAS protein, BRAF protein and nucleic acids encoding the proteins in a biological sample, the c-Met inhibitor would exert its efficacy in the biological sample or the patient. In addition, the method for selecting a subject suitable to the application of a c-Met inhibitor or for offering information on the selection may further comprise determining the biological sample or the patient as a subject suitable for the application of the c-Met inhibitor when a mutation of at least one selected from the group consisting of KRAS protein, BRAF protein and nucleic acids encoding the proteins is not detected biological sample.</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0077]" class="style-scope patent-text">
    
    [0077]
  </para-num> <div id="p0077" num="0077" class="description-line style-scope patent-text">Detecting a mutation of at least one selected from the group consisting of KRAS protein, BRAF protein and nucleic acids encoding the proteins in the biological sample may comprise i) treating the biological sample with a material detecting a mutation of at least one selected from the group consisting of KRAS protein, BRAF protein and nucleic acids encoding the proteins; and ii) analyzing the reaction mixture to determine the presence or absence of the mutation. In an aspect described herein, prior to the preparing step i), a step of preparing a biological sample may be further performed, wherein the preparation step may comprise obtaining (isolating) a biological sample from a patient or obtaining a biological sample which has been isolated from a patient. In step i), the detective material may be at least one selected from the group consisting of 1) a polynucleotide (e.g., a probe or aptamer) comprising a nucleotide sequence hybridizable with (e.g., complementary to) a mutation-containing fragment of a KRAS gene and/or BRAF gene (full-length DNA, cDNA or mRNA) ranging in size from about 5 to about 2000 bp, from about 5 to about 1500 bp, from about 5 to about 1000 bp, from about 5 to about 500 bp, from about 5 to about 100 bp, from about 5 to about 50 bp, from about 5 to about 30 bp, or from about 5 to about 25 bp, and a pair of primers having nucleotide sequences which are respectively hybridizable with (e.g., complementary to) 3'- and 5'-terminal regions ranging in size from about 5 to about 100 bp, from about 5 to about 50 bp, from about 5 to about 30 bp, or from about 5 to about 25 bp out of the gene fragment with a size of about 5 to about 2000 bp or about 5 to about 1000 bp, e.g., from about 10 to about 1500 bp, from about 10 to about 1000 bp, from about 10 to about 500 bp, from about 20 to about 200 bp, or from about 50 to about 200 bp; 2) a compound (a small molecular chemical; e.g., general label such as a fluorescent, a dye, etc.), an antibody, or an aptamer, all binding (e.g., specifically binding) to the KRAS or BRAF protein having the amino acid mutation. Optionally, the detective material may be conjugated with a label, such as a fluorescent, a secondary antibody, a bead (e.g., a magnetic bead or a polystyrene bead), a dye or a combination thereof. As used herein, the term "hybridizable" means pertaining to complementarily binding to a specific region of the gene, with a sequence homology of 80% or higher, e.g., 90% or higher, 95% or higher, 98% or higher, 99% or higher, or 100% between the primer, probe or aptamer and the gene region. The step i) may be configured to form a complex by adding (applying) the detective material to the biological sample.</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0078]" class="style-scope patent-text">
    
    [0078]
  </para-num> <div id="p0078" num="0078" class="description-line style-scope patent-text">In step ii), the reaction mixture may be the complex resulting from hybridization between a gene selected from a KRAS gene and a BRAF gene (which is mutated) and the detective material or resulting from an interaction between a compound (a small molecular chemical; e.g., general label such as a fluorescent, a dye, etc.), an antibody, or an aptamer, and a KRAS or BRA protein having the amino acid mutation (e.g., substitution), which can be obtained in step i). The analyzing may comprise detecting the presence of the complex or the label conjugated to the complex, or base or amino acid sequencing the KRAS, BRAF, KRAS gene and/or BRAF gene fragment segregated from the complex after the isolation of the complex from the biological sample.</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0079]" class="style-scope patent-text">
    
    [0079]
  </para-num> <div id="p0079" num="0079" class="description-line style-scope patent-text">Another aspect described herein provides a method for inhibiting c-Met, comprising administering a c-Met inhibitor to a subject who has a mutation of at least one of KRAS, BRAF, and nucleic acids encoding them. For example, the subject may be selected by the above method for selecting a subject suitable for the application of a c-Met inhibitor.</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0080]" class="style-scope patent-text">
    
    [0080]
  </para-num> <div id="p0080" num="0080" class="description-line style-scope patent-text">Another aspect described herein provides a method for preventing and/or treating cancer, comprising administering a c-Met inhibitor to a subject who has a mutation of at least one of KRAS, BRAF, and nucleic acids encoding them. For example, the subject may be selected by the above method for selecting a subject suitable for the application of a c-Met inhibitor.</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0081]" class="style-scope patent-text">
    
    [0081]
  </para-num> <div id="p0081" num="0081" class="description-line style-scope patent-text">The method for inhibiting c-Met or the method for preventing and/treating cancer may further comprise selecting a subject to which the c-Met inhibitor is applicable, prior to the administering step. Details of the selection are as described above. The c-Met inhibitor may be an anti-c-Met antibody.</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0082]" class="style-scope patent-text">
    
    [0082]
  </para-num> <div id="p0082" num="0082" class="description-line style-scope patent-text">In an aspect described herein, the method for inhibiting c-Met or for preventing and/or treating cancer may comprise:
</div> </li> <ul class="style-scope patent-text"> <li class="style-scope patent-text">identifying a subject to which a c-Met inhibitor is applicable; and</li> <li class="style-scope patent-text">administering a pharmaceutically effective amount of the c-Met inhibitor to the subject.</li> </ul>
    <li class="style-scope patent-text"> <para-num num="[0083]" class="style-scope patent-text">
    
    [0083]
  </para-num> <div id="p0083" num="0083" class="description-line style-scope patent-text">In another aspect described herein, the method for inhibiting c-Met or for preventing and/or treating cancer may comprise:
</div> </li> <ul class="style-scope patent-text"> <li class="style-scope patent-text">detecting a mutation on KRAS, BRAF, or nucleic acid encoding them in a biological sample to select a c-Met inhibitor-applicable subject; and</li> <li class="style-scope patent-text">administering a pharmaceutically effective amount of the c-Met inhibitor to the selected c-Met inhibitor-applicable subject. As used herein, the mutation of KRAS or BRAF protein may refer to the above described amino acid mutation (e.g., substitution), and the mutation of a nucleic acid encoding KRAS or BRAF protein may refer to a mutation (e.g., substitution) in the nucleic acid which induce the mutation of KRAS or BRAF protein as described above.</li> </ul>
    <li class="style-scope patent-text"> <para-num num="[0084]" class="style-scope patent-text">
    
    [0084]
  </para-num> <div id="p0084" num="0084" class="description-line style-scope patent-text">From the point of view of using a c-Met inhibitor such as an anti-c-Met antibody, a certain expression level of c-Met in cancer cells is prerequisite for the c-Met inhibitor therapy.</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0085]" class="style-scope patent-text">
    
    [0085]
  </para-num> <div id="p0085" num="0085" class="description-line style-scope patent-text">Accordingly, the composition and/or kit for predicting an efficacy of a c-Met inhibitor, selecting a subject for applying a c-Met inhibitor, or monitoring an efficacy of a c-Met inhibitor may further comprise a substance interacting with at least one selected from the group consisting of c-Met and c-Met coding gene, in addition to a substance interacting with at least one selected from the group consisting of IL-8, bIG-H3, MIF, KRAS/BRAF, and coding genes thereof. The interacting substance with c-Met and/or c-Met coding gene may be at least one selected from the group consisting of chemicals (small molecules; e.g., general label such as a fluorescent, a dye, etc.), proteins, peptides, nucleic acids (polynucleotides, oligonucleotides, etc.), and the like, which are specifically interact with (or bind to) c-Met and/or c-Met coding gene. For example, the substance interacting with c-Met and/or c-Met coding gene may be at least one selected from the group consisting of chemicals, antibodies, and aptamers, which specifically bind to c-Met, and nucleic acids (e.g., primers, probes, aptamers, etc.) which bind to an whole or a part (e.g., about 5 to about 100 bp, about 5 to about 50 bp, about 5 to about 30 bp, or about 5 to about 25 bp) of c-Met coding gene, which may be labeled with a general labeling material, such as a florescence, a secondary antibody, beads (e.g., a magnetic bead or polystyrene bead), a coloring material, and the like.</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0086]" class="style-scope patent-text">
    
    [0086]
  </para-num> <div id="p0086" num="0086" class="description-line style-scope patent-text">In addition, the method for predicting the efficacy of a c-Met inhibitor (or for offering information on the prediction of the efficacy of a c-Met inhibitor) or the method for selecting a subject suitable to the application of a c-Met inhibitor (or for offering information of the selection of a subject suitable to the application of a c-Met inhibitor) may further comprise measuring a level of c-Met protein or a gene thereof (e.g., full-length DNA, cDNA, mRNA) in the biological sample from the patient. The steps of measuring the level of c-Met and/or c-Met coding gene and measuring the level of at least one selected from the group consisting of IL-8, bIG-H3, MIF, KRAS/BRAF, and coding genes thereof may be performed simultaneously or sequentially in any order. Details of the measuring step are as described above. For example, a western blotting technique may be employed. In this regard, when a predetermined amount (e.g., about 10 g) of proteins obtained from a biological sample (e.g., cancer cells or tissues) is loaded on SDS PAGE gel, transferred onto the membrane, and reacted with an anti-c-Met antibody, and then, exposed on ECL reaction for a certain time (e.g., about 30 sec), the detection of a band may indicate that a prerequisite for the c-Met inhibitor therapy is establishedIf the c-Met level, which is determined by immunohistochemistry (IHC) using a tissue section (e.g., (Formalin-fixed paraffin-embedded tissues (FFPE), etc.) of a tumor tissue, is +2 or more, the tumor tissue can be determined that a c-Met inhibitor can exhibit its therapeutic efficacy thereon. When a biological sample is found to have a c-Met mRNA level of about 12,000 or higher, about 13,000 or higher, or about 14,000 or higher, as measured by Affymetrix array (Affymetrix GeneChip Human Genome U133 Plus 2.0 array; using the primer set "203510_at"), a prerequisite for the c-Met inhibitor therapy may be established. Cancer cells characterized by a high expression level of c-Met include cells from lung cancer, breast cancer, brain cancer, stomach cancer, liver cancer, and kidney cancer. However, any cancer cell, although derived from different kinds, may be a target of the c-Met inhibitor therapy if it expresses a high level of c-Met according to personal characteristics of patients. The claimed invention is limited to serum or blood as the biological sample. A biological sample used in the disclosed method for predicting the efficacy of a c-Met inhibitor (or for offering information on the prediction of the efficacy of a c-Met inhibitor) or the disclosed method for selecting a subject suitable to the application of a c-Met inhibitor (or for offering information of the selection of a subject suitable to the application of a c-Met inhibitor) may be a tissue, a cell or body fluid (blood, serum, urine, saliva, etc.) which shows a high expression level of c-Met, for example, a c-Met level of about 12,000 or higher, about 13,000 or higher, or about 14,000 or higher, as measured by Affymetrix array (Affymetrix GeneChip Human Genome U133 Plus 2.0 array; using the primer set "203510_at").</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0087]" class="style-scope patent-text">
    
    [0087]
  </para-num> <div id="p0087" num="0087" class="description-line style-scope patent-text">The method of predicting, monitoring, or selecting may further comprising administering a c-Met inhibitor to a subject, who is selected by the selecting method, or who is predicted or monitored that a c-Met inhibitor exerts its efficacy therein.</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0088]" class="style-scope patent-text">
    
    [0088]
  </para-num> <div id="p0088" num="0088" class="description-line style-scope patent-text">The method of predicting, monitoring, or selecting may further comprising optimizing the application of a c-Met inhibitor or a therapy with a c-Met inhibitor by 1) determining whether or not a c-Met inhibitor is administered to a subject according to the determination of the determining step of the predicting or selecting method (e.g., determining to administer a c-Met inhibitor to the subject when the level of IL-8 and/or a nucleic acid encoding IL-8 in a biological sample obtained (separated) from the subject is higher than that of a reference sample or when a mutation of at least one of KRAS, BRAF, and nucleic acids encoding the proteins is not present in the biological sample, or determining not to administer a c-Met inhibitor to the subject when the level of IL-8 and/or a nucleic acid encoding IL-8 in a biological sample obtained (separated) from the subject is equal to or lower than that of a reference sample or when a mutation of at least one of KRAS, BRAF, and nucleic acids encoding the proteins is present in the biological sample, or 2) determining whether the administration of a c-Met inhibitor to the subject is maintained (continued) or stopped according to the determination of the determining step of the monitoring method (e.g., determining to maintain the administration of c-Met inhibitor to the subject, when the level of IL-8, bIG-H3, MIF, and/or nucleic acids encoding the proteins in the biological sample after the administration of a c-Met inhibitor is decreased compared to before the administration, or determining to stop the administration of a c-Met inhibitor, when the level of IL-8, bIG-H3, MIF, and/or nucleic acids encoding the proteins in the biological sample after the administration of a c-Met inhibitor is equal to or increased compared to before the administration.</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0089]" class="style-scope patent-text">
    
    [0089]
  </para-num> <div id="p0089" num="0089" class="description-line style-scope patent-text">As used herein, the term "c-Met inhibitor-applicable subject" or "subject suitable for the application of the c-Met inhibitor" means a patient to which a c-Met inhibitor therapy is applicable suitably, and the term "subject" may be selected from the group consisting of mammals, such as rodents, e.g., mice, rats, etc., and primates, e.g., humans, monkeys, etc., e.g., a cancer patient. The biological sample may be a patient itself (mammals, such as primates, e.g., humans, monkeys, etc., or rodents, e.g., mice, rats, etc.) or a cell, a tissue or body fluid (e.g., blood, serum, urine, saliva, etc.) isolated from the patient or artificially an artificial culture thereof. The biological sample may be blood or a serum.</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0090]" class="style-scope patent-text">
    
    [0090]
  </para-num> <div id="p0090" num="0090" class="description-line style-scope patent-text">The reference sample may be selected from the group consisting of mammal, mammalian cells or tissues (including tumor (e.g., cancer) cells or tissues), and the like, on which a c-Met inhibitor has no efficacy (e.g., a c-Met inhibitory efficacy or an anti-cancer efficacy). The C-Met inhibitor of the invention is limited to the antibody specified in the claims. For the general disclosure the term "c-Met inhibitor" may refer to any agent capable of inhibiting activity and/or expression of c-Met, or blocking c-Met signaling by inhibiting a ligand of c-Met. In an particular embodiment described herein, the c-Met inhibitor may be at least one selected from the group consisting of an anti-c-Met antibody or an antigen-binding fragment thereof, crizotinib (PF-02341066; 3-((R)-1-(2,6-dichloro-3-fluorophenyl)ethoxy)-5-(1-(piperidin-4-yl)-1H-pyrazol-4-yl)pyridin-2-amine), cabozantinib (XL-184; N-(4-(6,7-dimethoxyquinolin-4-yloxy)phenyl)-N-(4-fluorophenyl)cyclopropane-1,1-dicarboxamide), foretinib (N-(3-fluoro-4-(6-methoxy-7-(3-morpholinopropoxy)quinolin-4-yloxy)phenyl)-N-(4-fiuorophenyl)cyclopropane-1,1-dicarboxamide), PHA-665752((R,Z)-5-(2,6-dichlorobenzylsulfonyl)-3-((3,5-dimethyl-4-(2-(pyrrolidin-1-ylmethyl)pyrrolidine-1-carbonyl)-1H-pyrrol-2-yl)methylene)indolin-2-one), SU11274((Z)-N-(3-chlorophenyl)-3-((3,5-dimethyl-4-(1-methylpiperazine-4-carbonyl)-1H-pyrrol-2-yl)methylene)-N-methyl-2-oxoindoline-5-sulfonamide), SGX-523(6-(6-(1-methyl-1H-pyrazol-4-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-ylthio)quinoline), PF-04217903(2-(4-(3-(quinolin-6-ylmethyl)-3H-[1,2,3]triazolo[4,5-b]pyrazin-5-yl)-1H-pyrazol-1-yl)ethanol), EMD 1214063 (Benzonitrile, 3-[1,6-Dihydro-1-[[3-[5-[(1-Methyl-4-Piperidinyl)Methoxy]-2-PyriMidinyl]Phenyl]Methyl]-6-Oxo-3-Pyridazinyl]), golvatinib (N-(2-fluoro-4-((2-(4-(4-methylpiperazin-1-yl)piperidine-1-carboxamido)pyridin-4-yl)oxy)phenyl)-N-(4-fluorophenyl)cyclopropane-1,1-dicarboxamide), INCB28060(2-fluoro-N-methyl-4-(7-(quinolin-6-ylmethyl)imidazo[1,2-b][1,2,4]triazin-2-yl)benzamide), MK-2461(N-((2R)-1,4-Dioxan-2-ylmethyl)-N-methyl-N'-[3-(1-methyl-1H-pyrazol-4-yl)-5-oxo-5H-benzo[4,5]cyclohepta[1,2-b]pyridin-7-yl]sulfamide), tivantinib (ARQ 197; (3R,4R)-3-(5,6-Dihydro-4H-pyrrolo[3,2,1-ij]quinolin-1-yl)-4-(1H-indol-3-yl)pyrrolidine-2,5-dione), NVP-BVU972(6-[[6-(1-Methyl-1H-pyrazol-4-yl)imidazo[1,2-b]pyridazin-3-yl]methyl]quinoline), AMG458({1-(2-hydroxy-2-methylpropyl)-N-[5-(7-methoxyquinolin-4-yloxy)pyridin-2-yl]-5-met hyl-3-oxo-2-phenyl-2,3-dihydro-1H-pyrazole-4-carboxamide}), BMS 794833(N-(4-((2-amino-3-chloropyridin-4-yl)oxy)-3-fluorophenyl)-5-(4-fluorophenyl)-4-oxo-1,4-dihydropyridine-3-carboxamide), BMS 777607(N-[4-[(2-Amino-3-chloropyridin-4-yl)oxy]-3-fluorophenyl]-4-ethoxy-1-(4-fluorophenyl)-2-oxo-1,2-dihydropyridine-3-carboxamide), MGCD-265(N-(3-Fluoro-4-(2-(1-methyl-1H-imidazol-4-yl)thieno[3,2-b]pyridin-7-yloxy)phenylcarbamothioyl)-2-phenylacetamide), AMG-208(7-Methoxy-4-[(6-phenyl-1,2,4-triazolo[4,3-b]pyridazin-3-yl)methoxy]quinoline), BMS-754807((2S)-1-[4-[(5-Cyclopropyl-1H-pyrazol-3-yl)amino]pyrrolo[2,1-f] [1,2,4]triazin-2-yl]-N-(6-fluoro-3-pyridinyl)-2-methyl-2-pyrrolidinecarboxamide), JNJ-38877605(6-[Difluoro[6-(1-methyl-1H-pyrazol-4-yl)-1,2,4-triazolo[4,3-b]pyridazin-3-yl]methyl]quinoline), and pharmaceutically acceptable salts thereof, or any combination thereof.</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0091]" class="style-scope patent-text">
    
    [0091]
  </para-num> <div id="p0091" num="0091" class="description-line style-scope patent-text">The anti-c-Met antibody or an antigen-binding fragment thereof may be any antibody which specifically recognizes c-Met as an antigen and/or specifically binds to c-Met, or an antigen-binding fragment thereof. For example, the anti-c-Met antibody may be any antibody that acts on c-Met to induce intracellular internalization and degradation of c-Met, or antigen-binding fragment thereof. The anti-c-Met antibody may recognize any specific region of c-Met, e.g., a specific region in the SEMA domain, as an epitope. Again, the C-Met inhibitor of the invention is limited to the antibody specified in the claims. Herein, unless stated otherwise, the term "anti-c-Met antibody" may be intended to cover not only an anti-c-Met antibody in a complete form (e.g., an IgG form) but also its antigen-binding fragment. The antigen-binding fragment thereof may be at least one selected from the group consisting of scFv, (scFv)2, scFv-Fc, Fab, Fab', and F(ab')2 of an anti-c-Met antibody.</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0092]" class="style-scope patent-text">
    
    [0092]
  </para-num> <div id="p0092" num="0092" class="description-line style-scope patent-text">"c-Met" or "c-Met protein" refers to a receptor tyrosine kinase (RTK) which binds hepatocyte growth factor (HGF). c-Met may be derived (obtained) from any species, particularly a mammal, for instance, primates such as human c-Met (e.g., GenBank Accession No. NP_000236.2), monkey c-Met (e.g., Macaca mulatta, GenBank Accession No. NP_001162100), or rodents such as mouse c-Met (e.g., GenBank Accession No. NP_032617.2), rat c-Met (e.g., GenBank Accession No. NP_113705.1), and the like. The c-Met protein may include a polypeptide encoded by the nucleotide sequence identified as GenBank Accession No. NM_000245.2, a polypeptide having the amino acid sequence identified as GenBank Accession No. NP_000236 or extracellular domains thereof. The receptor tyrosine kinase c-Met participates in various mechanisms, such as cancer incidence, metastasis, migration of cancer cells, invasion of cancer cells, angiogenesis, and the like.</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0093]" class="style-scope patent-text">
    
    [0093]
  </para-num> <div id="p0093" num="0093" class="description-line style-scope patent-text">c-Met, a receptor for hepatocyte growth factor (HGF), may be divided into three portions: extracellular, transmembrane, and intracellular. The extracellular portion is composed of an -subunit and a -subunit which are linked to each other through a disulfide bond, and includes a SEMA domain responsible for binding HGF, a PSI domain (plexin-semaphorins-integrin identity/homology domain) and an IPT domain (immunoglobulin-like fold shared by plexins and transcriptional factors domain). The SEMA domain of c-Met protein may have the amino acid sequence of SEQ ID NO: 79, and is an extracellular domain that functions to bind HGF. A specific region of the SEMA domain, that is, a region having the amino acid sequence of SEQ ID NO: 71, which corresponds to a range from amino acid residues 106 to 124 of the amino acid sequence of the SEMA domain (SEQ ID NO: 79), is a loop region between the second and the third beta propellers within the epitopes of the SEMA domain. This region acts as an epitope for the anti-c-Met antibody.</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0094]" class="style-scope patent-text">
    
    [0094]
  </para-num> <div id="p0094" num="0094" class="description-line style-scope patent-text">The term "epitope," as used herein, refers to an antigenic determinant, a part of an antigen recognized by an antibody. The epitope may be a region including about 5 or more contiguous (consecutive on primary, secondary (two-dimensional), or tertiary (three-dimensional) structure) amino acid residues within the SEMA domain (SEQ ID NO: 79) of c-Met protein, for instance, about 5 to about 19 contiguous amino acid residues within the amino acid sequence of SEQ ID NO: 71. For example, the epitope may be a polypeptide having about 5 to about 19 contiguous amino acids selected from among partial combinations of the amino acid sequence of SEQ ID NO: 71, wherein the polypeptide includes at least the amino sequence of SEQ ID NO: 73 (EEPSQ) which serves as an essential element for the epitope. For example, the epitope may be a polypeptide including, consisting essentially of, or consisting of the amino acid sequence of SEQ ID NO: 71, SEQ ID NO: 72, or SEQ ID NO: 73.</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0095]" class="style-scope patent-text">
    
    [0095]
  </para-num> <div id="p0095" num="0095" class="description-line style-scope patent-text">The epitope having the amino acid sequence of SEQ ID NO: 72 corresponds to the outermost part of the loop between the second and third beta propellers within the SEMA domain of a c-Met protein. The epitope having the amino acid sequence of SEQ ID NO: 73 is a site to which the antibody or antigen-binding fragment most specifically binds.</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0096]" class="style-scope patent-text">
    
    [0096]
  </para-num> <div id="p0096" num="0096" class="description-line style-scope patent-text">Thus, the anti-c-Met antibody of the invention binds to an epitope which includes about 5 to about 19 contiguous amino acids selected from among partial combinations of the amino acid sequence of SEQ ID NO: 71, including SEQ ID NO: 73 as an essential element. For example, the anti-c-Met antibody may specifically bind to an epitope comprising the amino acid sequence of SEQ ID NO: 71, SEQ ID NO: 72, or SEQ ID NO: 73.</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0097]" class="style-scope patent-text">
    
    [0097]
  </para-num> <div id="p0097" num="0097" class="description-line style-scope patent-text">In one embodiment described herein, the anti-c-Met antibody or an antigen-binding fragment thereof may comprise or consist essentially of:
</div> </li> <ol class="style-scope patent-text"> <li class="style-scope patent-text">(i) at least one heavy chain complementarity determining region (CDR) selected from the group consisting of (a) a CDR-H1 comprising the amino acid sequence of SEQ ID NO: 4; (b) a CDR-H2 comprising the amino acid sequence of SEQ ID NO: 5, the amino acid sequence of SEQ ID NO: 2, or an amino acid sequence comprising 8-19 consecutive amino acids within the amino acid sequence of SEQ ID NO: 2 comprising amino acid residues from the 3<sup class="style-scope patent-text">rd</sup> to 10<sup class="style-scope patent-text">th</sup> positions of the amino acid sequence of SEQ ID NO: 2; and (c) a CDR-H3 comprising the amino acid sequence of SEQ ID NO: 6, the amino acid sequence of SEQ ID NO: 85, or an amino acid sequence comprising 6-13 consecutive amino acids within the amino acid sequence of SEQ ID NO: 85 comprising amino acid residues from the 1<sup class="style-scope patent-text">st</sup> to 6<sup class="style-scope patent-text">th</sup> positions of the amino acid sequence of SEQ ID NO: 85, or a heavy chain variable region comprising the at least one heavy chain complementarity determining region;</li> <li class="style-scope patent-text">(ii) at least one light chain complementarity determining region (CDR) selected from the group consisting of (a) a CDR-L1 comprising the amino acid sequence of SEQ ID NO: 7, (b) a CDR-L2 comprising the amino acid sequence of SEQ ID NO: 8, and (c) a CDR-L3 comprising the amino acid sequence of SEQ ID NO: 9, the amino acid sequence of SEQ ID NO: 15, the amino acid sequence of SEQ ID NO: 86, or an amino acid sequence comprising 9-17 consecutive amino acids within the amino acid sequence of SEQ ID NO: 89 comprising amino acid residues from the 1<sup class="style-scope patent-text">st</sup> to 9<sup class="style-scope patent-text">th</sup> positions of the amino acid sequence of SEQ ID NO: 89, or a light chain variable region including the at least one light chain complementarity determining region;</li> <li class="style-scope patent-text">(iii) a combination of the at least one heavy chain complementarity determining region and at least one light chain complementarity determining region; or</li> <li class="style-scope patent-text">(iv) a combination of the heavy chain variable region and the light chain variable region.</li> </ol>
    <li class="style-scope patent-text"> <para-num num="[0098]" class="style-scope patent-text">
    
    [0098]
  </para-num> <div id="p0098" num="0098" class="description-line style-scope patent-text">Herein, the amino acid sequences of SEQ ID NOS: 4 to 9 are respectively represented by following Formulas I to VI, below:
</div> </li> <ul class="style-scope patent-text"> <li class="style-scope patent-text">Formula I: Xaa<sub class="style-scope patent-text">1</sub>-Xaa<sub class="style-scope patent-text">2</sub>-Tyr-Tyr-Met-Ser (SEQ ID NO: 4), wherein Xaa<sub class="style-scope patent-text">1</sub> is absent or Pro or Ser, and Xaa<sub class="style-scope patent-text">2</sub> is Glu or Asp,</li> <li class="style-scope patent-text">Formula II: Arg-Asn-Xaa<sub class="style-scope patent-text">3</sub>-Xaa<sub class="style-scope patent-text">4</sub>-Asn-Gly-Xaa<sub class="style-scope patent-text">5</sub>-Thr (SEQ ID NO: 5), wherein Xaa<sub class="style-scope patent-text">3</sub> is Asn or Lys, Xaa<sub class="style-scope patent-text">4</sub> is Ala or Val, and Xaa<sub class="style-scope patent-text">5</sub> is Asn or Thr,</li> <li class="style-scope patent-text">Formula III: Asp-Asn-Trp-Leu-Xaa<sub class="style-scope patent-text">6</sub>-Tyr (SEQ ID NO: 6), wherein Xaa<sub class="style-scope patent-text">6</sub> is Ser or Thr,</li> <li class="style-scope patent-text">Formula IV: Lys-Ser-Ser-Xaa<sub class="style-scope patent-text">7</sub>-Ser-Leu-Leu-Ala-Xaa<sub class="style-scope patent-text">8</sub>-Gly-Asn-Xaa<sub class="style-scope patent-text">9</sub>-Xaa<sub class="style-scope patent-text">10</sub>-Asn-Tyr-Leu-Ala (SEQ ID NO: 7), wherein Xaa<sub class="style-scope patent-text">7</sub> is His, Arg, Gln, or Lys, Xaa<sub class="style-scope patent-text">8</sub> is Ser or Trp, Xaa<sub class="style-scope patent-text">9</sub> is His or Gln, and Xaa<sub class="style-scope patent-text">10</sub> is Lys or Asn,</li> <li class="style-scope patent-text">Formula V: Trp-Xaa<sub class="style-scope patent-text">11</sub>-Ser-Xaa<sub class="style-scope patent-text">12</sub>-Arg-Val-Xaa<sub class="style-scope patent-text">13</sub> (SEQ ID NO: 8), wherein Xaa<sub class="style-scope patent-text">11</sub> is Ala or Gly, Xaa<sub class="style-scope patent-text">12</sub> is Thr or Lys, and Xaa<sub class="style-scope patent-text">13</sub> is Ser or Pro, and</li> <li class="style-scope patent-text">Formula VI: Xaa<sub class="style-scope patent-text">14</sub>-Gln-Ser-Tyr-Ser-Xaa<sub class="style-scope patent-text">15</sub>-Pro-Xaa<sub class="style-scope patent-text">16</sub>-Thr (SEQ ID NO: 9), wherein Xaa<sub class="style-scope patent-text">14</sub> is Gly, Ala, or Gln, Xaa<sub class="style-scope patent-text">15</sub> is Arg, His, Ser, Ala, Gly, or Lys, and Xaa<sub class="style-scope patent-text">16</sub> is Leu, Tyr, Phe, or Met. As described herein, the CDR-H1 may comprise an amino acid sequence selected from the group consisting of SEQ ID NO: 1, SEQ ID NO: 22, SEQ ID NO: 23, and SEQ ID NO: 24. The CDR-H2 may comprise an amino acid sequence selected from the group consisting of SEQ ID NO: 2, SEQ ID NO: 25, and SEQ ID NO: 26. The CDR-H3 may comprise an amino acid sequence selected from the group consisting of SEQ ID NO: 3, SEQ ID NO: 27, SEQ ID NO: 28, and SEQ ID NO: 85.</li> </ul>
    <li class="style-scope patent-text"> <para-num num="[0099]" class="style-scope patent-text">
    
    [0099]
  </para-num> <div id="p0099" num="0099" class="description-line style-scope patent-text">The CDR-L1 may comprise an amino acid sequence selected from the group consisting of SEQ ID NO: 10, SEQ ID NO: 29, SEQ ID NO: 30, SEQ ID NO: 31, SEQ ID NO: 32, SEQ ID NO: 33, and SEQ ID NO: 106. The CDR-L2 may comprise an amino acid sequence selected from the group consisting of SEQ ID NO: 11, SEQ ID NO: 34, SEQ ID NO: 35, and SEQ ID NO: 36. The CDR-L3 may comprise an amino acid sequence selected from the group consisting of SEQ ID NO: 12, SEQ ID NO: 13, SEQ ID NO: 14, SEQ ID NO: 15, SEQ ID NO: 16, SEQ ID NO: 37, SEQ ID NO: 86, and SEQ ID NO: 89. As described herein, the anti-c-Met antibody or an antigen-binding fragment thereof may comprise or consisting essentially of:
</div> </li> <ul class="style-scope patent-text"> <li class="style-scope patent-text">a heavy variable region comprising or consisting essentially of a polypeptide (CDR-H1) comprising an amino acid sequence selected from the group consisting of SEQ ID NO: 1, SEQ ID NO: 22, SEQ ID NO: 23, and SEQ ID NO: 24, a polypeptide (CDR-H2) comprising an amino acid sequence selected from the group consisting of SEQ ID NO: 2, SEQ ID NO: 25, and SEQ ID NO: 26, and a polypeptide (CDR-H3) comprising an amino acid sequence selected from the group consisting of SEQ ID NO: 3, SEQ ID NO: 27, SEQ ID NO: 28, and SEQ ID NO: 85; and</li> <li class="style-scope patent-text">a light variable region comprising or consisting essentially of a polypeptide (CDR-L1) comprising an amino acid sequence selected from the group consisting of SEQ ID NO: 10, SEQ ID NO: 29, SEQ ID NO: 30, SEQ ID NO: 31, SEQ ID NO: 32, SEQ ID NO: 33, and SEQ ID NO: 106, a polypeptide (CDR-L2) comprising an amino acid sequence selected from the group consisting of SEQ ID NO: 11, SEQ ID NO: 34, SEQ ID NO: 35, and SEQ ID NO: 36, and a polypeptide (CDR-L3) comprising an amino acid sequence selected from the group consisting of SEQ ID NO: 12, SEQ ID NO: 13, SEQ ID NO: 14, SEQ ID NO: 15, SEQ ID NO: 16, SEQ ID NO: 37, SEQ ID NO: 86, and SEQ ID NO: 89. As described herein, the anti-c-Met antibody or an antigen-binding fragment thereof may comprise or consist essentially of a heavy variable region comprising the amino acid sequence of SEQ ID NO: 17, SEQ ID NO: 74, SEQ ID NO: 87, SEQ ID NO: 90, SEQ ID NO: 91, SEQ ID NO: 92, SEQ ID NO: 93, or SEQ ID NO: 94, and a light variable region comprising the amino acid sequence of SEQ ID NO: 18, SEQ ID NO: 19, SEQ ID NO: 20, SEQ ID NO: 21, SEQ ID NO: 75, SEQ ID NO: 88, SEQ ID NO: 95, SEQ ID NO: 96, SEQ ID NO: 97, SEQ ID NO: 98, SEQ ID NO: 99, or SEQ ID NO: 107. As described herein, the anti-c-Met antibody or an antigen-binding fragment may be Onartuzumab (MetMab), LY2875358 (heavy chain: SEQ ID NO: 111; light chain: SEQ ID NO: 112), Rilotumumab (AMG102), or an antigen-binding fragment thereof, and the like.</li> </ul>
    <li class="style-scope patent-text"> <para-num num="[0100]" class="style-scope patent-text">
    
    [0100]
  </para-num> <div id="p0100" num="0100" class="description-line style-scope patent-text">Animal-derived antibodies produced by immunizing non-immune animals with a desired antigen generally invoke immunogenicity when injected into humans for the purpose of medical treatment, and thus chimeric antibodies have been developed to inhibit such immunogenicity. Chimeric antibodies are prepared by replacing constant regions of animal-derived antibodies that cause an anti-isotype response with constant regions of human antibodies by genetic engineering. Chimeric antibodies are considerably improved in an anti-isotype response compared to animal-derived antibodies, but animal-derived amino acids still have variable regions, so that chimeric antibodies have side effects with respect to a potential anti-idiotype response. Humanized antibodies have been developed to reduce such side effects. Humanized antibodies are produced by grafting complementarity determining regions (CDR) which serve an important role in antigen binding in variable regions of chimeric antibodies into a human antibody framework.</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0101]" class="style-scope patent-text">
    
    [0101]
  </para-num> <div id="p0101" num="0101" class="description-line style-scope patent-text">The most important thing in CDR grafting to produce humanized antibodies is choosing the optimized human antibodies for accepting CDRs of animal-derived antibodies. Antibody databases, analysis of a crystal structure, and technology for molecule modeling are used. However, even when the CDRs of animal-derived antibodies are grafted to the most optimized human antibody framework, amino acids positioned in a framework of the animal-derived CDRs affecting antigen binding are present. Therefore, in many cases, antigen binding affinity is not maintained, and thus application of additional antibody engineering technology for recovering the antigen binding affinity is necessary.</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0102]" class="style-scope patent-text">
    
    [0102]
  </para-num> <div id="p0102" num="0102" class="description-line style-scope patent-text">The anti c-Met antibodies may be mouse-derived antibodies, mouse-human chimeric antibodies, humanized antibodies, or human antibodies. The antibodies or antigen-binding fragments thereof may be isolated from a living body or non-naturally occurring. The antibodies or antigen-binding fragments thereof may be recombinant or synthetic. The antibody may be monoclonal.</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0103]" class="style-scope patent-text">
    
    [0103]
  </para-num> <div id="p0103" num="0103" class="description-line style-scope patent-text">An intact antibody includes two full-length light chains and two full-length heavy chains, in which each light chain is linked to a heavy chain by disulfide bonds. The antibody includes a heavy chain constant region and a light chain constant region. The heavy chain constant region is of a gamma (), mu (), alpha (), delta (), or epsilon () type, which may be further categorized as gamma 1 (1), gamma 2(2), gamma 3(3), gamma 4(4), alpha 1(1), or alpha 2(2). The light chain constant region is of either a kappa () or lambda () type.</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0104]" class="style-scope patent-text">
    
    [0104]
  </para-num> <div id="p0104" num="0104" class="description-line style-scope patent-text">As used herein, the term "heavy chain" refers to full-length heavy chain, and fragments thereof, including a variable region V<sub class="style-scope patent-text">H</sub> that includes amino acid sequences sufficient to provide specificity to antigens, and three constant regions, C<sub class="style-scope patent-text">H1</sub>, CH<sub class="style-scope patent-text">2</sub>, and C<sub class="style-scope patent-text">H3</sub>, and a hinge. The term "light chain" refers to a full-length light chain and fragments thereof, including a variable region V<sub class="style-scope patent-text">L</sub> that includes amino acid sequences sufficient to provide specificity to antigens, and a constant region C<sub class="style-scope patent-text">L</sub>.</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0105]" class="style-scope patent-text">
    
    [0105]
  </para-num> <div id="p0105" num="0105" class="description-line style-scope patent-text">The term "complementarity determining region (CDR)" refers to an amino acid sequence found in a hyper variable region of a heavy chain or a light chain of immunoglobulin. The heavy and light chains may respectively include three CDRs (CDRH1, CDRH2, and CDRH3; and CDRL1, CDRL2, and CDRL3). The CDRs may provide contact residues that play an important role in the binding of antibodies to antigens or epitopes. The terms "specifically binding" and "specifically recognized" are well known to one of ordinary skill in the art, and indicate that an antibody and an antigen specifically interact with each other to lead to an immunological activity.</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0106]" class="style-scope patent-text">
    
    [0106]
  </para-num> <div id="p0106" num="0106" class="description-line style-scope patent-text">The term "antigen-binding fragment" used herein refers to fragments of an intact immunoglobulin including portions of a polypeptide including antigen-binding regions having the ability to specifically bind to the antigen. The antigen-binding fragment may be selected from the group consisting of scFv, (scFv)<sub class="style-scope patent-text">2</sub>, Fab, Fab', and F(ab')<sub class="style-scope patent-text">2</sub>, but not be limited thereto.</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0107]" class="style-scope patent-text">
    
    [0107]
  </para-num> <div id="p0107" num="0107" class="description-line style-scope patent-text">Among the antigen-binding fragments, Fab that includes light chain and heavy chain variable regions, a light chain constant region, and a first heavy chain constant region C<sub class="style-scope patent-text">H1</sub>, includes one antigen-binding site.</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0108]" class="style-scope patent-text">
    
    [0108]
  </para-num> <div id="p0108" num="0108" class="description-line style-scope patent-text">The Fab' fragment is different from the Fab fragment, in that Fab' includes a hinge region with at least one cysteine residue at the C-terminal of C<sub class="style-scope patent-text">H1</sub>.</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0109]" class="style-scope patent-text">
    
    [0109]
  </para-num> <div id="p0109" num="0109" class="description-line style-scope patent-text">The F(ab')<sub class="style-scope patent-text">2</sub> antibody is formed through disulfide bridging of the cysteine residues in the hinge region of the Fab' fragment. Fv is the smallest antibody fragment with only a heavy chain variable region and a light chain variable region. Recombination techniques of generating the Fv fragment are widely known in the art.</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0110]" class="style-scope patent-text">
    
    [0110]
  </para-num> <div id="p0110" num="0110" class="description-line style-scope patent-text">Two-chain Fv includes a heavy chain variable region and a light chain region which are linked by a non-covalent bond. Single-chain Fv generally includes a heavy chain variable region and a light chain variable region which are linked by a covalent bond via a peptide linker or linked at the C-terminals to have a dimer structure like the two-chain Fv. The peptide linker may be a polypeptide comprising about 1 to about 100 or about 2 to about 50 amino acids, wherein the amino acids may be selected from any amino acids without limitation.</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0111]" class="style-scope patent-text">
    
    [0111]
  </para-num> <div id="p0111" num="0111" class="description-line style-scope patent-text">The antigen-binding fragments may be attainable using protease (for example, the Fab fragment may be obtained by restricted cleavage of a whole antibody with papain, and the F(ab')<sub class="style-scope patent-text">2</sub> fragment may be obtained by cleavage with pepsin), or may be prepared by using a genetic recombination technique.</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0112]" class="style-scope patent-text">
    
    [0112]
  </para-num> <div id="p0112" num="0112" class="description-line style-scope patent-text">The term "hinge region," as used herein, refers to a region between CH1 and CH2 domains within the heavy chain of an antibody which functions to provide flexibility for the antigen-binding site.</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0113]" class="style-scope patent-text">
    
    [0113]
  </para-num> <div id="p0113" num="0113" class="description-line style-scope patent-text">When an animal antibody undergoes a chimerization process, the IgG1 hinge of animal origin may be replaced with a human IgG1 hinge or IgG2 hinge while the disulfide bridges between two heavy chains are reduced from three to two in number. In addition, an animal-derived IgG1 hinge is shorter than a human IgG1 hinge. Accordingly, the rigidity of the hinge is changed. Thus, a modification of the hinge region may bring about an improvement in the antigen binding efficiency of the humanized antibody. The modification of the hinge region through amino acid deletion, addition, or substitution is well-known to those skilled in the art. As described herein, the anti-c-Met antibody or an antigen-binding fragment thereof may be modified by the deletion, insertion, addition, or substitution of at least one (e.g., two, three, four, five, six, seven, eight, nine, or ten) amino acid residue of the amino acid sequence of the hinge region so that it exhibits enhanced antigen-binding efficiency. For example, the antibody may include a hinge region including the amino acid sequence of SEQ ID NO: 100 (U7-HC6), 101 (U6-HC7), 102 (U3-HC9),103 (U6-HC8), or 104 (U8-HC5), or a hinge region including the amino acid sequence of SEQ ID NO: 105 (non-modified human hinge). Preferably, the hinge region includes the amino acid sequence of SEQ ID NO: 100 or 101. As described herein, the anti-c-Met antibody may be a monoclonal antibody. The monoclonal antibody may be produced by the hybridoma cell line deposited with the Korean Cell Line Research Foundation, an international depository authority located at Yungun-Dong, Jongno-Gu, Seoul, Korea, on Oct. 6, 2009, under Accession No. KCLRF-BP-00220, which binds specifically to the extracellular region of c-Met protein.</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0114]" class="style-scope patent-text">
    
    [0114]
  </para-num> <div id="p0114" num="0114" class="description-line style-scope patent-text">In the anti-c-Met antibody, the rest portion of the light chain and the heavy chain portion other than the CDRs, the light chain variable region, and the heavy chain variable region, e.g., a light chain constant region and/or a heavy chain constant region, may be from any subtype of immunoglobulin (e.g., IgA, IgD, IgE, IgG (IgG1, IgG2, IgG3, IgG4), IgM, etc.).</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0115]" class="style-scope patent-text">
    
    [0115]
  </para-num> <div id="p0115" num="0115" class="description-line style-scope patent-text">By way of further example, the anti-c-Met antibody may comprise or consist essentially of:
</div> </li> <ol class="style-scope patent-text"> <li class="style-scope patent-text">(a) a heavy chain comprising an amino acid sequence selected from the group consisting of the amino acid sequence of SEQ ID NO: 62 (wherein the amino acid sequence from amino acid residues from the 1<sup class="style-scope patent-text">st</sup> to 17<sup class="style-scope patent-text">th</sup> positions is a signal peptide), the amino acid sequence from the 18<sup class="style-scope patent-text">th</sup> to 462<sup class="style-scope patent-text">nd</sup> positions of SEQ ID NO: 62, the amino acid sequence of SEQ ID NO: 64 (wherein the amino acid sequence from the 1<sup class="style-scope patent-text">st</sup> to 17<sup class="style-scope patent-text">th</sup> positions is a signal peptide), the amino acid sequence from the 18<sup class="style-scope patent-text">th</sup> to 461<sup class="style-scope patent-text">st</sup> positions of SEQ ID NO: 64, the amino acid sequence of SEQ ID NO: 66 (wherein the amino acid sequence from the 1<sup class="style-scope patent-text">st</sup> to 17<sup class="style-scope patent-text">th</sup> positions is a signal peptide), and the amino acid sequence from the 18<sup class="style-scope patent-text">th</sup> to 460<sup class="style-scope patent-text">th</sup> positions of SEQ ID NO: 66; and</li> <li class="style-scope patent-text">(b) a light chain comprising an amino acid sequence selected from the group consisting of the amino acid sequence of SEQ ID NO: 68 (wherein the amino acid sequence from the 1<sup class="style-scope patent-text">st</sup> to 20<sup class="style-scope patent-text">th</sup> positions is a signal peptide), the amino acid sequence from the 21<sup class="style-scope patent-text">st</sup> to 240<sup class="style-scope patent-text">th</sup> positions of SEQ ID NO: 68, the amino acid sequence of SEQ ID NO: 70 (wherein the amino acid sequence from the 1<sup class="style-scope patent-text">st</sup> to 20<sup class="style-scope patent-text">th</sup> positions is a signal peptide), the amino acid sequence from the 21<sup class="style-scope patent-text">st</sup> to 240<sup class="style-scope patent-text">th</sup> positions of SEQ ID NO: 70, and the amino acid sequence of SEQ ID NO: 108.</li> </ol>
    <li class="style-scope patent-text"> <para-num num="[0116]" class="style-scope patent-text">
    
    [0116]
  </para-num> <div id="p0116" num="0116" class="description-line style-scope patent-text">For example, the anti-c-Met antibody may be selected from the group consisting of:
</div> </li> <ul class="style-scope patent-text"> <li class="style-scope patent-text">(i) an antibody comprising (a) a heavy chain comprising the amino acid sequence of SEQ ID NO: 62 or the amino acid sequence from the 18<sup class="style-scope patent-text">th</sup> to 462<sup class="style-scope patent-text">nd</sup> positions of SEQ ID NO: 62 and (b) a light chain comprising the amino acid sequence of SEQ ID NO: 68 or the amino acid sequence from the 21<sup class="style-scope patent-text">st</sup> to 240<sup class="style-scope patent-text">th</sup> positions of SEQ ID NO: 68;</li> <li class="style-scope patent-text">(ii) an antibody comprising (a) a heavy chain comprising the amino acid sequence of SEQ ID NO: 64 or the amino acid sequence from the 18<sup class="style-scope patent-text">th</sup> to 461<sup class="style-scope patent-text">st</sup> positions of SEQ ID NO: 64 and (b) a light chain including the amino acid sequence of SEQ ID NO: 68 or the amino acid sequence from the 21<sup class="style-scope patent-text">st</sup> to 240<sup class="style-scope patent-text">th</sup> positions of SEQ ID NO: 68;</li> <li class="style-scope patent-text">(iii) an antibody comprising (a) a heavy chain comprising the amino acid sequence of SEQ ID NO: 66 or the amino acid sequence from the 18<sup class="style-scope patent-text">th</sup> to 460<sup class="style-scope patent-text">th</sup> positions of SEQ ID NO: 66 and (b) a light chain comprising the amino acid sequence of SEQ ID NO: 68 or the amino acid sequence from the 21<sup class="style-scope patent-text">st</sup> to 240<sup class="style-scope patent-text">th</sup> positions of SEQ ID NO: 68;</li> <li class="style-scope patent-text">(iv) an antibody comprising (a) a heavy chain comprising the amino acid sequence of SEQ ID NO: 62 or the amino acid sequence from the 18<sup class="style-scope patent-text">th</sup> to 462<sup class="style-scope patent-text">nd</sup> positions of SEQ ID NO: 62 and (b) a light chain including the amino acid sequence of SEQ ID NO: 70 or the amino acid sequence from the 21<sup class="style-scope patent-text">st</sup> to 240<sup class="style-scope patent-text">th</sup> positions of SEQ ID NO: 70;</li> <li class="style-scope patent-text">(v) an antibody comprising a heavy chain comprising (a) the amino acid sequence of SEQ ID NO: 64 or the amino acid sequence from the 18<sup class="style-scope patent-text">th</sup> to 461<sup class="style-scope patent-text">st</sup> positions of SEQ ID NO: 64 and (b) a light chain comprising the amino acid sequence of SEQ ID NO: 70 or the amino acid sequence from the 21<sup class="style-scope patent-text">st</sup> to 240<sup class="style-scope patent-text">th</sup> positions of SEQ ID NO: 70;</li> <li class="style-scope patent-text">(v) an antibody comprising (a) a heavy chain comprising the amino acid sequence of SEQ ID NO: 66 or the amino acid sequence from the 18<sup class="style-scope patent-text">th</sup> to 460<sup class="style-scope patent-text">th</sup> positions of SEQ ID NO: 66 and (b) a light chain comprising the amino acid sequence of SEQ ID NO: 70 or the amino acid sequence from the 21<sup class="style-scope patent-text">st</sup> to 240<sup class="style-scope patent-text">th</sup> positions of SEQ ID NO: 70;</li> <li class="style-scope patent-text">(vi) an antibody comprising (a) a heavy chain comprising the amino acid sequence of SEQ ID NO: 62 or the amino acid sequence from the 18<sup class="style-scope patent-text">th</sup> to 462<sup class="style-scope patent-text">nd</sup> positions of SEQ ID NO: 62 and (b) a light chain comprising the amino acid sequence of SEQ ID NO: 108;</li> <li class="style-scope patent-text">(vii) an antibody comprising (a) a heavy chain comprising the amino acid sequence of SEQ ID NO: 64 or the amino acid sequence from the 18<sup class="style-scope patent-text">th</sup> to 461<sup class="style-scope patent-text">st</sup> positions of SEQ ID NO: 64 and (b) a light chain comprising the amino acid sequence of SEQ ID NO: 108; and</li> <li class="style-scope patent-text">(viii) an antibody comprising (a) a heavy chain comprising the amino acid sequence of SEQ ID NO: 66 or the amino acid sequence from the 18<sup class="style-scope patent-text">th</sup> to 460<sup class="style-scope patent-text">th</sup> positions of SEQ ID NO: 66 and (b) a light chain comprising the amino acid sequence of SEQ ID NO: 108.</li> </ul>
    <li class="style-scope patent-text"> <para-num num="[0117]" class="style-scope patent-text">
    
    [0117]
  </para-num> <div id="p0117" num="0117" class="description-line style-scope patent-text">The polypeptide comprising the amino acid sequence of SEQ ID NO: 108 is a polypeptide obtained by replacing serine at position 32 (position 27e according to Kabat numbering in the amino acid sequence from <figure-callout id="21" label="amino acid residues" filenames="imgf0001.png,imgf0002.png" class="style-scope patent-text"><a title="Show image containing callout" class="style-scope figure-callout">amino acid residues</a></figure-callout> 21 to 240 of SEQ ID NO: 68; positioned within CDR-L1) of SEQ ID NO: 108 with tryptophan. By such replacement, antibodies and antibody fragments including such sequences exhibit increased activities, such as c-Met biding affinity, c-Met degradation activity, Akt phosphorylation inhibition, and the like. As described herein, the anti c-Met antibody may comprising a light chain complementarity determining region comprising the amino acid sequence of SEQ ID NO: 106, a light chain variable region comprising the amino acid sequence of SEQ ID NO: 107, or a light chain comprising the amino acid sequence of SEQ ID NO: 108.</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0118]" class="style-scope patent-text">
    
    [0118]
  </para-num> <div id="p0118" num="0118" class="description-line style-scope patent-text">The c-Met inhibitor may be applied (administered) together with a pharmaceutically acceptable carrier. The pharmaceutically acceptable carrier may be those commonly used for the formulation of the inhibitor (e.g., antibodies), which may be one or more selected from the group consisting of lactose, dextrose, sucrose, sorbitol, mannitol, starch, gum acacia, calcium phosphate, alginates, gelatin, calcium silicate, micro-crystalline cellulose, polyvinylpyrrolidone, cellulose, water, syrup, methyl cellulose, methylhydroxy benzoate, propylhydroxy benzoate, talc, magnesium stearate, and mineral oil, but are not limited thereto. The c-Met inhibitor may further comprise one or more selected from the group consisting of a lubricant, a wetting agent, a sweetener, a flavor enhancer, an emulsifying agent, a suspension agent, and preservative.</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0119]" class="style-scope patent-text">
    
    [0119]
  </para-num> <div id="p0119" num="0119" class="description-line style-scope patent-text">The c-Met inhibitor may be administered orally or parenterally. The parenteral administration may selected from the group consisting of intravenous injection, subcutaneous injection, muscular injection, intraperitoneal injection, endothelial administration, local administration, intranasal administration, intrapulmonary administration, and rectal administration. Since oral administration leads to digestion of proteins or peptides, the c-Met inhibitor for oral administration must be coated or formulated to prevent digestion in stomach. In addition, the c-Met inhibitor may be administered using an optional device that enables an active substance to be delivered to target cells.</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0120]" class="style-scope patent-text">
    
    [0120]
  </para-num> <div id="p0120" num="0120" class="description-line style-scope patent-text">The term "the pharmaceutically effective amount" as used herein may refer to an amount of which the active ingredient can exert pharmaceutically significant effects. The pharmaceutically effective amount of the c-Met inhibitor for a single dose may be prescribed in a variety of ways, depending on factors such as formulation methods, administration manners, age of patients, body weight of patients, gender of patients, pathologic conditions of patients, diets, administration time, administration interval, administration route, excretion speed, and reaction sensitivity. For example, the pharmaceutically effective amount of the c-Met inhibitor for a single dose may be in ranges of 0.001 to 100mg/kg, or 0.02 to 10 mg/kg, but not limited thereto. The pharmaceutically effective amount for the single dose may be formulated into a single formulation in a unit dosage form or formulated in suitably divided dosage forms, or it may be manufactured to be contained in a multiple dosage container.</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0121]" class="style-scope patent-text">
    
    [0121]
  </para-num> <div id="p0121" num="0121" class="description-line style-scope patent-text">The c-Met inhibitor may be used in the prevention and/or treatment of a cancer. The cancer may be associated with over-expression and/or abnormal activation of c-Met. The cancer may be a solid cancer or a blood cancer. The cancer may be, but not limited to, one or more selected from the group consisting of squamous cell carcinoma, small-cell lung cancer, non-small-cell lung cancer, adenocarcinoma of the lung, squamous cell carcinoma of the lung, peritoneal carcinoma, skin cancer, melanoma in the skin or eyeball, rectal cancer, cancer near the anus, esophagus cancer, small intestinal tumor, endocrine gland cancer, parathyroid cancer, adrenal cancer, soft-tissue sarcoma, urethral cancer, chronic or acute leukemia, lymphocytic lymphoma, hepatoma, gastric cancer, gastrointestinal cancer, pancreatic cancer, glioblastoma, cervical cancer, ovarian cancer, liver cancer, bladder cancer, hepatocellular adenoma, breast cancer, colon cancer, large intestine cancer, endometrial carcinoma or uterine carcinoma, salivary gland tumor, kidney cancer, prostate cancer, vulvar cancer, thyroid cancer, head or neck cancer, brain cancer, osteosarcoma, and the like. The cancer may be a primary cancer or a metastatic cancer. The cancer may be a c-Met inhibitor (e.g., an anti-c-Met antibody) resistant cancer.</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0122]" class="style-scope patent-text">
    
    [0122]
  </para-num> <div id="p0122" num="0122" class="description-line style-scope patent-text">The prevention and/or treatment of cancer may be achieved by at least one effect of the c-Met inhibitor selected from cancer cell death, inhibition of cancer cell proliferation, inhibition of migration, invasion, or metastasis of cancer, improvement of symptoms associated with cancer, etc.</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0123]" class="style-scope patent-text">
    
    [0123]
  </para-num> <div id="p0123" num="0123" class="description-line style-scope patent-text">Biomarkers capable of predicting and/or monitoring an efficacy of a c-Met inhibitor may lead to improvement of the therapeutic effect of the c-Met inhibitor, and making it possible to provide a patient-tailored treatment which is optimized for individual patient, thereby increasing the therapeutic efficacy.</div>
    </li> <heading id="h0007" class="style-scope patent-text">
      <b class="style-scope patent-text">EXAMPLES</b>
    </heading>
    <li class="style-scope patent-text"> <para-num num="[0124]" class="style-scope patent-text">
    
    [0124]
  </para-num> <div id="p0124" num="0124" class="description-line style-scope patent-text">Hereafter, the present invention will be described in detail by examples. Only the examples relating to IL-8 constitute the invention. The following examples are intended merely to illustrate the invention and are not construed to restrict the invention.</div>
    </li> <heading id="h0008" class="style-scope patent-text">
      <b class="style-scope patent-text">REFERENCE EXAMPLE: Construction of Anti-c-Met Antibody</b>
    </heading>
    <heading id="h0009" class="style-scope patent-text">
      <b class="style-scope patent-text">1.1. Production of "AbF46", a Mouse Antibody to c-Met</b>
    </heading>
    <heading id="h0010" class="style-scope patent-text">
      <b class="style-scope patent-text">1.1.1. Immunization of mice</b>
    </heading>
    <li class="style-scope patent-text"> <para-num num="[0125]" class="style-scope patent-text">
    
    [0125]
  </para-num> <div id="p0125" num="0125" class="description-line style-scope patent-text">To obtain immunized mice necessary for the development of a hybridoma cell line, each of five BALB/c mice (Japan SLC, Inc.), 4 to 6 weeks old, was intraperitoneally injected with a mixture of 100 g of human c-Met/Fc fusion protein (R&amp;D Systems) and one volume of complete Freund's adjuvant. Two weeks after the injection, a second intraperitoneal injection was conducted on the same mice with a mixture of 50 g of human c-Met/Fc protein and one volume of incomplete Freund's adjuvant. One week after the second immunization, the immune response was finally boosted. Three days later, blood was taken from the tails of the mice and the sera were 1/1000 diluted in PBS and used to examine a titer of antibody to c-Met by ELISA. Mice found to have a sufficient antibody titer were selected for use in the cell fusion process.</div>
    </li> <heading id="h0011" class="style-scope patent-text">
      <b class="style-scope patent-text">1.1.2. Cell fusion and production of a hybridoma</b>
    </heading>
    <li class="style-scope patent-text"> <para-num num="[0126]" class="style-scope patent-text">
    
    [0126]
  </para-num> <div id="p0126" num="0126" class="description-line style-scope patent-text">Three days before cell fusion, BALB/c mice (Japan SLC, Inc.) were immunized with an intraperitoneal injection of a mixture of 50 g of human c-Met/Fc fusion protein and one volume of PBS. The immunized mice were anesthetized before excising the spleen from the left half of the body. The spleen was meshed to separate splenocytes which were then suspended in a culture medium (DMEM, GIBCO, Invitrogen). The cell suspension was centrifuged to recover the cell layer. The splenocytes thus obtained (1x10<sup class="style-scope patent-text">8</sup> cells) were mixed with myeloma cells (Sp2/0) (1x10<sup class="style-scope patent-text">8</sup> cells), followed by spinning to yield a cell pellet. The cell pellet was slowly suspended, treated with 45% polyethylene glycol (PEG) (1 mL) in DMEM for 1 min at 37 C, and supplemented with 1 mL of DMEM. To the cells was added 10 mL of DMEM over 10 min, after which incubation was conducted in a water bath at 37 C for 5 min. Then the cell volume was adjusted to 50 mL before centrifugation. The cell pellet thus formed was resuspended at a density of 1210<sup class="style-scope patent-text">5</sup> cells/mL in a selection medium (HAT medium). 0.1 mL of the cell suspension was allocated to each well of 96-well plates which were then incubated at 37 C in a CO<sub class="style-scope patent-text">2</sub> incubator to establish a hybridoma cell population.</div>
    </li> <heading id="h0012" class="style-scope patent-text">
      <b class="style-scope patent-text">1.1.3. Selection of hybridoma cells producing monoclonal antibodies to c-Met protein</b>
    </heading>
    <li class="style-scope patent-text"> <para-num num="[0127]" class="style-scope patent-text">
    
    [0127]
  </para-num> <div id="p0127" num="0127" class="description-line style-scope patent-text">From the hybridoma cell population established in Reference Example 1.1.2, hybridoma cells which showed a specific response to c-Met protein were screened by ELISA using human c-Met/Fc fusion protein and human Fc protein as antigens.</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0128]" class="style-scope patent-text">
    
    [0128]
  </para-num> <div id="p0128" num="0128" class="description-line style-scope patent-text">Human c-Met/Fc fusion protein was seeded in an amount of 50 L (2 g/mL)/well to microtiter plates and allowed to adhere to the surface of each well. The antibody that remained unbound was removed by washing. For use in selecting the antibodies that do not bind c-Met but recognize Fc, human Fc protein was attached to the plate surface in the same manner.</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0129]" class="style-scope patent-text">
    
    [0129]
  </para-num> <div id="p0129" num="0129" class="description-line style-scope patent-text">The hybridoma cell culture obtained in Reference Example 1.1.2 was added in an amount of 50 L to each well of the plates and incubated for 1 hour. The cells remaining unreacted were washed out with a sufficient amount of Tris-buffered saline and Tween 20 (TBST). Goat anti-mouse IgG-horseradish peroxidase (HRP) was added to the plates and incubated for 1 hour at room temperature. The plates were washed with a sufficient amount of TBST, followed by reacting the peroxidase with a substrate (OPD). Absorbance at 450 nm was measured on an ELISA reader.</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0130]" class="style-scope patent-text">
    
    [0130]
  </para-num> <div id="p0130" num="0130" class="description-line style-scope patent-text">Hybridoma cell lines which secrete antibodies that specifically and strongly bind to human c-Met but not human Fc were selected repeatedly. From the hybridoma cell lines obtained by repeated selection, a single clone producing a monoclonal antibody was finally separated by limiting dilution. The single clone of the hybridoma cell line producing the monoclonal antibody was deposited with the Korean Cell Line Research Foundation, an international depository authority located at Yungun-Dong, Jongno-Gu, Seoul, Korea, on Oct. 6, 2009, with Accession No. KCLRF-BP-00220 according to the Budapest Treaty (refer to Korean Patent Laid-Open Publication No. 2011-0047698).</div>
    </li> <heading id="h0013" class="style-scope patent-text">
      <b class="style-scope patent-text">1.1.4. Production and purification of a monoclonal antibody</b>
    </heading>
    <li class="style-scope patent-text"> <para-num num="[0131]" class="style-scope patent-text">
    
    [0131]
  </para-num> <div id="p0131" num="0131" class="description-line style-scope patent-text">The hybridoma cell line obtained in Reference Example 1.1.3 was cultured in a serum-free medium, and the monoclonal antibody (AbF46) was produced and purified from the cell culture.</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0132]" class="style-scope patent-text">
    
    [0132]
  </para-num> <div id="p0132" num="0132" class="description-line style-scope patent-text">First, the hybridoma cells cultured in 50 mL of a medium (DMEM) supplemented with 10% (v/v) FBS (fetal bovine serum) were centrifuged and the cell pellet was washed twice or more with 20 mL of PBS to remove the FBS therefrom. Then, the cells were resuspended in 50 mL of DMEM and incubated for 3 days at 37 C in a CO<sub class="style-scope patent-text">2</sub> incubator.</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0133]" class="style-scope patent-text">
    
    [0133]
  </para-num> <div id="p0133" num="0133" class="description-line style-scope patent-text">After the cells were removed by centrifugation, the supernatant was stored at 4 C before use or immediately used for the separation and purification of the antibody. An AKTA system (GE Healthcare) equipped with an affinity column (Protein G agarose column; Pharmacia, USA) was used to purify the antibody from 50 to 300 mL of the supernatant, followed by concentration with a filter (Amicon). The antibody was stored in PBS before use in the following examples.</div>
    </li> <heading id="h0014" class="style-scope patent-text">
      <b class="style-scope patent-text">1.2. Construction of chAbF46, a chimeric antibody to c-Met</b>
    </heading>
    <li class="style-scope patent-text"> <para-num num="[0134]" class="style-scope patent-text">
    
    [0134]
  </para-num> <div id="p0134" num="0134" class="description-line style-scope patent-text">A mouse antibody is apt to elicit immunogenicity in humans. To solve this problem, chAbF46, a chimeric antibody, was constructed from the mouse antibody AbF46 produced in Reference Example 1.1.4 by replacing the constant region, but not the variable region responsible for antibody specificity, with an amino sequence of the human IgG1 antibody.</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0135]" class="style-scope patent-text">
    
    [0135]
  </para-num> <div id="p0135" num="0135" class="description-line style-scope patent-text">In this regard, a gene was designed to include the nucleotide sequence of "EcoRI-signal sequence-VH-NheI-CH-TGA-XhoI" (SEQ ID NO: 38) for a heavy chain and the nucleotide sequence of "EcoRI-signal sequence-VL-BsiWI-CL-TGA-XhoI" (SEQ ID NO: 39) for a light chain and synthesized. Then, a DNA fragment having the heavy chain nucleotide sequence (SEQ ID NO: 38) and a DNA fragment having the light chain nucleotide sequence (SEQ ID NO: 39) were digested with EcoRI (NEB, R0101S) and XhoI (NEB, R0146S) before cloning into a vector from the pOptiVEC-TOPO TA Cloning Kit enclosed in an OptiCHO Antibody Express Kit (Cat no. 12762-019, Invitrogen), and a vector from the pcDNA3.3-TOPO TA Cloning Kit (Cat no. 8300-01), respectively.</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0136]" class="style-scope patent-text">
    
    [0136]
  </para-num> <div id="p0136" num="0136" class="description-line style-scope patent-text">Each of the constructed vectors was amplified using Qiagen Maxiprep kit (Cat no. 12662), and a transient expression was performed using Freestyle MAX 293 Expression System (Invitrogen). 293 F cells were used for the expression and cultured in FreeStyle 293 Expression Medium in a suspension culture manner. At one day before the transient expression, the cells were provided in the concentration of 5x10<sup class="style-scope patent-text">5</sup> cells/mL., After 24 hours, when the cell number reached to 1x10<sup class="style-scope patent-text">6</sup> cells/mL, the transient expression was performed. A transfection was performed by a liposomal reagent method using Freestyle MAX reagent (Invitrogen), wherein in a 15 mL tube, the DNA was provided in the mixture ratio of 1:1 (heavy chain DNA: light chain DNA) and mixed with 2 mL of OptiPro SFM (Invitrogen) (A). In another 15 mL tube, 100 L of Freestyle MAX reagent and 2 mL of OptiPro SFM were mixed (B), followed by mixing (A) and (B) and incubating for 15 minutes. The obtained mixture was slowly mixed with the cells provided one day before the transient expression. After completing the transfection, the cells were incubated in 130 rpm incubator for 5 days under the conditions of 37 C, 80% humidity, and 8% CO<sub class="style-scope patent-text">2</sub>.</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0137]" class="style-scope patent-text">
    
    [0137]
  </para-num> <div id="p0137" num="0137" class="description-line style-scope patent-text">Afterwards, the cells were incubated in DMEM supplemented with 10% (v/v) FBS for 5 hours at 37 C under a 5% CO<sub class="style-scope patent-text">2</sub> condition and then in FBS-free DMEM for 48 hours at 37 C under a 5% CO<sub class="style-scope patent-text">2</sub> condition.</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0138]" class="style-scope patent-text">
    
    [0138]
  </para-num> <div id="p0138" num="0138" class="description-line style-scope patent-text">After centrifugation, the supernatant was applied to AKTA prime (GE Healthcare) to purify the antibody. In this regard, 100 mL of the supernatant was loaded at a flow rate of 5 mL/min to AKTA Prime equipped with a Protein A column (GE Healthcare, 17-0405-03), followed by elution with an IgG elution buffer (Thermo Scientific, 21004). The buffer was exchanged with PBS to purify a chimeric antibody AbF46 (hereinafter referred to as "chAbF46").</div>
    </li> <heading id="h0015" class="style-scope patent-text">
      <b class="style-scope patent-text">1.3. Construction of Humanized Antibody huAbF46 from Chimeric Antibody chAbF46</b>
    </heading>
    <heading id="h0016" class="style-scope patent-text">
      <b class="style-scope patent-text">13.1. Heavy chain humanization</b>
    </heading>
    <li class="style-scope patent-text"> <para-num num="[0139]" class="style-scope patent-text">
    
    [0139]
  </para-num> <div id="p0139" num="0139" class="description-line style-scope patent-text">To design two domains H1-heavy and H3-heavy, human germline genes which share the highest identity/homology with the VH gene of the mouse antibody AbF46 purified in Reference Example 1.2 were analyzed. An Ig BLAST search (www.ncbi.nlm.nih.gov/igblast/) result revealed that VH3-71 has an identity/ identity/homology of 83% at the amino acid level. CDR-H1, CDR-H2, and CDR-H3 of the mouse antibody AbF46 were defined according to Kabat numbering. A design was made to introduce the CDR of the mouse antibody AbF46 into the framework of VH3-71. Hereupon, back mutations to the amino acid sequence of the mouse AbF46 were conducted at positions 30 (ST), 48 (VL), 73 (DN), and 78 (TL). Then, H1 was further mutated at positions 83 (RK) and 84 (AT) to finally establish H1-heavy (SEQ ID NO: 40) and H3-heavy (SEQ ID NO: 41).</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0140]" class="style-scope patent-text">
    
    [0140]
  </para-num> <div id="p0140" num="0140" class="description-line style-scope patent-text">For use in designing H4-heavy, human antibody frameworks were analyzed by a BLAST search. The result revealed that the VH3 subtype, known to be most stable, is very similar in framework and sequence to the mouse antibody AbF46. CDR-H1, CDR-H2, and CDR-H3 of the mouse antibody AbF46 were defined according to Kabat numbering and introduced into the VH3 subtype to construct H4-heavy (SEQ ID NO: 42).</div>
    </li> <heading id="h0017" class="style-scope patent-text">
      <b class="style-scope patent-text">1.3.2. Light chain humanization</b>
    </heading>
    <li class="style-scope patent-text"> <para-num num="[0141]" class="style-scope patent-text">
    
    [0141]
  </para-num> <div id="p0141" num="0141" class="description-line style-scope patent-text">To design two domains H1-light (SEQ ID NO: 43) and H2-light (SEQ ID NO: 44), human germline genes which share the highest identity/homology with the VH gene of the mouse antibody AbF46 were analyzed. An Ig BLAST search result revealed that VK4-1 has an identity/homology of 75% at the amino acid level. CDR-L1, CDR-L2, and CDR-L3 of the mouse antibody AbF46 were defined according to Kabat numbering. A design was made to introduce the CDR of the mouse antibody AbF46 into the framework of VK4-1. Hereupon, back mutations to the amino acid sequence of the mouse AbF46 were conducted at positions 36 (YH), 46 (LM), and 49 (YI). Only one back mutation was conducted at position 49 (YI) on H2-light.</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0142]" class="style-scope patent-text">
    
    [0142]
  </para-num> <div id="p0142" num="0142" class="description-line style-scope patent-text">To design H3-light (SEQ ID NO: 45), human germline genes which share the highest identity/homology with the VL gene of the mouse antibody AbF46 were analyzed by a BLAST search. As a result, VK2-40 was selected. VL and VK2-40 of the mouse antibody AbF46 were found to have a identity/homology of 61% at an amino acid level. CDR-L1, CDR-L2, and CDR-L3 of the mouse antibody were defined according to Kabat numbering and introduced into the framework of VK4-1. Back mutations were conducted at positions 36 (YH), 46 (LM), and 49 (YI) on H3-light.</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0143]" class="style-scope patent-text">
    
    [0143]
  </para-num> <div id="p0143" num="0143" class="description-line style-scope patent-text">For use in designing H4-light (SEQ ID NO: 46), human antibody frameworks were analyzed. A BLAST search revealed that the Vk1 subtype, known to be the most stable, is very similar in framework and sequence to the mouse antibody AbF46. CDR-L1, CDR-L2, and CDR-L3 of the mouse antibody AbF46 were defined according to Kabat numbering and introduced into the Vk1 subtype. Hereupon, back mutations were conducted at positions 36 (YH), 46 (LM), and 49 (YI) on H4-light.</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0144]" class="style-scope patent-text">
    
    [0144]
  </para-num> <div id="p0144" num="0144" class="description-line style-scope patent-text">Thereafter, DNA fragments having the heavy chain nucleotide sequences (H1-heavy: SEQ ID NO: 47, H3-heavy: SEQ ID NO: 48, H4-heavy: SEQ ID NO: 49) and DNA fragments having the light chain nucleotide sequences (H1-light: SEQ ID NO: 50, H2-light: SEQ ID NO: 51, H3-light: SEQ ID NO: 52, H4-light: SEQ ID NO: 53) were digested with EcoRI (NEB, R0101S) and XhoI (NEB, R0146S) before cloning into a vector from the pOptiVEC-TOPO TA Cloning Kit enclosed in an OptiCHO Antibody Express Kit (Cat no. 12762-019, Invitrogen) and a vector from the pcDNA3.3-TOPO TA Cloning Kit (Cat no. 8300-01), respectively, so as to construct recombinant vectors for expressing a humanized antibody.</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0145]" class="style-scope patent-text">
    
    [0145]
  </para-num> <div id="p0145" num="0145" class="description-line style-scope patent-text">Each of the constructed vectors was amplified using Qiagen Maxiprep kit (Cat no. 12662), and a transient expression was performed using Freestyle MAX 293 Expression System (Invitrogen). 293 F cells were used for the expression and cultured in FreeStyle 293 Expression Medium in a suspension culture manner. At one day before the transient expression, the cells were provided in the concentration of 5x10<sup class="style-scope patent-text">5</sup> cells/ml, and after 24 hours, when the cell number reached to 1x10<sup class="style-scope patent-text">6</sup> cells/mL, the transient expression was performed. A transfection was performed by a liposomal reagent method using Freestyle MAX reagent (Invitrogen), wherein in a 15 mL tube, the DNA was provided in the mixture ratio of 1:1 (heavy chain DNA : light chain DNA) and mixed with 2 mL of OptiPro SFM (Invitrogen) (A). In another 15 mL tube, 100 L of Freestyle MAX reagent and 2 mL of OptiPro SFM were mixed (B), followed by mixing (A) and (B) and incubating for 15 minutes. The obtained mixture was slowly mixed with the cells provided one day before the transient expression. After completing the transfection, the cells were incubated in 130 rpm incubator for 5 days under the conditions of 37 C, 80% humidity, and 8% CO<sub class="style-scope patent-text">2</sub>.</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0146]" class="style-scope patent-text">
    
    [0146]
  </para-num> <div id="p0146" num="0146" class="description-line style-scope patent-text">After centrifugation, the supernatant was applied to AKTA prime (GE Healthcare) to purify the antibody. In this regard, 100 mL of the supernatant was loaded at a flow rate of 5 mL/min to AKTA Prime equipped with a Protein A column (GE Healthcare, 17-0405-03), followed by elution with an IgG elution buffer (Thermo Scientific, 21004). The buffer was exchanged with PBS to purify a humanized antibody AbF46 (hereinafter referred to as "huAbF46"). The humanized antibody huAbF46 used in the following examples comprised a combination of H4-heavy (SEQ ID NO: 42) and H4-light (SEQ ID NO: 46).</div>
    </li> <heading id="h0018" class="style-scope patent-text">
      <b class="style-scope patent-text">1.4. Construction of scFV Library of huAbF46 Antibody</b>
    </heading>
    <li class="style-scope patent-text"> <para-num num="[0147]" class="style-scope patent-text">
    
    [0147]
  </para-num> <div id="p0147" num="0147" class="description-line style-scope patent-text">For use in constructing an scFv of the huAbF46 antibody from the heavy and light chain variable regions of the huAbF46 antibody, a gene was designed to have the structure of "VH-linker-VL" for each of the heavy and the light chain variable region, with the linker comprising the amino acid sequence "GLGGLGGGGSGGGGSGGSSGVGS" (SEQ ID NO: 54). A polynucleotide sequence (SEQ ID NO: 55) encoding the designed scFv of huAbF46 was synthesized in Bioneer and an expression vector for the polynucleotide had the nucleotide sequence of SEQ ID NO: 56.</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0148]" class="style-scope patent-text">
    
    [0148]
  </para-num> <div id="p0148" num="0148" class="description-line style-scope patent-text">After expression, the product was found to exhibit specificity to c-Met.</div>
    </li> <heading id="h0019" class="style-scope patent-text">
      <b class="style-scope patent-text">1.5. Construction of Library Genes for Affinity Maturation</b>
    </heading>
    <heading id="h0020" class="style-scope patent-text">
      <b class="style-scope patent-text">1.5.1. Selection of target CDRs and synthesis of primers</b>
    </heading>
    <li class="style-scope patent-text"> <para-num num="[0149]" class="style-scope patent-text">
    
    [0149]
  </para-num> <div id="p0149" num="0149" class="description-line style-scope patent-text">The affinity maturation of huAbF46 was achieved. First, six complementary determining regions (CDRs) were defined according to Kabat numbering. The CDRs are given in Table 2 below.
<tables id="tabl0002" num="0002" class="style-scope patent-text"> <patent-tables frame="all" class="style-scope patent-text">TABLE 2<table cols="2" class="description-table style-scope patent-text" width="100%"> <thead class="style-scope patent-text"> <tr class="description-tr style-scope patent-text"> <td align="center" valign="top" class="description-td style-scope patent-text">CDR</td> <td align="center" valign="top" class="description-td style-scope patent-text">Amino Acid Sequence</td> </tr> </thead>  <tbody class="style-scope patent-text"><tr class="description-tr style-scope patent-text"> <td align="center" class="description-td style-scope patent-text">CDR-H3</td> <td align="center" class="description-td style-scope patent-text">DYYMS (SEQ ID NO: 1)</td> </tr> <tr class="description-tr style-scope patent-text"> <td align="center" class="description-td style-scope patent-text">CDR-H2</td> <td align="center" class="description-td style-scope patent-text">FIRNKANGYTTEYSASVKG (SEQ ID NO: 2)</td> </tr> <tr class="description-tr style-scope patent-text"> <td align="center" class="description-td style-scope patent-text">CDR-H3</td> <td align="center" class="description-td style-scope patent-text">DNWFAY (SEQ ID NO: 3)</td> </tr> <tr class="description-tr style-scope patent-text"> <td align="center" class="description-td style-scope patent-text">CDR-L1</td> <td align="center" class="description-td style-scope patent-text">KSSQSLLASGNQNNYLA (SEQ ID NO: 10)</td> </tr> <tr class="description-tr style-scope patent-text"> <td align="center" class="description-td style-scope patent-text">CDR-L2</td> <td align="center" class="description-td style-scope patent-text">WASTRVS (SEQ ID NO: 11)</td> </tr> <tr class="description-tr style-scope patent-text"> <td align="center" class="description-td style-scope patent-text">CDR-L3</td> <td align="center" class="description-td style-scope patent-text">QQSYSAPLT (SEQ ID NO: 12)</td> </tr>  </tbody></table> </patent-tables> </tables> </div>
    </li> <li class="style-scope patent-text"> <para-num num="[0150]" class="style-scope patent-text">
    
    [0150]
  </para-num> <div id="p0150" num="0150" class="description-line style-scope patent-text">For use in the introduction of random sequences into the CDRs of the antibody, primers were designed as follows. Conventionally, N codons were utilized to introduce bases at the same ratio (25% A, 25% G, 25% C, 25% T) into desired sites of mutation. In this experiment, the introduction of random bases into the CDRs of huAbF46 was conducted in such a manner that, of the three nucleotides per codon in the wild-type polynucleotide encoding each CDR, the first and second nucleotides conserved over 85% of the entire sequence while the other three nucleotides were introduced at the same percentage (each 5%) and that the same possibility was imparted to the third nucleotide (33% G, 33% C, 33% T).</div>
    </li> <heading id="h0021" class="style-scope patent-text">
      <b class="style-scope patent-text">1.5.2. Construction of a library of huAbF46 antibodies and affinity for c-Met</b>
    </heading>
    <li class="style-scope patent-text"> <para-num num="[0151]" class="style-scope patent-text">
    
    [0151]
  </para-num> <div id="p0151" num="0151" class="description-line style-scope patent-text">The construction of antibody gene libraries through the introduction of random sequences was carried out using the primers synthesized in the same manner as in Reference Example 1.5.1. Two PCR products were obtained using a polynucleotide covering the scFV of huAbF46 as a template, and were subjected to overlap extension PCR to give scFv library genes for huAbF46 antibodies in which only desired CDRs were mutated. Libraries targeting each of the six CDRs prepared from the scFV library genes were constructed.</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0152]" class="style-scope patent-text">
    
    [0152]
  </para-num> <div id="p0152" num="0152" class="description-line style-scope patent-text">The affinity for c-Met of each library was compared to that of the wildtype. Most libraries were lower in affinity for c-Met, compared to the wild-type. The affinity for c-Met was retained in some mutants.</div>
    </li> <heading id="h0022" class="style-scope patent-text">
      <b class="style-scope patent-text">1.6. Selection of Antibody with Improved Affinity from Libraries</b>
    </heading>
    <li class="style-scope patent-text"> <para-num num="[0153]" class="style-scope patent-text">
    
    [0153]
  </para-num> <div id="p0153" num="0153" class="description-line style-scope patent-text">After maturation of the affinity of the constructed libraries for c-Met, the nucleotide sequence of scFv from each clone was analyzed. The nucleotide sequences thus obtained are summarized in Table 3 and were converted into IgG forms. Four antibodies which were respectively produced from clones L3-1, L3-2, L3-3, and L3-5 were used in the subsequent experiments.
<tables id="tabl0003" num="0003" class="style-scope patent-text"> <patent-tables frame="all" class="style-scope patent-text">TABLE 3<table cols="3" class="description-table style-scope patent-text" width="100%"> <thead class="style-scope patent-text"> <tr class="description-tr style-scope patent-text"> <td align="center" valign="top" class="description-td style-scope patent-text">Clone</td> <td align="center" valign="top" class="description-td style-scope patent-text">Library constructed</td> <td align="center" valign="top" class="description-td style-scope patent-text">CDR Sequence</td> </tr> </thead>  <tbody class="style-scope patent-text"><tr class="description-tr style-scope patent-text"> <td align="center" class="description-td style-scope patent-text">H11-4</td> <td align="center" class="description-td style-scope patent-text">CDR-H1</td> <td align="center" class="description-td style-scope patent-text">PEYYMS (SEQ ID NO: 22)</td> </tr> <tr class="description-tr style-scope patent-text"> <td align="center" class="description-td style-scope patent-text">YC151</td> <td align="center" class="description-td style-scope patent-text">CDR-H1</td> <td align="center" class="description-td style-scope patent-text">PDYYMS (SEQ ID NO: 23)</td> </tr> <tr class="description-tr style-scope patent-text"> <td align="center" class="description-td style-scope patent-text">YC193</td> <td align="center" class="description-td style-scope patent-text">CDR-H1</td> <td align="center" class="description-td style-scope patent-text">SDYYMS (SEQ ID NO: 24)</td> </tr> <tr class="description-tr style-scope patent-text"> <td align="center" class="description-td style-scope patent-text">YC244</td> <td align="center" class="description-td style-scope patent-text">CDR-H2</td> <td align="center" class="description-td style-scope patent-text">RNNANGNT (SEQ ID NO: 25)</td> </tr> <tr class="description-tr style-scope patent-text"> <td align="center" class="description-td style-scope patent-text">YC321</td> <td align="center" class="description-td style-scope patent-text">CDR-H2</td> <td align="center" class="description-td style-scope patent-text">RNKVNGYT (SEQ ID NO: 26)</td> </tr> <tr class="description-tr style-scope patent-text"> <td align="center" class="description-td style-scope patent-text">YC354</td> <td align="center" class="description-td style-scope patent-text">CDR-H3</td> <td align="center" class="description-td style-scope patent-text">DNWLSY (SEQ ID NO: 27)</td> </tr> <tr class="description-tr style-scope patent-text"> <td align="center" class="description-td style-scope patent-text">YC374</td> <td align="center" class="description-td style-scope patent-text">CDR-H3</td> <td align="center" class="description-td style-scope patent-text">DNWLTY (SEQ ID NO: 28)</td> </tr> <tr class="description-tr style-scope patent-text"> <td align="center" class="description-td style-scope patent-text">L1-1</td> <td align="center" class="description-td style-scope patent-text">CDR-L1</td> <td align="center" class="description-td style-scope patent-text">KSSHSLLASGNQNNYLA (SEQ ID NO: 29)</td> </tr> <tr class="description-tr style-scope patent-text"> <td align="center" class="description-td style-scope patent-text">L1-3</td> <td align="center" class="description-td style-scope patent-text">CDR-L1</td> <td align="center" class="description-td style-scope patent-text">KSSRSLLSSGNHKNYLA (SEQ ID NO: 30)</td> </tr> <tr class="description-tr style-scope patent-text"> <td align="center" class="description-td style-scope patent-text">L1-4</td> <td align="center" class="description-td style-scope patent-text">CDR-L1</td> <td align="center" class="description-td style-scope patent-text">KSSKSLLASGNQNNYLA (SEQ ID NO: 31)</td> </tr> <tr class="description-tr style-scope patent-text"> <td align="center" class="description-td style-scope patent-text">L1-12</td> <td align="center" class="description-td style-scope patent-text">CDR-L1</td> <td align="center" class="description-td style-scope patent-text">KSSRSLLASGNQNNYLA (SEQ ID NO: 32)</td> </tr> <tr class="description-tr style-scope patent-text"> <td align="center" class="description-td style-scope patent-text">L1-22</td> <td align="center" class="description-td style-scope patent-text">CDR-L1</td> <td align="center" class="description-td style-scope patent-text">KSSHSLLASGNQNNYLA (SEQ ID NO: 33)</td> </tr> <tr class="description-tr style-scope patent-text"> <td align="center" class="description-td style-scope patent-text">L2-9</td> <td align="center" class="description-td style-scope patent-text">CDR-L2</td> <td align="center" class="description-td style-scope patent-text">WASKRVS (SEQ ID NO: 34)</td> </tr> <tr class="description-tr style-scope patent-text"> <td align="center" class="description-td style-scope patent-text">L2-12</td> <td align="center" class="description-td style-scope patent-text">CDR-L2</td> <td align="center" class="description-td style-scope patent-text">WGSTRVS (SEQ ID NO: 35)</td> </tr> <tr class="description-tr style-scope patent-text"> <td align="center" class="description-td style-scope patent-text">L2-16</td> <td align="center" class="description-td style-scope patent-text">CDR-L2</td> <td align="center" class="description-td style-scope patent-text">WGSTRVP (SEQ ID NO: 36)</td> </tr> <tr class="description-tr style-scope patent-text"> <td align="center" class="description-td style-scope patent-text">L3-1</td> <td align="center" class="description-td style-scope patent-text">CDR-L3</td> <td align="center" class="description-td style-scope patent-text">QQSYSRPYT (SEQ ID NO: 13)</td> </tr> <tr class="description-tr style-scope patent-text"> <td align="center" class="description-td style-scope patent-text">L3-2</td> <td align="center" class="description-td style-scope patent-text">CDR-L3</td> <td align="center" class="description-td style-scope patent-text">GQSYSRPLT (SEQ ID NO: 14)</td> </tr> <tr class="description-tr style-scope patent-text"> <td align="center" class="description-td style-scope patent-text">L3-3</td> <td align="center" class="description-td style-scope patent-text">CDR-L3</td> <td align="center" class="description-td style-scope patent-text">AQSYSHPFS (SEQ ID NO: 15)</td> </tr> <tr class="description-tr style-scope patent-text"> <td align="center" class="description-td style-scope patent-text">L3-5</td> <td align="center" class="description-td style-scope patent-text">CDR-L3</td> <td align="center" class="description-td style-scope patent-text">QQSYSRPFT (SEQ ID NO: 16)</td> </tr> <tr class="description-tr style-scope patent-text"> <td align="center" class="description-td style-scope patent-text">L3-32</td> <td align="center" class="description-td style-scope patent-text">CDR-L3</td> <td align="center" class="description-td style-scope patent-text">QQSYSKPFT (SEQ ID NO: 37)</td> </tr>  </tbody></table> </patent-tables> </tables> </div>
    </li> <heading id="h0023" class="style-scope patent-text">
      <b class="style-scope patent-text">1.7. Conversion of Selected Antibodies into IgG</b>
    </heading>
    <li class="style-scope patent-text"> <para-num num="[0154]" class="style-scope patent-text">
    
    [0154]
  </para-num> <div id="p0154" num="0154" class="description-line style-scope patent-text">Respective polynucleotides encoding heavy chains of the four selected antibodies were designed to have the structure of "EcoRI-signal sequence-VH-NheI-CH-XhoI" (SEQ ID NO: 38). The heavy chains of huAbF46 antibodies were used as they were because their amino acids were not changed during affinity maturation. In the case of the hinge region, however, the U6-HC7 hinge (SEQ ID NO: 57) was employed instead of the hinge of human IgG1. Genes were also designed to have the structure of "EcoRI-signal sequence-VL-BsiWI-CL-XhoI" for the light chain. Polypeptides encoding light chain variable regions of the four antibodies which were selected after the affinity maturation were synthesized in Bioneer. Then, a DNA fragment having the heavy chain nucleotide sequence (SEQ ID NO: 38) and DNA fragments having the light chain nucleotide sequences (DNA fragment comprising L3-1-derived CDR-L3: SEQ ID NO: 58, DNA fragment comprising L3-2-derived CDR-L3: SEQ ID NO: 59, DNA fragment comprising L3-3-derived CDR-L3: SEQ ID NO: 60, and DNA fragment comprising L3-5-derived CDR-L3: SEQ ID NO: 61) were digested with EcoRI (NEB, R0101S) and XhoI (NEB, R0146S) before cloning into a vector from the pOptiVEC-TOPO TA Cloning Kit enclosed in an OptiCHO Antibody Express Kit (Cat no. 12762-019, Invitrogen) and a vector from the pcDNA3.3-TOPO TA Cloning Kit (Cat no. 8300-01), respectively, so as to construct recombinant vectors for expressing affinity-matured antibodies.</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0155]" class="style-scope patent-text">
    
    [0155]
  </para-num> <div id="p0155" num="0155" class="description-line style-scope patent-text">Each of the constructed vectors was amplified using Qiagen Maxiprep kit (Cat no. 12662), and a transient expression was performed using Freestyle MAX 293 Expression System (Invitrogen). 293 F cells were used for the expression and cultured in FreeStyle 293 Expression Medium in a suspension culture manner. At one day before the transient expression, the cells were provided in the concentration of 5x10<sup class="style-scope patent-text">5</sup> cells/mL. After 24 hours, when the cell number reached to 1x10<sup class="style-scope patent-text">6</sup> cells/mL, the transient expression was performed. A transfection was performed by a liposomal reagent method using Freestyle MAX reagent (Invitrogen), wherein in a 15 mL tube, the DNA was provided in the mixture ratio of 1:1 (heavy chain DNA : light chain DNA) and mixed with 2 mL of OptiPro SFM (Invitrogen) (A). I In another 15 mL tube, 100 L of Freestyle MAX reagent and 2 mL of OptiPro SFM were mixed (B), followed by mixing (A) and (B) and incubating for 15 minutes. The obtained mixture was slowly mixed with the cells provided one day before the transient expression. After completing the transfection, the cells were incubated in 130 rpm incubator for 5 days under the conditions of 37C, 80% humidity, and 8% CO<sub class="style-scope patent-text">2</sub>.</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0156]" class="style-scope patent-text">
    
    [0156]
  </para-num> <div id="p0156" num="0156" class="description-line style-scope patent-text">After centrifugation, the supernatant was applied to AKTA prime (GE Healthcare) to purify the antibody. In this regard, 100 mL of the supernatant was loaded at a flow rate of 5 mL/min to AKTA Prime equipped with a Protein A column (GE Healthcare, 17-0405-03), followed by elution with an IgG elution buffer (Thermo Scientific, 21004). The buffer was exchanged with PBS to purify four affinity-matured antibodies (hereinafter referred to as "huAbF46-H4-A1 (L3-1 origin), huAbF46-H4-A2 (L3-2 origin), huAbF46-H4-A3 (L3-3 origin), and huAbF46-H4-A5 (L3-5 origin)," respectively).</div>
    </li> <heading id="h0024" class="style-scope patent-text">
      <b class="style-scope patent-text">1.8. Construction of Constant Region- and/or Hinge Region-Substituted huAbF46-H4-A1</b>
    </heading>
    <li class="style-scope patent-text"> <para-num num="[0157]" class="style-scope patent-text">
    
    [0157]
  </para-num> <div id="p0157" num="0157" class="description-line style-scope patent-text">Among the four antibodies selected in Reference Example 1.7, huAbF46-H4-A1 was found to be the highest in affinity for c-Met and the lowest in Akt phosphorylation and c-Met degradation degree. In the antibody, the hinge region, or the constant region and the hinge region, were substituted.</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0158]" class="style-scope patent-text">
    
    [0158]
  </para-num> <div id="p0158" num="0158" class="description-line style-scope patent-text">The antibody huAbF46-H4-A1 (U6-HC7) was composed of a heavy chain comprising the heavy chain variable region of huAbF46-H4-A1, U6-HC7 hinge, and the constant region of human IgG1 constant region, and a light chain comprising the light chain variable region of huAbF46-H4-A1 and human kappa constant region. The antibody huAbF46-H4-A1 (IgG2 hinge) was composed of a heavy chain comprising a heavy chain variable region, a human IgG2 hinge region, and a human IgG1 constant region, and a light chain comprising the light chain variable region of huAbF46-H4-A1 and a human kappa constant region. The antibody huAbF46-H4-A1 (IgG2 Fc) was composed of the heavy chain variable region of huAbF46-H4-A1, a human IgG2 hinge region, and a human IgG2 constant region, and a light chain comprising the light variable region of huAbF46-H4-A1 and a human kappa constant region. Hereupon, the histidine residue at position 36 on the human kappa constant region of the light chain was changed to tyrosine in all of the three antibodies to increase antibody production.</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0159]" class="style-scope patent-text">
    
    [0159]
  </para-num> <div id="p0159" num="0159" class="description-line style-scope patent-text">For use in constructing the three antibodies, a polynucleotide (SEQ ID NO: 63) encoding a polypeptide (SEQ ID NO: 62) composed of the heavy chain variable region of huAbF46-H4-A1, a U6-HC7 hinge region, and a human IgG1 constant region, a polynucleotide (SEQ ID NO: 65) encoding a polypeptide (SEQ ID NO: 64) composed of the heavy chain variable region of huAbF46-H4-A1, a human IgG2 hinge region, and a human IgG1 region, a polynucleotide (SEQ ID NO: 67) encoding a polypeptide (SEQ ID NO: 66) composed of the heavy chain variable region of huAbF46-H4-A1, a human IgG2 region, and a human IgG2 constant region, and a polynucleotide (SEQ ID NO: 69) encoding a polypeptide (SEQ ID NO: 68) composed of the light chain variable region of huAbF46-H4-A1, with a tyrosine residue instead of histidine at position 36, and a human kappa constant region were synthesized in Bioneer. Then, the DNA fragments having heavy chain nucleotide sequences were inserted into a vector from the pOptiVEC-TOPO TA Cloning Kit enclosed in an OptiCHO Antibody Express Kit (Cat no. 12762-019, Invitrogen) while DNA fragments having light chain nucleotide sequences were inserted into a vector from the pcDNA3.3-TOPO TA Cloning Kit (Cat no. 8300-01) so as to construct vectors for expressing the antibodies.</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0160]" class="style-scope patent-text">
    
    [0160]
  </para-num> <div id="p0160" num="0160" class="description-line style-scope patent-text">Each of the constructed vectors was amplified using Qiagen Maxiprep kit (Cat no. 12662), and a transient expression was performed using Freestyle MAX 293 Expression System (Invitrogen). 293 F cells were used for the expression and cultured in FreeStyle 293 Expression Medium in a suspension culture manner. At one day before the transient expression, the cells were provided in the concentration of 5x10<sup class="style-scope patent-text">5</sup> cells/mL. After 24 hours, when the cell number reached to 1x10<sup class="style-scope patent-text">6</sup> cells/mL, the transient expression was performed. A transfection was performed by a liposomal reagent method using Freestyle MAX reagent (Invitrogen), wherein in a 15 mL tube, the DNA was provided in the mixture ratio of 1:1 (heavy chain DNA : light chain DNA) and mixed with 2 mL of OptiPro SFM (Invitrogen) (A). In another 15 mL tube, 100 L of Freestyle MAX reagent and 2 mL of OptiPro SFM were mixed (B), followed by mixing (A) and (B) and incubating for 15 minutes. The obtained mixture was slowly mixed with the cells provided one day before the transient expression. After completing the transfection, the cells were incubated in 130 rpm incubator for 5 days under the conditions of 37 C, 80% humidity, and 8% CO<sub class="style-scope patent-text">2</sub>.</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0161]" class="style-scope patent-text">
    
    [0161]
  </para-num> <div id="p0161" num="0161" class="description-line style-scope patent-text">After centrifugation, the supernatant was applied to AKTA prime (GE Healthcare) to purify the antibody. In this regard, 100 mL of the supernatant was loaded at a flow rate of 5 mL/min to AKTA Prime equipped with a Protein A column (GE Healthcare, 17-0405-03), followed by elution with IgG elution buffer (Thermo Scientific, 21004). The buffer was exchanged with PBS to finally purify three antibodies (huAbF46-H4-A1 (U6-HC7), huAbF46-H4-A1 (IgG2 hinge), and huAbF46-H4-A1 (IgG2 Fc)). Among the three antibodies, huAbF46-H4-A1 (U6-HC7) and huAbF46-H4-A1 (IgG2 Fc) were representatively selected for the following examples, and referred as anti-c-Met antibody L3-1Y and L3-1Y/IgG2, respectively.</div>
    </li> <heading id="h0025" class="style-scope patent-text">
      <b class="style-scope patent-text">EXAMPLE 1: Prediction and Evaluation of efficacy of Anti-c-Met Antibody Using IL-8</b>
    </heading>
    <heading id="h0026" class="style-scope patent-text">
      <b class="style-scope patent-text">1.1. Assay for predicting and evaluating efficacy of anti-c-Met antibody in cancer cell-implanted mouse model using IL-8</b>
    </heading>
    <heading id="h0027" class="style-scope patent-text">
      <b class="style-scope patent-text">1.1.1. Construction of cancer cell-implanted mouse model</b>
    </heading>
    <li class="style-scope patent-text"> <para-num num="[0162]" class="style-scope patent-text">
    
    [0162]
  </para-num> <div id="p0162" num="0162" class="description-line style-scope patent-text">For use in assays for predicting and evaluating the efficacy of an anti-c-Met antibody, xenograft mouse models were prepared by implanting various conventional cancer cell lines (Lovo, HT-29, EBC-1, MKN45, and Hs746T) to mice.</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0163]" class="style-scope patent-text">
    
    [0163]
  </para-num> <div id="p0163" num="0163" class="description-line style-scope patent-text">Briefly, the human colorectal cancer cell line HT29 (ATCC HTB-38) or Lovo (ATCC CCL-229) were injected s.c. at a dose of 5x10<sup class="style-scope patent-text">6</sup> cells into BALB/C nude mice (4-5 week old, male; Shanghai SLAC Laboratory Animal Co. Ltd.) to construct xenograft mouse models. For modeling, 15 mice were allocated to each group. Also, the human stomach cancer cell lines Hs746T (ATCC HTB-135) and MKN45 (ATCC RCB1001), and the human non-small cell cancer cell line EBC-1 (ATCC JCRB0820) were used in the same manner to construct xenograft mouse models.</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0164]" class="style-scope patent-text">
    
    [0164]
  </para-num> <div id="p0164" num="0164" class="description-line style-scope patent-text">That is, mouse models implanted, respectively, with Lovo, HT-29, EBC-1, Hs746T, MKN45, and MKN45 were constructed, and used in the following experiments.</div>
    </li> <heading id="h0028" class="style-scope patent-text">
      <b class="style-scope patent-text">1.1.2. Prediction of the efficacy of anti-c-Met antibody in cancer cell-implanted mouse model using IL-8</b>
    </heading>
    <li class="style-scope patent-text"> <para-num num="[0165]" class="style-scope patent-text">
    
    [0165]
  </para-num> <div id="p0165" num="0165" class="description-line style-scope patent-text">After the anti-c-Met antibody L3-1Y/IgG2 prepared in Reference Example 1 was administered to Lovo-, HT-29-, EBC-1-, MKN45-, or Hs746T-implanted mouse models constructed in Example 1.1.1, tumor sizes were measured to identify groups which were responsive to L3-1Y/IgG2 (responder; effective anticancer activity) and were not responsive (non-responder; no anticancer activity).</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0166]" class="style-scope patent-text">
    
    [0166]
  </para-num> <div id="p0166" num="0166" class="description-line style-scope patent-text">Briefly, the anti-c-Met antibody was injected to each group of the mouse models constructed in Example 1.1.1 from 7-10 days after implantation. The injection was conducted at regular intervals of 7 days for 4 weeks via an intravenous route. Tumor volumes were measured and recorded twice a week. For a control, PBS was injected. The anti-c-Met antibody was injected at a dose of 0.2, 1, 5, or 10 mg/kg to HT29- or Lovo-implanted groups, and at a dose of 0.03, 0.1, 0.3, 1.0, 3.0, or 10.0 mg/kg to EBC-1-, MKN45-, or Hs746T-implanted groups. Results are depicted in <figref idrefs="f0001 f0002 f0003 f0004 f0005" class="style-scope patent-text">FIGS. 1A to 1E</figref> (1a: Lovo, 1b: HT29, 1c: EBC-1, 1d: Hs746T, 1e: MKN45). <figref idrefs="f0001 f0002 f0003 f0004 f0005" class="style-scope patent-text">FIGS. 1A to 1E</figref> show results of the control PBS group and representative anti-c-Met antibody groups (HT29, Lovo, MKN45, EBC-1 and Hs746T models, the first three were injected at a dose of 5 mg/kg while the remaining two injected at a dose of 3 mg/kg) only. Points of time of antibody injection or euthanasia are indicated by arrows. As can be seen in <figref idrefs="f0001 f0002 f0003 f0004 f0005" class="style-scope patent-text">FIGS. 1A to 1E</figref>, the anticancer efficacy of L3-1Y/IgG2 was not detected in the Lovo- or the HT-29-implanted mouse models, but was apparent in EBC-1-, Hs746T- or MKN45-implanted mouse models. So, the Lovo- and the HT-29-implanted mouse models were determined to not be responsive to L3-1Y/IgG2 (non-responder group) while the EBC-1-, the Hs746T- and the MKN45-implanted mouse models were classified as responder groups.</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0167]" class="style-scope patent-text">
    
    [0167]
  </para-num> <div id="p0167" num="0167" class="description-line style-scope patent-text">An examination was made of a difference in serum IL-8 levels between the responder and the non-responder groups. Serum IL-8 levels of the Lovo-, the HT-29-, the EBC-1- and the Hs746T-implanted mouse models were compared to those of the control mice (injected with PBS only; at a dose of 100 L every 7 days for 4 weeks), and relationship between serum IL-8 level and responsiveness to L3-1Y/IgG2 was investigated.</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0168]" class="style-scope patent-text">
    
    [0168]
  </para-num> <div id="p0168" num="0168" class="description-line style-scope patent-text">Briefly, sera from the control of each model were analyzed using a BD Cytometric Bead Array kit. Whole blood was collected from the mouse models in a BD vacutainer SST tube. After collection of the whole blood, the tube was mixed by gently inverting for 5 times, and then, allowed to clot for 30 minutes at room temperature. After the incubation, the clot was removed by centrifuge the tube at 1500 xg for 10 minutes in a refrigerated centrifuge. The serum sample is obtained by transfer of the supernatant into a new tube. Experiments were performed with a human inflammatory cytokine kit. According to the manufacture's guideline, mouse serum was diluted 1/4 (v/v) in the assay diluent buffer and incubated for 1.5 hrs with biotinylated antihuman IL-8 antibody-coated beads (BD Cytometric Bead Array (CBA) Human inflammatory cytokines kit, #551811, BD biosciences). Thereafter, the sample was mixed with 1mL of the wash buffer containing in the BD Cytometric Bead Array (CBA) Human inflammatory cytokines kit, and centrifuged. After removal of the supernatant, the residue was incubated for 1.5 hrs with the streptavidin-PE of the kit, mixed with 1 mL of the wash buffer. After centrifugation (200 g, 5 min.), the supernatant containing unreacted materials was discarded. The precipitate was suspended in 200 L of wash buffer before FACS analysis (BD FACS CantoII flow cytometer, BD Bioscience). From the data thus obtained, serum IL-8 concentrations were calculated using the FCAP array program (BD Biosciences), and quantified by multiplication by the dilution factor.</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0169]" class="style-scope patent-text">
    
    [0169]
  </para-num> <div id="p0169" num="0169" class="description-line style-scope patent-text">The results are shown in <figref idrefs="f0006" class="style-scope patent-text">FIG. 2</figref>. As can be seen in <figref idrefs="f0006" class="style-scope patent-text">FIG. 2</figref>, the IL-8 level was measured about 500 pg/mL or higher in both the responder groups, but decreased to about 50-150 pg/ml in the non-responder groups. The serum IL-8 level of the responder groups was observed to be at least 3-fold higher than that of the non-responder. Accordingly, the cancer cells with high IL-8 levels are expected to allow L3-1Y/IgG2 to exert its anticancer activity more effectively.</div>
    </li> <heading id="h0029" class="style-scope patent-text">
      <b class="style-scope patent-text">1.1.3. Evaluation of the efficacy of anti-c-Met antibody in cancer cell-implanted mouse model using IL-8</b>
    </heading>
    <li class="style-scope patent-text"> <para-num num="[0170]" class="style-scope patent-text">
    
    [0170]
  </para-num> <div id="p0170" num="0170" class="description-line style-scope patent-text">To examine the relationship between the change of IL-8 level and the responsiveness to an anti-c-Met antibody, the changes of serum IL-8 levels after treatment of the anti-c-Met antibody in cancer cell-implanted mouse models were monitored.</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0171]" class="style-scope patent-text">
    
    [0171]
  </para-num> <div id="p0171" num="0171" class="description-line style-scope patent-text">Briefly, among the serum samples obtained from the mouse xenograft models of Example 1.1.2, the vehicle-treated sample (PBS-treated, control) and the anti-c-Met antibody treated samples with high and low doses were prepared. To this end, serum samples were taken from HT29 and Lovo models (non-responder groups) injected at doses of 0.2 mg/kg and 5 mg/kg and from EBC-1 and Hs746T models (responder groups) injected at doses of 1 mg/kg and 3 mg/kg, and examined for the relationship between the anticancer efficacy of the anti-c-Met antibody and the change of IL-8 level after anti-c-Met antibody treatment. Serum IL-8 levels were analyzed with reference to Example 1.1.2.</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0172]" class="style-scope patent-text">
    
    [0172]
  </para-num> <div id="p0172" num="0172" class="description-line style-scope patent-text">Results are depicted in <figref idrefs="f0007" class="style-scope patent-text">FIG. 3</figref>. As is understood from the data of <figref idrefs="f0007" class="style-scope patent-text">FIG. 3</figref>, the non-responder groups showed no significant differences or an increase in the IL-8 level upon treatment with L3-1Y/IgG2 compared to the non-treated group ("vehicle-treated"; injected with vehicle only, PBS) whereas the responder groups showed a significant decrease in IL-8 level compared to the untreated group. These data imply that a patient can be monitored for responsiveness to L3-1Y/IgG2, that is, the efficacy of L3-1Y/IgG2 by measuring the expression level of IL-8 in the patient treated with L3-1Y/IgG2.</div>
    </li> <heading id="h0030" class="style-scope patent-text">
      <b class="style-scope patent-text">1.2. Assay for predicting and evaluating efficacy of anti-c-Met antibody in mouse model implanted with patient-derived tumor tissues by measuring the serum level of IL-8.</b>
    </heading>
    <heading id="h0031" class="style-scope patent-text">
      <b class="style-scope patent-text">1.2.1. Construction of mouse model implanted with patient-derived tumor tissues.</b>
    </heading>
    <li class="style-scope patent-text"> <para-num num="[0173]" class="style-scope patent-text">
    
    [0173]
  </para-num> <div id="p0173" num="0173" class="description-line style-scope patent-text">For use in examining whether IL-8 can be used as a reliable biomarker in predicting or evaluating the efficacy of an anti-c-Met antibody when it is applied to patients, mouse models implanted with patient-derived tumor tissue suffering from cancer (lung cancer) were constructed.</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0174]" class="style-scope patent-text">
    
    [0174]
  </para-num> <div id="p0174" num="0174" class="description-line style-scope patent-text">This experiment was performed in the special company Oncotest (Oncotest GmbH, Freibrug Germany). Briefly, patient-derived lung cancer cell lines (non-small cell lung cancer (NSCLC)) LXFA297, 526, 623, 983, 1041 and 1647 were cultured and injected s.c. into NMRI nude mice (4-6 week old, female; Harlan) to construct xenograft mouse models. The construction was carried out according to the Oncotest SOP "Subcutaneous implantation" guideline. 10 mice were allocated to each group. After implantation, the mouse models were randomized to reduce measurement deviations of average tumor volumes between groups, and then injected with the drug. Experiments using patient-derived gastric cancer cell lines, GXF214 and GXF251, and patient-derived renal cancer cell lines, RXF488, RXF1114 and RXF1220 were performed referring to the above method.</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0175]" class="style-scope patent-text">
    
    [0175]
  </para-num> <div id="p0175" num="0175" class="description-line style-scope patent-text">The mouse models implanted with patient-derived tumor tissues were tested for responsiveness to an anti-c-Met antibody while L3-1Y/IgG2 was injected thereto.</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0176]" class="style-scope patent-text">
    
    [0176]
  </para-num> <div id="p0176" num="0176" class="description-line style-scope patent-text">Briefly, to monitor the anticancer efficacy of the antibody, the tumor volumes were regularly measured. Anticancer efficacy was calculated by dividing tumor volumes of each antibody-treated group (5mg/kg, iv) by those of the control group (PBS injected) after completion of the injection (% inhibition= 100-(tumor volume of test group /tumor volume of control *100)). The results are summarized in Tables 4 and 5.</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0177]" class="style-scope patent-text">
    
    [0177]
  </para-num> <div id="p0177" num="0177" class="description-line style-scope patent-text">A reduction of tumor volume by 30 % or greater upon treatment with L3-1Y/IgG2 was considered statistically significant, which led to determining the antibody as being efficacious, and the group as a responder.
<tables id="tabl0004" num="0004" class="style-scope patent-text"> <patent-tables frame="all" class="style-scope patent-text">TABLE 4<table cols="7" class="description-table style-scope patent-text" width="100%"> <thead class="style-scope patent-text"> <tr class="description-tr style-scope patent-text"> <td valign="top" class="description-td style-scope patent-text"> </td> <td namest="col2" nameend="col7" align="left" valign="top" class="description-td style-scope patent-text" colspan="6">NSCLC</td> </tr> </thead>  <tbody class="style-scope patent-text"><tr class="description-tr style-scope patent-text"> <td class="description-td style-scope patent-text">Model</td> <td class="description-td style-scope patent-text">LXFA297</td> <td class="description-td style-scope patent-text">LXFA526</td> <td class="description-td style-scope patent-text">LXFA623</td> <td class="description-td style-scope patent-text">LXFA983</td> <td class="description-td style-scope patent-text">LXFA1041</td> <td class="description-td style-scope patent-text">LXFA1647</td> </tr> <tr class="description-tr style-scope patent-text"> <td class="description-td style-scope patent-text">% inhibition</td> <td class="description-td style-scope patent-text">-57.12</td> <td class="description-td style-scope patent-text">63.95</td> <td class="description-td style-scope patent-text">99.99</td> <td class="description-td style-scope patent-text">20.05</td> <td class="description-td style-scope patent-text">-35.5</td> <td class="description-td style-scope patent-text">90.61</td> </tr> <tr class="description-tr style-scope patent-text"> <td class="description-td style-scope patent-text">Result</td> <td class="description-td style-scope patent-text">no efficacy</td> <td class="description-td style-scope patent-text">efficacy</td> <td class="description-td style-scope patent-text">efficacy</td> <td class="description-td style-scope patent-text">no efficacy</td> <td class="description-td style-scope patent-text">no efficacy</td> <td class="description-td style-scope patent-text">efficacy</td> </tr>  </tbody></table> </patent-tables> </tables> </div>
    </li> <li class="style-scope patent-text"> <para-num num="[0178]" class="style-scope patent-text">
    
    [0178]
  </para-num> <div id="p0178" num="0178" class="description-line style-scope patent-text">In Table 4, % inhibition= 100 - (tumor volume of test group /tumor volume of control *100)
<tables id="tabl0005" num="0005" class="style-scope patent-text"> <patent-tables frame="all" class="style-scope patent-text">TABLE 5<table cols="6" class="description-table style-scope patent-text" width="100%"> <thead class="style-scope patent-text"> <tr class="description-tr style-scope patent-text"> <td valign="top" class="description-td style-scope patent-text"> </td> <td namest="col2" nameend="col3" align="left" valign="top" class="description-td style-scope patent-text" colspan="2">Gastric</td> <td namest="col4" nameend="col6" align="left" valign="top" class="description-td style-scope patent-text" colspan="3">Renal</td> </tr> </thead>  <tbody class="style-scope patent-text"><tr class="description-tr style-scope patent-text"> <td class="description-td style-scope patent-text">Model</td> <td class="description-td style-scope patent-text">GXF214</td> <td class="description-td style-scope patent-text">GXF251</td> <td class="description-td style-scope patent-text">RXF488</td> <td class="description-td style-scope patent-text">RXF1114</td> <td class="description-td style-scope patent-text">RXF1220</td> </tr> <tr class="description-tr style-scope patent-text"> <td class="description-td style-scope patent-text">% inhibition</td> <td class="description-td style-scope patent-text">8.96</td> <td class="description-td style-scope patent-text">-20.77</td> <td class="description-td style-scope patent-text">24.82</td> <td class="description-td style-scope patent-text">92.56</td> <td class="description-td style-scope patent-text">6.79</td> </tr> <tr class="description-tr style-scope patent-text"> <td class="description-td style-scope patent-text">Result</td> <td class="description-td style-scope patent-text">no efficacy</td> <td class="description-td style-scope patent-text">no efficacy</td> <td class="description-td style-scope patent-text">no efficacy</td> <td class="description-td style-scope patent-text">efficacy</td> <td class="description-td style-scope patent-text">no efficacy</td> </tr>  </tbody></table> </patent-tables> </tables> </div>
    </li> <li class="style-scope patent-text"> <para-num num="[0179]" class="style-scope patent-text">
    
    [0179]
  </para-num> <div id="p0179" num="0179" class="description-line style-scope patent-text">As is understood from data of Tables 4 and 5, the lung cancer cell-implanted mouse models LXFA526, LXFA623, and LXFA1647, and the kidney cancer cell-implanted mouse model RXF1114 were found to respond to L3-1Y/IgG2 (responder) while the other mouse models implanted with patient-derived tumor tissue were not responsive to the antibody (non-responder)</div>
    </li> <heading id="h0032" class="style-scope patent-text">
      <b class="style-scope patent-text">1.2.2. Prediction of the efficacy of anti-c-Met antibody in mouse model implanted with patient-derived tumor tissues using measurement of the serum level of IL-8</b>
    </heading>
    <li class="style-scope patent-text"> <para-num num="[0180]" class="style-scope patent-text">
    
    [0180]
  </para-num> <div id="p0180" num="0180" class="description-line style-scope patent-text">Differences in the basal level of serum IL-8 between the responders and the non-responders were examined. In this regard, serum samples were taken from the vehicle groups of mouse models constructed in Example 1.2.1 and the IL-8 levels in the serum samples were used to examine relationship with responsiveness to L3-1Y/IgG2.</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0181]" class="style-scope patent-text">
    
    [0181]
  </para-num> <div id="p0181" num="0181" class="description-line style-scope patent-text">Briefly, serum samples taken from the mouse models implanted with patient-derived tumor tissues were classified according to test group. IL-8 levels were measured in vehicle treated groups from the 6 samples of lung cancer models, 2 samples of stomach cancer models, 3 samples of kidney cancer models. Measurement of the IL-8 levels was carried out in the same manner as in Example 1.1.2.</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0182]" class="style-scope patent-text">
    
    [0182]
  </para-num> <div id="p0182" num="0182" class="description-line style-scope patent-text">The results are shown in <figref idrefs="f0008" class="style-scope patent-text">FIG. 4</figref>. As is apparent from <figref idrefs="f0008" class="style-scope patent-text">FIG. 4</figref>, the serum IL-8 levels were higher than 750 pg/mL in the responder groups but the levels were lower than about 500 pg/ml in the non-responder groups. The serum IL-8 level of the responder groups was observed to be at least 1.5-fold higher than that of the non-responder. Accordingly, the human cancer cells with high IL-8 levels are expected to allow L3-1Y/IgG2 to exert its anticancer activity more effectively.</div>
    </li> <heading id="h0033" class="style-scope patent-text">
      <b class="style-scope patent-text">1.2.3. Evaluation of the efficacy of anti-c-Met antibody in mouse model implanted with patient-derived tumor tissues using measurement of the serum level of IL-8</b>
    </heading>
    <li class="style-scope patent-text"> <para-num num="[0183]" class="style-scope patent-text">
    
    [0183]
  </para-num> <div id="p0183" num="0183" class="description-line style-scope patent-text">To examine the relationship between IL-8 level and responsiveness to an anti-c-Met antibody, changes of serum IL-8 levels after treatment of an anti-c-Met antibody in mouse models implanted with patient-derived tumor tissues were monitored.</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0184]" class="style-scope patent-text">
    
    [0184]
  </para-num> <div id="p0184" num="0184" class="description-line style-scope patent-text">Briefly, serum samples taken from the mouse models implanted with patient-derived tumor tissues were classified according to test group. IL-8 levels were measured in 6 samples of lung cancer models, 2 samples of stomach cancer models, 3 samples of kidney cancer models after injection of the anti-c-Met antibody (5 mg/kg, iv) and in samples of the control (PBS injected), and examined for relationship between the anticancer efficacy of the anti-c-Met antibody and the change of IL-8 level after the anti-c-Met antibody treatment. Measurement of the IL-8 levels was carried out in the same manner as in Example 1.1.2.</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0185]" class="style-scope patent-text">
    
    [0185]
  </para-num> <div id="p0185" num="0185" class="description-line style-scope patent-text">Results are depicted in <figref idrefs="f0009" class="style-scope patent-text">FIG. 5</figref>. As is understood from the data of <figref idrefs="f0009" class="style-scope patent-text">FIG. 5</figref>, there are no significant differences in serum IL-8 levels between vehicle and L3-1Y/IgG2 treatment samples of non-responder groupwhereas the responder group showed significant decrease in serum IL-8 levels after treatment of L3-1Y/IgG2. These data imply that a patient can be monitored for responsiveness to L3-1Y/IgG2, that is, the efficacy of L3-1Y/IgG2 by measuring the expression level of IL-8 in the patient treated with L3-1Y/IgG2.</div>
    </li> <heading id="h0034" class="style-scope patent-text">
      <b class="style-scope patent-text">1.3. Change in IL-8 Level with Time after Anti-c-Met Antibody Injection</b>
    </heading>
    <heading id="h0035" class="style-scope patent-text">
      <b class="style-scope patent-text">1.3.1. Construction of cancer cell-implanted mouse model and Assay for anticancer activity of anti-c-Met antibody in the mouse model</b>
    </heading>
    <li class="style-scope patent-text"> <para-num num="[0186]" class="style-scope patent-text">
    
    [0186]
  </para-num> <div id="p0186" num="0186" class="description-line style-scope patent-text">The role of IL-8 as a pharmcodynamic marker of anti-c-Met antibodies was confirmed in xengraft mouse models which were prepared by implanting cancer cell lines known to be responsive to the antibody.</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0187]" class="style-scope patent-text">
    
    [0187]
  </para-num> <div id="p0187" num="0187" class="description-line style-scope patent-text">As opposed to Example 1.1, this experiment was configured to examine the responsiveness in a condition under which tumor volumes were little changed. After implantation, tumors were increased to a size of 1000 mm<sup class="style-scope patent-text">3</sup> and, then, the antibody was injected in various doses to the mice models. According time after injection, serum samples and tumor tissues were taken from three mice per group. In addition, tumor volumes were measured at regular intervals of time.</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0188]" class="style-scope patent-text">
    
    [0188]
  </para-num> <div id="p0188" num="0188" class="description-line style-scope patent-text">Briefly, xenograft mouse models implanted with the human stomach cell line Hs746T (Accession No. HTB-135) or human non-small cell lung cancer line EBC-1 (Accession No. JCRB0820) were employed. Each cancer cell line was injected s.c. at a dose of 5x10<sup class="style-scope patent-text">6</sup> cells to 150 Balb/c nude mice (Shanghai SLAC Laboratory Animal Co. Ltd.). All of the experimental animals were male and 5-6 weeks old upon the implantation, and bred in an SPF condition. In order to increase the tumor to a predetermined size, the mice implanted with the cancer cells were treated with the drug (antibody) only 16-20 days after the implantation. When the tumor grew to a size of about 1000 mm<sup class="style-scope patent-text">3</sup>, the mice were randomly divided into groups of 30: PBS-treated group (Group 1) and anti-c-Met antibody-treated groups (<figure-callout id="2" label="Groups" filenames="imgf0012.png,imgf0013.png" class="style-scope patent-text"><a title="Show image containing callout" class="style-scope figure-callout"> <figure-callout id="3" label="Groups" filenames="imgf0012.png,imgf0013.png" class="style-scope patent-text"><a title="Show image containing callout" class="style-scope figure-callout">Groups</a></figure-callout> </a></figure-callout> 2, 3, and 4). The treated groups were classified according to the dose of the antibody: 1 mg/kg (Group 2), 3 mg/kg (Group 3) and 10 mg/kg (Group 4). The antibody and the vehicle were administered twice at regular intervals of 7 days. Each sample was withdrawn 1 hr, 1 day (24 hrs), 2 days (48 hrs), 3 days (72 hrs), and 7 days (168 hrs) after the first injection. The same sampling time schedule was repeated after the second injection: 1 hr (169 hrs), 1 day (192 hrs), 2 days (216 hrs), 3 days (240 hrs), and 7 days (336 hrs). With regard to sampling, serum and tissues were taken from three mice which were sacrificed at each time point. Tumor volumes were also measured upon sampling to monitor the anticancer activity of the antibody (PharmaLegacy Laboratories Vivarium).</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0189]" class="style-scope patent-text">
    
    [0189]
  </para-num> <div id="p0189" num="0189" class="description-line style-scope patent-text">Anticancer activity data obtained above are depicted in <figref idrefs="f0010" class="style-scope patent-text">FIG. 6</figref> (EBC-1 implanted) and <figref idrefs="f0011" class="style-scope patent-text">FIG. 7</figref> (Hs746T implanted).</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0190]" class="style-scope patent-text">
    
    [0190]
  </para-num> <div id="p0190" num="0190" class="description-line style-scope patent-text">As is apparent from the data of <figref idrefs="f0010" class="style-scope patent-text">FIGS. 6</figref> and <figref idrefs="f0011" class="style-scope patent-text">7</figref>, the anti-c-Met antibody exhibited anticancer activity in mice bearing tumors of EBC-1 and Hs746T, as well, and the anticancer activity was dose-dependent.</div>
    </li> <heading id="h0036" class="style-scope patent-text">
      <b class="style-scope patent-text">1.3.2 Evaluation of the efficacy of anti-c-Met antibody in cancer cell-implanted mouse model using measurement of the serum level of IL-8</b>
    </heading>
    <li class="style-scope patent-text"> <para-num num="[0191]" class="style-scope patent-text">
    
    [0191]
  </para-num> <div id="p0191" num="0191" class="description-line style-scope patent-text">The following experiments were conducted with samples taken from the EBC-1- or Hs746T-implanted mouse models prepared in Example 1.3.1. To examine whether the anti-c-Met antibody-induced responsiveness of IL-8 is simply reflect the shrunken tumor size as a result from the efficacy of anti-cMet Ab, time course serum samples were analyzed from the EBC-1- or Hs746T-implanted mouse models to measure the short-term response to L3-1Y/IgG2.</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0192]" class="style-scope patent-text">
    
    [0192]
  </para-num> <div id="p0192" num="0192" class="description-line style-scope patent-text">Briefly, serum samples were taken in an amount of 100 L from each of 3 mice per group according to time after antibody dosing (see <figref idrefs="f0012" class="style-scope patent-text">FIG. 8</figref>). The serum samples from the same group were pooled, and quantitatively analyzed for IL-8 level using CBA method.</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0193]" class="style-scope patent-text">
    
    [0193]
  </para-num> <div id="p0193" num="0193" class="description-line style-scope patent-text">The results are summarized in <figref idrefs="f0012" class="style-scope patent-text">FIGS. 8</figref> and <figref idrefs="f0013" class="style-scope patent-text">9</figref> (wherein "1" between "before dosing" and "<figure-callout id="1" label="day" filenames="imgf0003.png,imgf0006.png" class="style-scope patent-text"><a title="Show image containing callout" class="style-scope figure-callout">day</a></figure-callout> 1" means "1 hour").</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0194]" class="style-scope patent-text">
    
    [0194]
  </para-num> <div id="p0194" num="0194" class="description-line style-scope patent-text">As can be seen in <figref idrefs="f0012" class="style-scope patent-text">FIGS. 8</figref> and <figref idrefs="f0013" class="style-scope patent-text">9</figref>, the serum IL-8 level was observed to decrease in a dose-dependent manner upon treatment with the anti-c-Met antibody, and was already lowered at 1 hr after treatment in the high-dose treatment group (10mg/kg). At the same time, the tumor size was not significantly change in L3-1Y/IgG2 treated mice at this time point (1hr after treatment). These data indicate that the change of serum IL-8 level shows a drug response in vivo xenograft models and it is not solely dependent on the tumor size. So, IL-8 can be used as an early marker indicative of in vivo responsiveness to an anti-c-Met antibody. Taken together, the data demonstrates that the responsiveness of IL-8 is not attributed simply to the change in tumor size and can be useful biomarker for c-Met targeted therapy.</div>
    </li> <heading id="h0037" class="style-scope patent-text">
      <b class="style-scope patent-text">1.4. Test of Efficacies of c-Met Inhibitors other than anti-c-Met Antibodies</b>
    </heading>
    <li class="style-scope patent-text"> <para-num num="[0195]" class="style-scope patent-text">
    
    [0195]
  </para-num> <div id="p0195" num="0195" class="description-line style-scope patent-text">It was verified whether or not the change in IL-8 level can be applicable to a monitoring of responsiveness to a c-Met targeting drug other than anti-c-Met antibodies, as a marker.</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0196]" class="style-scope patent-text">
    
    [0196]
  </para-num> <div id="p0196" num="0196" class="description-line style-scope patent-text">In particular, EBC-1 (human lung cancer cell line; Accession No. JCRB0820) and Hs746T (human stomach cancer cell line; Accession No. HTB-135), on which anti-c-Met antibody L3-1Y/IgG2 displays anticancer efficacies (anti-c-Met antibody responder groups), and Lovo (human colon cancer cell line; Accession No. CCL-229) and HT29 (human colon cancer cell line; Accession No. HTB-38), on which anti-c-Met antibody L3-1Y/IgG2 displays no anticancer efficacies (anti-c-Met antibody non-responder groups), were selected and cultured. The 4 cell lines were seeded on a 96 well plate at the same amount (1x10<sup class="style-scope patent-text">4</sup> cells/well) and cultured for 24 hours (media: RPMI(Gibco, Invitrogen), culture conditions: 37 C, 5% CO<sub class="style-scope patent-text">2</sub>). The cultured cells were treated with representative c-Met inhibitor, crizotinib(Selleck chemical) and PHA665752((R,Z)-5-(2,6-dichlorobenzylsulfonyl)-3-((3,5-dimethyl-4-(2-(pyrolidin-1-ylmethyl)pyrrolidine-1-carbonyl)-1H-pyrrol-2-yl)methylene)indolin-2-one), respectively. For comparison, human control IgG (chrompure human IgG (009-000-003, JACKSON IMMUNORESEARCH LABS INC.)) as a control and anti-c-Met antibody L3-1Y/IgG2 (Reference Example) were used respectively. Each of the inhibitors (or antibody) was treated at 10-fold serial diluted concentrations from 1000 nM to 0.01 nM. 72 hours after the treatment, the level of IL-8 in cell culture of each treatment group was assayed by Cytometric Bead Array (CBA) method using BD Cytometric Bead Array kit (see Example 1.1.2). In addition, in order to verify the anticancer efficacy of the c-Met inhibitors, the cell proliferation (%) was measured at 72 hours after c-Met inhibitor treatment through Cell-Titer Glo (CTG) assay.</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0197]" class="style-scope patent-text">
    
    [0197]
  </para-num> <div id="p0197" num="0197" class="description-line style-scope patent-text">The obtained results of cell proliferation (%) (i.e., results of CTG assay) at 72 hours were shown in <figref idrefs="f0024" class="style-scope patent-text">FIG. 20</figref> (anti-c-Met antibody responder groups) and <figref idrefs="f0025" class="style-scope patent-text">FIG. 21</figref> (anti-c-Met antibody non-responder groups). As shown in <figref idrefs="f0024" class="style-scope patent-text">FIGs. 20</figref> and <figref idrefs="f0025" class="style-scope patent-text">21</figref>, the profile of responsiveness to each c-Met inhibitor, crizotinib and PHA665752, is similar to that to anti-c-Met antibody L3-1Y/IgG2. That is, when crizotinib or PHA665752 was treated, the cell proliferation of L3-1Y/IgG2 responder groups, EBC-1 and Hs746T cell lines was significantly inhibited (decreased) at the inhibitor concentration of 10 nM or more (see <figref idrefs="f0024" class="style-scope patent-text">FIG. 20</figref>), whereas the cell proliferation of L3-1Y/IgG2 non-responder groups, Lovo and HT29 cell lines displays no significant decrease (see <figref idrefs="f0025" class="style-scope patent-text">FIG. 21</figref>).</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0198]" class="style-scope patent-text">
    
    [0198]
  </para-num> <div id="p0198" num="0198" class="description-line style-scope patent-text">In addition, at the concentration of 10nM, from which the responsiveness to the inhibitors can be observed, the level of IL-8 in a cell culture of each treatment group was measured by Cytometric Bead Array (CBA) method using BD Cytometric Bead Array kit (see, Example 1.1.2), and the obtained results are shown in <figref idrefs="f0026" class="style-scope patent-text">FIGs 22</figref> and <figref idrefs="f0027" class="style-scope patent-text">23</figref> as relative ratio to the level of IL-8 in medium (100%). As shown in <figref idrefs="f0026" class="style-scope patent-text">FIGs. 22</figref> and <figref idrefs="f0027" class="style-scope patent-text">23</figref>, the level of IL-8 was significantly decreased in the responder groups, EBC-1 and Hs746T cell lines, which displayed significant decrease in cell proliferation, whereas any significant decrease in the level of IL-8 was not observed in the non-responder groups, Lovo and HT-29 cell lines.</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0199]" class="style-scope patent-text">
    
    [0199]
  </para-num> <div id="p0199" num="0199" class="description-line style-scope patent-text">These results indicate that the decrease in IL-8 level can also be useful as a maker for evaluation of the efficacy of not only anti-c-Met antibodies but also c-Met inhibitors other than anti-c-Met antibodies.</div>
    </li> <heading id="h0038" class="style-scope patent-text">
      <b class="style-scope patent-text">EXAMPLE 2: Evaluation of efficacy of Anti-c-Met Antibody Using bIG-H3</b>
    </heading>
    <heading id="h0039" class="style-scope patent-text">
      <b class="style-scope patent-text">2.1. Selection of bIG-H3 as pharmacodynamic marker for anti-c-Met antibody</b>
    </heading>
    <li class="style-scope patent-text"> <para-num num="[0200]" class="style-scope patent-text">
    
    [0200]
  </para-num> <div id="p0200" num="0200" class="description-line style-scope patent-text">Proteins which showed a significant difference in the expression level between an anti-c-Met antibody-treated group and an untreated group responsive to the anti-c-Met antibody were selected as possible biomarkers for evaluating the efficacy of the anti-c-Met antibody, using an antibody array membrane capable of detecting 119 soluble receptors (a human soluble receptor array kit non-hematopoietic panel, cat# ARY012; R&amp;D; alternatively, a human cytokine array kit (e.g., #ARY005; R&amp;D) can be used).</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0201]" class="style-scope patent-text">
    
    [0201]
  </para-num> <div id="p0201" num="0201" class="description-line style-scope patent-text">In mouse models which were constructed with U87MG (Accession No. HTB-14) in the same manner as in Example 1.1.1, changes in tumor size with treatment with the anti-c-Met antibody L3-1Y/IgG2 were monitored. The results are shown in <figref idrefs="f0014" class="style-scope patent-text">FIG. 10</figref>. As can be seen in <figref idrefs="f0014" class="style-scope patent-text">FIG. 10</figref>, the anti-c-Met antibody L3-1Y/IgG2 exhibited anticancer activity in a dose-dependent manner in the U87MG-implanted mouse models.</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0202]" class="style-scope patent-text">
    
    [0202]
  </para-num> <div id="p0202" num="0202" class="description-line style-scope patent-text">Of the U87MG cells which were identified to respond to the anti-c-Met antibody, differences in protein expression level between anti-c-Met antibody-treated cells groups and untreated cells groups were investigated.</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0203]" class="style-scope patent-text">
    
    [0203]
  </para-num> <div id="p0203" num="0203" class="description-line style-scope patent-text">In this regard, serum samples taken from mouse models which were constructed with U87MG (Accession No. HTB-14) in the same manner as in Example 1.1.1 were incubated with the antibody array membrane (R&amp;D, cat# ARY012) to examine responsiveness to the anti-c-Met antibody. In the membrane, 200 l of the mouse serum was incubated for overnight at 4 C with the buffer and the capture antibody, followed by developing the membrane in chemiluminescence immunoassay. The antibody L3-1Y/IgG2 was intravenously injected at a dose of 10 mg/ml every 7 days for 4 weeks from 7-10 days after implantation.</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0204]" class="style-scope patent-text">
    
    [0204]
  </para-num> <div id="p0204" num="0204" class="description-line style-scope patent-text">The results are depicted in <figref idrefs="f0015" class="style-scope patent-text">FIG. 11</figref>. On the membrane, positive control dots appear at the corners and at middle regions while significant changes are detected as indicated by boxed dots. They were identified as bIG-H3. As compared to the control (PBS treated), L3-1Y/IgG2 significantly decreased the expression level of bIG-H3. Based on this finding, bIG-H3 is first suggested as a pharmacodynamic marker for anti-c-Met antibodies.</div>
    </li> <heading id="h0040" class="style-scope patent-text">
      <b class="style-scope patent-text">2.2. Evaluation of the efficacy of anti-c-Met antibody in cancer cell-implanted mouse model using bIG-H3</b>
    </heading>
    
    <heading id="h0041" class="style-scope patent-text">
      <b class="style-scope patent-text">2.2.1. Construction of cancer cell-implanted mouse model</b>
    </heading>
    <li class="style-scope patent-text"> <para-num num="[0205]" class="style-scope patent-text">
    
    [0205]
  </para-num> <div id="p0205" num="0205" class="description-line style-scope patent-text">For use in assays for evaluating the efficacy of an anti-c-Met antibody, xenograft mouse models were prepared by implanting various cancer cell lines (anti-c-Met antibody non-responsive cell lines: Lovo (Accession No.CCL-229), HT-29 (Accession No. HTB-38), PC3 (Accession No.CRL-1435), BxPC3 (Accession No.CRL-1687), MDAMB231 (Accession No. HTB-26); anti-c-Met antibody responsive cell lines: Hs746T (Accession No. HTB-135), MKN45 (Accession No. RCB1001), EBC-1 (Accession No. JCRB0820), U87MG (Accession No.HTB-14), MHCC97H (Accession No. NB100-122)) to mice in the same manner as in Example 1.1.1.</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0206]" class="style-scope patent-text">
    
    [0206]
  </para-num> <div id="p0206" num="0206" class="description-line style-scope patent-text">Of the mouse models, Hs746T-, MKN45- and EBC-1-implanted mouse models were found to have responsiveness to the anti-c-Met antibody, as demonstrated in Example 1.1.2.</div>
    </li> <heading id="h0042" class="style-scope patent-text">
      <b class="style-scope patent-text">2.2.2. Evaluation of the efficacy of anti-c-Met antibody in cancer cell-implanted mouse model using bIG-H3</b>
    </heading>
    <li class="style-scope patent-text"> <para-num num="[0207]" class="style-scope patent-text">
    
    [0207]
  </para-num> <div id="p0207" num="0207" class="description-line style-scope patent-text">To examine relationship between bIG-H3 level and responsiveness to anti-c-Met antibody, changes of serum bIG-H3 levels with treatment with an anti-c-Met antibody in cancer cell-implanted mouse models were monitored.</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0208]" class="style-scope patent-text">
    
    [0208]
  </para-num> <div id="p0208" num="0208" class="description-line style-scope patent-text">Briefly, serum samples taken from mouse models in a group were pooled, and quantitatively analyzed for bIG-H3 level using a bIG-H3 ELISA kit (R&amp;D) in comparison with the control (injected with vehicle (PBS) only). More specifically, whole blood was collected from the mouse models in a BD vacutainer SST tube. After collection of the whole blood, the tube was mixed by gently inverting for 5 times, and then allowed to clot for 30 minutes at room temperature before centrifuging for 15 minutes at 1000 x g to obtain serum. For individual ELISA assay, MIF(R&amp;D, DMF00B) and IG-H3(R&amp;D, DY2935) ELISA kit were used following the manufacture's protocol. Briefly, 100 l Assay Diluent RD1-53 was added to each well. The serum sample was added to a coated plate at the amount of 50 l per well, and then incubated 2 hours at room temperature. After a washing step, 200 l of antibody conjugate was added to each well and incubated 2 hours and further incubated for 30 minutes after adding substrate solution. Wavelength at 450nm was read using a microplate reader.</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0209]" class="style-scope patent-text">
    
    [0209]
  </para-num> <div id="p0209" num="0209" class="description-line style-scope patent-text">Results are depicted in <figref idrefs="f0016" class="style-scope patent-text">FIG. 12</figref>. As is understood from the data of <figref idrefs="f0016" class="style-scope patent-text">FIG. 12</figref>, the non-responder groups showed no significant differences or an increase in the bIG-H3 expression level upon treatment with L3-1Y/IgG2, compared to the non-treated group (injected with vehicle only, PBS) whereas the responder group significantly decreased in bIG-H3 expression level, compared to the untreated group, or expressed little bIG-H3. These data imply that a patient can be monitored for responsiveness to L3-1Y/IgG2, that is, the efficacy of L3-1Y/IgG2 by measuring the expression level of bIG-H3 in the patient treated with L3-1Y/IgG2.</div>
    </li> <heading id="h0043" class="style-scope patent-text">
      <b class="style-scope patent-text">2.3. Evaluation of efficacy of anti-c-Met antibody in mouse model implanted with patient-derived tumor tissues using bIG-H3</b>
    </heading>
    <heading id="h0044" class="style-scope patent-text">
      <b class="style-scope patent-text">23.1. Construction of mouse model implanted with patient-derived tumor tissue</b>
    </heading>
    <li class="style-scope patent-text"> <para-num num="[0210]" class="style-scope patent-text">
    
    [0210]
  </para-num> <div id="p0210" num="0210" class="description-line style-scope patent-text">With reference to Example 1.2.1, patient-derived lung cancer cell-implanted mouse models LXFA297, LXFA526, LXFA623, LXFA983, LXFA1041, and LXFA1647 were constructed. Of them, LXFA526, LXFA623, and LXFA1647 were observed to be responsive to the anti-c-Met antibody as shown in Table 4.</div>
    </li> <heading id="h0045" class="style-scope patent-text">
      <b class="style-scope patent-text">2.3.2. Evaluation of efficacy of anti-c-Met antibody in mouse model implanted with patient-derived tumor tissues using bIG-H3</b>
    </heading>
    <li class="style-scope patent-text"> <para-num num="[0211]" class="style-scope patent-text">
    
    [0211]
  </para-num> <div id="p0211" num="0211" class="description-line style-scope patent-text">To examine the relationship between bIG-H3 level and responsiveness to an anti-c-Met antibody, changes of serum bIG-H3 levels with treatment with an anti-c-Met antibody in patient-derived tumor tissues-implanted mouse models were monitored.</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0212]" class="style-scope patent-text">
    
    [0212]
  </para-num> <div id="p0212" num="0212" class="description-line style-scope patent-text">Briefly, serum samples taken from mouse models in a group were pooled, and quantitatively analyzed for bIG-H3 level using a bIG-H3 ELISA kit (R&amp;D) in comparison with the control (injected with vehicle (PBS) only), in the same manner as in Example 2.2.2 (refer to Example 1.1.2).</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0213]" class="style-scope patent-text">
    
    [0213]
  </para-num> <div id="p0213" num="0213" class="description-line style-scope patent-text">Results are depicted in <figref idrefs="f0017" class="style-scope patent-text">FIG. 13</figref>. As is understood from the data of <figref idrefs="f0017" class="style-scope patent-text">FIG. 13</figref>, the non-responder groups showed no significant differences or an increase in the bIG-H3 expression level upon treatment with L3-1Y/IgG2, compared to the non-treated group (injected with vehicle only, PBS) whereas the responder group significantly decreased in bIG-H3 expression level, compared to the untreated group, or expressed little bIG-H3. These data imply that a patient can be monitored for responsiveness to L3-1Y/IgG2, that is, the efficacy of L3-1Y/IgG2 by measuring the expression level of bIG-H3 in the patient treated with L3-1Y/IgG2.</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0214]" class="style-scope patent-text">
    
    [0214]
  </para-num> <div id="p0214" num="0214" class="description-line style-scope patent-text">Cancer tissues isolated from L3-1Y/IgG2-treated or untreated groups of the animal models were homogenized and lysed in 500 l of a lysis buffer (Roche). After centrifugation, the cell soup (cell lysate) was harvested and quantified. The cell soup was loaded in an amount corresponding to 1 ug of the total cell protein to plates of the bIG-H3 ELISA kit (R&amp;D). The plates were previously coated with a capture antibody for bIG-H3. The HRP-conjugated detection antibody was applied to the plates before reading O.D 450.</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0215]" class="style-scope patent-text">
    
    [0215]
  </para-num> <div id="p0215" num="0215" class="description-line style-scope patent-text">The results are depicted in <figref idrefs="f0018" class="style-scope patent-text">FIG. 14</figref>. As can be seen in <figref idrefs="f0018" class="style-scope patent-text">FIG. 14</figref>, it was also observed from the cell soup that the content of bIG-H3 in 1 g of the total cell protein was remarkably reduced in the antibody-treated group of the responder, compared to the untreated group.</div>
    </li> <heading id="h0046" class="style-scope patent-text">
      <b class="style-scope patent-text">EXAMPLE 3: Evaluation of efficacy of Anti-c-Met Antibody Using MIF</b>
    </heading>
    <heading id="h0047" class="style-scope patent-text">
      <b class="style-scope patent-text">3.1. Selection of MIF as pharmacodynamic marker for anti-c-Met antibody</b>
    </heading>
    <li class="style-scope patent-text"> <para-num num="[0216]" class="style-scope patent-text">
    
    [0216]
  </para-num> <div id="p0216" num="0216" class="description-line style-scope patent-text">A protein which showed a significant difference in the expression level between an anti-c-Met antibody-treated group and an untreated group of the LXFA623 mouse model responsive to the anti-c-Met antibody (refer to Example 1.2.1 and Table 4) was selected as a marker for evaluating the efficacy of the anti-c-Met antibody, using an antibody array membrane capable of detecting 46 cytokines (R&amp;D ARY005).</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0217]" class="style-scope patent-text">
    
    [0217]
  </para-num> <div id="p0217" num="0217" class="description-line style-scope patent-text">Briefly, 200 l of each of serum samples taken from the antibody-treated group (L3-1Y/IgG2, 5 mg/kg) and the untreated group (PBS injected, control) of the LXFA623 mouse model were incubated overnight 4 C with the buffer provided in the kit, followed by developing dots in chemiluminescence immunoassay. This experiment was performed with antibody array membrane (R&amp;D ARY005).</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0218]" class="style-scope patent-text">
    
    [0218]
  </para-num> <div id="p0218" num="0218" class="description-line style-scope patent-text">The results are depicted in <figref idrefs="f0019" class="style-scope patent-text">FIG. 15</figref>. On the membrane of <figref idrefs="f0019" class="style-scope patent-text">FIG. 15</figref>, L3-1Y/IgG2 remarkably reduced the level of MIF, compared to the control (PBS injected), indicating that MIF can be used as a pharmacodynamic mark for anti-c-Met antibodies.</div>
    </li> <heading id="h0048" class="style-scope patent-text">
      <b class="style-scope patent-text">3.2. Evaluation of the efficacy of anti-c-Met antibody in cancer cell-implanted mouse model using MIF</b>
    </heading>
    <li class="style-scope patent-text"> <para-num num="[0219]" class="style-scope patent-text">
    
    [0219]
  </para-num> <div id="p0219" num="0219" class="description-line style-scope patent-text">In the same manner as in Example 2.2.1, xenograft mouse models were constructed by implanting various cancer cell lines (non-responder: Lovo (Accession No.CCL-229), HT-29 (Accession No. HTB-38), PC3 (Accession No.CRL-1435), BxPC3 (Accession No.CRL-1687), MDAMB231 (Accession No. HTB-26); responder: Hs746T (Accession No. HTB-135), MKN45 (Accession No. RCB1001), EBC-1 (Accession No. JCRB0820), U87MG (Accession No.HTB-14), MHCC97H (Accession No.NB100-122)).</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0220]" class="style-scope patent-text">
    
    [0220]
  </para-num> <div id="p0220" num="0220" class="description-line style-scope patent-text">To examine relationship between MIF level and responsiveness to anti-c-Met antibody, changes of MIF levels with treatment with an anti-c-Met antibody in cancer cell-implanted mouse models were monitored.</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0221]" class="style-scope patent-text">
    
    [0221]
  </para-num> <div id="p0221" num="0221" class="description-line style-scope patent-text">Briefly, serum samples taken from mouse models in each group, e.g., L3-1Y/IgG2-treated group or untreated group (PBS injected, control) of the xenograft animal models, were pooled, and quantitatively analyzed for MIF level using an MIF ELISA kit (R&amp;D). The experiment was conducted according to the manufacturer's manual.</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0222]" class="style-scope patent-text">
    
    [0222]
  </para-num> <div id="p0222" num="0222" class="description-line style-scope patent-text">Results are depicted in <figref idrefs="f0020" class="style-scope patent-text">FIG. 16</figref>. As is understood from the data of <figref idrefs="f0020" class="style-scope patent-text">FIG. 16</figref>, the non-responder groups showed no significant differences or an increase in the MIF expression level upon treatment with L3-1Y/IgG2, compared to the untreated group (injected with vehicle only, PBS) whereas the responder group significantly decreased in MIF expression level, compared to the untreated group, or expressed little MIF. These data imply that a patient can be monitored for responsiveness to L3-1Y/IgG2, that is, the efficacy of L3-1Y/IgG2 by measuring the expression level of MIF in the patient treated with L3-1Y/IgG2.</div>
    </li> <heading id="h0049" class="style-scope patent-text">
      <b class="style-scope patent-text">3.3. Evaluation of efficacy of anti-c-Met antibody in mouse model implanted with patient-derived tumor tissues using MIF</b>
    </heading>
    <li class="style-scope patent-text"> <para-num num="[0223]" class="style-scope patent-text">
    
    [0223]
  </para-num> <div id="p0223" num="0223" class="description-line style-scope patent-text">With reference to Example 1.2.1, patient-derived lung cancer cell-implanted mouse models LXFA297, LXFA526, LXFA623, LXFA983, LXFA1041, and LXFA1647 were constructed. Of them, LXFA526, LXFA623, and LXFA1647 were observed to be responsive to the anti-c-Met antibody as shown in Table 4.</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0224]" class="style-scope patent-text">
    
    [0224]
  </para-num> <div id="p0224" num="0224" class="description-line style-scope patent-text">To examine the relationship between MIF level and responsiveness to an anti-c-Met antibody, changes of serum MIF levels with treatment with an anti-c-Met antibody in patient-derived tumor tissues-implanted mouse models were monitored.</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0225]" class="style-scope patent-text">
    
    [0225]
  </para-num> <div id="p0225" num="0225" class="description-line style-scope patent-text">Briefly, MIF levels were using an MIF ELISA kit in the same manner as in Example 3.2</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0226]" class="style-scope patent-text">
    
    [0226]
  </para-num> <div id="p0226" num="0226" class="description-line style-scope patent-text">Results are depicted in <figref idrefs="f0021" class="style-scope patent-text">FIG. 17</figref>. As is understood from the data of <figref idrefs="f0021" class="style-scope patent-text">FIG. 17</figref>, the non-responder groups showed no significant differences or an increase in the MIF expression level upon treatment with L3-1Y/IgG2, compared to the non-treated group (injected with vehicle only) whereas the responder group significantly decreased in MIF expression level, compared to the untreated group, or expressed little MIF. These data imply that a patient can be monitored for responsiveness to L3-1Y/IgG2, that is, the efficacy of L3-1Y/IgG2 by measuring the expression level of MIF in the patient treated with L3-1Y/IgG2.</div>
    </li> <heading id="h0050" class="style-scope patent-text">
      <b class="style-scope patent-text">EXAMPLE 4: Prediction of efficacy of Anti-c-Met Antibody Using RAS-RAF Mutation</b>
    </heading>
    <heading id="h0051" class="style-scope patent-text">
      <b class="style-scope patent-text">4.1. Assay for predicting efficacy of anti-c-Met antibody in mouse model implanted with patient-derived tumor tissue using RAS-RAF Mutation</b>
    </heading>
    <heading id="h0052" class="style-scope patent-text">
      <b class="style-scope patent-text">4.1.1. Construction of mouse model implanted with patient-derived tumor tissue</b>
    </heading>
    <li class="style-scope patent-text"> <para-num num="[0227]" class="style-scope patent-text">
    
    [0227]
  </para-num> <div id="p0227" num="0227" class="description-line style-scope patent-text">For use in predicting the efficacy of anti-c-Met antibodies, xenograft mouse models implanted with patient-derived tumor tissues were constructed.</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0228]" class="style-scope patent-text">
    
    [0228]
  </para-num> <div id="p0228" num="0228" class="description-line style-scope patent-text">Briefly female NMRI nude mice (Charles River or Harlan, 4-6 weeks old) were implanted s.c. with cancer tissues extracted from patients (LXFA: lung cancer, GXF: stomach cancer, RXF: kidney cancer, GXA: gastric cancer, LXFL: lung large cell carcinoma, OVXF: ovarian cancer, PAXF: pancreatic cancer, CXF: colon cancer). When the tumor grew to a volume of 80 to 200mm<sup class="style-scope patent-text">3</sup>, the mice were randomly divided into groups of 10. L3-1Y/IgG2 was injected i.v. at a dose of 5 mg/kg while PBS was used for a control group. On <figure-callout id="0" label="day" filenames="imgf0002.png,imgf0006.png" class="style-scope patent-text"><a title="Show image containing callout" class="style-scope figure-callout"> <figure-callout id="7" label="day" filenames="imgf0001.png,imgf0002.png" class="style-scope patent-text"><a title="Show image containing callout" class="style-scope figure-callout"> <figure-callout id="14" label="day" filenames="imgf0001.png,imgf0002.png" class="style-scope patent-text"><a title="Show image containing callout" class="style-scope figure-callout"> <figure-callout id="21" label="day" filenames="imgf0001.png,imgf0002.png" class="style-scope patent-text"><a title="Show image containing callout" class="style-scope figure-callout"> <figure-callout id="28" label="day" filenames="imgf0001.png,imgf0002.png" class="style-scope patent-text"><a title="Show image containing callout" class="style-scope figure-callout"> <figure-callout id="35" label="day" filenames="imgf0005.png,imgf0010.png" class="style-scope patent-text"><a title="Show image containing callout" class="style-scope figure-callout">day</a></figure-callout> </a></figure-callout> </a></figure-callout> </a></figure-callout> </a></figure-callout> </a></figure-callout> 0, 7, 14, 21, 28, and 35 after randomization, the antibody was administered. When the tumor volume reached 2000 mm<sup class="style-scope patent-text">3</sup>, the mice were sacrificed and used in the following experiments.</div>
    </li> <heading id="h0053" class="style-scope patent-text">
      <b class="style-scope patent-text">4.1.2. Measurement of c-Met expression level in patient-derived tumor tissues-implanted mouse model</b>
    </heading>
    <li class="style-scope patent-text"> <para-num num="[0229]" class="style-scope patent-text">
    
    [0229]
  </para-num> <div id="p0229" num="0229" class="description-line style-scope patent-text">c-Met expression levels in the patient-derived cancer cell-implanted mouse models were measured using a Western blotting method.</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0230]" class="style-scope patent-text">
    
    [0230]
  </para-num> <div id="p0230" num="0230" class="description-line style-scope patent-text">Briefly, tumor tissues isolated from the animal models were homogenized and lyzed in 500 l of a lysis buffer (Roche). After centrifugation, the cell soup (cell lysate) was harvested and quantified. The cell soup was loaded in an amount corresponding to 10 g of the total cell protein (SDS-PAGE), followed by exposure to the membrane (Cell Signal; including the antibody)</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0231]" class="style-scope patent-text">
    
    [0231]
  </para-num> <div id="p0231" num="0231" class="description-line style-scope patent-text">The results are depicted in <figref idrefs="f0022" class="style-scope patent-text">FIG. 18</figref>. In <figref idrefs="f0022" class="style-scope patent-text">FIG. 18</figref>, the models which developed c-Met bands can be classified as being responsive to L3-1Y/IgG2. However, LXFA2201 did not respond to L3-1Y/IgG2 due to its RAF mutation although the band was detected.</div>
    </li> <heading id="h0054" class="style-scope patent-text">
      <b class="style-scope patent-text">4.1.3. Determination of RAS-RAF mutation and responsiveness to anti-c-Met antibody in patient-derived tumor tissues-implanted mouse model</b>
    </heading>
    <li class="style-scope patent-text"> <para-num num="[0232]" class="style-scope patent-text">
    
    [0232]
  </para-num> <div id="p0232" num="0232" class="description-line style-scope patent-text">The patient-derived tumor tissues-implanted mouse models were examined for the presence of mutation of K-RAS and B-RAF, and for responsiveness to the anti-c-Met antibody.</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0233]" class="style-scope patent-text">
    
    [0233]
  </para-num> <div id="p0233" num="0233" class="description-line style-scope patent-text">DNA isolated from cancer cells was amplified by PCR using a Sequenom system including the primers to discriminate the wild-type from mutants. Mutants were detected mostly at G12V, G12C, Q61H, and G12C for K-RAS, and at G596R and D594A for B-RAF.</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0234]" class="style-scope patent-text">
    
    [0234]
  </para-num> <div id="p0234" num="0234" class="description-line style-scope patent-text">This experiment was carried out with reference to Example 1.2.1.</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0235]" class="style-scope patent-text">
    
    [0235]
  </para-num> <div id="p0235" num="0235" class="description-line style-scope patent-text">Results are summarized in <figref idrefs="f0023" class="style-scope patent-text">FIG. 19</figref> (efficacy of anti-c-Met antibody in LXFA 2201 and LXFA 2158 models; refer to Tables 4 and 5 for the other mouse models) and Table 6 (mutation of K-RAS and B-RAF in each mouse model). The level of c-Met in each mouse model was measured by Affymetrix array (Affymetrix GeneChip Human Genome U133 Plus 2.0 array; using the primer set "203510_at") according to the manufacturer's manual.
<tables id="tabl0006" num="0006" class="style-scope patent-text"> <patent-tables frame="all" class="style-scope patent-text">TABLE 6<table cols="5" class="description-table style-scope patent-text" width="100%"> <thead class="style-scope patent-text"> <tr class="description-tr style-scope patent-text"> <td align="center" valign="middle" class="description-td style-scope patent-text">tumor model</td> <td align="center" valign="middle" class="description-td style-scope patent-text">L3-1Y/IgG2 EFFICACY</td> <td align="center" valign="middle" class="description-td style-scope patent-text">MET level (by Affymetrix)</td> <td align="center" valign="middle" class="description-td style-scope patent-text">K-RAS mutation</td> <td align="center" valign="middle" class="description-td style-scope patent-text">B-RAF mutation</td> </tr> </thead>  <tbody class="style-scope patent-text"><tr class="description-tr style-scope patent-text"> <td align="center" valign="middle" class="description-td style-scope patent-text">LXFA 2201</td> <td align="center" valign="middle" class="description-td style-scope patent-text">NO</td> <td align="center" valign="middle" class="description-td style-scope patent-text">14,770</td> <td align="center" valign="middle" class="description-td style-scope patent-text">wild type</td> <td align="center" valign="middle" class="description-td style-scope patent-text">Mutation G596R</td> </tr> <tr class="description-tr style-scope patent-text"> <td align="center" valign="middle" class="description-td style-scope patent-text">LXFA 2158</td> <td align="center" valign="middle" class="description-td style-scope patent-text">Efficacy</td> <td align="center" valign="middle" class="description-td style-scope patent-text">14,750</td> <td align="center" valign="middle" class="description-td style-scope patent-text">wild type</td> <td align="center" valign="middle" class="description-td style-scope patent-text">wild type</td> </tr> <tr class="description-tr style-scope patent-text"> <td align="center" valign="middle" class="description-td style-scope patent-text">LXFA 1647</td> <td align="center" valign="middle" class="description-td style-scope patent-text">Efficacy</td> <td align="center" valign="middle" class="description-td style-scope patent-text">14,000</td> <td align="center" valign="middle" class="description-td style-scope patent-text">wild type</td> <td align="center" valign="middle" class="description-td style-scope patent-text">wild type</td> </tr> <tr class="description-tr style-scope patent-text"> <td align="center" valign="middle" class="description-td style-scope patent-text">LXFA 526</td> <td align="center" valign="middle" class="description-td style-scope patent-text">Efficacy</td> <td align="center" valign="middle" class="description-td style-scope patent-text">14,000</td> <td align="center" valign="middle" class="description-td style-scope patent-text">wild type</td> <td align="center" valign="middle" class="description-td style-scope patent-text">wild type</td> </tr> <tr class="description-tr style-scope patent-text"> <td align="center" valign="middle" class="description-td style-scope patent-text">LXFA 623</td> <td align="center" valign="middle" class="description-td style-scope patent-text">Efficacy</td> <td align="center" valign="middle" class="description-td style-scope patent-text">14,000</td> <td align="center" valign="middle" class="description-td style-scope patent-text">wild type</td> <td align="center" valign="middle" class="description-td style-scope patent-text">wild type</td> </tr> <tr class="description-tr style-scope patent-text"> <td align="center" valign="middle" class="description-td style-scope patent-text">LXFA 1041</td> <td align="center" valign="middle" class="description-td style-scope patent-text">NO</td> <td align="center" valign="middle" class="description-td style-scope patent-text">12,390</td> <td align="center" valign="middle" class="description-td style-scope patent-text">Mutation (G12V)</td> <td align="center" valign="middle" class="description-td style-scope patent-text">wild type</td> </tr> <tr class="description-tr style-scope patent-text"> <td align="center" valign="middle" class="description-td style-scope patent-text">LXFA 923</td> <td align="center" valign="middle" class="description-td style-scope patent-text">NO</td> <td align="center" valign="middle" class="description-td style-scope patent-text">12,250</td> <td align="center" valign="middle" class="description-td style-scope patent-text">Mutation (G12C)</td> <td align="center" valign="middle" class="description-td style-scope patent-text">wild type</td> </tr> <tr class="description-tr style-scope patent-text"> <td align="center" valign="middle" class="description-td style-scope patent-text">LXFA 1848</td> <td align="center" valign="middle" class="description-td style-scope patent-text">NO</td> <td align="center" valign="middle" class="description-td style-scope patent-text">12,150</td> <td align="center" valign="middle" class="description-td style-scope patent-text">Mutation (Q61H)</td> <td align="center" valign="middle" class="description-td style-scope patent-text">wild type</td> </tr> <tr class="description-tr style-scope patent-text"> <td align="center" valign="middle" class="description-td style-scope patent-text">LXFA 677</td> <td align="center" valign="middle" class="description-td style-scope patent-text">NO</td> <td align="center" valign="middle" class="description-td style-scope patent-text">12,060</td> <td align="center" valign="middle" class="description-td style-scope patent-text">wild type</td> <td align="center" valign="middle" class="description-td style-scope patent-text">Mutation (D594A)</td> </tr> <tr class="description-tr style-scope patent-text"> <td align="center" valign="middle" class="description-td style-scope patent-text">LXFA 983</td> <td align="center" valign="middle" class="description-td style-scope patent-text">NO</td> <td align="center" valign="middle" class="description-td style-scope patent-text">12,000</td> <td align="center" valign="middle" class="description-td style-scope patent-text">Mutation (G12C)</td> <td align="center" valign="middle" class="description-td style-scope patent-text">wild type</td> </tr>  </tbody></table> </patent-tables> </tables> </div>
    </li> <li class="style-scope patent-text"> <para-num num="[0236]" class="style-scope patent-text">
    
    [0236]
  </para-num> <div id="p0236" num="0236" class="description-line style-scope patent-text">As can be seen in Table 6, when one or more mutations are present in K-RAS or B-RAF, the anti-c-Met antibody is not allowed to sufficiently its activity in spite of a high expression level of c-Met (e.g., LXFA 2201). This indicates that the presence or absence of mutations in K-RAS or B-RAF is a critical factor to predicting the efficacy of the anti-c-Met antibody.</div>
    </li> <heading id="h0055" class="style-scope patent-text"> <b class="style-scope patent-text">4.2. Assay for predicting efficacy of anti-c-Met antibody in cancer cell line using RAS-RAF mutation</b> (<i class="style-scope patent-text">in vitro</i>)</heading>
    <heading id="h0056" class="style-scope patent-text">
      <b class="style-scope patent-text">4.2.1. Preparation of cancer cell line</b>
    </heading>
    <li class="style-scope patent-text"> <para-num num="[0237]" class="style-scope patent-text">
    
    [0237]
  </para-num> <div id="p0237" num="0237" class="description-line style-scope patent-text">NCI-H441 (HTB-114), NCI-H1993 (CRL-5909), NCI-H1373 (CRL-5866), A549 (CCL-185), HCC827 (CRL-2868), and EBC-1 (Accession No. JCRB0820) cells were seeded at a density of 1x10<sup class="style-scope patent-text">4</sup> cells/well to plates and incubated with the antibody L3-1Y/IgG2 (1 g/ml) for 72 hrs. Cell growth was compared between antibody-treated and untreated groups.</div>
    </li> <heading id="h0057" class="style-scope patent-text">
      <b class="style-scope patent-text">4.2.2. Examination of cancer cell-implanted mouse model for presence of RAS-RAF mutation and responsiveness to anti-c-Met antibody</b>
    </heading>
    <li class="style-scope patent-text"> <para-num num="[0238]" class="style-scope patent-text">
    
    [0238]
  </para-num> <div id="p0238" num="0238" class="description-line style-scope patent-text">The cancer cell lines were examined for the presence of mutations in K-RAS and B-RAF and responsiveness to anti-c-Met antibody.</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0239]" class="style-scope patent-text">
    
    [0239]
  </para-num> <div id="p0239" num="0239" class="description-line style-scope patent-text">Briefly, DNA isolated from the cancer cells was amplified using a Sequenom system including the primers to discriminate the wild-type from mutants. Mutations were detected mostly at G12V, G12C, and G12S for K-RAS, and at G596R and D594A for B-RAF.</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0240]" class="style-scope patent-text">
    
    [0240]
  </para-num> <div id="p0240" num="0240" class="description-line style-scope patent-text">Results are summarized in Table 7.
<tables id="tabl0007" num="0007" class="style-scope patent-text"> <patent-tables frame="all" class="style-scope patent-text">TABLE 7<table cols="4" class="description-table style-scope patent-text" width="100%"> <thead class="style-scope patent-text"> <tr class="description-tr style-scope patent-text"> <td valign="top" class="description-td style-scope patent-text">CELL LINE</td> <td valign="top" class="description-td style-scope patent-text">L3-1Y/IgG2 EFFICACY</td> <td valign="top" class="description-td style-scope patent-text">K-RAS mutation</td> <td valign="top" class="description-td style-scope patent-text">B-RAF mutation</td> </tr> </thead>  <tbody class="style-scope patent-text"><tr class="description-tr style-scope patent-text"> <td class="description-td style-scope patent-text">*NCI-H441</td> <td class="description-td style-scope patent-text">X</td> <td class="description-td style-scope patent-text">Mutation (G12V)</td> <td class="description-td style-scope patent-text">wild type</td> </tr> <tr class="description-tr style-scope patent-text"> <td class="description-td style-scope patent-text">NCI-H1993</td> <td class="description-td style-scope patent-text">Efficacy</td> <td class="description-td style-scope patent-text">wild type</td> <td class="description-td style-scope patent-text">wild type</td> </tr> <tr class="description-tr style-scope patent-text"> <td class="description-td style-scope patent-text">NCI-H1373</td> <td class="description-td style-scope patent-text">X</td> <td class="description-td style-scope patent-text">Mutation (G12C)</td> <td class="description-td style-scope patent-text">N.A</td> </tr> <tr class="description-tr style-scope patent-text"> <td class="description-td style-scope patent-text">A549</td> <td class="description-td style-scope patent-text">X</td> <td class="description-td style-scope patent-text">Mutation (G12S)</td> <td class="description-td style-scope patent-text">N.A</td> </tr> <tr class="description-tr style-scope patent-text"> <td class="description-td style-scope patent-text">HCC827</td> <td class="description-td style-scope patent-text">Efficacy</td> <td class="description-td style-scope patent-text">wild type</td> <td class="description-td style-scope patent-text">wild type</td> </tr> <tr class="description-tr style-scope patent-text"> <td class="description-td style-scope patent-text">EBC1</td> <td class="description-td style-scope patent-text">Efficacy</td> <td class="description-td style-scope patent-text">wild type</td> <td class="description-td style-scope patent-text">wild type</td> </tr>  </tbody></table> <table cols="4" rowsep="0" class="description-table style-scope patent-text" width="100%"> <tbody class="style-scope patent-text"><tr class="description-tr style-scope patent-text"> <td namest="col1" nameend="col4" align="justify" class="description-td style-scope patent-text" colspan="4">(Efficacy: 30 % or higher inhibition relative to the control, N.A.: not available)</td> </tr>  </tbody></table> </patent-tables> </tables> </div>
    </li> <li class="style-scope patent-text"> <para-num num="[0241]" class="style-scope patent-text">
    
    [0241]
  </para-num> <div id="p0241" num="0241" class="description-line style-scope patent-text">As can be seen in Table 7, the anti-c-Met antibody can exert its anticancer activity in cancer models only when both K-RAS and B-RAF are wild-types.</div>
    </li> <heading id="h0058" class="style-scope patent-text">
      <b class="style-scope patent-text">Example 5: Prediction Accuracy of each Marker</b>
    </heading>
    <heading id="h0059" class="style-scope patent-text">
      <b class="style-scope patent-text">5.1. Test of in vivo efficacy of Antibody</b>
    </heading>
    <li class="style-scope patent-text"> <para-num num="[0242]" class="style-scope patent-text">
    
    [0242]
  </para-num> <div id="p0242" num="0242" class="description-line style-scope patent-text">Fourteen (14) mouse xenograft models, which were subjected to subcutaneously grafting of patient derived tumor tissues (Non-small cell lung cancer: NSCLC), were examined by Oncotest GmbH (Germany).</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0243]" class="style-scope patent-text">
    
    [0243]
  </para-num> <div id="p0243" num="0243" class="description-line style-scope patent-text">To each of the 14 mouse xenograft models, L3-1Y/IgG2 and empty vehicle (control) were administered, respectively, and the size of the tumor tissues was measured to determine the responsiveness to the antibody.</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0244]" class="style-scope patent-text">
    
    [0244]
  </para-num> <div id="p0244" num="0244" class="description-line style-scope patent-text">When the tumor size in the mouse xenograft models reaches 100 mm<sup class="style-scope patent-text">3</sup> or more, the mouse xenograft models were administered (iv) with L3-1Y/IgG2 (PBS buffer in case of control) at the amount of 5 mg/kg once a week for 6 weeks in total, and the tumor size reaches 2000 mm<sup class="style-scope patent-text">3</sup> or more, the experiment was stopped.</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0245]" class="style-scope patent-text">
    
    [0245]
  </para-num> <div id="p0245" num="0245" class="description-line style-scope patent-text">The tumor size (mm<sup class="style-scope patent-text">3</sup>) was calculated by the following formula: <maths id="math0001" num="" class="style-scope patent-text"> <math display="block" class="style-scope patent-text"> <mrow class="style-scope patent-text"> <mi mathvariant="normal" class="style-scope patent-text"> <figure-callout id="3" label="Tumor size mm" filenames="imgf0012.png,imgf0013.png" class="style-scope patent-text"><a title="Show image containing callout" class="style-scope figure-callout">Tumor size</a></figure-callout> </mi> <figure-callout id="3" label="Tumor size mm" filenames="imgf0012.png,imgf0013.png" class="style-scope patent-text"><a title="Show image containing callout" class="style-scope figure-callout"> <mspace width="1em" class="style-scope patent-text"> </mspace> <mfenced class="style-scope patent-text"> <msup class="style-scope patent-text"> <mi mathvariant="normal" class="style-scope patent-text">mm</mi> </msup> </mfenced> </a></figure-callout> <mfenced class="style-scope patent-text"> <msup class="style-scope patent-text"> <mi mathvariant="normal" class="style-scope patent-text"> </mi> <mn mathvariant="normal" class="style-scope patent-text">3</mn> </msup> </mfenced> <mo class="style-scope patent-text">=</mo> <mfenced separators="" class="style-scope patent-text"> <mi mathvariant="normal" class="style-scope patent-text">major axis</mi> <mo class="style-scope patent-text">*</mo> <mi mathvariant="normal" class="style-scope patent-text">minor axis</mi> <mo class="style-scope patent-text">*</mo> <mi mathvariant="normal" class="style-scope patent-text">minor axis</mi> </mfenced> <mo class="style-scope patent-text">*</mo> <mn mathvariant="normal" class="style-scope patent-text">1</mn> <mo class="style-scope patent-text">/</mo> <mn mathvariant="normal" class="style-scope patent-text">2</mn> </mrow> </math> <div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/83/a6/29/3c427e25695f59/imgb0004.png" class="style-scope patent-text"><img id="ib0004" file="imgb0004.tif" wi="101" he="6" img-content="math" img-format="tif" width="404" height="24" alt="Figure imgb0004" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/83/a6/29/3c427e25695f59/imgb0004.png"></a></div> </maths> </div>
    </li> <li class="style-scope patent-text"> <para-num num="[0246]" class="style-scope patent-text">
    
    [0246]
  </para-num> <div id="p0246" num="0246" class="description-line style-scope patent-text">The determination of responder (efficacy) group was conducted by ANOVA analysis where the hypothesis corresponding to p-value of 0.05 or less was excluded. That is, the hypothesis that the tumor size distribution is not changed in a drug(antibody)-administered group compared to non-administered group was subjected to ANOVA testing, and the group where p-value is more than 0.05 was determined as a non-responder (non-efficacy) group, and the group where p-value is 0.05 or less was determined as a responder (efficacy) group.</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0247]" class="style-scope patent-text">
    
    [0247]
  </para-num> <div id="p0247" num="0247" class="description-line style-scope patent-text">The obtained results for the responsiveness of the xenograft models to L3-1Y/IgG2 were summarized in Table 8:
<tables id="tabl0008" num="0008" class="style-scope patent-text"> <patent-tables frame="all" class="style-scope patent-text">[Table 8]<table cols="3" class="description-table style-scope patent-text" width="100%"> <thead class="style-scope patent-text"> <tr class="description-tr style-scope patent-text"> <td valign="top" class="description-td style-scope patent-text"> </td> <td valign="top" class="description-td style-scope patent-text">Responder (Efficacy) Group</td> <td valign="top" class="description-td style-scope patent-text">Non-Responder (Non-Efficacy) Group</td> </tr> </thead>  <tbody class="style-scope patent-text"><tr class="description-tr style-scope patent-text"> <td class="description-td style-scope patent-text">Samples</td> <td class="description-td style-scope patent-text">LXFA1647, LXFA2158, LXFA526, LXFA623</td> <td class="description-td style-scope patent-text">LXFA1041, LXFA677, LXFA1848, LXFA2201, LXFA289, LXFA297, LXFA400, LXFA749, LXFA923, LXFA983</td> </tr>  </tbody></table> </patent-tables> </tables> </div>
    </li> <heading id="h0060" class="style-scope patent-text">
      <b class="style-scope patent-text">5.2. Test of Prediction Accuracy to the Efficacy of the Antibody</b>
    </heading>
    <li class="style-scope patent-text"> <para-num num="[0248]" class="style-scope patent-text">
    
    [0248]
  </para-num> <div id="p0248" num="0248" class="description-line style-scope patent-text">To the 14 mouse xenograft models were subjected to following 7 tests (see Examples 5.2.1 to 5.2.7). In each test, the prediction accuracy, prediction sensitivity, and prediction specificity were calculated as follows: <maths id="math0002" num="" class="style-scope patent-text"> <math display="block" class="style-scope patent-text"> <mrow class="style-scope patent-text"> <mi class="style-scope patent-text">Prediction Accuracy</mi> <mfenced class="style-scope patent-text"> <mo class="style-scope patent-text">%</mo> </mfenced> <mo class="style-scope patent-text">=</mo> <mfenced open="[" close="]" separators="" class="style-scope patent-text"> <mfenced separators="" class="style-scope patent-text"> <mi class="style-scope patent-text">TP</mi> <mo class="style-scope patent-text">+</mo> <mi class="style-scope patent-text">TN</mi> </mfenced> <mo class="style-scope patent-text">/</mo> <mn class="style-scope patent-text">14</mn> </mfenced> <mo class="style-scope patent-text">*</mo> <mn class="style-scope patent-text">100</mn> </mrow> </math> <div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/c6/9f/eb/d2bb015b9204f8/imgb0005.png" class="style-scope patent-text"><img id="ib0005" file="imgb0005.tif" wi="74" he="5" img-content="math" img-format="tif" width="296" height="20" alt="Figure imgb0005" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/c6/9f/eb/d2bb015b9204f8/imgb0005.png"></a></div> </maths> <maths id="math0003" num="" class="style-scope patent-text"> <math display="block" class="style-scope patent-text"> <mrow class="style-scope patent-text"> <mi class="style-scope patent-text">Prediction Sensitivity</mi> <mfenced class="style-scope patent-text"> <mo class="style-scope patent-text">%</mo> </mfenced> <mo class="style-scope patent-text">=</mo> <mfenced separators="" class="style-scope patent-text"> <mi class="style-scope patent-text">TP</mi> <mo class="style-scope patent-text">/</mo> <mi class="style-scope patent-text">the number of antibody efficacy positive</mi> <mfenced class="style-scope patent-text"> <mi class="style-scope patent-text">responder</mi> </mfenced> <mi class="style-scope patent-text">models</mi> </mfenced> <mo class="style-scope patent-text">*</mo> <mn class="style-scope patent-text">100</mn> </mrow> </math> <div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/62/ce/41/f1d1cf4eb2dfc9/imgb0006.png" class="style-scope patent-text"><img id="ib0006" file="imgb0006.tif" wi="153" he="12" img-content="math" img-format="tif" width="612" height="48" alt="Figure imgb0006" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/62/ce/41/f1d1cf4eb2dfc9/imgb0006.png"></a></div> </maths> <maths id="math0004" num="" class="style-scope patent-text"> <math display="block" class="style-scope patent-text"> <mrow class="style-scope patent-text"> <mi class="style-scope patent-text">Prediction Specificity</mi> <mfenced class="style-scope patent-text"> <mo class="style-scope patent-text">%</mo> </mfenced> <mo class="style-scope patent-text">=</mo> <mfenced separators="" class="style-scope patent-text"> <mi class="style-scope patent-text">TN</mi> <mo class="style-scope patent-text">/</mo> <mi class="style-scope patent-text">the number of antibody efficacy negative</mi> <mfenced separators="" class="style-scope patent-text"> <mi class="style-scope patent-text">non</mi> <mo class="style-scope patent-text"></mo> <mi class="style-scope patent-text">responder</mi> </mfenced> <mi class="style-scope patent-text">models</mi> </mfenced> <mo class="style-scope patent-text">*</mo> <mn class="style-scope patent-text">100</mn> </mrow> </math> <div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/3c/3b/e9/c0a4c814448bb9/imgb0007.png" class="style-scope patent-text"><img id="ib0007" file="imgb0007.tif" wi="153" he="13" img-content="math" img-format="tif" width="612" height="52" alt="Figure imgb0007" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/3c/3b/e9/c0a4c814448bb9/imgb0007.png"></a></div> </maths> </div>
    </li> <li class="style-scope patent-text"> <para-num num="[0249]" class="style-scope patent-text">
    
    [0249]
  </para-num> <div id="p0249" num="0249" class="description-line style-scope patent-text">[TP (true positive): the number of models that are determined as being efficacy positive in both antibody efficacy test (Example 5.2) and each test (one of Examples 5.2.1 to 5.2.7); and</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0250]" class="style-scope patent-text">
    
    [0250]
  </para-num> <div id="p0250" num="0250" class="description-line style-scope patent-text">TN (true negative): the number of models that are determined as being efficacy negative in both antibody efficacy test (Example 5.2) and each test (one of Examples 5.2.1 to 5.2.7)]</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0251]" class="style-scope patent-text">
    
    [0251]
  </para-num> <div id="p0251" num="0251" class="description-line style-scope patent-text">The results of 7 tests are shown in Table 9 as below, wherein:
</div> </li> <ul class="style-scope patent-text"> <li class="style-scope patent-text">TP (true positive) refers to the case that is determined as being efficacy positive in both antibody efficacy test (Example 5.2) and each test (one of Examples 5.2.1 to 5.2.7);</li> <li class="style-scope patent-text">TN (true negative) refers to the case that is determined as being efficacy negative in both antibody efficacy test (Example 5.2) and each test (one of Examples 5.2.1 to 5.2.7);</li> <li class="style-scope patent-text">FP (false positive) refers to the case that is determined as being efficacy negative in antibody efficacy test (Example 5.2) but efficacy positive in each test (one of Examples 5.2.1 to 5.2.7); and</li> <li class="style-scope patent-text">FN (false negative) refers to the case that is determined as being efficacy positive in antibody efficacy test (Example 5.2) but efficacy negative in each test (one of Examples 5.2.1 to 5.2.7).</li> </ul>
    <heading id="h0061" class="style-scope patent-text">
      <b class="style-scope patent-text">5.2.1. c-Met IHC: Ventana (Comparison Example)</b>
    </heading>
    <li class="style-scope patent-text"> <para-num num="[0252]" class="style-scope patent-text">
    
    [0252]
  </para-num> <div id="p0252" num="0252" class="description-line style-scope patent-text">The mouse tumor tissues that have been subject to the experiment of Example 5.1 were extracted, and a part of them was used in preparing a formalin fixed paraffin embedded (FFPE) block. The prepared FFPE block was used for measuring the level of surface expression c-MET by Ventana MET IHC (immunohistochemistry) (using sp44 (Ventana, Catalog Number 790-4430), which is an assay used for a clinical trial (phase III) of metmab (Genentech); see <a id="pcit0002" dnum="US2013089541A1" class="patcit style-scope patent-text" href="/patent/US20130089541"> <text class="style-scope patent-text">US2013089541 A1</text> </a>) according to a standard protocol of the manufacturer.</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0253]" class="style-scope patent-text">
    
    [0253]
  </para-num> <div id="p0253" num="0253" class="description-line style-scope patent-text">The case, where the IHC score according to the Ventana MET IHC assay is 23, was determined as a responder (efficacy or positive) group.</div>
    </li> <heading id="h0062" class="style-scope patent-text">
      <b class="style-scope patent-text">5.2.2. Efficacy Prediction using a modified c-Met IHC</b>
    </heading>
    <li class="style-scope patent-text"> <para-num num="[0254]" class="style-scope patent-text">
    
    [0254]
  </para-num> <div id="p0254" num="0254" class="description-line style-scope patent-text">A modified Ventana MET IHC assay was performed, wherein the assay was identical to the Ventana MET IHC described Example 5.2.1, except that the Ventana antibody sp44 was used by 5/6 dilution. The case, where the IHC score according the modified Ventana MET IHC assay is 23, was determined as a responder (efficacy or positive) group.</div>
    </li> <heading id="h0063" class="style-scope patent-text">
      <b class="style-scope patent-text">5.2.3. Efficacy Prediction using IL-8</b>
    </heading>
    <li class="style-scope patent-text"> <para-num num="[0255]" class="style-scope patent-text">
    
    [0255]
  </para-num> <div id="p0255" num="0255" class="description-line style-scope patent-text">The level of IL-8 in serum of each mouse xenograft model was quantified referring to Examples 1.1.2. The case, where the level of serum IL-8 is 500 pg/ml or more, was determined as a responder (efficacy or positive) group, and the case, where the level of serum IL-8 is less than 500 pg/ml, was determined as a non-responder (non-efficacy or negative) group.</div>
    </li> <heading id="h0064" class="style-scope patent-text">
      <b class="style-scope patent-text">5.2.4. Combination I (Examples 5.2.2 and 5.2.3)</b>
    </heading>
    <li class="style-scope patent-text"> <para-num num="[0256]" class="style-scope patent-text">
    
    [0256]
  </para-num> <div id="p0256" num="0256" class="description-line style-scope patent-text">The results from Example 5.2.2 (efficacy prediction by the modified Ventana MET IHC) and Example 5.2.3(efficacy prediction using IL-8) were combined to predict the efficacy of anti-c-Met antibody L3-1Y/IgG2. In particular, the case, where the IHC score according to the modified Ventana MET IHC assay of Example 5.2.2 is 23 and the serum IL-8 level according to Example 5.2.3 is 500 pg/ml or more, was determined as a responder (efficacy or positive) group, and the other case was determined as a non-responder (non-efficacy or negative) group.</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0257]" class="style-scope patent-text">
    
    [0257]
  </para-num> <div id="p0257" num="0257" class="description-line style-scope patent-text">The results from Examples 5.2.1, 5.2.2, 5.2.3, and 5.2.4 are summarized in Table 9, as below:
<tables id="tabl0009" num="0009" class="style-scope patent-text"> <patent-tables frame="all" class="style-scope patent-text">[Table 9]<figure-callout id="3" label="TP TP" filenames="imgf0012.png,imgf0013.png" class="style-scope patent-text"><a title="Show image containing callout" class="style-scope figure-callout"> </a></figure-callout><figure-callout id="4" label="TP TP" filenames="imgf0003.png,imgf0004.png" class="style-scope patent-text"><a title="Show image containing callout" class="style-scope figure-callout"> </a></figure-callout><figure-callout id="1" label="TP TP" filenames="imgf0003.png,imgf0006.png" class="style-scope patent-text"><a title="Show image containing callout" class="style-scope figure-callout"> </a></figure-callout><figure-callout id="2" label="FP TN" filenames="imgf0012.png,imgf0013.png" class="style-scope patent-text"><a title="Show image containing callout" class="style-scope figure-callout"> </a></figure-callout><figure-callout id="3" label="TP TP" filenames="imgf0012.png,imgf0013.png" class="style-scope patent-text"><a title="Show image containing callout" class="style-scope figure-callout"> </a></figure-callout><figure-callout id="4" label="FP FP" filenames="imgf0003.png,imgf0004.png" class="style-scope patent-text"><a title="Show image containing callout" class="style-scope figure-callout"> </a></figure-callout><figure-callout id="6" label="FP TN" filenames="imgf0011.png" class="style-scope patent-text"><a title="Show image containing callout" class="style-scope figure-callout"> </a></figure-callout><figure-callout id="7" label="FP FP" filenames="imgf0001.png,imgf0002.png" class="style-scope patent-text"><a title="Show image containing callout" class="style-scope figure-callout"> </a></figure-callout><figure-callout id="100" label="% Prediction sensitivity" filenames="imgf0004.png,imgf0024.png" class="style-scope patent-text"><a title="Show image containing callout" class="style-scope figure-callout"> </a></figure-callout><figure-callout id="100" label="% Prediction sensitivity" filenames="imgf0004.png,imgf0024.png" class="style-scope patent-text"><a title="Show image containing callout" class="style-scope figure-callout"> </a></figure-callout><figure-callout id="0" label="% Prediction specificity" filenames="imgf0002.png,imgf0006.png" class="style-scope patent-text"><a title="Show image containing callout" class="style-scope figure-callout"> </a></figure-callout><figure-callout id="0" label="% Prediction specificity" filenames="imgf0002.png,imgf0006.png" class="style-scope patent-text"><a title="Show image containing callout" class="style-scope figure-callout"> </a></figure-callout><table cols="10" class="description-table style-scope patent-text" width="100%"> <thead class="style-scope patent-text"> <tr class="description-tr style-scope patent-text"> <td namest="col1" nameend="col2" align="center" valign="middle" class="description-td style-scope patent-text" colspan="2"> </td> <td align="center" valign="middle" class="description-td style-scope patent-text"> </td> <td namest="col4" nameend="col7" align="center" valign="middle" class="description-td style-scope patent-text" colspan="4"> <b class="style-scope patent-text">c-Met IHC</b> </td> <td namest="col8" nameend="col9" align="center" valign="middle" class="description-td style-scope patent-text" colspan="2"> <b class="style-scope patent-text">Serum IL-8</b> </td> <td align="center" valign="middle" class="description-td style-scope patent-text"> <b class="style-scope patent-text">Combined</b> </td> </tr> <tr class="description-tr style-scope patent-text"> <td align="center" valign="middle" class="description-td style-scope patent-text">No</td> <td align="center" valign="middle" class="description-td style-scope patent-text">Model Name</td> <td align="center" valign="middle" class="description-td style-scope patent-text">in <figure-callout id="1" label="vivo efficacy" filenames="imgf0003.png,imgf0006.png" class="style-scope patent-text"><a title="Show image containing callout" class="style-scope figure-callout">vivo efficacy</a></figure-callout> </td> <td namest="col4" nameend="col5" align="center" valign="middle" class="description-td style-scope patent-text" colspan="2">1. Ventana (standard: 2+)</td> <td namest="col6" nameend="col7" align="center" valign="middle" class="description-td style-scope patent-text" colspan="2">2. Modified SAIT method (standard: 2+)</td> <td namest="col8" nameend="col9" align="center" valign="middle" class="description-td style-scope patent-text" colspan="2">3. serum level of IL-8 (vehicle group) (pg/mL) (standard: 500pg/mL or more)</td> <td align="center" valign="middle" class="description-td style-scope patent-text">4. Combined (modified <figure-callout id="2" label="Ventana" filenames="imgf0012.png,imgf0013.png" class="style-scope patent-text"><a title="Show image containing callout" class="style-scope figure-callout">Ventana</a></figure-callout> 2+ AND IL-8 500pg/mL or more)</td> </tr> </thead>  <tbody class="style-scope patent-text"><tr class="description-tr style-scope patent-text"> <td align="center" valign="middle" class="description-td style-scope patent-text">1</td> <td align="center" valign="middle" class="description-td style-scope patent-text">LXFA297</td> <td align="center" valign="middle" class="description-td style-scope patent-text">(-)</td> <td align="center" valign="middle" class="description-td style-scope patent-text">3</td> <td valign="middle" class="description-td style-scope patent-text"> <figure-callout id="1" label="FP" filenames="imgf0003.png,imgf0006.png" class="style-scope patent-text"><a title="Show image containing callout" class="style-scope figure-callout">FP</a></figure-callout> </td> <td align="center" valign="middle" class="description-td style-scope patent-text">1</td> <td align="center" valign="middle" class="description-td style-scope patent-text">TN<sup class="style-scope patent-text">*</sup> </td> <td align="center" valign="bottom" class="description-td style-scope patent-text">250.96</td> <td align="center" valign="middle" class="description-td style-scope patent-text">TN<sup class="style-scope patent-text">*</sup> </td> <td align="center" valign="middle" class="description-td style-scope patent-text">TN</td> </tr> <tr class="description-tr style-scope patent-text"> <td align="center" valign="middle" class="description-td style-scope patent-text">2</td> <td align="center" valign="middle" class="description-td style-scope patent-text">LXFA526</td> <td align="center" valign="middle" class="description-td style-scope patent-text">moderate</td> <td align="center" valign="middle" class="description-td style-scope patent-text">3</td> <td align="center" valign="middle" class="description-td style-scope patent-text"> <figure-callout id="3" label="TP" filenames="imgf0012.png,imgf0013.png" class="style-scope patent-text"><a title="Show image containing callout" class="style-scope figure-callout">TP</a></figure-callout> </td> <td align="center" valign="middle" class="description-td style-scope patent-text">3</td> <td align="center" valign="middle" class="description-td style-scope patent-text">TP</td> <td align="center" valign="bottom" class="description-td style-scope patent-text">980.36</td> <td align="center" valign="middle" class="description-td style-scope patent-text"> <figure-callout id="3" label="TP TP" filenames="imgf0012.png,imgf0013.png" class="style-scope patent-text"><a title="Show image containing callout" class="style-scope figure-callout">TP</a></figure-callout> </td> <td align="center" valign="middle" class="description-td style-scope patent-text">TP</td>  <td align="center" valign="middle" class="description-td style-scope patent-text"> </td> </tr> <tr class="description-tr style-scope patent-text"> <td align="center" valign="middle" class="description-td style-scope patent-text">3</td> <td align="center" valign="middle" class="description-td style-scope patent-text">LXFA623</td> <td align="center" valign="middle" class="description-td style-scope patent-text">excellent</td> <td align="center" valign="middle" class="description-td style-scope patent-text">3</td> <td align="center" valign="middle" class="description-td style-scope patent-text"> <figure-callout id="3" label="TP" filenames="imgf0012.png,imgf0013.png" class="style-scope patent-text"><a title="Show image containing callout" class="style-scope figure-callout">TP</a></figure-callout> </td> <td align="center" valign="middle" class="description-td style-scope patent-text">3</td> <td align="center" valign="middle" class="description-td style-scope patent-text">TP</td> <td align="center" valign="bottom" class="description-td style-scope patent-text">22316.88</td> <td align="center" valign="middle" class="description-td style-scope patent-text"> <figure-callout id="4" label="TP TP" filenames="imgf0003.png,imgf0004.png" class="style-scope patent-text"><a title="Show image containing callout" class="style-scope figure-callout">TP</a></figure-callout> </td> <td align="center" valign="middle" class="description-td style-scope patent-text">TP</td>  <td align="center" valign="middle" class="description-td style-scope patent-text"> </td> </tr> <tr class="description-tr style-scope patent-text"> <td align="center" valign="middle" class="description-td style-scope patent-text">4</td> <td align="center" valign="middle" class="description-td style-scope patent-text">LXFA983</td> <td align="center" valign="middle" class="description-td style-scope patent-text">(-)</td> <td align="center" valign="middle" class="description-td style-scope patent-text">3</td> <td valign="middle" class="description-td style-scope patent-text"> <figure-callout id="1" label="FP" filenames="imgf0003.png,imgf0006.png" class="style-scope patent-text"><a title="Show image containing callout" class="style-scope figure-callout">FP</a></figure-callout> </td> <td align="center" valign="middle" class="description-td style-scope patent-text">1</td> <td align="center" valign="middle" class="description-td style-scope patent-text">TN<sup class="style-scope patent-text">*</sup> </td> <td align="center" valign="bottom" class="description-td style-scope patent-text">147.4</td> <td align="center" valign="middle" class="description-td style-scope patent-text">TN<sup class="style-scope patent-text">*</sup> </td> <td align="center" valign="middle" class="description-td style-scope patent-text">TN</td> </tr> <tr class="description-tr style-scope patent-text"> <td align="center" valign="middle" class="description-td style-scope patent-text">5</td> <td align="center" valign="middle" class="description-td style-scope patent-text">LXFA1041</td> <td align="center" valign="middle" class="description-td style-scope patent-text">(-)</td> <td align="center" valign="middle" class="description-td style-scope patent-text">3</td> <td valign="middle" class="description-td style-scope patent-text"> <figure-callout id="1" label="FP" filenames="imgf0003.png,imgf0006.png" class="style-scope patent-text"><a title="Show image containing callout" class="style-scope figure-callout">FP</a></figure-callout> </td> <td align="center" valign="middle" class="description-td style-scope patent-text">1</td> <td align="center" valign="middle" class="description-td style-scope patent-text">TN<sup class="style-scope patent-text">*</sup> </td> <td align="center" valign="bottom" class="description-td style-scope patent-text">317.6</td> <td align="center" valign="middle" class="description-td style-scope patent-text">TN<sup class="style-scope patent-text">*</sup> </td> <td align="center" valign="middle" class="description-td style-scope patent-text">TN</td> </tr> <tr class="description-tr style-scope patent-text"> <td align="center" valign="middle" class="description-td style-scope patent-text">6</td> <td align="center" valign="middle" class="description-td style-scope patent-text">LXFA1647</td> <td align="center" valign="middle" class="description-td style-scope patent-text">excellent</td> <td align="center" valign="middle" class="description-td style-scope patent-text">3</td> <td align="center" valign="middle" class="description-td style-scope patent-text"> <figure-callout id="3" label="TP" filenames="imgf0012.png,imgf0013.png" class="style-scope patent-text"><a title="Show image containing callout" class="style-scope figure-callout">TP</a></figure-callout> </td> <td align="center" valign="middle" class="description-td style-scope patent-text">3</td> <td align="center" valign="middle" class="description-td style-scope patent-text">TP</td> <td align="center" valign="bottom" class="description-td style-scope patent-text">962.88</td> <td align="center" valign="middle" class="description-td style-scope patent-text"> <figure-callout id="1" label="TP TP" filenames="imgf0003.png,imgf0006.png" class="style-scope patent-text"><a title="Show image containing callout" class="style-scope figure-callout">TP</a></figure-callout> </td> <td align="center" valign="middle" class="description-td style-scope patent-text">TP</td>  <td align="center" valign="middle" class="description-td style-scope patent-text"> </td> </tr> <tr class="description-tr style-scope patent-text"> <td align="center" valign="middle" class="description-td style-scope patent-text">1</td> <td align="center" valign="middle" class="description-td style-scope patent-text">LXFA1848</td> <td align="center" valign="middle" class="description-td style-scope patent-text">(-)</td> <td align="center" valign="middle" class="description-td style-scope patent-text">3</td> <td valign="middle" class="description-td style-scope patent-text"> <figure-callout id="1" label="FP" filenames="imgf0003.png,imgf0006.png" class="style-scope patent-text"><a title="Show image containing callout" class="style-scope figure-callout">FP</a></figure-callout> </td> <td align="center" valign="middle" class="description-td style-scope patent-text">1</td> <td align="center" valign="middle" class="description-td style-scope patent-text">TN<sup class="style-scope patent-text">*</sup> </td> <td align="center" valign="bottom" class="description-td style-scope patent-text">668.88</td> <td valign="middle" class="description-td style-scope patent-text"> <figure-callout id="2" label="FP TN" filenames="imgf0012.png,imgf0013.png" class="style-scope patent-text"><a title="Show image containing callout" class="style-scope figure-callout">FP</a></figure-callout> </td> <td align="center" valign="middle" class="description-td style-scope patent-text">TN</td>  <td align="center" valign="middle" class="description-td style-scope patent-text"> </td> </tr> <tr class="description-tr style-scope patent-text"> <td align="center" valign="middle" class="description-td style-scope patent-text">2</td> <td align="center" valign="middle" class="description-td style-scope patent-text">LXFA2158</td> <td align="center" valign="middle" class="description-td style-scope patent-text">excellent</td> <td align="center" valign="middle" class="description-td style-scope patent-text">3</td> <td align="center" valign="middle" class="description-td style-scope patent-text"> <figure-callout id="3" label="TP" filenames="imgf0012.png,imgf0013.png" class="style-scope patent-text"><a title="Show image containing callout" class="style-scope figure-callout">TP</a></figure-callout> </td> <td align="center" valign="middle" class="description-td style-scope patent-text">3</td> <td align="center" valign="middle" class="description-td style-scope patent-text">TP</td> <td align="center" valign="bottom" class="description-td style-scope patent-text">1921.76</td> <td align="center" valign="middle" class="description-td style-scope patent-text"> <figure-callout id="3" label="TP TP" filenames="imgf0012.png,imgf0013.png" class="style-scope patent-text"><a title="Show image containing callout" class="style-scope figure-callout">TP</a></figure-callout> </td> <td align="center" valign="middle" class="description-td style-scope patent-text">TP</td>  <td align="center" valign="middle" class="description-td style-scope patent-text"> </td> </tr> <tr class="description-tr style-scope patent-text"> <td align="center" valign="middle" class="description-td style-scope patent-text">3</td> <td align="center" valign="middle" class="description-td style-scope patent-text">LXFA2201</td> <td align="center" valign="middle" class="description-td style-scope patent-text">(-)</td> <td align="center" valign="middle" class="description-td style-scope patent-text">3</td> <td valign="middle" class="description-td style-scope patent-text"> <figure-callout id="3" label="FP" filenames="imgf0012.png,imgf0013.png" class="style-scope patent-text"><a title="Show image containing callout" class="style-scope figure-callout">FP</a></figure-callout> </td> <td align="center" valign="middle" class="description-td style-scope patent-text">3</td> <td valign="middle" class="description-td style-scope patent-text">FP</td> <td align="center" valign="bottom" class="description-td style-scope patent-text">1100.56</td> <td valign="middle" class="description-td style-scope patent-text"> <figure-callout id="4" label="FP FP" filenames="imgf0003.png,imgf0004.png" class="style-scope patent-text"><a title="Show image containing callout" class="style-scope figure-callout">FP</a></figure-callout> </td> <td valign="middle" class="description-td style-scope patent-text">FP</td>  <td valign="middle" class="description-td style-scope patent-text"> </td> </tr> <tr class="description-tr style-scope patent-text"> <td align="center" valign="middle" class="description-td style-scope patent-text">4</td> <td align="center" valign="middle" class="description-td style-scope patent-text">LXFA289</td> <td align="center" valign="middle" class="description-td style-scope patent-text">(-)</td> <td align="center" valign="middle" class="description-td style-scope patent-text">3</td> <td valign="middle" class="description-td style-scope patent-text"> <figure-callout id="2" label="FP" filenames="imgf0012.png,imgf0013.png" class="style-scope patent-text"><a title="Show image containing callout" class="style-scope figure-callout">FP</a></figure-callout> </td> <td align="center" valign="middle" class="description-td style-scope patent-text">2</td> <td valign="middle" class="description-td style-scope patent-text">FP</td> <td align="center" valign="bottom" class="description-td style-scope patent-text">444.64</td> <td align="center" valign="middle" class="description-td style-scope patent-text">TN<sup class="style-scope patent-text">*</sup> </td> <td align="center" valign="middle" class="description-td style-scope patent-text">TN<sup class="style-scope patent-text">**</sup> </td> </tr> <tr class="description-tr style-scope patent-text"> <td align="center" valign="middle" class="description-td style-scope patent-text">5</td> <td align="center" valign="middle" class="description-td style-scope patent-text">LXFA400</td> <td align="center" valign="middle" class="description-td style-scope patent-text">(-)</td> <td align="center" valign="middle" class="description-td style-scope patent-text">2</td> <td valign="middle" class="description-td style-scope patent-text"> <figure-callout id="1" label="FP" filenames="imgf0003.png,imgf0006.png" class="style-scope patent-text"><a title="Show image containing callout" class="style-scope figure-callout">FP</a></figure-callout> </td> <td align="center" valign="middle" class="description-td style-scope patent-text">1</td> <td align="center" valign="middle" class="description-td style-scope patent-text">TN<sup class="style-scope patent-text">*</sup> </td> <td align="center" valign="middle" class="description-td style-scope patent-text">1203.32</td> <td valign="middle" class="description-td style-scope patent-text"> <figure-callout id="6" label="FP TN" filenames="imgf0011.png" class="style-scope patent-text"><a title="Show image containing callout" class="style-scope figure-callout">FP</a></figure-callout> </td> <td align="center" valign="middle" class="description-td style-scope patent-text">TN</td>  <td align="center" valign="middle" class="description-td style-scope patent-text"> </td> </tr> <tr class="description-tr style-scope patent-text"> <td align="center" valign="middle" class="description-td style-scope patent-text">6</td> <td align="center" valign="middle" class="description-td style-scope patent-text">LXFA677</td> <td align="center" valign="middle" class="description-td style-scope patent-text">(-)</td> <td align="center" valign="middle" class="description-td style-scope patent-text">3</td> <td valign="middle" class="description-td style-scope patent-text"> <figure-callout id="2" label="FP" filenames="imgf0012.png,imgf0013.png" class="style-scope patent-text"><a title="Show image containing callout" class="style-scope figure-callout">FP</a></figure-callout> </td> <td align="center" valign="middle" class="description-td style-scope patent-text">2</td> <td valign="middle" class="description-td style-scope patent-text">FP</td> <td align="center" valign="middle" class="description-td style-scope patent-text">607.08</td> <td valign="middle" class="description-td style-scope patent-text"> <figure-callout id="7" label="FP FP" filenames="imgf0001.png,imgf0002.png" class="style-scope patent-text"><a title="Show image containing callout" class="style-scope figure-callout">FP</a></figure-callout> </td> <td valign="middle" class="description-td style-scope patent-text">FP</td>  <td valign="middle" class="description-td style-scope patent-text"> </td> </tr> <tr class="description-tr style-scope patent-text"> <td align="center" valign="middle" class="description-td style-scope patent-text">7</td> <td align="center" valign="middle" class="description-td style-scope patent-text">LXFA749</td> <td align="center" valign="middle" class="description-td style-scope patent-text">(-)</td> <td align="center" valign="middle" class="description-td style-scope patent-text">3</td> <td valign="middle" class="description-td style-scope patent-text"> <figure-callout id="2" label="FP" filenames="imgf0012.png,imgf0013.png" class="style-scope patent-text"><a title="Show image containing callout" class="style-scope figure-callout">FP</a></figure-callout> </td> <td align="center" valign="middle" class="description-td style-scope patent-text">2</td> <td valign="middle" class="description-td style-scope patent-text"> <figure-callout id="0" label="FP" filenames="imgf0002.png,imgf0006.png" class="style-scope patent-text"><a title="Show image containing callout" class="style-scope figure-callout">FP</a></figure-callout> </td> <td align="center" valign="middle" class="description-td style-scope patent-text">0</td> <td align="center" valign="middle" class="description-td style-scope patent-text">TN<sup class="style-scope patent-text">*</sup> </td> <td align="center" valign="middle" class="description-td style-scope patent-text">TN<sup class="style-scope patent-text">**</sup> </td> </tr> <tr class="description-tr style-scope patent-text"> <td align="center" valign="middle" class="description-td style-scope patent-text">8</td> <td align="center" valign="middle" class="description-td style-scope patent-text">LXFA923</td> <td align="center" valign="middle" class="description-td style-scope patent-text">(-)</td> <td align="center" valign="middle" class="description-td style-scope patent-text">3</td> <td valign="middle" class="description-td style-scope patent-text"> <figure-callout id="2" label="FP" filenames="imgf0012.png,imgf0013.png" class="style-scope patent-text"><a title="Show image containing callout" class="style-scope figure-callout">FP</a></figure-callout> </td> <td align="center" valign="middle" class="description-td style-scope patent-text">2</td> <td valign="middle" class="description-td style-scope patent-text">FP</td> <td align="center" valign="middle" class="description-td style-scope patent-text">138.6</td> <td align="center" valign="middle" class="description-td style-scope patent-text">TN<sup class="style-scope patent-text">*</sup> </td> <td align="center" valign="middle" class="description-td style-scope patent-text">TN<sup class="style-scope patent-text">**</sup> </td> </tr> <tr class="description-tr style-scope patent-text"> <td namest="col1" nameend="col3" align="center" valign="middle" class="description-td style-scope patent-text" colspan="3">Prediction accuracy</td> <td namest="col4" nameend="col5" align="center" valign="middle" class="description-td style-scope patent-text" colspan="2">28.57%</td> <td namest="col6" nameend="col7" align="center" valign="middle" class="description-td style-scope patent-text" colspan="2">64.29%</td> <td namest="col8" nameend="col9" align="center" valign="middle" class="description-td style-scope patent-text" colspan="2">71.43%</td> <td align="center" valign="middle" class="description-td style-scope patent-text">85.71<figure-callout id="100" label="% Prediction sensitivity" filenames="imgf0004.png,imgf0024.png" class="style-scope patent-text"><a title="Show image containing callout" class="style-scope figure-callout">%</a></figure-callout> </td>  </tr> <tr class="description-tr style-scope patent-text"> <td namest="col1" nameend="col3" align="center" valign="middle" class="description-td style-scope patent-text" colspan="3">Prediction sensitivity</td> </tr>  <tr class="description-tr style-scope patent-text"> <td namest="col1" nameend="col3" align="center" valign="middle" class="description-td style-scope patent-text" colspan="3"> </td> <td namest="col4" nameend="col5" align="center" valign="middle" class="description-td style-scope patent-text" colspan="2">100%</td> <td namest="col6" nameend="col7" align="center" valign="middle" class="description-td style-scope patent-text" colspan="2">100%</td> <td namest="col8" nameend="col9" align="center" valign="middle" class="description-td style-scope patent-text" colspan="2">100%</td> <td align="center" valign="middle" class="description-td style-scope patent-text">100<figure-callout id="0" label="% Prediction specificity" filenames="imgf0002.png,imgf0006.png" class="style-scope patent-text"><a title="Show image containing callout" class="style-scope figure-callout">%</a></figure-callout> </td>  </tr> <tr class="description-tr style-scope patent-text"> <td namest="col1" nameend="col3" align="center" valign="middle" class="description-td style-scope patent-text" colspan="3">Prediction specificity</td> </tr>  <tr class="description-tr style-scope patent-text"> <td namest="col1" nameend="col3" align="center" valign="middle" class="description-td style-scope patent-text" colspan="3"> </td> <td namest="col4" nameend="col5" align="center" valign="middle" class="description-td style-scope patent-text" colspan="2">0%</td> <td namest="col6" nameend="col7" align="center" valign="middle" class="description-td style-scope patent-text" colspan="2">50%</td> <td namest="col8" nameend="col9" align="center" valign="middle" class="description-td style-scope patent-text" colspan="2">60%</td> <td align="center" valign="middle" class="description-td style-scope patent-text">80%</td> </tr>  </tbody></table> <table cols="10" rowsep="0" class="description-table style-scope patent-text" width="100%"> <tbody class="style-scope patent-text"><tr class="description-tr style-scope patent-text"> <td namest="col1" nameend="col10" align="justify" class="description-td style-scope patent-text" colspan="10">(<sup class="style-scope patent-text">*</sup>: improved accuracy compared to "1"; sand<sup class="style-scope patent-text">**</sup>: improved accuracy compared to "2")</td> </tr>  </tbody></table> </patent-tables> </tables> </div>
    </li> <heading id="h0065" class="style-scope patent-text">
      <b class="style-scope patent-text">5.2.5. Efficacy Prediction according to RAS-RAF mutation</b>
    </heading>
    <li class="style-scope patent-text"> <para-num num="[0258]" class="style-scope patent-text">
    
    [0258]
  </para-num> <div id="p0258" num="0258" class="description-line style-scope patent-text">The 14 mouse xenograft models were subject to the experiment according to Example 4.1.3, to examine the presence or absence of K-RAS and/or B-RAF mutation. The case, where both of K-RAS and B-RAF are wild-type, was determined as a responder (efficacy or positive) group, and the case, where at least one of K-RAS and B-RAF is mutated, was determined as a non-responder (non-efficacy or negative) group.</div>
    </li> <heading id="h0066" class="style-scope patent-text">
      <b class="style-scope patent-text">5.2.6. Combination II (Examples 5.2.3 and 5.2.5)</b>
    </heading>
    <li class="style-scope patent-text"> <para-num num="[0259]" class="style-scope patent-text">
    
    [0259]
  </para-num> <div id="p0259" num="0259" class="description-line style-scope patent-text">The results from Example 5.2.3 (efficacy prediction using IL-8) and Example 5.2.5 (efficacy prediction according to K-RAS and B-RAF mutation) were combined to predict the efficacy of anti-c-Met antibody L3-1Y/IgG2. In particular, the case, where the serum IL-8 level according to Example 5.2.3 is 500 pg/ml or more and both of K-RAS and B-RAF are wild-type, was determined as a responder (efficacy or positive) group, and the other case was determined as a non-responder (non-efficacy or negative) group.</div>
    </li> <heading id="h0067" class="style-scope patent-text">
      <b class="style-scope patent-text">5.2.7. Combination III (Examples 5.2.2,5.23, and 5.2.5)</b>
    </heading>
    <li class="style-scope patent-text"> <para-num num="[0260]" class="style-scope patent-text">
    
    [0260]
  </para-num> <div id="p0260" num="0260" class="description-line style-scope patent-text">The results from Example 5.2.2 (efficacy prediction by the modified Ventana MET IHC), Example 5.2.3(efficacy prediction using IL-8), and Example 5.2.5 (efficacy prediction according to K-RAS and B-RAF mutation) were combined to predict the efficacy of anti-c-Met antibody L3-1Y/IgG2. In particular, the case, where when the IHC score according to the modified Ventana MET IHC assay of Example 5.2.2 is 23, the serum IL-8 level according to Example 5.2.3 is 500 pg/ml or more, and both of K-RAS and B-RAF are wild-type, the mouse xenograft model was determined as a responder (efficacy or positive) group, and the other case was determined as a non-responder (non-efficacy or negative) group.</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0261]" class="style-scope patent-text">
    
    [0261]
  </para-num> <div id="p0261" num="0261" class="description-line style-scope patent-text">The results from Examples 5.2.5,5.2.6, and 5.2.7 are summarized in Table 10, as below:
<tables id="tabl0010" num="0010" class="style-scope patent-text"> <patent-tables frame="all" class="style-scope patent-text">[Table 10]<figure-callout id="5" label="efficacy KRAS BRAF" filenames="imgf0003.png,imgf0010.png" class="style-scope patent-text"><a title="Show image containing callout" class="style-scope figure-callout"> </a></figure-callout><figure-callout id="2" label="FP TN TN" filenames="imgf0012.png,imgf0013.png" class="style-scope patent-text"><a title="Show image containing callout" class="style-scope figure-callout"> </a></figure-callout><figure-callout id="3" label="TP TP TP" filenames="imgf0012.png,imgf0013.png" class="style-scope patent-text"><a title="Show image containing callout" class="style-scope figure-callout"> </a></figure-callout><figure-callout id="4" label="TP TP TP" filenames="imgf0003.png,imgf0004.png" class="style-scope patent-text"><a title="Show image containing callout" class="style-scope figure-callout"> </a></figure-callout><figure-callout id="5" label="TN TN TN" filenames="imgf0003.png,imgf0010.png" class="style-scope patent-text"><a title="Show image containing callout" class="style-scope figure-callout"> </a></figure-callout><figure-callout id="6" label="TN TN TN" filenames="imgf0011.png" class="style-scope patent-text"><a title="Show image containing callout" class="style-scope figure-callout"> </a></figure-callout><figure-callout id="1" label="TP TP TP" filenames="imgf0003.png,imgf0006.png" class="style-scope patent-text"><a title="Show image containing callout" class="style-scope figure-callout"> </a></figure-callout><figure-callout id="2" label="TN TN TN" filenames="imgf0012.png,imgf0013.png" class="style-scope patent-text"><a title="Show image containing callout" class="style-scope figure-callout"> </a></figure-callout><figure-callout id="3" label="TP TP TP" filenames="imgf0012.png,imgf0013.png" class="style-scope patent-text"><a title="Show image containing callout" class="style-scope figure-callout"> </a></figure-callout><figure-callout id="4" label="TN TN TN" filenames="imgf0003.png,imgf0004.png" class="style-scope patent-text"><a title="Show image containing callout" class="style-scope figure-callout"> </a></figure-callout><figure-callout id="5" label="FP FP TN" filenames="imgf0003.png,imgf0010.png" class="style-scope patent-text"><a title="Show image containing callout" class="style-scope figure-callout"> </a></figure-callout><figure-callout id="6" label="FP TN TN" filenames="imgf0011.png" class="style-scope patent-text"><a title="Show image containing callout" class="style-scope figure-callout"> </a></figure-callout><figure-callout id="7" label="TN TN TN" filenames="imgf0001.png,imgf0002.png" class="style-scope patent-text"><a title="Show image containing callout" class="style-scope figure-callout"> </a></figure-callout><figure-callout id="8" label="FP FP TN" filenames="imgf0006.png,imgf0007.png" class="style-scope patent-text"><a title="Show image containing callout" class="style-scope figure-callout"> </a></figure-callout><figure-callout id="100" label="% Prediction sensitivity" filenames="imgf0004.png,imgf0024.png" class="style-scope patent-text"><a title="Show image containing callout" class="style-scope figure-callout"> </a></figure-callout><figure-callout id="100" label="% Prediction sensitivity" filenames="imgf0004.png,imgf0024.png" class="style-scope patent-text"><a title="Show image containing callout" class="style-scope figure-callout"> </a></figure-callout><figure-callout id="60" label="% Prediction specificity" filenames="imgf0021.png" class="style-scope patent-text"><a title="Show image containing callout" class="style-scope figure-callout"> </a></figure-callout><figure-callout id="60" label="% Prediction specificity" filenames="imgf0021.png" class="style-scope patent-text"><a title="Show image containing callout" class="style-scope figure-callout"> </a></figure-callout><table cols="8" class="description-table style-scope patent-text" width="100%"> <thead class="style-scope patent-text"> <tr class="description-tr style-scope patent-text"> <td namest="col1" nameend="col2" morerows="1" rowsep="1" align="left" valign="middle" class="description-td style-scope patent-text" rowspan="2" colspan="2"> </td> <td valign="middle" class="description-td style-scope patent-text"> </td> <td namest="col4" nameend="col6" morerows="1" rowsep="1" align="left" valign="middle" class="description-td style-scope patent-text" rowspan="2" colspan="3">KRAS-BRAF mutation</td> <td align="center" valign="middle" class="description-td style-scope patent-text">SAIT IHC+</td> <td align="center" valign="middle" class="description-td style-scope patent-text">SAIT IHC+IL8+</td> </tr> <tr class="description-tr style-scope patent-text"> <td valign="middle" class="description-td style-scope patent-text"> </td> <td valign="middle" class="description-td style-scope patent-text">Mutation</td> <td valign="middle" class="description-td style-scope patent-text">Mutation</td> </tr> <tr class="description-tr style-scope patent-text"> <td align="center" valign="middle" class="description-td style-scope patent-text">No</td> <td align="center" valign="middle" class="description-td style-scope patent-text">Model Name</td> <td align="center" valign="middle" class="description-td style-scope patent-text">in vivo <figure-callout id="5" label="efficacy KRAS BRAF" filenames="imgf0003.png,imgf0010.png" class="style-scope patent-text"><a title="Show image containing callout" class="style-scope figure-callout">efficacy</a></figure-callout> </td> <td align="center" valign="middle" class="description-td style-scope patent-text">KRAS</td> <td align="center" valign="middle" class="description-td style-scope patent-text">BRAF</td>  <td align="center" valign="middle" class="description-td style-scope patent-text"> </td> <td align="center" valign="middle" class="description-td style-scope patent-text">5. <figure-callout id="2" label="MUTATION" filenames="imgf0012.png,imgf0013.png" class="style-scope patent-text"><a title="Show image containing callout" class="style-scope figure-callout">MUTATION</a></figure-callout> </td> <td align="center" valign="middle" class="description-td style-scope patent-text">2+5 <figure-callout id="2" label="Modified SAIT" filenames="imgf0012.png,imgf0013.png" class="style-scope patent-text"><a title="Show image containing callout" class="style-scope figure-callout">Modified SAIT</a></figure-callout> 2+ AND <figure-callout id="2" label="mutation status" filenames="imgf0012.png,imgf0013.png" class="style-scope patent-text"><a title="Show image containing callout" class="style-scope figure-callout">mutation status</a></figure-callout> </td> <td align="center" valign="middle" class="description-td style-scope patent-text">2+3+5. <figure-callout id="2" label="Modified SAIT" filenames="imgf0012.png,imgf0013.png" class="style-scope patent-text"><a title="Show image containing callout" class="style-scope figure-callout">Modified SAIT</a></figure-callout> 2+ AND mutation status AND serum IL-8</td> </tr> </thead>  <tbody class="style-scope patent-text"><tr class="description-tr style-scope patent-text"> <td align="center" valign="middle" class="description-td style-scope patent-text">1</td> <td align="center" valign="middle" class="description-td style-scope patent-text">LXFA297</td> <td align="center" valign="middle" class="description-td style-scope patent-text">(-)</td> <td align="center" valign="middle" class="description-td style-scope patent-text">W</td> <td align="center" valign="middle" class="description-td style-scope patent-text">W</td> <td align="center" valign="middle" class="description-td style-scope patent-text"> <figure-callout id="2" label="FP TN TN" filenames="imgf0012.png,imgf0013.png" class="style-scope patent-text"><a title="Show image containing callout" class="style-scope figure-callout">FP</a></figure-callout> </td> <td align="center" valign="middle" class="description-td style-scope patent-text">TN</td> <td align="center" valign="middle" class="description-td style-scope patent-text">TN</td>  <td align="center" valign="middle" class="description-td style-scope patent-text"> </td> </tr> <tr class="description-tr style-scope patent-text"> <td align="center" valign="middle" class="description-td style-scope patent-text">2</td> <td align="center" valign="middle" class="description-td style-scope patent-text">LXFA526</td> <td align="center" valign="middle" class="description-td style-scope patent-text">moderate</td> <td align="center" valign="middle" class="description-td style-scope patent-text">W</td> <td align="center" valign="middle" class="description-td style-scope patent-text">W</td> <td align="center" valign="middle" class="description-td style-scope patent-text"> <figure-callout id="3" label="TP TP TP" filenames="imgf0012.png,imgf0013.png" class="style-scope patent-text"><a title="Show image containing callout" class="style-scope figure-callout">TP</a></figure-callout> </td> <td align="center" valign="middle" class="description-td style-scope patent-text">TP</td> <td align="center" valign="middle" class="description-td style-scope patent-text">TP</td>  <td align="center" valign="middle" class="description-td style-scope patent-text"> </td> </tr> <tr class="description-tr style-scope patent-text"> <td align="center" valign="middle" class="description-td style-scope patent-text">3</td> <td align="center" valign="middle" class="description-td style-scope patent-text">LXFA623</td> <td align="center" valign="middle" class="description-td style-scope patent-text">excellent</td> <td align="center" valign="middle" class="description-td style-scope patent-text">W</td> <td align="center" valign="middle" class="description-td style-scope patent-text">W</td> <td align="center" valign="middle" class="description-td style-scope patent-text"> <figure-callout id="4" label="TP TP TP" filenames="imgf0003.png,imgf0004.png" class="style-scope patent-text"><a title="Show image containing callout" class="style-scope figure-callout">TP</a></figure-callout> </td> <td align="center" valign="middle" class="description-td style-scope patent-text">TP</td> <td align="center" valign="middle" class="description-td style-scope patent-text">TP</td>  <td align="center" valign="middle" class="description-td style-scope patent-text"> </td> </tr> <tr class="description-tr style-scope patent-text"> <td align="center" valign="middle" class="description-td style-scope patent-text">4</td> <td align="center" valign="middle" class="description-td style-scope patent-text">LXFA983</td> <td align="center" valign="middle" class="description-td style-scope patent-text">(-)</td> <td align="center" valign="middle" class="description-td style-scope patent-text">M(G12C)</td> <td align="center" valign="middle" class="description-td style-scope patent-text">W</td> <td align="center" valign="middle" class="description-td style-scope patent-text"> <figure-callout id="5" label="TN TN TN" filenames="imgf0003.png,imgf0010.png" class="style-scope patent-text"><a title="Show image containing callout" class="style-scope figure-callout">TN</a></figure-callout> </td> <td align="center" valign="middle" class="description-td style-scope patent-text">TN</td> <td align="center" valign="middle" class="description-td style-scope patent-text">TN</td>  <td align="center" valign="middle" class="description-td style-scope patent-text"> </td> </tr> <tr class="description-tr style-scope patent-text"> <td align="center" valign="middle" class="description-td style-scope patent-text">5</td> <td align="center" valign="middle" class="description-td style-scope patent-text">LXFA1041</td> <td align="center" valign="middle" class="description-td style-scope patent-text">(-)</td> <td align="center" valign="middle" class="description-td style-scope patent-text">M(G12V)</td> <td align="center" valign="middle" class="description-td style-scope patent-text">W</td> <td align="center" valign="middle" class="description-td style-scope patent-text"> <figure-callout id="6" label="TN TN TN" filenames="imgf0011.png" class="style-scope patent-text"><a title="Show image containing callout" class="style-scope figure-callout">TN</a></figure-callout> </td> <td align="center" valign="middle" class="description-td style-scope patent-text">TN</td> <td align="center" valign="middle" class="description-td style-scope patent-text">TN</td>  <td align="center" valign="middle" class="description-td style-scope patent-text"> </td> </tr> <tr class="description-tr style-scope patent-text"> <td align="center" valign="middle" class="description-td style-scope patent-text">6</td> <td align="center" valign="middle" class="description-td style-scope patent-text">LXFA1647</td> <td align="center" valign="middle" class="description-td style-scope patent-text">excellent</td> <td align="center" valign="middle" class="description-td style-scope patent-text">W</td> <td align="center" valign="middle" class="description-td style-scope patent-text">W</td> <td align="center" valign="middle" class="description-td style-scope patent-text"> <figure-callout id="1" label="TP TP TP" filenames="imgf0003.png,imgf0006.png" class="style-scope patent-text"><a title="Show image containing callout" class="style-scope figure-callout">TP</a></figure-callout> </td> <td align="center" valign="middle" class="description-td style-scope patent-text">TP</td> <td align="center" valign="middle" class="description-td style-scope patent-text">TP</td>  <td align="center" valign="middle" class="description-td style-scope patent-text"> </td> </tr> <tr class="description-tr style-scope patent-text"> <td align="center" valign="middle" class="description-td style-scope patent-text">1</td> <td align="center" valign="middle" class="description-td style-scope patent-text">LXFA1848</td> <td align="center" valign="middle" class="description-td style-scope patent-text">(-)</td> <td align="center" valign="middle" class="description-td style-scope patent-text">M(Q61H)</td> <td align="center" valign="middle" class="description-td style-scope patent-text">W</td> <td align="center" valign="middle" class="description-td style-scope patent-text"> <figure-callout id="2" label="TN TN TN" filenames="imgf0012.png,imgf0013.png" class="style-scope patent-text"><a title="Show image containing callout" class="style-scope figure-callout">TN</a></figure-callout> </td> <td align="center" valign="middle" class="description-td style-scope patent-text">TN</td> <td align="center" valign="middle" class="description-td style-scope patent-text">TN</td>  <td align="center" valign="middle" class="description-td style-scope patent-text"> </td> </tr> <tr class="description-tr style-scope patent-text"> <td align="center" valign="middle" class="description-td style-scope patent-text">2</td> <td align="center" valign="middle" class="description-td style-scope patent-text">LXFA2158</td> <td align="center" valign="middle" class="description-td style-scope patent-text">excellent</td> <td align="center" valign="middle" class="description-td style-scope patent-text">W</td> <td align="center" valign="middle" class="description-td style-scope patent-text">W</td> <td align="center" valign="middle" class="description-td style-scope patent-text"> <figure-callout id="3" label="TP TP TP" filenames="imgf0012.png,imgf0013.png" class="style-scope patent-text"><a title="Show image containing callout" class="style-scope figure-callout">TP</a></figure-callout> </td> <td align="center" valign="middle" class="description-td style-scope patent-text">TP</td> <td align="center" valign="middle" class="description-td style-scope patent-text">TP</td>  <td align="center" valign="middle" class="description-td style-scope patent-text"> </td> </tr> <tr class="description-tr style-scope patent-text"> <td align="center" valign="middle" class="description-td style-scope patent-text">3</td> <td align="center" valign="middle" class="description-td style-scope patent-text">LXFA2201</td> <td align="center" valign="middle" class="description-td style-scope patent-text">(-)</td> <td align="center" valign="middle" class="description-td style-scope patent-text">W</td> <td align="center" valign="middle" class="description-td style-scope patent-text">M(G596R)</td> <td align="center" valign="middle" class="description-td style-scope patent-text"> <figure-callout id="4" label="TN TN TN" filenames="imgf0003.png,imgf0004.png" class="style-scope patent-text"><a title="Show image containing callout" class="style-scope figure-callout">TN</a></figure-callout> </td> <td align="center" valign="middle" class="description-td style-scope patent-text">TN</td> <td align="center" valign="middle" class="description-td style-scope patent-text">TN</td>  <td align="center" valign="middle" class="description-td style-scope patent-text"> </td> </tr> <tr class="description-tr style-scope patent-text"> <td align="center" valign="middle" class="description-td style-scope patent-text">4</td> <td align="center" valign="middle" class="description-td style-scope patent-text">LXFA289</td> <td align="center" valign="middle" class="description-td style-scope patent-text">(-)</td> <td align="center" valign="middle" class="description-td style-scope patent-text">W</td> <td align="center" valign="middle" class="description-td style-scope patent-text">W</td> <td align="center" valign="middle" class="description-td style-scope patent-text"> <figure-callout id="5" label="FP FP TN" filenames="imgf0003.png,imgf0010.png" class="style-scope patent-text"><a title="Show image containing callout" class="style-scope figure-callout">FP</a></figure-callout> </td> <td align="center" valign="middle" class="description-td style-scope patent-text">FP</td> <td align="center" valign="middle" class="description-td style-scope patent-text">TN</td>  <td align="center" valign="middle" class="description-td style-scope patent-text"> </td> </tr> <tr class="description-tr style-scope patent-text"> <td align="center" valign="middle" class="description-td style-scope patent-text">5</td> <td align="center" valign="middle" class="description-td style-scope patent-text">LXFA400</td> <td align="center" valign="middle" class="description-td style-scope patent-text">(-)</td> <td align="center" valign="middle" class="description-td style-scope patent-text">W</td> <td align="center" valign="middle" class="description-td style-scope patent-text">W</td> <td align="center" valign="middle" class="description-td style-scope patent-text"> <figure-callout id="6" label="FP TN TN" filenames="imgf0011.png" class="style-scope patent-text"><a title="Show image containing callout" class="style-scope figure-callout">FP</a></figure-callout> </td> <td align="center" valign="middle" class="description-td style-scope patent-text">TN</td> <td align="center" valign="middle" class="description-td style-scope patent-text">TN</td>  <td align="center" valign="middle" class="description-td style-scope patent-text"> </td> </tr> <tr class="description-tr style-scope patent-text"> <td align="center" valign="middle" class="description-td style-scope patent-text">6</td> <td align="center" valign="middle" class="description-td style-scope patent-text">LXFA677</td> <td align="center" valign="middle" class="description-td style-scope patent-text">(-)</td> <td align="center" valign="middle" class="description-td style-scope patent-text">W</td> <td align="center" valign="middle" class="description-td style-scope patent-text">M(D594A)</td> <td align="center" valign="middle" class="description-td style-scope patent-text"> <figure-callout id="7" label="TN TN TN" filenames="imgf0001.png,imgf0002.png" class="style-scope patent-text"><a title="Show image containing callout" class="style-scope figure-callout">TN</a></figure-callout> </td> <td align="center" valign="middle" class="description-td style-scope patent-text">TN</td> <td align="center" valign="middle" class="description-td style-scope patent-text">TN</td>  <td align="center" valign="middle" class="description-td style-scope patent-text"> </td> </tr> <tr class="description-tr style-scope patent-text"> <td align="center" valign="middle" class="description-td style-scope patent-text">7</td> <td align="center" valign="middle" class="description-td style-scope patent-text">LXFA749</td> <td align="center" valign="middle" class="description-td style-scope patent-text">(-)</td> <td align="center" valign="middle" class="description-td style-scope patent-text">W</td> <td align="center" valign="middle" class="description-td style-scope patent-text">W</td> <td align="center" valign="middle" class="description-td style-scope patent-text"> <figure-callout id="8" label="FP FP TN" filenames="imgf0006.png,imgf0007.png" class="style-scope patent-text"><a title="Show image containing callout" class="style-scope figure-callout">FP</a></figure-callout> </td> <td align="center" valign="middle" class="description-td style-scope patent-text">FP</td> <td align="center" valign="middle" class="description-td style-scope patent-text">TN</td>  <td align="center" valign="middle" class="description-td style-scope patent-text"> </td> </tr> <tr class="description-tr style-scope patent-text"> <td align="center" valign="middle" class="description-td style-scope patent-text">8</td> <td align="center" valign="middle" class="description-td style-scope patent-text">LXFA923</td> <td align="center" valign="middle" class="description-td style-scope patent-text">(-)</td> <td align="center" valign="middle" class="description-td style-scope patent-text">M(G12C)</td> <td align="center" valign="middle" class="description-td style-scope patent-text">W</td> <td align="center" valign="middle" class="description-td style-scope patent-text">TN</td> <td align="center" valign="middle" class="description-td style-scope patent-text">TN</td> <td align="center" valign="middle" class="description-td style-scope patent-text">TN</td> </tr> <tr class="description-tr style-scope patent-text"> <td namest="col1" nameend="col3" align="center" valign="middle" class="description-td style-scope patent-text" colspan="3">Prediction accuracy =</td> <td namest="col4" nameend="col6" align="center" valign="middle" class="description-td style-scope patent-text" colspan="3">71.43%</td> <td align="center" valign="middle" class="description-td style-scope patent-text">85.71%</td> <td align="center" valign="middle" class="description-td style-scope patent-text">100<figure-callout id="100" label="% Prediction sensitivity" filenames="imgf0004.png,imgf0024.png" class="style-scope patent-text"><a title="Show image containing callout" class="style-scope figure-callout">%</a></figure-callout> </td>  </tr> <tr class="description-tr style-scope patent-text"> <td namest="col1" nameend="col3" align="center" valign="middle" class="description-td style-scope patent-text" colspan="3">Prediction sensitivity</td> </tr>  <tr class="description-tr style-scope patent-text"> <td namest="col1" nameend="col3" align="center" valign="middle" class="description-td style-scope patent-text" colspan="3"> </td> <td namest="col4" nameend="col6" align="center" valign="middle" class="description-td style-scope patent-text" colspan="3">100%</td> <td align="center" valign="middle" class="description-td style-scope patent-text">100%</td> <td align="center" valign="middle" class="description-td style-scope patent-text">100<figure-callout id="60" label="% Prediction specificity" filenames="imgf0021.png" class="style-scope patent-text"><a title="Show image containing callout" class="style-scope figure-callout">%</a></figure-callout> </td>  </tr> <tr class="description-tr style-scope patent-text"> <td namest="col1" nameend="col3" align="center" valign="middle" class="description-td style-scope patent-text" colspan="3">Prediction specificity</td> </tr>  <tr class="description-tr style-scope patent-text"> <td namest="col1" nameend="col3" align="center" valign="middle" class="description-td style-scope patent-text" colspan="3"> </td> <td namest="col4" nameend="col6" align="center" valign="middle" class="description-td style-scope patent-text" colspan="3">60%</td> <td align="center" valign="middle" class="description-td style-scope patent-text">80%</td> <td align="center" valign="middle" class="description-td style-scope patent-text">100%</td> </tr>  </tbody></table> </patent-tables> </tables> </div>
    </li> <li class="style-scope patent-text"> <para-num num="[0262]" class="style-scope patent-text">
    
    [0262]
  </para-num> <div id="p0262" num="0262" class="description-line style-scope patent-text">As shown in Tables 9 and 10, when the modified c-MET IHC assay, IL-8 marker, and KRAS-BRAF mutation marker are respectively used, the prediction accuracy is 64.29%, 71.43%, and 71.43%, respectively, which are all excellent compared to that of the control (Example 5.2.1; 28.57%). A combination of at least two of the modified c-MET IHC assay, IL-8 marker, and KRAS-BRAF mutation marker shows better prediction accuracy. In particular, the combination of all of the modified c-MET IHC assay, IL-8 marker, and KRAS-BRAF mutation marker shows excellent prediction accuracy (100%).
</div> </li> <ul class="style-scope patent-text"> <li class="style-scope patent-text">&lt;110&gt; Samsung Electronics Co. Ltd</li> <li class="style-scope patent-text">&lt;120&gt; Biomarker for predicting or monitoring efficacy of a c-Met inhibitor</li> <li class="style-scope patent-text">&lt;130&gt; EP98277FZTRpau</li> <li class="style-scope patent-text">&lt;140&gt; not yet assigned<br class="style-scope patent-text">
&lt;141&gt; herewith</li> <li class="style-scope patent-text">&lt;150&gt; KR10-2014-0001799<br class="style-scope patent-text">
&lt;151&gt; 2014-01-07</li> <li class="style-scope patent-text">&lt;150&gt; KR10-2015-0000956<br class="style-scope patent-text">
&lt;151&gt; 2015-01-06</li> <li class="style-scope patent-text">&lt;160&gt; 114</li> <li class="style-scope patent-text">&lt;170&gt; KopatentIn 1.71</li> <li class="style-scope patent-text">&lt;210&gt; 1<br class="style-scope patent-text">
&lt;211&gt; 5<br class="style-scope patent-text">
&lt;212&gt; PRT<br class="style-scope patent-text">
&lt;213&gt; Artificial Sequence</li> <li class="style-scope patent-text">&lt;220&gt;<br class="style-scope patent-text">
&lt;223&gt; heavy chain CDR1 of AbF46</li> <li class="style-scope patent-text">&lt;400&gt; 1
<div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/e6/8f/89/8426050d050a35/imgb0008.png" class="style-scope patent-text"><img id="ib0008" file="imgb0008.tif" wi="42" he="8" img-content="dna" img-format="tif" width="168" height="32" alt="Figure imgb0008" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/e6/8f/89/8426050d050a35/imgb0008.png"></a></div> </li> <li class="style-scope patent-text">&lt;210&gt; 2<br class="style-scope patent-text">
&lt;211&gt; 19<br class="style-scope patent-text">
&lt;212&gt; PRT<br class="style-scope patent-text">
&lt;213&gt; Artificial Sequence</li> <li class="style-scope patent-text">&lt;220&gt;<br class="style-scope patent-text">
&lt;223&gt; heavy chain CDR2 of AbF46</li> <li class="style-scope patent-text">&lt;400&gt; 2
<div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/0a/0f/76/86a02402419560/imgb0009.png" class="style-scope patent-text"><img id="ib0009" file="imgb0009.tif" wi="136" he="16" img-content="dna" img-format="tif" width="544" height="64" alt="Figure imgb0009" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/0a/0f/76/86a02402419560/imgb0009.png"></a></div> </li> <li class="style-scope patent-text">&lt;210&gt; 3<br class="style-scope patent-text">
&lt;211&gt; 6<br class="style-scope patent-text">
&lt;212&gt; PRT<br class="style-scope patent-text">
&lt;213&gt; Artificial Sequence</li> <li class="style-scope patent-text">&lt;220&gt;<br class="style-scope patent-text">
&lt;223&gt; heavy chain CDR3 of AbF46</li> <li class="style-scope patent-text">&lt;400&gt; 3
<div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/3a/34/38/34b4dabb8cd127/imgb0010.png" class="style-scope patent-text"><img id="ib0010" file="imgb0010.tif" wi="51" he="8" img-content="dna" img-format="tif" width="204" height="32" alt="Figure imgb0010" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/3a/34/38/34b4dabb8cd127/imgb0010.png"></a></div> </li> <li class="style-scope patent-text">&lt;210&gt; 4<br class="style-scope patent-text">
&lt;211&gt; 6<br class="style-scope patent-text">
&lt;212&gt; PRT<br class="style-scope patent-text">
&lt;213&gt; Artificial Sequence</li> <li class="style-scope patent-text">&lt;220&gt;<br class="style-scope patent-text">
&lt;223&gt; heavy chain CDR1 of c-Met antibody</li> <li class="style-scope patent-text">&lt;220&gt;<br class="style-scope patent-text">
&lt;221&gt; MOD_RES<br class="style-scope patent-text">
&lt;222&gt; (1)<br class="style-scope patent-text">
&lt;223&gt; X is Pro or Ser or absent</li> <li class="style-scope patent-text">&lt;220&gt;<br class="style-scope patent-text">
&lt;221&gt; MOD_RES<br class="style-scope patent-text">
&lt;222&gt; (2)<br class="style-scope patent-text">
&lt;223&gt; X is Glu or Asp</li> <li class="style-scope patent-text">&lt;400&gt; 4
<div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/ff/c7/1a/73f60257dc262c/imgb0011.png" class="style-scope patent-text"><img id="ib0011" file="imgb0011.tif" wi="51" he="8" img-content="dna" img-format="tif" width="204" height="32" alt="Figure imgb0011" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/ff/c7/1a/73f60257dc262c/imgb0011.png"></a></div> </li> <li class="style-scope patent-text">&lt;210&gt; 5<br class="style-scope patent-text">
&lt;211&gt; 8<br class="style-scope patent-text">
&lt;212&gt; PRT<br class="style-scope patent-text">
&lt;213&gt; Artificial Sequence</li> <li class="style-scope patent-text">&lt;220&gt;<br class="style-scope patent-text">
&lt;223&gt; heavy chain CDR2 of c-Met antibody</li> <li class="style-scope patent-text">&lt;220&gt;<br class="style-scope patent-text">
&lt;221&gt; MOD_RES<br class="style-scope patent-text">
&lt;222&gt; (3)<br class="style-scope patent-text">
&lt;223&gt; X is Asn or Lys</li> <li class="style-scope patent-text">&lt;220&gt;<br class="style-scope patent-text">
&lt;221&gt; MOD_RES<br class="style-scope patent-text">
&lt;222&gt; (4)<br class="style-scope patent-text">
&lt;223&gt; X is Ala or Val</li> <li class="style-scope patent-text">&lt;220&gt;<br class="style-scope patent-text">
&lt;221&gt; MOD_RES<br class="style-scope patent-text">
&lt;222&gt; (7)<br class="style-scope patent-text">
&lt;223&gt; X is Asn or Thr</li> <li class="style-scope patent-text">&lt;400&gt; 5
<div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/ad/3e/09/121d006b403404/imgb0012.png" class="style-scope patent-text"><img id="ib0012" file="imgb0012.tif" wi="68" he="8" img-content="dna" img-format="tif" width="272" height="32" alt="Figure imgb0012" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/ad/3e/09/121d006b403404/imgb0012.png"></a></div> </li> <li class="style-scope patent-text">&lt;210&gt; 6<br class="style-scope patent-text">
&lt;211&gt; 6<br class="style-scope patent-text">
&lt;212&gt; PRT<br class="style-scope patent-text">
&lt;213&gt; Artificial Sequence</li> <li class="style-scope patent-text">&lt;220&gt;<br class="style-scope patent-text">
&lt;223&gt; heavy chain CDR3 of c-Met antibody</li> <li class="style-scope patent-text">&lt;220&gt;<br class="style-scope patent-text">
&lt;221&gt; MOD_RES<br class="style-scope patent-text">
&lt;222&gt; (5)<br class="style-scope patent-text">
&lt;223&gt; X is Ser or Thr</li> <li class="style-scope patent-text">&lt;400&gt; 6
<div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/86/46/4c/a13cb8330559ab/imgb0013.png" class="style-scope patent-text"><img id="ib0013" file="imgb0013.tif" wi="55" he="11" img-content="dna" img-format="tif" width="220" height="44" alt="Figure imgb0013" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/86/46/4c/a13cb8330559ab/imgb0013.png"></a></div> </li> <li class="style-scope patent-text">&lt;210&gt; 7<br class="style-scope patent-text">
&lt;211&gt; 17<br class="style-scope patent-text">
&lt;212&gt; PRT<br class="style-scope patent-text">
&lt;213&gt; Artificial Sequence</li> <li class="style-scope patent-text">&lt;220&gt;<br class="style-scope patent-text">
&lt;223&gt; light chain CDR1 of c-Met antibody</li> <li class="style-scope patent-text">&lt;220&gt;<br class="style-scope patent-text">
&lt;221&gt; MOD_RES<br class="style-scope patent-text">
&lt;222&gt; (4)<br class="style-scope patent-text">
&lt;223&gt; X is His, Arg, Gln or Lys</li> <li class="style-scope patent-text">&lt;220&gt;<br class="style-scope patent-text">
&lt;221&gt; MOD_RES<br class="style-scope patent-text">
&lt;222&gt; (12)<br class="style-scope patent-text">
&lt;223&gt; X is His or Gln</li> <li class="style-scope patent-text">&lt;220&gt;<br class="style-scope patent-text">
&lt;221&gt; MOD_RES<br class="style-scope patent-text">
&lt;222&gt; (13)<br class="style-scope patent-text">
&lt;223&gt; X is Lys or Asn</li> <li class="style-scope patent-text">&lt;220&gt;<br class="style-scope patent-text">
&lt;221&gt; MOD_RES<br class="style-scope patent-text">
&lt;222&gt; (9)<br class="style-scope patent-text">
&lt;223&gt; X is Ser or Trp</li> <li class="style-scope patent-text">&lt;400&gt; 7
<div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/00/eb/22/fafea6770eb973/imgb0014.png" class="style-scope patent-text"><img id="ib0014" file="imgb0014.tif" wi="136" he="15" img-content="dna" img-format="tif" width="544" height="60" alt="Figure imgb0014" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/00/eb/22/fafea6770eb973/imgb0014.png"></a></div> </li> <li class="style-scope patent-text">&lt;210&gt; 8<br class="style-scope patent-text">
&lt;211&gt; 7<br class="style-scope patent-text">
&lt;212&gt; PRT<br class="style-scope patent-text">
&lt;213&gt; Artificial Sequence</li> <li class="style-scope patent-text">&lt;220&gt;<br class="style-scope patent-text">
&lt;223&gt; light chain CDR2 of c-Met antibody</li> <li class="style-scope patent-text">&lt;220&gt;<br class="style-scope patent-text">
&lt;221&gt; MOD_RES<br class="style-scope patent-text">
&lt;222&gt; (2)<br class="style-scope patent-text">
&lt;223&gt; X is Ala or Gly</li> <li class="style-scope patent-text">&lt;220&gt;<br class="style-scope patent-text">
&lt;221&gt; MOD_RES<br class="style-scope patent-text">
&lt;222&gt; (4)<br class="style-scope patent-text">
&lt;223&gt; X is Thr or Lys</li> <li class="style-scope patent-text">&lt;220&gt;<br class="style-scope patent-text">
&lt;221&gt; MOD_RES<br class="style-scope patent-text">
&lt;222&gt; (7)<br class="style-scope patent-text">
&lt;223&gt; X is Ser or Pro</li> <li class="style-scope patent-text">&lt;400&gt; 8
<div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/34/47/4d/4a3af4a3efe215/imgb0015.png" class="style-scope patent-text"><img id="ib0015" file="imgb0015.tif" wi="59" he="8" img-content="dna" img-format="tif" width="236" height="32" alt="Figure imgb0015" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/34/47/4d/4a3af4a3efe215/imgb0015.png"></a></div> </li> <li class="style-scope patent-text">&lt;210&gt; 9<br class="style-scope patent-text">
&lt;211&gt; 9<br class="style-scope patent-text">
&lt;212&gt; PRT<br class="style-scope patent-text">
&lt;213&gt; Artificial Sequence</li> <li class="style-scope patent-text">&lt;220&gt;<br class="style-scope patent-text">
&lt;223&gt; light chain CDR3 of c-Met antibody</li> <li class="style-scope patent-text">&lt;220&gt;<br class="style-scope patent-text">
&lt;221&gt; MOD_RES<br class="style-scope patent-text">
&lt;222&gt; (1)<br class="style-scope patent-text">
&lt;223&gt; X is Gly, Ala or Gln</li> <li class="style-scope patent-text">&lt;220&gt;<br class="style-scope patent-text">
&lt;221&gt; MOD_RES<br class="style-scope patent-text">
&lt;222&gt; (6)<br class="style-scope patent-text">
&lt;223&gt; X is Arg, His, Ser, Ala, Gly or Lys</li> <li class="style-scope patent-text">&lt;220&gt;<br class="style-scope patent-text">
&lt;221&gt; MOD_RES<br class="style-scope patent-text">
&lt;222&gt; (8)<br class="style-scope patent-text">
&lt;223&gt; X is Leu, Tyr, Phe or Met</li> <li class="style-scope patent-text">&lt;400&gt; 9
<div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/e2/db/a9/b96aea4d47a3d7/imgb0016.png" class="style-scope patent-text"><img id="ib0016" file="imgb0016.tif" wi="76" he="8" img-content="dna" img-format="tif" width="304" height="32" alt="Figure imgb0016" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/e2/db/a9/b96aea4d47a3d7/imgb0016.png"></a></div> </li> <li class="style-scope patent-text">&lt;210&gt; 10<br class="style-scope patent-text">
&lt;211&gt; 17<br class="style-scope patent-text">
&lt;212&gt; PRT<br class="style-scope patent-text">
&lt;213&gt; Artificial Sequence</li> <li class="style-scope patent-text">&lt;220&gt;<br class="style-scope patent-text">
&lt;223&gt; light chain CDR1 of AbF46</li> <li class="style-scope patent-text">&lt;400&gt; 10
<div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/a8/fa/a8/5d1e15c7dd8a1d/imgb0017.png" class="style-scope patent-text"><img id="ib0017" file="imgb0017.tif" wi="136" he="15" img-content="dna" img-format="tif" width="544" height="60" alt="Figure imgb0017" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/a8/fa/a8/5d1e15c7dd8a1d/imgb0017.png"></a></div> </li> <li class="style-scope patent-text">&lt;210&gt; 11<br class="style-scope patent-text">
&lt;211&gt; 7<br class="style-scope patent-text">
&lt;212&gt; PRT<br class="style-scope patent-text">
&lt;213&gt; Artificial Sequence</li> <li class="style-scope patent-text">&lt;220&gt;<br class="style-scope patent-text">
&lt;223&gt; light chain CDR2 of AbF46</li> <li class="style-scope patent-text">&lt;400&gt; 11
<div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/89/dd/a0/001bbaa5913d63/imgb0018.png" class="style-scope patent-text"><img id="ib0018" file="imgb0018.tif" wi="59" he="8" img-content="dna" img-format="tif" width="236" height="32" alt="Figure imgb0018" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/89/dd/a0/001bbaa5913d63/imgb0018.png"></a></div> </li> <li class="style-scope patent-text">&lt;210&gt; 12<br class="style-scope patent-text">
&lt;211&gt; 9<br class="style-scope patent-text">
&lt;212&gt; PRT<br class="style-scope patent-text">
&lt;213&gt; Artificial Sequence</li> <li class="style-scope patent-text">&lt;220&gt;<br class="style-scope patent-text">
&lt;223&gt; light chain CDR3 of AbF46</li> <li class="style-scope patent-text">&lt;400&gt; 12
<div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/4c/c3/24/9d7ec1a20b9ee0/imgb0019.png" class="style-scope patent-text"><img id="ib0019" file="imgb0019.tif" wi="76" he="8" img-content="dna" img-format="tif" width="304" height="32" alt="Figure imgb0019" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/4c/c3/24/9d7ec1a20b9ee0/imgb0019.png"></a></div> </li> <li class="style-scope patent-text">&lt;210&gt; 13<br class="style-scope patent-text">
&lt;211&gt; 9<br class="style-scope patent-text">
&lt;212&gt; PRT<br class="style-scope patent-text">
&lt;213&gt; Artificial Sequence</li> <li class="style-scope patent-text">&lt;220&gt;<br class="style-scope patent-text">
&lt;223&gt; CDR-L3 derived from L3-1 clone</li> <li class="style-scope patent-text">&lt;400&gt; 13
<div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/12/d1/26/bf73ea92c4c112/imgb0020.png" class="style-scope patent-text"><img id="ib0020" file="imgb0020.tif" wi="76" he="8" img-content="dna" img-format="tif" width="304" height="32" alt="Figure imgb0020" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/12/d1/26/bf73ea92c4c112/imgb0020.png"></a></div> </li> <li class="style-scope patent-text">&lt;210&gt; 14<br class="style-scope patent-text">
&lt;211&gt; 9<br class="style-scope patent-text">
&lt;212&gt; PRT<br class="style-scope patent-text">
&lt;213&gt; Artificial Sequence</li> <li class="style-scope patent-text">&lt;220&gt;<br class="style-scope patent-text">
&lt;223&gt; CDR-L3 derived from L3-2 clone</li> <li class="style-scope patent-text">&lt;400&gt; 14
<div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/77/86/3c/fcefa870f1f076/imgb0021.png" class="style-scope patent-text"><img id="ib0021" file="imgb0021.tif" wi="76" he="8" img-content="dna" img-format="tif" width="304" height="32" alt="Figure imgb0021" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/77/86/3c/fcefa870f1f076/imgb0021.png"></a></div> </li> <li class="style-scope patent-text">&lt;210&gt; 15<br class="style-scope patent-text">
&lt;211&gt; 9<br class="style-scope patent-text">
&lt;212&gt; PRT<br class="style-scope patent-text">
&lt;213&gt; Artificial Sequence</li> <li class="style-scope patent-text">&lt;220&gt;<br class="style-scope patent-text">
&lt;223&gt; CDR-L3 derived from L3-3 clone</li> <li class="style-scope patent-text">&lt;400&gt; 15
<div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/9f/1d/72/3bde2273317338/imgb0022.png" class="style-scope patent-text"><img id="ib0022" file="imgb0022.tif" wi="76" he="8" img-content="dna" img-format="tif" width="304" height="32" alt="Figure imgb0022" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/9f/1d/72/3bde2273317338/imgb0022.png"></a></div> </li> <li class="style-scope patent-text">&lt;210&gt; 16<br class="style-scope patent-text">
&lt;211&gt; 9<br class="style-scope patent-text">
&lt;212&gt; PRT<br class="style-scope patent-text">
&lt;213&gt; Artificial Sequence</li> <li class="style-scope patent-text">&lt;220&gt;<br class="style-scope patent-text">
&lt;223&gt; CDR-L3 derived from L3-5 clone</li> <li class="style-scope patent-text">&lt;400&gt; 16
<div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/56/35/5a/9587b5d1d3ec75/imgb0023.png" class="style-scope patent-text"><img id="ib0023" file="imgb0023.tif" wi="76" he="8" img-content="dna" img-format="tif" width="304" height="32" alt="Figure imgb0023" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/56/35/5a/9587b5d1d3ec75/imgb0023.png"></a></div> </li> <li class="style-scope patent-text">&lt;210&gt; 17<br class="style-scope patent-text">
&lt;211&gt; 117<br class="style-scope patent-text">
&lt;212&gt; PRT<br class="style-scope patent-text">
&lt;213&gt; Artificial Sequence</li> <li class="style-scope patent-text">&lt;220&gt;<br class="style-scope patent-text">
&lt;223&gt; heavy chain variable region of anti c-Met humanized antibody(huAbF46-H4)</li> <li class="style-scope patent-text">&lt;400&gt; 17
<div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/45/2c/9d/9c41be6016ea83/imgb0024.png" class="style-scope patent-text"><img id="ib0024" file="imgb0024.tif" wi="136" he="66" img-content="dna" img-format="tif" width="544" height="264" alt="Figure imgb0024" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/45/2c/9d/9c41be6016ea83/imgb0024.png"></a></div>
<div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/15/45/c6/03c3f739267d00/imgb0025.png" class="style-scope patent-text"><img id="ib0025" file="imgb0025.tif" wi="136" he="19" img-content="dna" img-format="tif" width="544" height="76" alt="Figure imgb0025" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/15/45/c6/03c3f739267d00/imgb0025.png"></a></div> </li> <li class="style-scope patent-text">&lt;210&gt; 18<br class="style-scope patent-text">
&lt;211&gt; 114<br class="style-scope patent-text">
&lt;212&gt; PRT<br class="style-scope patent-text">
&lt;213&gt; Artificial Sequence</li> <li class="style-scope patent-text">&lt;220&gt;<br class="style-scope patent-text">
&lt;223&gt; light chain variable region of anti c-Met humanized antibody(huAbF46-H4)</li> <li class="style-scope patent-text">&lt;400&gt; 18
<div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/d0/5f/70/654a1905978a11/imgb0026.png" class="style-scope patent-text"><img id="ib0026" file="imgb0026.tif" wi="136" he="86" img-content="dna" img-format="tif" width="544" height="344" alt="Figure imgb0026" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/d0/5f/70/654a1905978a11/imgb0026.png"></a></div> </li> <li class="style-scope patent-text">&lt;210&gt; 19<br class="style-scope patent-text">
&lt;211&gt; 114<br class="style-scope patent-text">
&lt;212&gt; PRT<br class="style-scope patent-text">
&lt;213&gt; Artificial Sequence</li> <li class="style-scope patent-text">&lt;220&gt;<br class="style-scope patent-text">
&lt;223&gt; light chain variable region of anti c-Met humanized antibody(huAbF46-H4)</li> <li class="style-scope patent-text">&lt;400&gt; 19
<div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/7a/fc/63/8e2671d988c51e/imgb0027.png" class="style-scope patent-text"><img id="ib0027" file="imgb0027.tif" wi="136" he="31" img-content="dna" img-format="tif" width="544" height="124" alt="Figure imgb0027" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/7a/fc/63/8e2671d988c51e/imgb0027.png"></a></div>
<div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/02/cc/62/e80c71320800c4/imgb0028.png" class="style-scope patent-text"><img id="ib0028" file="imgb0028.tif" wi="136" he="51" img-content="dna" img-format="tif" width="544" height="204" alt="Figure imgb0028" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/02/cc/62/e80c71320800c4/imgb0028.png"></a></div> </li> <li class="style-scope patent-text">&lt;210&gt; 20<br class="style-scope patent-text">
&lt;211&gt; 114<br class="style-scope patent-text">
&lt;212&gt; PRT<br class="style-scope patent-text">
&lt;213&gt; Artificial Sequence</li> <li class="style-scope patent-text">&lt;220&gt;<br class="style-scope patent-text">
&lt;223&gt; light chain variable region of anti c-Met humanized antibody(huAbF46-H4)</li> <li class="style-scope patent-text">&lt;400&gt; 20
<div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/55/37/96/c8650e1d2df67c/imgb0029.png" class="style-scope patent-text"><img id="ib0029" file="imgb0029.tif" wi="136" he="86" img-content="dna" img-format="tif" width="544" height="344" alt="Figure imgb0029" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/55/37/96/c8650e1d2df67c/imgb0029.png"></a></div> </li> <li class="style-scope patent-text">&lt;210&gt; 21<br class="style-scope patent-text">
&lt;211&gt; 114<br class="style-scope patent-text">
&lt;212&gt; PRT<br class="style-scope patent-text">
&lt;213&gt; Artificial Sequence</li> <li class="style-scope patent-text">&lt;220&gt;<br class="style-scope patent-text">
&lt;223&gt; light chain variable region of anti c-Met humanized antibody(huAbF46-H4)</li> <li class="style-scope patent-text">&lt;400&gt; 21
<div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/90/25/e7/0308ab77f7870b/imgb0030.png" class="style-scope patent-text"><img id="ib0030" file="imgb0030.tif" wi="136" he="86" img-content="dna" img-format="tif" width="544" height="344" alt="Figure imgb0030" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/90/25/e7/0308ab77f7870b/imgb0030.png"></a></div> </li> <li class="style-scope patent-text">&lt;210&gt; 22<br class="style-scope patent-text">
&lt;211&gt; 6<br class="style-scope patent-text">
&lt;212&gt; PRT<br class="style-scope patent-text">
&lt;213&gt; Artificial Sequence</li> <li class="style-scope patent-text">&lt;220&gt;<br class="style-scope patent-text">
&lt;223&gt; CDR-H1 derived from H11-4 clone</li> <li class="style-scope patent-text">&lt;400&gt; 22
<div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/b1/fd/3f/a7f5129af02e3a/imgb0031.png" class="style-scope patent-text"><img id="ib0031" file="imgb0031.tif" wi="51" he="8" img-content="dna" img-format="tif" width="204" height="32" alt="Figure imgb0031" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/b1/fd/3f/a7f5129af02e3a/imgb0031.png"></a></div> </li> <li class="style-scope patent-text">&lt;210&gt; 23<br class="style-scope patent-text">
&lt;211&gt; 6<br class="style-scope patent-text">
&lt;212&gt; PRT<br class="style-scope patent-text">
&lt;213&gt; Artificial Sequence</li> <li class="style-scope patent-text">&lt;220&gt;<br class="style-scope patent-text">
&lt;223&gt; CDR-H1 derived from YC151 clone</li> <li class="style-scope patent-text">&lt;400&gt; 23
<div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/be/87/bf/bfa3b4819931ce/imgb0032.png" class="style-scope patent-text"><img id="ib0032" file="imgb0032.tif" wi="51" he="8" img-content="dna" img-format="tif" width="204" height="32" alt="Figure imgb0032" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/be/87/bf/bfa3b4819931ce/imgb0032.png"></a></div> </li> <li class="style-scope patent-text">&lt;210&gt; 24<br class="style-scope patent-text">
&lt;211&gt; 6<br class="style-scope patent-text">
&lt;212&gt; PRT<br class="style-scope patent-text">
&lt;213&gt; Artificial Sequence</li> <li class="style-scope patent-text">&lt;220&gt;<br class="style-scope patent-text">
&lt;223&gt; CDR-H1 derived from YC193 clone</li> <li class="style-scope patent-text">&lt;400&gt; 24
<div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/f0/26/93/6576068229d4fc/imgb0033.png" class="style-scope patent-text"><img id="ib0033" file="imgb0033.tif" wi="51" he="8" img-content="dna" img-format="tif" width="204" height="32" alt="Figure imgb0033" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/f0/26/93/6576068229d4fc/imgb0033.png"></a></div> </li> <li class="style-scope patent-text">&lt;210&gt; 25<br class="style-scope patent-text">
&lt;211&gt; 8<br class="style-scope patent-text">
&lt;212&gt; PRT<br class="style-scope patent-text">
&lt;213&gt; Artificial Sequence</li> <li class="style-scope patent-text">&lt;220&gt;<br class="style-scope patent-text">
&lt;223&gt; CDR-H2 derived from YC244 clone</li> <li class="style-scope patent-text">&lt;400&gt; 25
<div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/76/cb/87/87c69b1dccbb91/imgb0034.png" class="style-scope patent-text"><img id="ib0034" file="imgb0034.tif" wi="68" he="8" img-content="dna" img-format="tif" width="272" height="32" alt="Figure imgb0034" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/76/cb/87/87c69b1dccbb91/imgb0034.png"></a></div> </li> <li class="style-scope patent-text">&lt;210&gt; 26<br class="style-scope patent-text">
&lt;211&gt; 8<br class="style-scope patent-text">
&lt;212&gt; PRT<br class="style-scope patent-text">
&lt;213&gt; Artificial Sequence</li> <li class="style-scope patent-text">&lt;220&gt;<br class="style-scope patent-text">
&lt;223&gt; CDR-H2 derived from YC321 clone</li> <li class="style-scope patent-text">&lt;400&gt; 26
<div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/88/c5/b7/5fa476a8b90627/imgb0035.png" class="style-scope patent-text"><img id="ib0035" file="imgb0035.tif" wi="68" he="8" img-content="dna" img-format="tif" width="272" height="32" alt="Figure imgb0035" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/88/c5/b7/5fa476a8b90627/imgb0035.png"></a></div> </li> <li class="style-scope patent-text">&lt;210&gt; 27<br class="style-scope patent-text">
&lt;211&gt; 6<br class="style-scope patent-text">
&lt;212&gt; PRT<br class="style-scope patent-text">
&lt;213&gt; Artificial Sequence</li> <li class="style-scope patent-text">&lt;220&gt;<br class="style-scope patent-text">
&lt;223&gt; CDR-H3 derived from YC354 clone</li> <li class="style-scope patent-text">&lt;400&gt; 27
<div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/e9/25/c2/5faf961d92329b/imgb0036.png" class="style-scope patent-text"><img id="ib0036" file="imgb0036.tif" wi="51" he="8" img-content="dna" img-format="tif" width="204" height="32" alt="Figure imgb0036" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/e9/25/c2/5faf961d92329b/imgb0036.png"></a></div> </li> <li class="style-scope patent-text">&lt;210&gt; 28<br class="style-scope patent-text">
&lt;211&gt; 6<br class="style-scope patent-text">
&lt;212&gt; PRT<br class="style-scope patent-text">
&lt;213&gt; Artificial Sequence</li> <li class="style-scope patent-text">&lt;220&gt;<br class="style-scope patent-text">
&lt;223&gt; CDR-H3 derived from YC374 clone</li> <li class="style-scope patent-text">&lt;400&gt; 28
<div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/04/01/04/74c91a40ec31ca/imgb0037.png" class="style-scope patent-text"><img id="ib0037" file="imgb0037.tif" wi="51" he="8" img-content="dna" img-format="tif" width="204" height="32" alt="Figure imgb0037" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/04/01/04/74c91a40ec31ca/imgb0037.png"></a></div> </li> <li class="style-scope patent-text">&lt;210&gt; 29<br class="style-scope patent-text">
&lt;211&gt; 17<br class="style-scope patent-text">
&lt;212&gt; PRT<br class="style-scope patent-text">
&lt;213&gt; Artificial Sequence</li> <li class="style-scope patent-text">&lt;220&gt;<br class="style-scope patent-text">
&lt;223&gt; CDR-L1 derived from L1-1 clone</li> <li class="style-scope patent-text">&lt;400&gt; 29
<div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/0b/d0/bd/74baee902bf605/imgb0038.png" class="style-scope patent-text"><img id="ib0038" file="imgb0038.tif" wi="136" he="15" img-content="dna" img-format="tif" width="544" height="60" alt="Figure imgb0038" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/0b/d0/bd/74baee902bf605/imgb0038.png"></a></div> </li> <li class="style-scope patent-text">&lt;210&gt; 30<br class="style-scope patent-text">
&lt;211&gt; 17<br class="style-scope patent-text">
&lt;212&gt; PRT<br class="style-scope patent-text">
&lt;213&gt; Artificial Sequence</li> <li class="style-scope patent-text">&lt;220&gt;<br class="style-scope patent-text">
&lt;223&gt; CDR-L1 derived from L1-3 clone</li> <li class="style-scope patent-text">&lt;400&gt; 30
<div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/82/51/76/a42695b0040153/imgb0039.png" class="style-scope patent-text"><img id="ib0039" file="imgb0039.tif" wi="136" he="15" img-content="dna" img-format="tif" width="544" height="60" alt="Figure imgb0039" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/82/51/76/a42695b0040153/imgb0039.png"></a></div> </li> <li class="style-scope patent-text">&lt;210&gt; 31<br class="style-scope patent-text">
&lt;211&gt; 17<br class="style-scope patent-text">
&lt;212&gt; PRT<br class="style-scope patent-text">
&lt;213&gt; Artificial Sequence</li> <li class="style-scope patent-text">&lt;220&gt;<br class="style-scope patent-text">
&lt;223&gt; CDR-L1 derived from L1-4 clone</li> <li class="style-scope patent-text">&lt;400&gt; 31
<div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/49/91/98/7ad4ade423829e/imgb0040.png" class="style-scope patent-text"><img id="ib0040" file="imgb0040.tif" wi="136" he="15" img-content="dna" img-format="tif" width="544" height="60" alt="Figure imgb0040" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/49/91/98/7ad4ade423829e/imgb0040.png"></a></div> </li> <li class="style-scope patent-text">&lt;210&gt; 32<br class="style-scope patent-text">
&lt;211&gt; 17<br class="style-scope patent-text">
&lt;212&gt; PRT<br class="style-scope patent-text">
&lt;213&gt; Artificial Sequence</li> <li class="style-scope patent-text">&lt;220&gt;<br class="style-scope patent-text">
&lt;223&gt; CDR-L1 derived from L1-12 clone</li> <li class="style-scope patent-text">&lt;400&gt; 32
<div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/04/91/3a/1c13a44111ee0d/imgb0041.png" class="style-scope patent-text"><img id="ib0041" file="imgb0041.tif" wi="136" he="15" img-content="dna" img-format="tif" width="544" height="60" alt="Figure imgb0041" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/04/91/3a/1c13a44111ee0d/imgb0041.png"></a></div> </li> <li class="style-scope patent-text">&lt;210&gt; 33<br class="style-scope patent-text">
&lt;211&gt; 17<br class="style-scope patent-text">
&lt;212&gt; PRT<br class="style-scope patent-text">
&lt;213&gt; Artificial Sequence</li> <li class="style-scope patent-text">&lt;220&gt;<br class="style-scope patent-text">
&lt;223&gt; CDR-L1 derived from L1-22 clone</li> <li class="style-scope patent-text">&lt;400&gt; 33
<div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/e5/92/f3/9770e81639114f/imgb0042.png" class="style-scope patent-text"><img id="ib0042" file="imgb0042.tif" wi="136" he="15" img-content="dna" img-format="tif" width="544" height="60" alt="Figure imgb0042" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/e5/92/f3/9770e81639114f/imgb0042.png"></a></div> </li> <li class="style-scope patent-text">&lt;210&gt; 34<br class="style-scope patent-text">
&lt;211&gt; 7<br class="style-scope patent-text">
&lt;212&gt; PRT<br class="style-scope patent-text">
&lt;213&gt; Artificial Sequence</li> <li class="style-scope patent-text">&lt;220&gt;<br class="style-scope patent-text">
&lt;223&gt; CDR-L2 derived from L2-9 clone</li> <li class="style-scope patent-text">&lt;400&gt; 34
<div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/75/7b/61/16e0e74dc14a7c/imgb0043.png" class="style-scope patent-text"><img id="ib0043" file="imgb0043.tif" wi="59" he="8" img-content="dna" img-format="tif" width="236" height="32" alt="Figure imgb0043" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/75/7b/61/16e0e74dc14a7c/imgb0043.png"></a></div> </li> <li class="style-scope patent-text">&lt;210&gt; 35<br class="style-scope patent-text">
&lt;211&gt; 7<br class="style-scope patent-text">
&lt;212&gt; PRT<br class="style-scope patent-text">
&lt;213&gt; Artificial Sequence</li> <li class="style-scope patent-text">&lt;220&gt;<br class="style-scope patent-text">
&lt;223&gt; CDR-L2 derived from L2-12 clone</li> <li class="style-scope patent-text">&lt;400&gt; 35
<div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/78/e7/b3/f44d739b3f4436/imgb0044.png" class="style-scope patent-text"><img id="ib0044" file="imgb0044.tif" wi="59" he="8" img-content="dna" img-format="tif" width="236" height="32" alt="Figure imgb0044" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/78/e7/b3/f44d739b3f4436/imgb0044.png"></a></div> </li> <li class="style-scope patent-text">&lt;210&gt; 36<br class="style-scope patent-text">
&lt;211&gt; 7<br class="style-scope patent-text">
&lt;212&gt; PRT<br class="style-scope patent-text">
&lt;213&gt; Artificial Sequence</li> <li class="style-scope patent-text">&lt;220&gt;<br class="style-scope patent-text">
&lt;223&gt; CDR-L2 derived from L2-16 clone</li> <li class="style-scope patent-text">&lt;400&gt; 36
<div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/24/42/7d/7094b313f2732b/imgb0045.png" class="style-scope patent-text"><img id="ib0045" file="imgb0045.tif" wi="59" he="8" img-content="dna" img-format="tif" width="236" height="32" alt="Figure imgb0045" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/24/42/7d/7094b313f2732b/imgb0045.png"></a></div> </li> <li class="style-scope patent-text">&lt;210&gt; 37<br class="style-scope patent-text">
&lt;211&gt; 9<br class="style-scope patent-text">
&lt;212&gt; PRT<br class="style-scope patent-text">
&lt;213&gt; Artificial Sequence</li> <li class="style-scope patent-text">&lt;220&gt;<br class="style-scope patent-text">
&lt;223&gt; CDR-L3 derived from L3-32 clone</li> <li class="style-scope patent-text">&lt;400&gt; 37
<div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/da/1b/c0/d61b5169b56bbf/imgb0046.png" class="style-scope patent-text"><img id="ib0046" file="imgb0046.tif" wi="76" he="8" img-content="dna" img-format="tif" width="304" height="32" alt="Figure imgb0046" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/da/1b/c0/d61b5169b56bbf/imgb0046.png"></a></div> </li> <li class="style-scope patent-text">&lt;210&gt; 38<br class="style-scope patent-text">
&lt;211&gt; 1416<br class="style-scope patent-text">
&lt;212&gt; DNA<br class="style-scope patent-text">
&lt;213&gt; Artificial Sequence</li> <li class="style-scope patent-text">&lt;220&gt;<br class="style-scope patent-text">
&lt;223&gt; nucleotide sequence of heavy chain of chAbF46</li> <li class="style-scope patent-text">&lt;220&gt;<br class="style-scope patent-text">
&lt;221&gt; misc_feature<br class="style-scope patent-text">
&lt;222&gt; (1)..(6)<br class="style-scope patent-text">
&lt;223&gt; EcoRI restriction site</li> <li class="style-scope patent-text">&lt;220&gt;<br class="style-scope patent-text">
&lt;221&gt; misc_feature<br class="style-scope patent-text">
&lt;222&gt; (7)..(66)<br class="style-scope patent-text">
&lt;223&gt; signal sequence</li> <li class="style-scope patent-text">&lt;220&gt;<br class="style-scope patent-text">
&lt;221&gt; misc_feature<br class="style-scope patent-text">
&lt;222&gt; (67)..(417)<br class="style-scope patent-text">
&lt;223&gt; VH - heavy chain variable region</li> <li class="style-scope patent-text">&lt;220&gt;<br class="style-scope patent-text">
&lt;221&gt; misc_feature<br class="style-scope patent-text">
&lt;222&gt; (418)..(423)<br class="style-scope patent-text">
&lt;223&gt; NdeI restriction site</li> <li class="style-scope patent-text">&lt;220&gt;<br class="style-scope patent-text">
&lt;221&gt; misc_feature<br class="style-scope patent-text">
&lt;222&gt; (418)..(1407)<br class="style-scope patent-text">
&lt;223&gt; CH - heavy chain constant region</li> <li class="style-scope patent-text">&lt;220&gt;<br class="style-scope patent-text">
&lt;221&gt; misc_feature<br class="style-scope patent-text">
&lt;222&gt; (1408)..(1410)<br class="style-scope patent-text">
&lt;223&gt; TGA - stop codon</li> <li class="style-scope patent-text">&lt;220&gt;<br class="style-scope patent-text">
&lt;221&gt; misc_feature<br class="style-scope patent-text">
&lt;222&gt; (1411)..(1416)<br class="style-scope patent-text">
&lt;223&gt; XhoI restriction site</li> <li class="style-scope patent-text">&lt;400&gt; 38
<div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/c0/78/83/2e4bb5b95557d6/imgb0047.png" class="style-scope patent-text"><img id="ib0047" file="imgb0047.tif" wi="163" he="183" img-content="dna" img-format="tif" width="652" height="732" alt="Figure imgb0047" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/c0/78/83/2e4bb5b95557d6/imgb0047.png"></a></div> </li> <li class="style-scope patent-text">&lt;210&gt; 39<br class="style-scope patent-text">
&lt;211&gt; 759<br class="style-scope patent-text">
&lt;212&gt; DNA<br class="style-scope patent-text">
&lt;213&gt; Artificial Sequence</li> <li class="style-scope patent-text">&lt;220&gt;<br class="style-scope patent-text">
&lt;223&gt; nucleotide sequence of light chain of chAbF46</li> <li class="style-scope patent-text">&lt;220&gt;<br class="style-scope patent-text">
&lt;221&gt; misc_difference<br class="style-scope patent-text">
&lt;222&gt; (1)..(6)<br class="style-scope patent-text">
&lt;223&gt; EcoRI restriction site</li> <li class="style-scope patent-text">&lt;220&gt;<br class="style-scope patent-text">
&lt;221&gt; misc_difference<br class="style-scope patent-text">
&lt;222&gt; (7)..(90)<br class="style-scope patent-text">
&lt;223&gt; signal sequence</li> <li class="style-scope patent-text">&lt;220&gt;<br class="style-scope patent-text">
&lt;221&gt; misc_difference<br class="style-scope patent-text">
&lt;222&gt; (91)..(432)<br class="style-scope patent-text">
&lt;223&gt; VL - light chain variable region</li> <li class="style-scope patent-text">&lt;220&gt;<br class="style-scope patent-text">
&lt;221&gt; misc_difference<br class="style-scope patent-text">
&lt;222&gt; (430)..(435)<br class="style-scope patent-text">
&lt;223&gt; BsiWI restriction site</li> <li class="style-scope patent-text">&lt;220&gt;<br class="style-scope patent-text">
&lt;221&gt; misc_difference<br class="style-scope patent-text">
&lt;222&gt; (433)..(750)<br class="style-scope patent-text">
&lt;223&gt; CL - light chain constant region</li> <li class="style-scope patent-text">&lt;220&gt;<br class="style-scope patent-text">
&lt;221&gt; misc_difference<br class="style-scope patent-text">
&lt;222&gt; (751)..(753)<br class="style-scope patent-text">
&lt;223&gt; stop codon</li> <li class="style-scope patent-text">&lt;220&gt;<br class="style-scope patent-text">
&lt;221&gt; misc_difference<br class="style-scope patent-text">
&lt;222&gt; (754)..(759)<br class="style-scope patent-text">
&lt;223&gt; XhoI restriction site</li> <li class="style-scope patent-text">&lt;400&gt; 39
<div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/34/b5/e9/552a5d01b6c726/imgb0048.png" class="style-scope patent-text"><img id="ib0048" file="imgb0048.tif" wi="163" he="90" img-content="dna" img-format="tif" width="652" height="360" alt="Figure imgb0048" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/34/b5/e9/552a5d01b6c726/imgb0048.png"></a></div>
<div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/0e/51/96/f4d8849b784f58/imgb0049.png" class="style-scope patent-text"><img id="ib0049" file="imgb0049.tif" wi="163" he="4" img-content="dna" img-format="tif" width="652" height="16" alt="Figure imgb0049" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/0e/51/96/f4d8849b784f58/imgb0049.png"></a></div> </li> <li class="style-scope patent-text">&lt;210&gt; 40<br class="style-scope patent-text">
&lt;211&gt; 447<br class="style-scope patent-text">
&lt;212&gt; PRT<br class="style-scope patent-text">
&lt;213&gt; Artificial Sequence</li> <li class="style-scope patent-text">&lt;220&gt;<br class="style-scope patent-text">
&lt;223&gt; amino acid sequence of H1-heavy</li> <li class="style-scope patent-text">&lt;400&gt; 40
<div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/c3/0c/8e/9bcb71312aaa10/imgb0050.png" class="style-scope patent-text"><img id="ib0050" file="imgb0050.tif" wi="136" he="194" img-content="dna" img-format="tif" width="544" height="776" alt="Figure imgb0050" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/c3/0c/8e/9bcb71312aaa10/imgb0050.png"></a></div>
<div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/fc/38/a6/bc142794109981/imgb0051.png" class="style-scope patent-text"><img id="ib0051" file="imgb0051.tif" wi="136" he="124" img-content="dna" img-format="tif" width="544" height="496" alt="Figure imgb0051" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/fc/38/a6/bc142794109981/imgb0051.png"></a></div> </li> <li class="style-scope patent-text">&lt;210&gt; 41<br class="style-scope patent-text">
&lt;211&gt; 447<br class="style-scope patent-text">
&lt;212&gt; PRT<br class="style-scope patent-text">
&lt;213&gt; Artificial Sequence</li> <li class="style-scope patent-text">&lt;220&gt;<br class="style-scope patent-text">
&lt;223&gt; amino acid sequence of H3-heavy</li> <li class="style-scope patent-text">&lt;400&gt; 41
<div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/7b/8e/91/0ca74192d2341f/imgb0052.png" class="style-scope patent-text"><img id="ib0052" file="imgb0052.tif" wi="136" he="63" img-content="dna" img-format="tif" width="544" height="252" alt="Figure imgb0052" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/7b/8e/91/0ca74192d2341f/imgb0052.png"></a></div>
<div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/0d/12/00/628ba276080167/imgb0053.png" class="style-scope patent-text"><img id="ib0053" file="imgb0053.tif" wi="129" he="233" img-content="dna" img-format="tif" width="516" height="932" alt="Figure imgb0053" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/0d/12/00/628ba276080167/imgb0053.png"></a></div>
<div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/46/48/a8/86c05057680e79/imgb0054.png" class="style-scope patent-text"><img id="ib0054" file="imgb0054.tif" wi="127" he="15" img-content="dna" img-format="tif" width="508" height="60" alt="Figure imgb0054" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/46/48/a8/86c05057680e79/imgb0054.png"></a></div> </li> <li class="style-scope patent-text">&lt;210&gt; 42<br class="style-scope patent-text">
&lt;211&gt; 447<br class="style-scope patent-text">
&lt;212&gt; PRT<br class="style-scope patent-text">
&lt;213&gt; Artificial Sequence</li> <li class="style-scope patent-text">&lt;220&gt;<br class="style-scope patent-text">
&lt;223&gt; amino acid sequence of H4-heavy</li> <li class="style-scope patent-text">&lt;400&gt; 42
<div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/8b/1a/7d/ec2c62f8ea3011/imgb0055.png" class="style-scope patent-text"><img id="ib0055" file="imgb0055.tif" wi="136" he="171" img-content="dna" img-format="tif" width="544" height="684" alt="Figure imgb0055" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/8b/1a/7d/ec2c62f8ea3011/imgb0055.png"></a></div>
<div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/8b/d4/b1/33f9a3570db6dd/imgb0056.png" class="style-scope patent-text"><img id="ib0056" file="imgb0056.tif" wi="136" he="147" img-content="dna" img-format="tif" width="544" height="588" alt="Figure imgb0056" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/8b/d4/b1/33f9a3570db6dd/imgb0056.png"></a></div> </li> <li class="style-scope patent-text">&lt;210&gt; 43<br class="style-scope patent-text">
&lt;211&gt; 220<br class="style-scope patent-text">
&lt;212&gt; PRT<br class="style-scope patent-text">
&lt;213&gt; Artificial Sequence</li> <li class="style-scope patent-text">&lt;220&gt;<br class="style-scope patent-text">
&lt;223&gt; amino acid sequence of H1-light</li> <li class="style-scope patent-text">&lt;400&gt; 43
<div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/8b/3e/cb/1ac214e9a117c3/imgb0057.png" class="style-scope patent-text"><img id="ib0057" file="imgb0057.tif" wi="136" he="42" img-content="dna" img-format="tif" width="544" height="168" alt="Figure imgb0057" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/8b/3e/cb/1ac214e9a117c3/imgb0057.png"></a></div>
<div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/1c/7c/54/c59498d9eda859/imgb0058.png" class="style-scope patent-text"><img id="ib0058" file="imgb0058.tif" wi="136" he="112" img-content="dna" img-format="tif" width="544" height="448" alt="Figure imgb0058" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/1c/7c/54/c59498d9eda859/imgb0058.png"></a></div> </li> <li class="style-scope patent-text">&lt;210&gt; 44<br class="style-scope patent-text">
&lt;211&gt; 220<br class="style-scope patent-text">
&lt;212&gt; PRT<br class="style-scope patent-text">
&lt;213&gt; Artificial Sequence</li> <li class="style-scope patent-text">&lt;220&gt;<br class="style-scope patent-text">
&lt;223&gt; amino acid sequence of H2-light</li> <li class="style-scope patent-text">&lt;400&gt; 44
<div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/9f/0d/b5/047e364c28060a/imgb0059.png" class="style-scope patent-text"><img id="ib0059" file="imgb0059.tif" wi="136" he="77" img-content="dna" img-format="tif" width="544" height="308" alt="Figure imgb0059" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/9f/0d/b5/047e364c28060a/imgb0059.png"></a></div>
<div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/49/1b/db/715ea6bf5a9758/imgb0060.png" class="style-scope patent-text"><img id="ib0060" file="imgb0060.tif" wi="136" he="77" img-content="dna" img-format="tif" width="544" height="308" alt="Figure imgb0060" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/49/1b/db/715ea6bf5a9758/imgb0060.png"></a></div> </li> <li class="style-scope patent-text">&lt;210&gt; 45<br class="style-scope patent-text">
&lt;211&gt; 220<br class="style-scope patent-text">
&lt;212&gt; PRT<br class="style-scope patent-text">
&lt;213&gt; Artificial Sequence</li> <li class="style-scope patent-text">&lt;220&gt;<br class="style-scope patent-text">
&lt;223&gt; amino acid sequence of H3-light</li> <li class="style-scope patent-text">&lt;400&gt; 45
<div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/e5/86/48/fca8273c88dcfc/imgb0061.png" class="style-scope patent-text"><img id="ib0061" file="imgb0061.tif" wi="136" he="121" img-content="dna" img-format="tif" width="544" height="484" alt="Figure imgb0061" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/e5/86/48/fca8273c88dcfc/imgb0061.png"></a></div>
<div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/9f/d5/23/99143f6f17f350/imgb0062.png" class="style-scope patent-text"><img id="ib0062" file="imgb0062.tif" wi="136" he="39" img-content="dna" img-format="tif" width="544" height="156" alt="Figure imgb0062" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/9f/d5/23/99143f6f17f350/imgb0062.png"></a></div> </li> <li class="style-scope patent-text">&lt;210&gt; 46<br class="style-scope patent-text">
&lt;211&gt; 219<br class="style-scope patent-text">
&lt;212&gt; PRT<br class="style-scope patent-text">
&lt;213&gt; Artificial Sequence</li> <li class="style-scope patent-text">&lt;220&gt;<br class="style-scope patent-text">
&lt;223&gt; amino acid sequence of H4-light</li> <li class="style-scope patent-text">&lt;400&gt; 46
<div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/17/93/5e/523540dca02ce2/imgb0063.png" class="style-scope patent-text"><img id="ib0063" file="imgb0063.tif" wi="136" he="159" img-content="dna" img-format="tif" width="544" height="636" alt="Figure imgb0063" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/17/93/5e/523540dca02ce2/imgb0063.png"></a></div> </li> <li class="style-scope patent-text">&lt;210&gt; 47<br class="style-scope patent-text">
&lt;211&gt; 1350<br class="style-scope patent-text">
&lt;212&gt; DNA<br class="style-scope patent-text">
&lt;213&gt; Artificial Sequence</li> <li class="style-scope patent-text">&lt;220&gt;<br class="style-scope patent-text">
&lt;223&gt; nucleotide sequence of H1-heavy</li> <li class="style-scope patent-text">&lt;400&gt; 47
<div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/c5/a0/16/f7885067c12ef8/imgb0064.png" class="style-scope patent-text"><img id="ib0064" file="imgb0064.tif" wi="163" he="175" img-content="dna" img-format="tif" width="652" height="700" alt="Figure imgb0064" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/c5/a0/16/f7885067c12ef8/imgb0064.png"></a></div> </li> <li class="style-scope patent-text">&lt;210&gt; 48<br class="style-scope patent-text">
&lt;211&gt; 1350<br class="style-scope patent-text">
&lt;212&gt; DNA<br class="style-scope patent-text">
&lt;213&gt; Artificial Sequence</li> <li class="style-scope patent-text">&lt;220&gt;<br class="style-scope patent-text">
&lt;223&gt; nucleotide sequence of H3-heavy</li> <li class="style-scope patent-text">&lt;400&gt; 48
<div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/e4/d9/40/981fbaa7191ec5/imgb0065.png" class="style-scope patent-text"><img id="ib0065" file="imgb0065.tif" wi="163" he="175" img-content="dna" img-format="tif" width="652" height="700" alt="Figure imgb0065" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/e4/d9/40/981fbaa7191ec5/imgb0065.png"></a></div> </li> <li class="style-scope patent-text">&lt;210&gt; 49<br class="style-scope patent-text">
&lt;211&gt; 1350<br class="style-scope patent-text">
&lt;212&gt; DNA<br class="style-scope patent-text">
&lt;213&gt; Artificial Sequence</li> <li class="style-scope patent-text">&lt;220&gt;<br class="style-scope patent-text">
&lt;223&gt; nucleotide sequence of H4-heavy</li> <li class="style-scope patent-text">&lt;400&gt; 49
<div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/4d/08/18/c70131e6e2ccfd/imgb0066.png" class="style-scope patent-text"><img id="ib0066" file="imgb0066.tif" wi="163" he="175" img-content="dna" img-format="tif" width="652" height="700" alt="Figure imgb0066" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/4d/08/18/c70131e6e2ccfd/imgb0066.png"></a></div> </li> <li class="style-scope patent-text">&lt;210&gt; 50<br class="style-scope patent-text">
&lt;211&gt; 669<br class="style-scope patent-text">
&lt;212&gt; DNA<br class="style-scope patent-text">
&lt;213&gt; Artificial Sequence</li> <li class="style-scope patent-text">&lt;220&gt;<br class="style-scope patent-text">
&lt;223&gt; nucleotide sequence of H1-light</li> <li class="style-scope patent-text">&lt;400&gt; 50
<div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/12/a1/e4/3531ac9059a985/imgb0067.png" class="style-scope patent-text"><img id="ib0067" file="imgb0067.tif" wi="163" he="20" img-content="dna" img-format="tif" width="652" height="80" alt="Figure imgb0067" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/12/a1/e4/3531ac9059a985/imgb0067.png"></a></div>
<div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/76/1d/46/c2593ae64e232a/imgb0068.png" class="style-scope patent-text"><img id="ib0068" file="imgb0068.tif" wi="163" he="66" img-content="dna" img-format="tif" width="652" height="264" alt="Figure imgb0068" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/76/1d/46/c2593ae64e232a/imgb0068.png"></a></div> </li> <li class="style-scope patent-text">&lt;210&gt; 51<br class="style-scope patent-text">
&lt;211&gt; 669<br class="style-scope patent-text">
&lt;212&gt; DNA<br class="style-scope patent-text">
&lt;213&gt; Artificial Sequence</li> <li class="style-scope patent-text">&lt;220&gt;<br class="style-scope patent-text">
&lt;223&gt; nucleotide sequence of H2-light</li> <li class="style-scope patent-text">&lt;400&gt; 51
<div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/1f/4c/1c/9e829d909df633/imgb0069.png" class="style-scope patent-text"><img id="ib0069" file="imgb0069.tif" wi="163" he="90" img-content="dna" img-format="tif" width="652" height="360" alt="Figure imgb0069" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/1f/4c/1c/9e829d909df633/imgb0069.png"></a></div> </li> <li class="style-scope patent-text">&lt;210&gt; 52<br class="style-scope patent-text">
&lt;211&gt; 669<br class="style-scope patent-text">
&lt;212&gt; DNA<br class="style-scope patent-text">
&lt;213&gt; Artificial Sequence</li> <li class="style-scope patent-text">&lt;220&gt;<br class="style-scope patent-text">
&lt;223&gt; nucleotide sequence of H3-light</li> <li class="style-scope patent-text">&lt;400&gt; 52
<div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/7e/da/d7/7f1d3f08e65dd0/imgb0070.png" class="style-scope patent-text"><img id="ib0070" file="imgb0070.tif" wi="163" he="90" img-content="dna" img-format="tif" width="652" height="360" alt="Figure imgb0070" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/7e/da/d7/7f1d3f08e65dd0/imgb0070.png"></a></div> </li> <li class="style-scope patent-text">&lt;210&gt; 53<br class="style-scope patent-text">
&lt;211&gt; 669<br class="style-scope patent-text">
&lt;212&gt; DNA<br class="style-scope patent-text">
&lt;213&gt; Artificial Sequence</li> <li class="style-scope patent-text">&lt;220&gt;<br class="style-scope patent-text">
&lt;223&gt; nucleotide sequence of H4-light</li> <li class="style-scope patent-text">&lt;400&gt; 53
<div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/64/a3/61/b472354afd37b1/imgb0071.png" class="style-scope patent-text"><img id="ib0071" file="imgb0071.tif" wi="163" he="90" img-content="dna" img-format="tif" width="652" height="360" alt="Figure imgb0071" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/64/a3/61/b472354afd37b1/imgb0071.png"></a></div> </li> <li class="style-scope patent-text">&lt;210&gt; 54<br class="style-scope patent-text">
&lt;211&gt; 23<br class="style-scope patent-text">
&lt;212&gt; PRT<br class="style-scope patent-text">
&lt;213&gt; Artificial Sequence</li> <li class="style-scope patent-text">&lt;220&gt;<br class="style-scope patent-text">
&lt;223&gt; linker between VH and VL</li> <li class="style-scope patent-text">&lt;400&gt; 54
<div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/30/5c/f0/427e9410da9f1f/imgb0072.png" class="style-scope patent-text"><img id="ib0072" file="imgb0072.tif" wi="136" he="19" img-content="dna" img-format="tif" width="544" height="76" alt="Figure imgb0072" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/30/5c/f0/427e9410da9f1f/imgb0072.png"></a></div> </li> <li class="style-scope patent-text">&lt;210&gt; 55<br class="style-scope patent-text">
&lt;211&gt; 1088<br class="style-scope patent-text">
&lt;212&gt; DNA<br class="style-scope patent-text">
&lt;213&gt; Artificial Sequence</li> <li class="style-scope patent-text">&lt;220&gt;<br class="style-scope patent-text">
&lt;223&gt; polynucleotide encoding scFv of huAbF46 antibody</li> <li class="style-scope patent-text">&lt;400&gt; 55
<div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/19/4d/b5/061adbb6b3c6a1/imgb0073.png" class="style-scope patent-text"><img id="ib0073" file="imgb0073.tif" wi="163" he="144" img-content="dna" img-format="tif" width="652" height="576" alt="Figure imgb0073" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/19/4d/b5/061adbb6b3c6a1/imgb0073.png"></a></div> </li> <li class="style-scope patent-text">&lt;210&gt; 56<br class="style-scope patent-text">
&lt;211&gt; 5597<br class="style-scope patent-text">
&lt;212&gt; DNA<br class="style-scope patent-text">
&lt;213&gt; Artificial Sequence</li> <li class="style-scope patent-text">&lt;220&gt;<br class="style-scope patent-text">
&lt;223&gt; expression vector including polynucleotide encoding scFv of huAbF46 antibody</li> <li class="style-scope patent-text">&lt;220&gt;<br class="style-scope patent-text">
&lt;221&gt; misc_difference<br class="style-scope patent-text">
&lt;222&gt; (573)..(578)<br class="style-scope patent-text">
&lt;223&gt; NheI restriction site</li> <li class="style-scope patent-text">&lt;220&gt;<br class="style-scope patent-text">
&lt;221&gt; misc_difference<br class="style-scope patent-text">
&lt;222&gt; (588)..(938)<br class="style-scope patent-text">
&lt;223&gt; huAbF46 VH</li> <li class="style-scope patent-text">&lt;220&gt;<br class="style-scope patent-text">
&lt;221&gt; misc_difference<br class="style-scope patent-text">
&lt;222&gt; (939)..(1007)<br class="style-scope patent-text">
&lt;223&gt; linker</li> <li class="style-scope patent-text">&lt;220&gt;<br class="style-scope patent-text">
&lt;221&gt; misc_difference<br class="style-scope patent-text">
&lt;222&gt; (1008)..(1349)<br class="style-scope patent-text">
&lt;223&gt; huAbF46 VL</li> <li class="style-scope patent-text">&lt;220&gt;<br class="style-scope patent-text">
&lt;221&gt; misc_difference<br class="style-scope patent-text">
&lt;222&gt; (1350)..(1355)<br class="style-scope patent-text">
&lt;223&gt; EcoRI restriction site</li> <li class="style-scope patent-text">&lt;220&gt;<br class="style-scope patent-text">
&lt;221&gt; misc_difference<br class="style-scope patent-text">
&lt;222&gt; (1356)..(1397)<br class="style-scope patent-text">
&lt;223&gt; V5 epitope</li> <li class="style-scope patent-text">&lt;220&gt;<br class="style-scope patent-text">
&lt;221&gt; misc_difference<br class="style-scope patent-text">
&lt;222&gt; (1398)..(1442)<br class="style-scope patent-text">
&lt;223&gt; (G4S)3 linker</li> <li class="style-scope patent-text">&lt;220&gt;<br class="style-scope patent-text">
&lt;221&gt; misc_difference<br class="style-scope patent-text">
&lt;222&gt; (1443)..(1649)<br class="style-scope patent-text">
&lt;223&gt; Aga2</li> <li class="style-scope patent-text">&lt;220&gt;<br class="style-scope patent-text">
&lt;221&gt; misc_difference<br class="style-scope patent-text">
&lt;222&gt; (1650)..(1652)<br class="style-scope patent-text">
&lt;223&gt; TGA(stop codon)</li> <li class="style-scope patent-text">&lt;220&gt;<br class="style-scope patent-text">
&lt;221&gt; misc_difference<br class="style-scope patent-text">
&lt;222&gt; (1653)..(1660)<br class="style-scope patent-text">
&lt;223&gt; PmeI restriction site</li> <li class="style-scope patent-text">&lt;400&gt; 56
<div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/7b/a2/89/1a1ef93208a1c5/imgb0074.png" class="style-scope patent-text"><img id="ib0074" file="imgb0074.tif" wi="163" he="206" img-content="dna" img-format="tif" width="652" height="824" alt="Figure imgb0074" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/7b/a2/89/1a1ef93208a1c5/imgb0074.png"></a></div>
<div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/8a/2c/b6/df5a04b8a7728f/imgb0075.png" class="style-scope patent-text"><img id="ib0075" file="imgb0075.tif" wi="155" he="233" img-content="dna" img-format="tif" width="620" height="932" alt="Figure imgb0075" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/8a/2c/b6/df5a04b8a7728f/imgb0075.png"></a></div>
<div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/34/29/b0/6cbab1490a27e5/imgb0076.png" class="style-scope patent-text"><img id="ib0076" file="imgb0076.tif" wi="160" he="233" img-content="dna" img-format="tif" width="640" height="932" alt="Figure imgb0076" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/34/29/b0/6cbab1490a27e5/imgb0076.png"></a></div>
<div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/0e/a2/73/a1221d3811e671/imgb0077.png" class="style-scope patent-text"><img id="ib0077" file="imgb0077.tif" wi="163" he="28" img-content="dna" img-format="tif" width="652" height="112" alt="Figure imgb0077" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/0e/a2/73/a1221d3811e671/imgb0077.png"></a></div> </li> <li class="style-scope patent-text">&lt;210&gt; 57<br class="style-scope patent-text">
&lt;211&gt; 13<br class="style-scope patent-text">
&lt;212&gt; PRT<br class="style-scope patent-text">
&lt;213&gt; Artificial Sequence</li> <li class="style-scope patent-text">&lt;220&gt;<br class="style-scope patent-text">
&lt;223&gt; U6-HC7 hinge</li> <li class="style-scope patent-text">&lt;400&gt; 57
<div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/67/32/c0/428820a5b178b3/imgb0078.png" class="style-scope patent-text"><img id="ib0078" file="imgb0078.tif" wi="110" he="8" img-content="dna" img-format="tif" width="440" height="32" alt="Figure imgb0078" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/67/32/c0/428820a5b178b3/imgb0078.png"></a></div> </li> <li class="style-scope patent-text">&lt;210&gt; 58<br class="style-scope patent-text">
&lt;211&gt; 435<br class="style-scope patent-text">
&lt;212&gt; DNA<br class="style-scope patent-text">
&lt;213&gt; Artificial Sequence</li> <li class="style-scope patent-text">&lt;220&gt;<br class="style-scope patent-text">
&lt;223&gt; polynucleotide encoding CDR-L3 derived from L3-1 clone</li> <li class="style-scope patent-text">&lt;400&gt; 58
<div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/81/a6/6b/e53aaa63f757f5/imgb0079.png" class="style-scope patent-text"><img id="ib0079" file="imgb0079.tif" wi="163" he="59" img-content="dna" img-format="tif" width="652" height="236" alt="Figure imgb0079" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/81/a6/6b/e53aaa63f757f5/imgb0079.png"></a></div> </li> <li class="style-scope patent-text">&lt;210&gt; 59<br class="style-scope patent-text">
&lt;211&gt; 435<br class="style-scope patent-text">
&lt;212&gt; DNA<br class="style-scope patent-text">
&lt;213&gt; Artificial Sequence</li> <li class="style-scope patent-text">&lt;220&gt;<br class="style-scope patent-text">
&lt;223&gt; polynucleotide encoding CDR-L3 derived from L3-2 clone</li> <li class="style-scope patent-text">&lt;400&gt; 59
<div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/eb/0a/64/6fa9586ab065b5/imgb0080.png" class="style-scope patent-text"><img id="ib0080" file="imgb0080.tif" wi="163" he="12" img-content="dna" img-format="tif" width="652" height="48" alt="Figure imgb0080" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/eb/0a/64/6fa9586ab065b5/imgb0080.png"></a></div>
<div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/0c/3c/26/4e3317b89c74f5/imgb0081.png" class="style-scope patent-text"><img id="ib0081" file="imgb0081.tif" wi="163" he="43" img-content="dna" img-format="tif" width="652" height="172" alt="Figure imgb0081" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/0c/3c/26/4e3317b89c74f5/imgb0081.png"></a></div> </li> <li class="style-scope patent-text">&lt;210&gt; 60<br class="style-scope patent-text">
&lt;211&gt; 435<br class="style-scope patent-text">
&lt;212&gt; DNA<br class="style-scope patent-text">
&lt;213&gt; Artificial Sequence</li> <li class="style-scope patent-text">&lt;220&gt;<br class="style-scope patent-text">
&lt;223&gt; polynucleotide encoding CDR-L3 derived from L3-3 clone</li> <li class="style-scope patent-text">&lt;400&gt; 60
<div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/9c/d5/79/6254b447c1185b/imgb0082.png" class="style-scope patent-text"><img id="ib0082" file="imgb0082.tif" wi="163" he="59" img-content="dna" img-format="tif" width="652" height="236" alt="Figure imgb0082" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/9c/d5/79/6254b447c1185b/imgb0082.png"></a></div> </li> <li class="style-scope patent-text">&lt;210&gt; 61<br class="style-scope patent-text">
&lt;211&gt; 435<br class="style-scope patent-text">
&lt;212&gt; DNA<br class="style-scope patent-text">
&lt;213&gt; Artificial Sequence</li> <li class="style-scope patent-text">&lt;220&gt;<br class="style-scope patent-text">
&lt;223&gt; polynucleotide encoding CDR-L3 derived from L3-5 clone</li> <li class="style-scope patent-text">&lt;400&gt; 61
<div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/2b/e9/ff/683cad0993f64f/imgb0083.png" class="style-scope patent-text"><img id="ib0083" file="imgb0083.tif" wi="163" he="43" img-content="dna" img-format="tif" width="652" height="172" alt="Figure imgb0083" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/2b/e9/ff/683cad0993f64f/imgb0083.png"></a></div>
<div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/c8/bb/79/d8f6b5c8a4cac9/imgb0084.png" class="style-scope patent-text"><img id="ib0084" file="imgb0084.tif" wi="163" he="12" img-content="dna" img-format="tif" width="652" height="48" alt="Figure imgb0084" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/c8/bb/79/d8f6b5c8a4cac9/imgb0084.png"></a></div> </li> <li class="style-scope patent-text">&lt;210&gt; 62<br class="style-scope patent-text">
&lt;211&gt; 462<br class="style-scope patent-text">
&lt;212&gt; PRT<br class="style-scope patent-text">
&lt;213&gt; Artificial Sequence</li> <li class="style-scope patent-text">&lt;220&gt;<br class="style-scope patent-text">
&lt;223&gt; polypeptide consisting of heavy chain of huAbF46-H4-A1, U6-HC7 hinge and constant region of human IgG1</li> <li class="style-scope patent-text">&lt;400&gt; 62
<div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/02/50/5c/f9aa02d03a9529/imgb0085.png" class="style-scope patent-text"><img id="ib0085" file="imgb0085.tif" wi="136" he="182" img-content="dna" img-format="tif" width="544" height="728" alt="Figure imgb0085" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/02/50/5c/f9aa02d03a9529/imgb0085.png"></a></div>
<div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/88/18/e8/4fa55951568dd0/imgb0086.png" class="style-scope patent-text"><img id="ib0086" file="imgb0086.tif" wi="136" he="147" img-content="dna" img-format="tif" width="544" height="588" alt="Figure imgb0086" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/88/18/e8/4fa55951568dd0/imgb0086.png"></a></div> </li> <li class="style-scope patent-text">&lt;210&gt; 63<br class="style-scope patent-text">
&lt;211&gt; 1410<br class="style-scope patent-text">
&lt;212&gt; DNA<br class="style-scope patent-text">
&lt;213&gt; Artificial Sequence</li> <li class="style-scope patent-text">&lt;220&gt;<br class="style-scope patent-text">
&lt;223&gt; polynucleotide encoding polypeptide consisting of heavy chain of huAbF46-H4-A1, U6-HC7 hinge and constant region of human IgG1</li> <li class="style-scope patent-text">&lt;400&gt; 63
<div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/f8/25/30/daa8025dfc10e0/imgb0087.png" class="style-scope patent-text"><img id="ib0087" file="imgb0087.tif" wi="163" he="35" img-content="dna" img-format="tif" width="652" height="140" alt="Figure imgb0087" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/f8/25/30/daa8025dfc10e0/imgb0087.png"></a></div>
<div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/0c/da/6a/8cd49a2381eba5/imgb0088.png" class="style-scope patent-text"><img id="ib0088" file="imgb0088.tif" wi="163" he="144" img-content="dna" img-format="tif" width="652" height="576" alt="Figure imgb0088" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/0c/da/6a/8cd49a2381eba5/imgb0088.png"></a></div> </li> <li class="style-scope patent-text">&lt;210&gt; 64<br class="style-scope patent-text">
&lt;211&gt; 461<br class="style-scope patent-text">
&lt;212&gt; PRT<br class="style-scope patent-text">
&lt;213&gt; Artificial Sequence</li> <li class="style-scope patent-text">&lt;220&gt;<br class="style-scope patent-text">
&lt;223&gt; polypeptide consisting of heavy chain of huAbF46-H4-A1, human IgG2 hinge and constant region of human IgG1</li> <li class="style-scope patent-text">&lt;400&gt; 64
<div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/09/cd/37/7125eb3b16f897/imgb0089.png" class="style-scope patent-text"><img id="ib0089" file="imgb0089.tif" wi="136" he="42" img-content="dna" img-format="tif" width="544" height="168" alt="Figure imgb0089" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/09/cd/37/7125eb3b16f897/imgb0089.png"></a></div>
<div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/67/f3/90/afd5d0b9c7b3cd/imgb0090.png" class="style-scope patent-text"><img id="ib0090" file="imgb0090.tif" wi="132" he="233" img-content="dna" img-format="tif" width="528" height="932" alt="Figure imgb0090" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/67/f3/90/afd5d0b9c7b3cd/imgb0090.png"></a></div>
<div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/71/b3/81/77f67aaad5a511/imgb0091.png" class="style-scope patent-text"><img id="ib0091" file="imgb0091.tif" wi="136" he="42" img-content="dna" img-format="tif" width="544" height="168" alt="Figure imgb0091" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/71/b3/81/77f67aaad5a511/imgb0091.png"></a></div> </li> <li class="style-scope patent-text">&lt;210&gt; 65<br class="style-scope patent-text">
&lt;211&gt; 1407<br class="style-scope patent-text">
&lt;212&gt; DNA<br class="style-scope patent-text">
&lt;213&gt; Artificial Sequence</li> <li class="style-scope patent-text">&lt;220&gt;<br class="style-scope patent-text">
&lt;223&gt; polynucleotide encoding polypeptide consisting of heavy chain of huAbF46-H4-A1, human IgG2 hinge and constant region of human IgG1</li> <li class="style-scope patent-text">&lt;400&gt; 65
<div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/fe/57/05/3232fc72f631ec/imgb0092.png" class="style-scope patent-text"><img id="ib0092" file="imgb0092.tif" wi="163" he="144" img-content="dna" img-format="tif" width="652" height="576" alt="Figure imgb0092" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/fe/57/05/3232fc72f631ec/imgb0092.png"></a></div>
<div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/08/77/e1/80f5ca38cfc510/imgb0093.png" class="style-scope patent-text"><img id="ib0093" file="imgb0093.tif" wi="163" he="35" img-content="dna" img-format="tif" width="652" height="140" alt="Figure imgb0093" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/08/77/e1/80f5ca38cfc510/imgb0093.png"></a></div> </li> <li class="style-scope patent-text">&lt;210&gt; 66<br class="style-scope patent-text">
&lt;211&gt; 460<br class="style-scope patent-text">
&lt;212&gt; PRT<br class="style-scope patent-text">
&lt;213&gt; Artificial Sequence</li> <li class="style-scope patent-text">&lt;220&gt;<br class="style-scope patent-text">
&lt;223&gt; polypeptide consisting of heavy chain of huAbF46-H4-A1, human IgG2 hinge and constant region of human IgG2</li> <li class="style-scope patent-text">&lt;400&gt; 66
<div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/a1/74/fc/8c889782c022f8/imgb0094.png" class="style-scope patent-text"><img id="ib0094" file="imgb0094.tif" wi="136" he="156" img-content="dna" img-format="tif" width="544" height="624" alt="Figure imgb0094" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/a1/74/fc/8c889782c022f8/imgb0094.png"></a></div>
<div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/dd/1d/85/b25ee9c8ad661f/imgb0095.png" class="style-scope patent-text"><img id="ib0095" file="imgb0095.tif" wi="136" he="178" img-content="dna" img-format="tif" width="544" height="712" alt="Figure imgb0095" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/dd/1d/85/b25ee9c8ad661f/imgb0095.png"></a></div> </li> <li class="style-scope patent-text">&lt;210&gt; 67<br class="style-scope patent-text">
&lt;211&gt; 1404<br class="style-scope patent-text">
&lt;212&gt; DNA<br class="style-scope patent-text">
&lt;213&gt; Artificial Sequence</li> <li class="style-scope patent-text">&lt;220&gt;<br class="style-scope patent-text">
&lt;223&gt; polynucleotide encoding polypeptide consisting of heavy chain of huAbF46-H4-A1, human IgG2 hinge and constant region of human IgG2</li> <li class="style-scope patent-text">&lt;400&gt; 67
<div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/32/37/3f/3b6883ec492aa5/imgb0096.png" class="style-scope patent-text"><img id="ib0096" file="imgb0096.tif" wi="163" he="12" img-content="dna" img-format="tif" width="652" height="48" alt="Figure imgb0096" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/32/37/3f/3b6883ec492aa5/imgb0096.png"></a></div>
<div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/e6/79/2d/908e16a1c9d5a4/imgb0097.png" class="style-scope patent-text"><img id="ib0097" file="imgb0097.tif" wi="163" he="167" img-content="dna" img-format="tif" width="652" height="668" alt="Figure imgb0097" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/e6/79/2d/908e16a1c9d5a4/imgb0097.png"></a></div> </li> <li class="style-scope patent-text">&lt;210&gt; 68<br class="style-scope patent-text">
&lt;211&gt; 240<br class="style-scope patent-text">
&lt;212&gt; PRT<br class="style-scope patent-text">
&lt;213&gt; Artificial Sequence</li> <li class="style-scope patent-text">&lt;220&gt;<br class="style-scope patent-text">
&lt;223&gt; polypeptide consisting of light chain of huAbF46-H4-A1(H36Y) and human kappa constant region</li> <li class="style-scope patent-text">&lt;400&gt; 68
<div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/1a/8c/97/79b5696f3b8e6f/imgb0098.png" class="style-scope patent-text"><img id="ib0098" file="imgb0098.tif" wi="136" he="28" img-content="dna" img-format="tif" width="544" height="112" alt="Figure imgb0098" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/1a/8c/97/79b5696f3b8e6f/imgb0098.png"></a></div>
<div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/83/34/d6/b3c2f20d37d9b3/imgb0099.png" class="style-scope patent-text"><img id="ib0099" file="imgb0099.tif" wi="136" he="143" img-content="dna" img-format="tif" width="544" height="572" alt="Figure imgb0099" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/83/34/d6/b3c2f20d37d9b3/imgb0099.png"></a></div> </li> <li class="style-scope patent-text">&lt;210&gt; 69<br class="style-scope patent-text">
&lt;211&gt; 758<br class="style-scope patent-text">
&lt;212&gt; DNA<br class="style-scope patent-text">
&lt;213&gt; Artificial Sequence</li> <li class="style-scope patent-text">&lt;220&gt;<br class="style-scope patent-text">
&lt;223&gt; polynucleotide encoding polypeptide consisting of light chain of huAbF46-H4-A1(H36Y) and human kappa constant region</li> <li class="style-scope patent-text">&lt;400&gt; 69
<div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/8c/8e/26/6033d0ae533ed4/imgb0100.png" class="style-scope patent-text"><img id="ib0100" file="imgb0100.tif" wi="163" he="51" img-content="dna" img-format="tif" width="652" height="204" alt="Figure imgb0100" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/8c/8e/26/6033d0ae533ed4/imgb0100.png"></a></div>
<div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/27/f8/9f/745ba15763d377/imgb0101.png" class="style-scope patent-text"><img id="ib0101" file="imgb0101.tif" wi="163" he="43" img-content="dna" img-format="tif" width="652" height="172" alt="Figure imgb0101" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/27/f8/9f/745ba15763d377/imgb0101.png"></a></div> </li> <li class="style-scope patent-text">&lt;210&gt; 70<br class="style-scope patent-text">
&lt;211&gt; 240<br class="style-scope patent-text">
&lt;212&gt; PRT<br class="style-scope patent-text">
&lt;213&gt; Artificial Sequence</li> <li class="style-scope patent-text">&lt;220&gt;<br class="style-scope patent-text">
&lt;223&gt; polypeptide consisting of light chain of huAbF46-H4-A1 and human kappa constant region</li> <li class="style-scope patent-text">&lt;400&gt; 70
<div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/c7/92/66/eadba36ebe35ad/imgb0102.png" class="style-scope patent-text"><img id="ib0102" file="imgb0102.tif" wi="136" he="147" img-content="dna" img-format="tif" width="544" height="588" alt="Figure imgb0102" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/c7/92/66/eadba36ebe35ad/imgb0102.png"></a></div>
<div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/1c/59/59/a328c99dab50d2/imgb0103.png" class="style-scope patent-text"><img id="ib0103" file="imgb0103.tif" wi="135" he="19" img-content="dna" img-format="tif" width="540" height="76" alt="Figure imgb0103" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/1c/59/59/a328c99dab50d2/imgb0103.png"></a></div> </li> <li class="style-scope patent-text">&lt;210&gt; 71<br class="style-scope patent-text">
&lt;211&gt; 19<br class="style-scope patent-text">
&lt;212&gt; PRT<br class="style-scope patent-text">
&lt;213&gt; Artificial Sequence</li> <li class="style-scope patent-text">&lt;220&gt;<br class="style-scope patent-text">
&lt;223&gt; epitope in SEMA domain of c-Met</li> <li class="style-scope patent-text">&lt;400&gt; 71
<div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/eb/c0/1c/c14c8add375df3/imgb0104.png" class="style-scope patent-text"><img id="ib0104" file="imgb0104.tif" wi="135" he="15" img-content="dna" img-format="tif" width="540" height="60" alt="Figure imgb0104" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/eb/c0/1c/c14c8add375df3/imgb0104.png"></a></div> </li> <li class="style-scope patent-text">&lt;210&gt; 72<br class="style-scope patent-text">
&lt;211&gt; 10<br class="style-scope patent-text">
&lt;212&gt; PRT<br class="style-scope patent-text">
&lt;213&gt; Artificial Sequence</li> <li class="style-scope patent-text">&lt;220&gt;<br class="style-scope patent-text">
&lt;223&gt; epitope in SEMA domain of c-Met</li> <li class="style-scope patent-text">&lt;400&gt; 72
<div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/e5/25/27/3dd4a8945da157/imgb0105.png" class="style-scope patent-text"><img id="ib0105" file="imgb0105.tif" wi="84" he="8" img-content="dna" img-format="tif" width="336" height="32" alt="Figure imgb0105" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/e5/25/27/3dd4a8945da157/imgb0105.png"></a></div> </li> <li class="style-scope patent-text">&lt;210&gt; 73<br class="style-scope patent-text">
&lt;211&gt; 5<br class="style-scope patent-text">
&lt;212&gt; PRT<br class="style-scope patent-text">
&lt;213&gt; Artificial Sequence</li> <li class="style-scope patent-text">&lt;220&gt;<br class="style-scope patent-text">
&lt;223&gt; epitope in SEMA domain of c-Met</li> <li class="style-scope patent-text">&lt;400&gt; 73
<div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/a4/52/02/2912f099c7bde7/imgb0106.png" class="style-scope patent-text"><img id="ib0106" file="imgb0106.tif" wi="42" he="8" img-content="dna" img-format="tif" width="168" height="32" alt="Figure imgb0106" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/a4/52/02/2912f099c7bde7/imgb0106.png"></a></div> </li> <li class="style-scope patent-text">&lt;210&gt; 74<br class="style-scope patent-text">
&lt;211&gt; 117<br class="style-scope patent-text">
&lt;212&gt; PRT<br class="style-scope patent-text">
&lt;213&gt; Artificial Sequence</li> <li class="style-scope patent-text">&lt;220&gt;<br class="style-scope patent-text">
&lt;223&gt; heavy chain variable region of anti-c-Met antibody (AbF46 or huAbF46-H1)</li> <li class="style-scope patent-text">&lt;400&gt; 74
<div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/77/df/cb/b7ef243848238a/imgb0107.png" class="style-scope patent-text"><img id="ib0107" file="imgb0107.tif" wi="136" he="89" img-content="dna" img-format="tif" width="544" height="356" alt="Figure imgb0107" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/77/df/cb/b7ef243848238a/imgb0107.png"></a></div> </li> <li class="style-scope patent-text">&lt;210&gt; 75<br class="style-scope patent-text">
&lt;211&gt; 114<br class="style-scope patent-text">
&lt;212&gt; PRT<br class="style-scope patent-text">
&lt;213&gt; Artificial Sequence</li> <li class="style-scope patent-text">&lt;220&gt;<br class="style-scope patent-text">
&lt;223&gt; light chain variable region of anti-c-Met antibody (AbF46 or huAbF46-H1)</li> <li class="style-scope patent-text">&lt;400&gt; 75
<div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/9e/f9/af/1639e64b72684d/imgb0108.png" class="style-scope patent-text"><img id="ib0108" file="imgb0108.tif" wi="136" he="86" img-content="dna" img-format="tif" width="544" height="344" alt="Figure imgb0108" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/9e/f9/af/1639e64b72684d/imgb0108.png"></a></div> </li> <li class="style-scope patent-text">&lt;210&gt; 76<br class="style-scope patent-text">
&lt;211&gt; 1416<br class="style-scope patent-text">
&lt;212&gt; DNA<br class="style-scope patent-text">
&lt;213&gt; Artificial Sequence</li> <li class="style-scope patent-text">&lt;220&gt;<br class="style-scope patent-text">
&lt;223&gt; nucleotide sequence of heavy chain of nti-c-Met antibody (AbF46 or huAbF46-H1)</li> <li class="style-scope patent-text">&lt;220&gt;<br class="style-scope patent-text">
&lt;221&gt; misc_feature<br class="style-scope patent-text">
&lt;222&gt; (1)..(6)<br class="style-scope patent-text">
&lt;223&gt; EcoRI restriction site</li> <li class="style-scope patent-text">&lt;220&gt;<br class="style-scope patent-text">
&lt;221&gt; misc_feature<br class="style-scope patent-text">
&lt;222&gt; (7)..(66)<br class="style-scope patent-text">
&lt;223&gt; signal sequence</li> <li class="style-scope patent-text">&lt;220&gt;<br class="style-scope patent-text">
&lt;221&gt; misc_feature<br class="style-scope patent-text">
&lt;222&gt; (67)..(417)<br class="style-scope patent-text">
&lt;223&gt; VH - heavy chain variable region</li> <li class="style-scope patent-text">&lt;220&gt;<br class="style-scope patent-text">
&lt;221&gt; misc_feature<br class="style-scope patent-text">
&lt;222&gt; (418)..(423)<br class="style-scope patent-text">
&lt;223&gt; NdeI restriction site</li> <li class="style-scope patent-text">&lt;220&gt;<br class="style-scope patent-text">
&lt;221&gt; misc_feature<br class="style-scope patent-text">
&lt;222&gt; (418)..(1407)<br class="style-scope patent-text">
&lt;223&gt; CH - heavy chain constant region</li> <li class="style-scope patent-text">&lt;220&gt;<br class="style-scope patent-text">
&lt;221&gt; misc_feature<br class="style-scope patent-text">
&lt;222&gt; (1408)..(1410)<br class="style-scope patent-text">
&lt;223&gt; TGA - stop codon</li> <li class="style-scope patent-text">&lt;220&gt;<br class="style-scope patent-text">
&lt;221&gt; misc_feature<br class="style-scope patent-text">
&lt;222&gt; (1411)..(1416)<br class="style-scope patent-text">
&lt;223&gt; XhoI restriction site</li> <li class="style-scope patent-text">&lt;400&gt; 76
<div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/0d/96/d6/a214f90596bfef/imgb0109.png" class="style-scope patent-text"><img id="ib0109" file="imgb0109.tif" wi="163" he="43" img-content="dna" img-format="tif" width="652" height="172" alt="Figure imgb0109" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/0d/96/d6/a214f90596bfef/imgb0109.png"></a></div>
<div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/f6/13/ed/61c24907d52bfb/imgb0110.png" class="style-scope patent-text"><img id="ib0110" file="imgb0110.tif" wi="163" he="136" img-content="dna" img-format="tif" width="652" height="544" alt="Figure imgb0110" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/f6/13/ed/61c24907d52bfb/imgb0110.png"></a></div> </li> <li class="style-scope patent-text">&lt;210&gt; 77<br class="style-scope patent-text">
&lt;211&gt; 759<br class="style-scope patent-text">
&lt;212&gt; DNA<br class="style-scope patent-text">
&lt;213&gt; Artificial Sequence</li> <li class="style-scope patent-text">&lt;220&gt;<br class="style-scope patent-text">
&lt;223&gt; nucleotide sequence of light chain of anti-c-Met antibody (AbF46 or huAbF46-H1)</li> <li class="style-scope patent-text">&lt;220&gt;<br class="style-scope patent-text">
&lt;221&gt; misc_difference<br class="style-scope patent-text">
&lt;222&gt; (1)..(6)<br class="style-scope patent-text">
&lt;223&gt; EcoRI restriction site</li> <li class="style-scope patent-text">&lt;220&gt;<br class="style-scope patent-text">
&lt;221&gt; misc_difference<br class="style-scope patent-text">
&lt;222&gt; (7)..(90)<br class="style-scope patent-text">
&lt;223&gt; signal sequence</li> <li class="style-scope patent-text">&lt;220&gt;<br class="style-scope patent-text">
&lt;221&gt; misc_difference<br class="style-scope patent-text">
&lt;222&gt; (91)..(432)<br class="style-scope patent-text">
&lt;223&gt; VL - light chain variable region</li> <li class="style-scope patent-text">&lt;220&gt;<br class="style-scope patent-text">
&lt;221&gt; misc_difference<br class="style-scope patent-text">
&lt;222&gt; (430)..(435)<br class="style-scope patent-text">
&lt;223&gt; BsiWI restriction site</li> <li class="style-scope patent-text">&lt;220&gt;<br class="style-scope patent-text">
&lt;221&gt; misc_difference<br class="style-scope patent-text">
&lt;222&gt; (433)..(750)<br class="style-scope patent-text">
&lt;223&gt; CL - light chain constant region</li> <li class="style-scope patent-text">&lt;220&gt;<br class="style-scope patent-text">
&lt;221&gt; misc_difference<br class="style-scope patent-text">
&lt;222&gt; (751)..(753)<br class="style-scope patent-text">
&lt;223&gt; stop codon</li> <li class="style-scope patent-text">&lt;220&gt;<br class="style-scope patent-text">
&lt;221&gt; misc_difference<br class="style-scope patent-text">
&lt;222&gt; (754)..(759)<br class="style-scope patent-text">
&lt;223&gt; XhoI restriction site</li> <li class="style-scope patent-text">&lt;400&gt; 77
<div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/74/da/e4/90a89b76b29c66/imgb0111.png" class="style-scope patent-text"><img id="ib0111" file="imgb0111.tif" wi="163" he="98" img-content="dna" img-format="tif" width="652" height="392" alt="Figure imgb0111" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/74/da/e4/90a89b76b29c66/imgb0111.png"></a></div> </li> <li class="style-scope patent-text">&lt;210&gt; 78<br class="style-scope patent-text">
&lt;211&gt; 4170<br class="style-scope patent-text">
&lt;212&gt; DNA<br class="style-scope patent-text">
&lt;213&gt; Artificial Sequence</li> <li class="style-scope patent-text">&lt;220&gt;<br class="style-scope patent-text">
&lt;223&gt; polynucleotide encoding c-Met protein</li> <li class="style-scope patent-text">&lt;400&gt; 78
<div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/28/aa/a1/69191efdad4ed0/imgb0112.png" class="style-scope patent-text"><img id="ib0112" file="imgb0112.tif" wi="160" he="233" img-content="dna" img-format="tif" width="640" height="932" alt="Figure imgb0112" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/28/aa/a1/69191efdad4ed0/imgb0112.png"></a></div>
<div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/e3/2b/41/68d54dcf165788/imgb0113.png" class="style-scope patent-text"><img id="ib0113" file="imgb0113.tif" wi="160" he="233" img-content="dna" img-format="tif" width="640" height="932" alt="Figure imgb0113" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/e3/2b/41/68d54dcf165788/imgb0113.png"></a></div>
<div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/5c/e4/c5/5d8222ec7324cd/imgb0114.png" class="style-scope patent-text"><img id="ib0114" file="imgb0114.tif" wi="163" he="59" img-content="dna" img-format="tif" width="652" height="236" alt="Figure imgb0114" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/5c/e4/c5/5d8222ec7324cd/imgb0114.png"></a></div> </li> <li class="style-scope patent-text">&lt;210&gt; 79<br class="style-scope patent-text">
&lt;211&gt; 444<br class="style-scope patent-text">
&lt;212&gt; PRT<br class="style-scope patent-text">
&lt;213&gt; Artificial Sequence</li> <li class="style-scope patent-text">&lt;220&gt;<br class="style-scope patent-text">
&lt;223&gt; SEMA domain of c-Met</li> <li class="style-scope patent-text">&lt;400&gt; 79
<div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/9d/ff/ee/aa888c7fb5ab29/imgb0115.png" class="style-scope patent-text"><img id="ib0115" file="imgb0115.tif" wi="136" he="136" img-content="dna" img-format="tif" width="544" height="544" alt="Figure imgb0115" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/9d/ff/ee/aa888c7fb5ab29/imgb0115.png"></a></div>
<div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/b6/5a/56/74d09acb0d642a/imgb0116.png" class="style-scope patent-text"><img id="ib0116" file="imgb0116.tif" wi="136" he="182" img-content="dna" img-format="tif" width="544" height="728" alt="Figure imgb0116" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/b6/5a/56/74d09acb0d642a/imgb0116.png"></a></div> </li> <li class="style-scope patent-text">&lt;210&gt; 80<br class="style-scope patent-text">
&lt;211&gt; 451<br class="style-scope patent-text">
&lt;212&gt; PRT<br class="style-scope patent-text">
&lt;213&gt; Artificial Sequence</li> <li class="style-scope patent-text">&lt;220&gt;<br class="style-scope patent-text">
&lt;223&gt; PSI-IPT domain of c-Met</li> <li class="style-scope patent-text">&lt;400&gt; 80
<div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/2e/23/60/1d4de3d05d812d/imgb0117.png" class="style-scope patent-text"><img id="ib0117" file="imgb0117.tif" wi="136" he="16" img-content="dna" img-format="tif" width="544" height="64" alt="Figure imgb0117" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/2e/23/60/1d4de3d05d812d/imgb0117.png"></a></div>
<div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/99/47/08/0d3155b467a47b/imgb0118.png" class="style-scope patent-text"><img id="ib0118" file="imgb0118.tif" wi="129" he="233" img-content="dna" img-format="tif" width="516" height="932" alt="Figure imgb0118" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/99/47/08/0d3155b467a47b/imgb0118.png"></a></div>
<div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/54/f6/3e/54351d0a3f67bd/imgb0119.png" class="style-scope patent-text"><img id="ib0119" file="imgb0119.tif" wi="136" he="74" img-content="dna" img-format="tif" width="544" height="296" alt="Figure imgb0119" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/54/f6/3e/54351d0a3f67bd/imgb0119.png"></a></div> </li> <li class="style-scope patent-text">&lt;210&gt; 81<br class="style-scope patent-text">
&lt;211&gt; 313<br class="style-scope patent-text">
&lt;212&gt; PRT<br class="style-scope patent-text">
&lt;213&gt; Artificial Sequence</li> <li class="style-scope patent-text">&lt;220&gt;<br class="style-scope patent-text">
&lt;223&gt; TyrKc domain of c-Met</li> <li class="style-scope patent-text">&lt;400&gt; 81
<div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/93/ab/52/cbc2b297048602/imgb0120.png" class="style-scope patent-text"><img id="ib0120" file="imgb0120.tif" wi="136" he="124" img-content="dna" img-format="tif" width="544" height="496" alt="Figure imgb0120" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/93/ab/52/cbc2b297048602/imgb0120.png"></a></div>
<div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/97/69/95/73f91f54c431fc/imgb0121.png" class="style-scope patent-text"><img id="ib0121" file="imgb0121.tif" wi="136" he="101" img-content="dna" img-format="tif" width="544" height="404" alt="Figure imgb0121" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/97/69/95/73f91f54c431fc/imgb0121.png"></a></div> </li> <li class="style-scope patent-text">&lt;210&gt; 82<br class="style-scope patent-text">
&lt;211&gt; 1332<br class="style-scope patent-text">
&lt;212&gt; DNA<br class="style-scope patent-text">
&lt;213&gt; Artificial Sequence</li> <li class="style-scope patent-text">&lt;220&gt;<br class="style-scope patent-text">
&lt;223&gt; polynucleotide encoding SEMA domain of c-Met</li> <li class="style-scope patent-text">&lt;400&gt; 82
<div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/0e/fd/70/0df41a262965bb/imgb0122.png" class="style-scope patent-text"><img id="ib0122" file="imgb0122.tif" wi="163" he="90" img-content="dna" img-format="tif" width="652" height="360" alt="Figure imgb0122" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/0e/fd/70/0df41a262965bb/imgb0122.png"></a></div>
<div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/69/38/25/0398af2f1f5f7a/imgb0123.png" class="style-scope patent-text"><img id="ib0123" file="imgb0123.tif" wi="163" he="82" img-content="dna" img-format="tif" width="652" height="328" alt="Figure imgb0123" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/69/38/25/0398af2f1f5f7a/imgb0123.png"></a></div> </li> <li class="style-scope patent-text">&lt;210&gt; 83<br class="style-scope patent-text">
&lt;211&gt; 1299<br class="style-scope patent-text">
&lt;212&gt; DNA<br class="style-scope patent-text">
&lt;213&gt; Artificial Sequence</li> <li class="style-scope patent-text">&lt;220&gt;<br class="style-scope patent-text">
&lt;223&gt; polynucleotide encoding PSI-IPT domain of c-Met</li> <li class="style-scope patent-text">&lt;400&gt; 83
<div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/6f/20/da/a17a79489125f6/imgb0124.png" class="style-scope patent-text"><img id="ib0124" file="imgb0124.tif" wi="163" he="113" img-content="dna" img-format="tif" width="652" height="452" alt="Figure imgb0124" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/6f/20/da/a17a79489125f6/imgb0124.png"></a></div>
<div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/26/23/b6/e6b66ef30ec821/imgb0125.png" class="style-scope patent-text"><img id="ib0125" file="imgb0125.tif" wi="163" he="51" img-content="dna" img-format="tif" width="652" height="204" alt="Figure imgb0125" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/26/23/b6/e6b66ef30ec821/imgb0125.png"></a></div> </li> <li class="style-scope patent-text">&lt;210&gt; 84<br class="style-scope patent-text">
&lt;211&gt; 939<br class="style-scope patent-text">
&lt;212&gt; DNA<br class="style-scope patent-text">
&lt;213&gt; Artificial Sequence</li> <li class="style-scope patent-text">&lt;220&gt;<br class="style-scope patent-text">
&lt;223&gt; polynucleotide encoding TyrKc domain of c-Met</li> <li class="style-scope patent-text">&lt;400&gt; 84
<div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/d8/de/94/1f36e2145922d9/imgb0126.png" class="style-scope patent-text"><img id="ib0126" file="imgb0126.tif" wi="163" he="121" img-content="dna" img-format="tif" width="652" height="484" alt="Figure imgb0126" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/d8/de/94/1f36e2145922d9/imgb0126.png"></a></div> </li> <li class="style-scope patent-text">&lt;210&gt; 85<br class="style-scope patent-text">
&lt;211&gt; 13<br class="style-scope patent-text">
&lt;212&gt; PRT<br class="style-scope patent-text">
&lt;213&gt; Artificial Sequence</li> <li class="style-scope patent-text">&lt;220&gt;<br class="style-scope patent-text">
&lt;223&gt; heavy chain CDR3 of anti-c-Met antibody</li> <li class="style-scope patent-text">&lt;400&gt; 85
<div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/02/db/87/0f5b5e78218e85/imgb0127.png" class="style-scope patent-text"><img id="ib0127" file="imgb0127.tif" wi="110" he="8" img-content="dna" img-format="tif" width="440" height="32" alt="Figure imgb0127" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/02/db/87/0f5b5e78218e85/imgb0127.png"></a></div> </li> <li class="style-scope patent-text">&lt;210&gt; 86<br class="style-scope patent-text">
&lt;211&gt; 10<br class="style-scope patent-text">
&lt;212&gt; PRT<br class="style-scope patent-text">
&lt;213&gt; Artificial Sequence</li> <li class="style-scope patent-text">&lt;220&gt;<br class="style-scope patent-text">
&lt;223&gt; light chain CDR3 of anti-c-Met antibody</li> <li class="style-scope patent-text">&lt;400&gt; 86
<div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/84/cb/52/1b004f57b7f5d4/imgb0128.png" class="style-scope patent-text"><img id="ib0128" file="imgb0128.tif" wi="85" he="8" img-content="dna" img-format="tif" width="340" height="32" alt="Figure imgb0128" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/84/cb/52/1b004f57b7f5d4/imgb0128.png"></a></div> </li> <li class="style-scope patent-text">&lt;210&gt; 87<br class="style-scope patent-text">
&lt;211&gt; 117<br class="style-scope patent-text">
&lt;212&gt; PRT<br class="style-scope patent-text">
&lt;213&gt; Artificial Sequence</li> <li class="style-scope patent-text">&lt;220&gt;<br class="style-scope patent-text">
&lt;223&gt; heavy chain variable region of monoclonal antibody AbF46</li> <li class="style-scope patent-text">&lt;400&gt; 87
<div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/a3/ea/24/84ba7435c3bafc/imgb0129.png" class="style-scope patent-text"><img id="ib0129" file="imgb0129.tif" wi="136" he="89" img-content="dna" img-format="tif" width="544" height="356" alt="Figure imgb0129" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/a3/ea/24/84ba7435c3bafc/imgb0129.png"></a></div> </li> <li class="style-scope patent-text">&lt;210&gt; 88<br class="style-scope patent-text">
&lt;211&gt; 114<br class="style-scope patent-text">
&lt;212&gt; PRT<br class="style-scope patent-text">
&lt;213&gt; Artificial Sequence</li> <li class="style-scope patent-text">&lt;220&gt;<br class="style-scope patent-text">
&lt;223&gt; light chain variable region of anti-c-Met antibody</li> <li class="style-scope patent-text">&lt;400&gt; 88
<div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/25/56/7a/41160e1e4bb0e3/imgb0130.png" class="style-scope patent-text"><img id="ib0130" file="imgb0130.tif" wi="136" he="86" img-content="dna" img-format="tif" width="544" height="344" alt="Figure imgb0130" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/25/56/7a/41160e1e4bb0e3/imgb0130.png"></a></div> </li> <li class="style-scope patent-text">&lt;210&gt; 89<br class="style-scope patent-text">
&lt;211&gt; 17<br class="style-scope patent-text">
&lt;212&gt; PRT<br class="style-scope patent-text">
&lt;213&gt; Artificial Sequence</li> <li class="style-scope patent-text">&lt;220&gt;<br class="style-scope patent-text">
&lt;223&gt; light chain CDR3 of anti-c-Met antibody</li> <li class="style-scope patent-text">&lt;400&gt; 89
<div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/c5/5b/b9/7a39a70ac4aeee/imgb0131.png" class="style-scope patent-text"><img id="ib0131" file="imgb0131.tif" wi="136" he="15" img-content="dna" img-format="tif" width="544" height="60" alt="Figure imgb0131" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/c5/5b/b9/7a39a70ac4aeee/imgb0131.png"></a></div> </li> <li class="style-scope patent-text">&lt;210&gt; 90<br class="style-scope patent-text">
&lt;211&gt; 117<br class="style-scope patent-text">
&lt;212&gt; PRT<br class="style-scope patent-text">
&lt;213&gt; Artificial Sequence</li> <li class="style-scope patent-text">&lt;220&gt;<br class="style-scope patent-text">
&lt;223&gt; heavy chain variable region of AT-VH1</li> <li class="style-scope patent-text">&lt;400&gt; 90
<div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/a1/c8/fb/00923339d7fd96/imgb0132.png" class="style-scope patent-text"><img id="ib0132" file="imgb0132.tif" wi="136" he="19" img-content="dna" img-format="tif" width="544" height="76" alt="Figure imgb0132" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/a1/c8/fb/00923339d7fd96/imgb0132.png"></a></div>
<div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/3c/41/5e/6703fd7ad4a137/imgb0133.png" class="style-scope patent-text"><img id="ib0133" file="imgb0133.tif" wi="136" he="66" img-content="dna" img-format="tif" width="544" height="264" alt="Figure imgb0133" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/3c/41/5e/6703fd7ad4a137/imgb0133.png"></a></div> </li> <li class="style-scope patent-text">&lt;210&gt; 91<br class="style-scope patent-text">
&lt;211&gt; 117<br class="style-scope patent-text">
&lt;212&gt; PRT<br class="style-scope patent-text">
&lt;213&gt; Artificial Sequence</li> <li class="style-scope patent-text">&lt;220&gt;<br class="style-scope patent-text">
&lt;223&gt; heavy chain variable region of AT-VH2</li> <li class="style-scope patent-text">&lt;400&gt; 91
<div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/98/7d/7f/e5434b7f8617ab/imgb0134.png" class="style-scope patent-text"><img id="ib0134" file="imgb0134.tif" wi="136" he="89" img-content="dna" img-format="tif" width="544" height="356" alt="Figure imgb0134" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/98/7d/7f/e5434b7f8617ab/imgb0134.png"></a></div> </li> <li class="style-scope patent-text">&lt;210&gt; 92<br class="style-scope patent-text">
&lt;211&gt; 117<br class="style-scope patent-text">
&lt;212&gt; PRT<br class="style-scope patent-text">
&lt;213&gt; Artificial Sequence</li> <li class="style-scope patent-text">&lt;220&gt;<br class="style-scope patent-text">
&lt;223&gt; heavy chain variable region of AT-VH3</li> <li class="style-scope patent-text">&lt;400&gt; 92
<div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/6b/26/5e/75625144083d8b/imgb0135.png" class="style-scope patent-text"><img id="ib0135" file="imgb0135.tif" wi="136" he="89" img-content="dna" img-format="tif" width="544" height="356" alt="Figure imgb0135" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/6b/26/5e/75625144083d8b/imgb0135.png"></a></div> </li> <li class="style-scope patent-text">&lt;210&gt; 93<br class="style-scope patent-text">
&lt;211&gt; 117<br class="style-scope patent-text">
&lt;212&gt; PRT<br class="style-scope patent-text">
&lt;213&gt; Artificial Sequence</li> <li class="style-scope patent-text">&lt;220&gt;<br class="style-scope patent-text">
&lt;223&gt; heavy chain variable region of AT-VH4</li> <li class="style-scope patent-text">&lt;400&gt; 93
<div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/78/e0/b8/e53e65d520fe0c/imgb0136.png" class="style-scope patent-text"><img id="ib0136" file="imgb0136.tif" wi="136" he="89" img-content="dna" img-format="tif" width="544" height="356" alt="Figure imgb0136" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/78/e0/b8/e53e65d520fe0c/imgb0136.png"></a></div> </li> <li class="style-scope patent-text">&lt;210&gt; 94<br class="style-scope patent-text">
&lt;211&gt; 117<br class="style-scope patent-text">
&lt;212&gt; PRT<br class="style-scope patent-text">
&lt;213&gt; Artificial Sequence</li> <li class="style-scope patent-text">&lt;220&gt;<br class="style-scope patent-text">
&lt;223&gt; heavy chain variable region of AT-VH5</li> <li class="style-scope patent-text">&lt;400&gt; 94
<div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/cf/38/ba/5e05ec7e5cefe4/imgb0137.png" class="style-scope patent-text"><img id="ib0137" file="imgb0137.tif" wi="136" he="89" img-content="dna" img-format="tif" width="544" height="356" alt="Figure imgb0137" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/cf/38/ba/5e05ec7e5cefe4/imgb0137.png"></a></div> </li> <li class="style-scope patent-text">&lt;210&gt; 95<br class="style-scope patent-text">
&lt;211&gt; 114<br class="style-scope patent-text">
&lt;212&gt; PRT<br class="style-scope patent-text">
&lt;213&gt; Artificial Sequence</li> <li class="style-scope patent-text">&lt;220&gt;<br class="style-scope patent-text">
&lt;223&gt; light chain variable region of anti c-Met humanized antibody(huAbF46-H4)</li> <li class="style-scope patent-text">&lt;400&gt; 95
<div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/9b/49/dc/97ea4d7398690d/imgb0138.png" class="style-scope patent-text"><img id="ib0138" file="imgb0138.tif" wi="136" he="74" img-content="dna" img-format="tif" width="544" height="296" alt="Figure imgb0138" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/9b/49/dc/97ea4d7398690d/imgb0138.png"></a></div>
<div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/cb/a5/44/ee3a09bf99e138/imgb0139.png" class="style-scope patent-text"><img id="ib0139" file="imgb0139.tif" wi="118" he="12" img-content="dna" img-format="tif" width="472" height="48" alt="Figure imgb0139" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/cb/a5/44/ee3a09bf99e138/imgb0139.png"></a></div> </li> <li class="style-scope patent-text">&lt;210&gt; 96<br class="style-scope patent-text">
&lt;211&gt; 113<br class="style-scope patent-text">
&lt;212&gt; PRT<br class="style-scope patent-text">
&lt;213&gt; Artificial Sequence</li> <li class="style-scope patent-text">&lt;220&gt;<br class="style-scope patent-text">
&lt;223&gt; light chain variable region of AT-Vk1</li> <li class="style-scope patent-text">&lt;400&gt; 96
<div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/fd/ee/6f/3530421a397bc7/imgb0140.png" class="style-scope patent-text"><img id="ib0140" file="imgb0140.tif" wi="136" he="86" img-content="dna" img-format="tif" width="544" height="344" alt="Figure imgb0140" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/fd/ee/6f/3530421a397bc7/imgb0140.png"></a></div> </li> <li class="style-scope patent-text">&lt;210&gt; 97<br class="style-scope patent-text">
&lt;211&gt; 113<br class="style-scope patent-text">
&lt;212&gt; PRT<br class="style-scope patent-text">
&lt;213&gt; Artificial Sequence</li> <li class="style-scope patent-text">&lt;220&gt;<br class="style-scope patent-text">
&lt;223&gt; light chain variable region of AT-Vk2</li> <li class="style-scope patent-text">&lt;400&gt; 97
<div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/b3/25/77/7171b756cd4478/imgb0141.png" class="style-scope patent-text"><img id="ib0141" file="imgb0141.tif" wi="136" he="42" img-content="dna" img-format="tif" width="544" height="168" alt="Figure imgb0141" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/b3/25/77/7171b756cd4478/imgb0141.png"></a></div>
<div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/2d/ea/4d/5410a91b8f1694/imgb0142.png" class="style-scope patent-text"><img id="ib0142" file="imgb0142.tif" wi="136" he="39" img-content="dna" img-format="tif" width="544" height="156" alt="Figure imgb0142" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/2d/ea/4d/5410a91b8f1694/imgb0142.png"></a></div> </li> <li class="style-scope patent-text">&lt;210&gt; 98<br class="style-scope patent-text">
&lt;211&gt; 113<br class="style-scope patent-text">
&lt;212&gt; PRT<br class="style-scope patent-text">
&lt;213&gt; Artificial Sequence</li> <li class="style-scope patent-text">&lt;220&gt;<br class="style-scope patent-text">
&lt;223&gt; light chain variable region of AT-Vk3</li> <li class="style-scope patent-text">&lt;400&gt; 98
<div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/a4/05/5b/23c6ccc9fbf129/imgb0143.png" class="style-scope patent-text"><img id="ib0143" file="imgb0143.tif" wi="136" he="86" img-content="dna" img-format="tif" width="544" height="344" alt="Figure imgb0143" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/a4/05/5b/23c6ccc9fbf129/imgb0143.png"></a></div> </li> <li class="style-scope patent-text">&lt;210&gt; 99<br class="style-scope patent-text">
&lt;211&gt; 113<br class="style-scope patent-text">
&lt;212&gt; PRT<br class="style-scope patent-text">
&lt;213&gt; Artificial Sequence</li> <li class="style-scope patent-text">&lt;220&gt;<br class="style-scope patent-text">
&lt;223&gt; light chain variable region of AT-Vk4</li> <li class="style-scope patent-text">&lt;400&gt; 99
<div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/48/ad/23/5b9c4b619bc134/imgb0144.png" class="style-scope patent-text"><img id="ib0144" file="imgb0144.tif" wi="136" he="19" img-content="dna" img-format="tif" width="544" height="76" alt="Figure imgb0144" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/48/ad/23/5b9c4b619bc134/imgb0144.png"></a></div>
<div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/20/e8/c1/b25c5cc7bdc330/imgb0145.png" class="style-scope patent-text"><img id="ib0145" file="imgb0145.tif" wi="136" he="63" img-content="dna" img-format="tif" width="544" height="252" alt="Figure imgb0145" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/20/e8/c1/b25c5cc7bdc330/imgb0145.png"></a></div> </li> <li class="style-scope patent-text">&lt;210&gt; 100<br class="style-scope patent-text">
&lt;211&gt; 13<br class="style-scope patent-text">
&lt;212&gt; PRT<br class="style-scope patent-text">
&lt;213&gt; Artificial Sequence</li> <li class="style-scope patent-text">&lt;220&gt;<br class="style-scope patent-text">
&lt;223&gt; modified hinge region(U7-HC6)</li> <li class="style-scope patent-text">&lt;400&gt; 100
<div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/54/1d/64/79f9f0182acb77/imgb0146.png" class="style-scope patent-text"><img id="ib0146" file="imgb0146.tif" wi="110" he="8" img-content="dna" img-format="tif" width="440" height="32" alt="Figure imgb0146" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/54/1d/64/79f9f0182acb77/imgb0146.png"></a></div> </li> <li class="style-scope patent-text">&lt;210&gt; 101<br class="style-scope patent-text">
&lt;211&gt; 13<br class="style-scope patent-text">
&lt;212&gt; PRT<br class="style-scope patent-text">
&lt;213&gt; Artificial Sequence</li> <li class="style-scope patent-text">&lt;220&gt;<br class="style-scope patent-text">
&lt;223&gt; modified hinge region(U6-HC7)</li> <li class="style-scope patent-text">&lt;400&gt; 101
<div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/80/f4/fa/91d6fe43516b99/imgb0147.png" class="style-scope patent-text"><img id="ib0147" file="imgb0147.tif" wi="110" he="8" img-content="dna" img-format="tif" width="440" height="32" alt="Figure imgb0147" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/80/f4/fa/91d6fe43516b99/imgb0147.png"></a></div> </li> <li class="style-scope patent-text">&lt;210&gt; 102<br class="style-scope patent-text">
&lt;211&gt; 12<br class="style-scope patent-text">
&lt;212&gt; PRT<br class="style-scope patent-text">
&lt;213&gt; Artificial Sequence</li> <li class="style-scope patent-text">&lt;220&gt;<br class="style-scope patent-text">
&lt;223&gt; modified hinge region(U3-HC9)</li> <li class="style-scope patent-text">&lt;400&gt; 102
<div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/29/ea/e9/68c4dc88d8fd9d/imgb0148.png" class="style-scope patent-text"><img id="ib0148" file="imgb0148.tif" wi="101" he="8" img-content="dna" img-format="tif" width="404" height="32" alt="Figure imgb0148" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/29/ea/e9/68c4dc88d8fd9d/imgb0148.png"></a></div> </li> <li class="style-scope patent-text">&lt;210&gt; 103<br class="style-scope patent-text">
&lt;211&gt; 14<br class="style-scope patent-text">
&lt;212&gt; PRT<br class="style-scope patent-text">
&lt;213&gt; Artificial Sequence</li> <li class="style-scope patent-text">&lt;220&gt;<br class="style-scope patent-text">
&lt;223&gt; modified hinge region(U6-HC8)</li> <li class="style-scope patent-text">&lt;400&gt; 103
<div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/ab/3a/ef/13dfacc60adaf7/imgb0149.png" class="style-scope patent-text"><img id="ib0149" file="imgb0149.tif" wi="118" he="8" img-content="dna" img-format="tif" width="472" height="32" alt="Figure imgb0149" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/ab/3a/ef/13dfacc60adaf7/imgb0149.png"></a></div> </li> <li class="style-scope patent-text">&lt;210&gt; 104<br class="style-scope patent-text">
&lt;211&gt; 13<br class="style-scope patent-text">
&lt;212&gt; PRT<br class="style-scope patent-text">
&lt;213&gt; Artificial Sequence</li> <li class="style-scope patent-text">&lt;220&gt;<br class="style-scope patent-text">
&lt;223&gt; modified hinge region(U8-HC5)</li> <li class="style-scope patent-text">&lt;400&gt; 104
<div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/30/79/b9/db59db7011c50f/imgb0150.png" class="style-scope patent-text"><img id="ib0150" file="imgb0150.tif" wi="110" he="8" img-content="dna" img-format="tif" width="440" height="32" alt="Figure imgb0150" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/30/79/b9/db59db7011c50f/imgb0150.png"></a></div> </li> <li class="style-scope patent-text">&lt;210&gt; 105<br class="style-scope patent-text">
&lt;211&gt; 15<br class="style-scope patent-text">
&lt;212&gt; PRT<br class="style-scope patent-text">
&lt;213&gt; Artificial Sequence</li> <li class="style-scope patent-text">&lt;220&gt;<br class="style-scope patent-text">
&lt;223&gt; human hinge region</li> <li class="style-scope patent-text">&lt;400&gt; 105
<div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/6a/84/99/33680126194c4e/imgb0151.png" class="style-scope patent-text"><img id="ib0151" file="imgb0151.tif" wi="127" he="8" img-content="dna" img-format="tif" width="508" height="32" alt="Figure imgb0151" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/6a/84/99/33680126194c4e/imgb0151.png"></a></div> </li> <li class="style-scope patent-text">&lt;210&gt; 106<br class="style-scope patent-text">
&lt;211&gt; 17<br class="style-scope patent-text">
&lt;212&gt; PRT<br class="style-scope patent-text">
&lt;213&gt; Artificial Sequence</li> <li class="style-scope patent-text">&lt;220&gt;<br class="style-scope patent-text">
&lt;223&gt; CDR-L1 of antibody L3-11Y</li> <li class="style-scope patent-text">&lt;400&gt; 106
<div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/a4/b5/eb/fba805bb252661/imgb0152.png" class="style-scope patent-text"><img id="ib0152" file="imgb0152.tif" wi="136" he="15" img-content="dna" img-format="tif" width="544" height="60" alt="Figure imgb0152" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/a4/b5/eb/fba805bb252661/imgb0152.png"></a></div> </li> <li class="style-scope patent-text">&lt;210&gt; 107<br class="style-scope patent-text">
&lt;211&gt; 114<br class="style-scope patent-text">
&lt;212&gt; PRT<br class="style-scope patent-text">
&lt;213&gt; Artificial Sequence</li> <li class="style-scope patent-text">&lt;220&gt;<br class="style-scope patent-text">
&lt;223&gt; amino acid sequence of light chain variable region of antibody L3-11Y</li> <li class="style-scope patent-text">&lt;400&gt; 107
<div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/c8/1a/4e/1963a325d7b836/imgb0153.png" class="style-scope patent-text"><img id="ib0153" file="imgb0153.tif" wi="136" he="86" img-content="dna" img-format="tif" width="544" height="344" alt="Figure imgb0153" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/c8/1a/4e/1963a325d7b836/imgb0153.png"></a></div> </li> <li class="style-scope patent-text">&lt;210&gt; 108<br class="style-scope patent-text">
&lt;211&gt; 220<br class="style-scope patent-text">
&lt;212&gt; PRT<br class="style-scope patent-text">
&lt;213&gt; Artificial Sequence</li> <li class="style-scope patent-text">&lt;220&gt;<br class="style-scope patent-text">
&lt;223&gt; amino acid sequence of light chain of antibody L3-11Y</li> <li class="style-scope patent-text">&lt;400&gt; 108
<div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/ef/4b/31/9d3cc54ff2d99f/imgb0154.png" class="style-scope patent-text"><img id="ib0154" file="imgb0154.tif" wi="136" he="86" img-content="dna" img-format="tif" width="544" height="344" alt="Figure imgb0154" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/ef/4b/31/9d3cc54ff2d99f/imgb0154.png"></a></div>
<div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/31/bf/1d/901e4e10b71756/imgb0155.png" class="style-scope patent-text"><img id="ib0155" file="imgb0155.tif" wi="136" he="74" img-content="dna" img-format="tif" width="544" height="296" alt="Figure imgb0155" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/31/bf/1d/901e4e10b71756/imgb0155.png"></a></div> </li> <li class="style-scope patent-text">&lt;210&gt; 109<br class="style-scope patent-text">
&lt;211&gt; 188<br class="style-scope patent-text">
&lt;212&gt; PRT<br class="style-scope patent-text">
&lt;213&gt; Artificial Sequence</li> <li class="style-scope patent-text">&lt;220&gt;<br class="style-scope patent-text">
&lt;223&gt; wild type KRAS (accession number NP_004976)</li> <li class="style-scope patent-text">&lt;400&gt; 109
<div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/09/66/db/fd82007bf296c5/imgb0156.png" class="style-scope patent-text"><img id="ib0156" file="imgb0156.tif" wi="136" he="124" img-content="dna" img-format="tif" width="544" height="496" alt="Figure imgb0156" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/09/66/db/fd82007bf296c5/imgb0156.png"></a></div>
<div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/69/32/52/aaa7156ebcb1ae/imgb0157.png" class="style-scope patent-text"><img id="ib0157" file="imgb0157.tif" wi="101" he="8" img-content="dna" img-format="tif" width="404" height="32" alt="Figure imgb0157" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/69/32/52/aaa7156ebcb1ae/imgb0157.png"></a></div> </li> <li class="style-scope patent-text">&lt;210&gt; 110<br class="style-scope patent-text">
&lt;211&gt; 766<br class="style-scope patent-text">
&lt;212&gt; PRT<br class="style-scope patent-text">
&lt;213&gt; Artificial Sequence</li> <li class="style-scope patent-text">&lt;220&gt;<br class="style-scope patent-text">
&lt;223&gt; wild type BRAF (accession number NP_004324)</li> <li class="style-scope patent-text">&lt;400&gt; 110
<div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/24/61/d6/496989f8006d6c/imgb0158.png" class="style-scope patent-text"><img id="ib0158" file="imgb0158.tif" wi="136" he="182" img-content="dna" img-format="tif" width="544" height="728" alt="Figure imgb0158" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/24/61/d6/496989f8006d6c/imgb0158.png"></a></div>
<div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/14/5a/0d/9c9a4f8b6a02ab/imgb0159.png" class="style-scope patent-text"><img id="ib0159" file="imgb0159.tif" wi="132" he="233" img-content="dna" img-format="tif" width="528" height="932" alt="Figure imgb0159" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/14/5a/0d/9c9a4f8b6a02ab/imgb0159.png"></a></div>
<div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/27/69/d5/e59695de15c85e/imgb0160.png" class="style-scope patent-text"><img id="ib0160" file="imgb0160.tif" wi="136" he="124" img-content="dna" img-format="tif" width="544" height="496" alt="Figure imgb0160" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/27/69/d5/e59695de15c85e/imgb0160.png"></a></div> </li> <li class="style-scope patent-text">&lt;210&gt; 111<br class="style-scope patent-text">
&lt;211&gt; 442<br class="style-scope patent-text">
&lt;212&gt; PRT<br class="style-scope patent-text">
&lt;213&gt; Artificial Sequence</li> <li class="style-scope patent-text">&lt;220&gt;<br class="style-scope patent-text">
&lt;223&gt; Heavy chain of anti-c-Met antibody LY2875358</li> <li class="style-scope patent-text">&lt;400&gt; 111
<div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/b4/f2/86/d850acbed4334f/imgb0161.png" class="style-scope patent-text"><img id="ib0161" file="imgb0161.tif" wi="136" he="66" img-content="dna" img-format="tif" width="544" height="264" alt="Figure imgb0161" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/b4/f2/86/d850acbed4334f/imgb0161.png"></a></div>
<div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/2e/8b/78/1c5cda6184ce73/imgb0162.png" class="style-scope patent-text"><img id="ib0162" file="imgb0162.tif" wi="132" he="233" img-content="dna" img-format="tif" width="528" height="932" alt="Figure imgb0162" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/2e/8b/78/1c5cda6184ce73/imgb0162.png"></a></div>
<div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/ee/78/70/1f2f21fd8fbb04/imgb0163.png" class="style-scope patent-text"><img id="ib0163" file="imgb0163.tif" wi="84" he="8" img-content="dna" img-format="tif" width="336" height="32" alt="Figure imgb0163" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/ee/78/70/1f2f21fd8fbb04/imgb0163.png"></a></div> </li> <li class="style-scope patent-text">&lt;210&gt; 112<br class="style-scope patent-text">
&lt;211&gt; 215<br class="style-scope patent-text">
&lt;212&gt; PRT<br class="style-scope patent-text">
&lt;213&gt; Artificial Sequence</li> <li class="style-scope patent-text">&lt;220&gt;<br class="style-scope patent-text">
&lt;223&gt; Light chain of anti-c-Met antibody LY2875358</li> <li class="style-scope patent-text">&lt;400&gt; 112
<div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/f9/8e/00/5832369ab8bf17/imgb0164.png" class="style-scope patent-text"><img id="ib0164" file="imgb0164.tif" wi="136" he="159" img-content="dna" img-format="tif" width="544" height="636" alt="Figure imgb0164" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/f9/8e/00/5832369ab8bf17/imgb0164.png"></a></div> </li> <li class="style-scope patent-text">&lt;210&gt; 113<br class="style-scope patent-text">
&lt;211&gt; 24<br class="style-scope patent-text">
&lt;212&gt; DNA<br class="style-scope patent-text">
&lt;213&gt; Artificial Sequence</li> <li class="style-scope patent-text">&lt;220&gt;<br class="style-scope patent-text">
&lt;223&gt; Forward primer for IL-8 gene (ACCESSION NO: BC013615.1)</li> <li class="style-scope patent-text">&lt;400&gt; 113<br class="style-scope patent-text">
atgacttcca agctggccgt ggct24</li> <li class="style-scope patent-text">&lt;210&gt; 114<br class="style-scope patent-text">
&lt;211&gt; 24<br class="style-scope patent-text">
&lt;212&gt; DNA<br class="style-scope patent-text">
&lt;213&gt; Artificial Sequence</li> <li class="style-scope patent-text">&lt;220&gt;<br class="style-scope patent-text">
&lt;223&gt; Reverse primer for IL-8 gene (ACCESSION NO: BC013615.1)</li> <li class="style-scope patent-text">&lt;400&gt; 114<br class="style-scope patent-text">
tctcagccct cttcaaaaac ttct24</li> </ul>
  </ul>
  </section>
      <div id="margin" class="style-scope patent-text">
        <div id="createHighlight" style="top: 0px;" class="style-scope patent-text" hidden="">
          <iron-icon id="comment" icon="editor:insert-comment" class="style-scope patent-text x-scope iron-icon-0"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M20 2H4c-1.1 0-2 .9-2 2v12c0 1.1.9 2 2 2h14l4 4V4c0-1.1-.9-2-2-2zm-2 12H6v-2h12v2zm0-3H6V9h12v2zm0-3H6V6h12v2z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
        </div>
      </div>
    </div>
  </patent-text>
              </section>
            </div>
            <div class="flex flex-width style-scope patent-result">
              <section id="claims" class="style-scope patent-result">
                <h3 class="style-scope patent-result">
                  <div class="layout horizontal style-scope patent-result">
                    <div class="flex style-scope patent-result">Claims <span class="style-scope patent-result">(4)</span></div>
                    <div class="collapse style-scope patent-result">
                      Hide Dependent <iron-icon style="height: 15px; width: 15px;" icon="expand-less" class="style-scope patent-result x-scope iron-icon-0"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M12 8l-6 6 1.41 1.41L12 10.83l4.59 4.58L18 14z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon><template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </div>
                  </div>
                  <div class="layout horizontal style-scope patent-result">
                    <div class="flex style-scope patent-result"></div>
                    <div class="righthead style-scope patent-result" hidden="">translated from </div>
                  </div>
                </h3>
                <patent-text name="claims" enable-text-selection="" class="style-scope patent-result" style="padding-top: 0px;">
    
    
    <template is="dom-if" restamp="" class="style-scope patent-text"></template>
    <overlay-tooltip id="tooltip" class="style-scope patent-text" style="display: none;">
    
    <div id="arrow" class="style-scope overlay-tooltip" hidden=""></div>
    <div class="style-scope overlay-tooltip">
      
    </div>
  </overlay-tooltip>
    <div class="layout horizontal style-scope patent-text">
      <section id="text" class="flex style-scope patent-text"><ol mxw-id="PCLM116089972" lang="EN" load-source="patent-office" class="claims style-scope patent-text">
    
    <li class="claim style-scope patent-text"> <div id="c-en-01-0001" num="0001" class="claim style-scope patent-text">
      <div class="claim-text style-scope patent-text">A method for predicting the antitumor or anticancer efficacy of a c-Met inhibitor in a subject or selecting a subject with cancer suitable for the application of a c-Met inhibitor, comprising:
<div class="claim-text style-scope patent-text">measuring, in a serum or blood sample, a level of IL-8; and</div>
<div class="claim-text style-scope patent-text">comparing the measured level with a reference,</div>
<div class="claim-text style-scope patent-text">wherein an increase in the measured level of IL-8 in a serum or blood sample obtained from the subject, relative to the reference which is a serum or blood sample where the c-Met inhibitor is not effective, indicates that the c-Met inhibitor would be effective or that the subject is suitable for the application of a c-Met inhibitor, and</div>
wherein the c-Met inhibitor is an anti-c-Met antibody or an antigen-binding fragment thereof, which recognizes or binds an epitope comprising 5 to 19 contiguous amino acid residues within SEQ ID NO: 71 and wherein the epitope comprises at least SEQ ID NO: 73.</div>
    </div>
    </li> <li class="claim-dependent style-scope patent-text"> <div id="c-en-01-0002" num="0002" class="claim style-scope patent-text">
      <div class="claim-text style-scope patent-text">The method of claim 1, wherein the anti-c-Met antibody or an antigen-binding fragment thereof comprises:
<div class="claim-text style-scope patent-text">(i) heavy chain complementarity determining regions (CDRs) comprising (a) a CDR-H1 comprising SEQ ID NO: 4; (b) a CDR-H2 comprising SEQ ID NO: 2, SEQ ID NO: 5, or an amino acid sequence comprising 8-19 consecutive amino acids within SEQ ID NO: 2 including the 3<sup class="style-scope patent-text">rd</sup> to 10<sup class="style-scope patent-text">th</sup> positions of SEQ ID NO: 2; and (c) a CDR-H3 comprising an amino acid sequence comprising 6-13 consecutive amino acids within SEQ ID NO: 85 including the 1<sup class="style-scope patent-text">st</sup> to 6<sup class="style-scope patent-text">th</sup> positions of the amino acid sequence of SEQ ID NO: 85, SEQ ID NO: 85, or SEQ ID NO: 6; and</div>
<div class="claim-text style-scope patent-text">(ii) light chain CDRs comprising (a) a CDR-L1 comprising SEQ ID NO: 7, (b) a CDR-L2 comprising SEQ ID NO: 8, and (c) a CDR-L3 comprising SEQ ID NO: 9, SEQ ID NO: 15, SEQ ID NO: 86, or 9-17 consecutive amino acids within SEQ ID NO: 89 including the 1<sup class="style-scope patent-text">st</sup> to 9<sup class="style-scope patent-text">th</sup> positions of SEQ ID NO: 89.</div> </div>
    </div>
    </li> <li class="claim-dependent style-scope patent-text"> <div id="c-en-01-0003" num="0003" class="claim style-scope patent-text">
      <div class="claim-text style-scope patent-text">A use of at least one interacting material selected from the group consisting of an IL-8 binding antibody and an IL-8 binding aptamer in the method of claim 1 or 2.</div>
    </div>
    </li> <li class="claim-dependent style-scope patent-text"> <div id="c-en-01-0004" num="0004" class="claim style-scope patent-text">
      <div class="claim-text style-scope patent-text">A c-Met inhibitor as defined in claim 1 or 2 for use in a method of treating a cancer in a subject, wherein the subject has been selected by the method of claim 1.</div>
    </div>
  </li> </ol>
  </section>
      <div id="margin" class="style-scope patent-text">
        <div id="createHighlight" style="top: 0px;" class="style-scope patent-text" hidden="">
          <iron-icon id="comment" icon="editor:insert-comment" class="style-scope patent-text x-scope iron-icon-0"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M20 2H4c-1.1 0-2 .9-2 2v12c0 1.1.9 2 2 2h14l4 4V4c0-1.1-.9-2-2-2zm-2 12H6v-2h12v2zm0-3H6V9h12v2zm0-3H6V6h12v2z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
        </div>
      </div>
    </div>
  </patent-text>
              </section>
            </div>
          </div>

          <div class="footer style-scope patent-result">

            
            <h3 id="patentCitations" class="scroll-target style-scope patent-result">
              Patent Citations (20)
              <a href="#title" class="style-scope patent-result"><iron-icon icon="arrow-drop-up" class="style-scope patent-result x-scope iron-icon-0"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M7 14l5-5 5 5z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon></a>
            </h3>
            <div class="responsive-table style-scope patent-result">
              <div class="table style-scope patent-result">
                <div class="thead style-scope patent-result">
                  <div class="tr style-scope patent-result">
                    <span class="th style-scope patent-result">Publication number</span>
                    <span class="th style-scope patent-result">Priority date</span>
                    <span class="th style-scope patent-result">Publication date</span>
                    <span class="th style-scope patent-result">Assignee</span>
                    <span class="th style-scope patent-result">Title</span>
                  </div>
                </div>
                <div class="tbody style-scope patent-result">
                  <template is="dom-repeat" class="style-scope patent-result"></template>

                  <div class="tr style-scope patent-result">
                    <span class="td famheader style-scope patent-result">Family To Family Citations</span>
                    <span class="td famheader style-scope patent-result"></span>
                    <span class="td famheader style-scope patent-result"></span>
                    <span class="td famheader style-scope patent-result"></span>
                    <span class="td famheader style-scope patent-result"></span>
                  </div>

                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/GB1582658A/en"><a id="link" href="#" class="style-scope state-modifier">GB1582658A</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      *<template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">1977-12-29</span>
                    <span class="td style-scope patent-result">1981-01-14</span>
                    <span class="td style-scope patent-result">Witherow R O</span>
                    <span class="td style-scope patent-result">Drainage device 
     </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/US20060150260A1/en"><a id="link" href="#" class="style-scope state-modifier">US20060150260A1</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2004-10-28</span>
                    <span class="td style-scope patent-result">2006-07-06</span>
                    <span class="td style-scope patent-result">Northwestern University</span>
                    <span class="td style-scope patent-result">Genes related to drug resistance 
     </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/ES2717627T3/en"><a id="link" href="#" class="style-scope state-modifier">ES2717627T3</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2005-07-29</span>
                    <span class="td style-scope patent-result">2019-06-24</span>
                    <span class="td style-scope patent-result">Siemens Healthcare Diagnostics Inc</span>
                    <span class="td style-scope patent-result">
  Methods, kits, systems and databases related to neoplastic diseases
 
     </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/ES2370054T3/en"><a id="link" href="#" class="style-scope state-modifier">ES2370054T3</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2005-08-24</span>
                    <span class="td style-scope patent-result">2011-12-12</span>
                    <span class="td style-scope patent-result">Bristol-Myers Squibb Company</span>
                    <span class="td style-scope patent-result">
  BIOMARKERS AND PROCEDURES TO DETERMINE THE SENSITIVITY TO MODULATORS OF THE RECEIVER OF THE EPIDERMAL GROWTH FACTOR.
 
     </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/EP2061904A2/en"><a id="link" href="#" class="style-scope state-modifier">EP2061904A2</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2006-09-06</span>
                    <span class="td style-scope patent-result">2009-05-27</span>
                    <span class="td style-scope patent-result">Ortho-McNeil Pharmaceutical, Inc.</span>
                    <span class="td style-scope patent-result">Biomarkers for assessing response to c-met treatment 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/JP2010528585A/en"><a id="link" href="#" class="style-scope state-modifier">JP2010528585A</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2007-02-26</span>
                    <span class="td style-scope patent-result">2010-08-26</span>
                    <span class="td style-scope patent-result">      </span>
                    <span class="td style-scope patent-result">
  Usefulness of B-RAF DNA mutations in the diagnosis and treatment of cancer
 
     </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/EP2118322A2/en"><a id="link" href="#" class="style-scope state-modifier">EP2118322A2</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2007-03-13</span>
                    <span class="td style-scope patent-result">2009-11-18</span>
                    <span class="td style-scope patent-result">Amgen Inc.</span>
                    <span class="td style-scope patent-result">K-ras and b-raf mutations and anti-egfr antibody therapy 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/US8664358B2/en"><a id="link" href="#" class="style-scope state-modifier">US8664358B2</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2007-06-29</span>
                    <span class="td style-scope patent-result">2014-03-04</span>
                    <span class="td style-scope patent-result">Vermillion, Inc.</span>
                    <span class="td style-scope patent-result">Predictive markers for ovarian cancer 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/WO2009114836A1/en"><a id="link" href="#" class="style-scope state-modifier">WO2009114836A1</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2008-03-14</span>
                    <span class="td style-scope patent-result">2009-09-17</span>
                    <span class="td style-scope patent-result">Genomic Health, Inc.</span>
                    <span class="td style-scope patent-result">Gene expression markers for prediction of patient response to chemotherapy 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/US8133686B2/en"><a id="link" href="#" class="style-scope state-modifier">US8133686B2</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2008-05-15</span>
                    <span class="td style-scope patent-result">2012-03-13</span>
                    <span class="td style-scope patent-result">Van Andel Research Institute</span>
                    <span class="td style-scope patent-result">IL-8 as a biomarker for sunitinib resistance 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/KR20110069092A/en"><a id="link" href="#" class="style-scope state-modifier">KR20110069092A</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      *<template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2008-10-17</span>
                    <span class="td style-scope patent-result">2011-06-22</span>
                    <span class="td style-scope patent-result">, .</span>
                    <span class="td style-scope patent-result">Treatment method 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/EP2384367A4/en"><a id="link" href="#" class="style-scope state-modifier">EP2384367A4</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2008-12-30</span>
                    <span class="td style-scope patent-result">2013-07-10</span>
                    <span class="td style-scope patent-result">Janssen Biotech Inc</span>
                    <span class="td style-scope patent-result">Serum markers predicting clinical response to anti-tnf antibodies in patients with ankylosing spondylitis 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/JP2010178651A/en"><a id="link" href="#" class="style-scope state-modifier">JP2010178651A</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      *<template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2009-02-04</span>
                    <span class="td style-scope patent-result">2010-08-19</span>
                    <span class="td style-scope patent-result">Eisai R &amp; D Management Co Ltd</span>
                    <span class="td style-scope patent-result">Method for detecting action of hgfr inhibitor 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/KR101671378B1/en"><a id="link" href="#" class="style-scope state-modifier">KR101671378B1</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      *<template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2009-10-30</span>
                    <span class="td style-scope patent-result">2016-11-01</span>
                    <span class="td style-scope patent-result"> </span>
                    <span class="td style-scope patent-result">c-Met specific antibodies and uses thereof 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/CN102115782B/en"><a id="link" href="#" class="style-scope state-modifier">CN102115782B</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2009-12-30</span>
                    <span class="td style-scope patent-result">2014-06-18</span>
                    <span class="td style-scope patent-result"></span>
                    <span class="td style-scope patent-result">Kit for quantitative detection of K-ras mutation 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/EP2542893A2/en"><a id="link" href="#" class="style-scope state-modifier">EP2542893A2</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2010-03-03</span>
                    <span class="td style-scope patent-result">2013-01-09</span>
                    <span class="td style-scope patent-result">OSI Pharmaceuticals, LLC</span>
                    <span class="td style-scope patent-result">Biological markers predictive of anti-cancer response to insulin-like growth factor-1 receptor kinase inhibitors 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/JP2013528357A/en"><a id="link" href="#" class="style-scope state-modifier">JP2013528357A</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2010-03-29</span>
                    <span class="td style-scope patent-result">2013-07-11</span>
                    <span class="td style-scope patent-result"></span>
                    <span class="td style-scope patent-result">
  Antibody with enhanced or suppressed effector function
 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/RU2013114360A/en"><a id="link" href="#" class="style-scope state-modifier">RU2013114360A</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2010-08-31</span>
                    <span class="td style-scope patent-result">2014-10-10</span>
                    <span class="td style-scope patent-result">, .</span>
                    <span class="td style-scope patent-result">
  BIOMARKERS AND TREATMENT METHODS
 
     </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/KR101875935B1/en"><a id="link" href="#" class="style-scope state-modifier">KR101875935B1</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2010-11-23</span>
                    <span class="td style-scope patent-result">2018-07-09</span>
                    <span class="td style-scope patent-result"> </span>
                    <span class="td style-scope patent-result">A Biomarker of the resistance about HER2 inhibitor 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/KR20130036993A/en"><a id="link" href="#" class="style-scope state-modifier">KR20130036993A</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      *<template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2011-10-05</span>
                    <span class="td style-scope patent-result">2013-04-15</span>
                    <span class="td style-scope patent-result"></span>
                    <span class="td style-scope patent-result">Antibodies specifically binding to epitope in sema domain of c-met 
       </span>
                  </div>
                  <template is="dom-repeat" class="style-scope patent-result"></template>

                </div>
              </div>
            </div>
            <div style="padding: 10px 12px; font-size: 11px;" class="style-scope patent-result">* Cited by examiner,  Cited by third party</div>
            <template is="dom-if" class="style-scope patent-result"></template>

            
            <h3 id="nplCitations" class="scroll-target style-scope patent-result">
              Non-Patent Citations (1)
              <a href="#title" class="style-scope patent-result"><iron-icon icon="arrow-drop-up" class="style-scope patent-result x-scope iron-icon-0"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M7 14l5-5 5 5z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon></a>
            </h3>
            <div class="responsive-table style-scope patent-result">
              <div class="table style-scope patent-result">
                <div class="thead style-scope patent-result">
                  <div class="tr style-scope patent-result">
                    <span class="th style-scope patent-result">Title</span>
                  </div>
                </div>
                <div class="tbody style-scope patent-result">
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      M. MERCHANT ET AL: "Monovalent antibody design and mechanism of action of onartuzumab, a MET antagonist with anti-tumor activity as a therapeutic agent", PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES, vol. 110, no. 32, 6 August 2013 (2013-08-06), pages E2987 - E2996, ISSN: 0027-8424, DOI: 10.1073/pnas.1302725110
                      *<template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                  </div>
                  <template is="dom-repeat" class="style-scope patent-result"></template>
                </div>
              </div>
            </div>
            <div style="padding: 10px 12px; font-size: 11px;" class="style-scope patent-result">* Cited by examiner,  Cited by third party</div>
            <template is="dom-if" class="style-scope patent-result"></template>

            
            <h3 id="citedBy" class="scroll-target style-scope patent-result">
              Cited By (1)
              <a href="#title" class="style-scope patent-result"><iron-icon icon="arrow-drop-up" class="style-scope patent-result x-scope iron-icon-0"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M7 14l5-5 5 5z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon></a>
            </h3>
            <div class="responsive-table style-scope patent-result">
              <div class="table style-scope patent-result">
                <div class="thead style-scope patent-result">
                  <div class="tr style-scope patent-result">
                    <span class="th style-scope patent-result">Publication number</span>
                    <span class="th style-scope patent-result">Priority date</span>
                    <span class="th style-scope patent-result">Publication date</span>
                    <span class="th style-scope patent-result">Assignee</span>
                    <span class="th style-scope patent-result">Title</span>
                  </div>
                </div>
                <div class="tbody style-scope patent-result">
                  <template is="dom-repeat" class="style-scope patent-result"></template>

                  <div class="tr style-scope patent-result">
                    <span class="td famheader style-scope patent-result">Family To Family Citations</span>
                    <span class="td famheader style-scope patent-result"></span>
                    <span class="td famheader style-scope patent-result"></span>
                    <span class="td famheader style-scope patent-result"></span>
                    <span class="td famheader style-scope patent-result"></span>
                  </div>

                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/CN116656583A/en"><a id="link" href="#" class="style-scope state-modifier">CN116656583A</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      *<template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2023-01-13</span>
                    <span class="td style-scope patent-result">2023-08-29</span>
                    <span class="td style-scope patent-result"></span>
                    <span class="td style-scope patent-result">Tumor-targeted helicobacter pylori mutant strain and gastric cancer-resistant outer membrane vesicle composition 
       </span>
                  </div>
                  <template is="dom-repeat" class="style-scope patent-result"></template>
                </div>

              </div>
            </div>
            <div style="padding: 10px 12px; font-size: 11px;" class="style-scope patent-result">* Cited by examiner,  Cited by third party,  Family to family citation</div>
            <template is="dom-if" class="style-scope patent-result"></template>

            
            <h3 id="similarDocuments" class="scroll-target style-scope patent-result">
              Similar Documents
              <a href="#title" class="style-scope patent-result"><iron-icon icon="arrow-drop-up" class="style-scope patent-result x-scope iron-icon-0"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M7 14l5-5 5 5z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon></a>
            </h3>
            <div class="responsive-table style-scope patent-result">
              <div class="table style-scope patent-result">
                <div class="thead style-scope patent-result">
                  <div class="tr style-scope patent-result">
                    <span class="th style-scope patent-result">Publication</span>
                    <span class="th style-scope patent-result">Publication Date</span>
                    <span class="th style-scope patent-result">Title</span>
                  </div>
                </div>
                <div class="tbody style-scope patent-result">
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      
                        <template is="dom-if" class="style-scope patent-result"></template>
                        
                        <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/JP6694850B2/en"><a id="link" href="#" class="style-scope state-modifier">JP6694850B2</a></state-modifier>
                        <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2020-05-20</span>
                    <span class="td style-scope patent-result">
  Antibody that specifically binds to an epitope within the SEMA domain of c-Met
 
     </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      
                        <template is="dom-if" class="style-scope patent-result"></template>
                        
                        <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/CN116410316A/en"><a id="link" href="#" class="style-scope state-modifier">CN116410316A</a></state-modifier>
                        <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2023-07-11</span>
                    <span class="td style-scope patent-result">anti-CD 47 antibodies and uses thereof 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      
                        <template is="dom-if" class="style-scope patent-result"></template>
                        
                        <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/US9567641B2/en"><a id="link" href="#" class="style-scope state-modifier">US9567641B2</a></state-modifier>
                        <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2017-02-14</span>
                    <span class="td style-scope patent-result">Combination therapy for the treatment of cancer using an anti-C-met antibody 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      
                        <template is="dom-if" class="style-scope patent-result"></template>
                        
                        <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/US9213032B2/en"><a id="link" href="#" class="style-scope state-modifier">US9213032B2</a></state-modifier>
                        <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2015-12-15</span>
                    <span class="td style-scope patent-result">Use of LRIG1 as a biomarker for identifying a subject for application of anti-c-Met antibodies 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      
                        <template is="dom-if" class="style-scope patent-result"></template>
                        
                        <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/US9213031B2/en"><a id="link" href="#" class="style-scope state-modifier">US9213031B2</a></state-modifier>
                        <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2015-12-15</span>
                    <span class="td style-scope patent-result">Use of Cbl as biomarker for identifying subject suitable for treatment with anti-c-Met antibody 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      
                        <template is="dom-if" class="style-scope patent-result"></template>
                        
                        <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/TW201521724A/en"><a id="link" href="#" class="style-scope state-modifier">TW201521724A</a></state-modifier>
                        <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2015-06-16</span>
                    <span class="td style-scope patent-result">Methods for treating cancer using TOR kinase inhibitor combination therapy 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      
                        <template is="dom-if" class="style-scope patent-result"></template>
                        
                        <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/EP3272772A1/en"><a id="link" href="#" class="style-scope state-modifier">EP3272772A1</a></state-modifier>
                        <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2018-01-24</span>
                    <span class="td style-scope patent-result">Use of an anti-ang2 antibody 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      
                        <template is="dom-if" class="style-scope patent-result"></template>
                        
                        <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/KR102405278B1/en"><a id="link" href="#" class="style-scope state-modifier">KR102405278B1</a></state-modifier>
                        <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2022-06-07</span>
                    <span class="td style-scope patent-result">
  ALK7 binding proteins and uses thereof
 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      
                        <template is="dom-if" class="style-scope patent-result"></template>
                        
                        <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/US10378061B2/en"><a id="link" href="#" class="style-scope state-modifier">US10378061B2</a></state-modifier>
                        <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2019-08-13</span>
                    <span class="td style-scope patent-result">Biomarker for predicting effect of an anti-c-Met antibody 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      
                        <template is="dom-if" class="style-scope patent-result"></template>
                        
                        <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/KR102428255B1/en"><a id="link" href="#" class="style-scope state-modifier">KR102428255B1</a></state-modifier>
                        <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2022-08-03</span>
                    <span class="td style-scope patent-result">
  Compositions and methods for detection and treatment of gastric cancer
 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      
                        <template is="dom-if" class="style-scope patent-result"></template>
                        
                        <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/WO2020211804A1/en"><a id="link" href="#" class="style-scope state-modifier">WO2020211804A1</a></state-modifier>
                        <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2020-10-22</span>
                    <span class="td style-scope patent-result">Use of anti-pd-1 antibody in preparation of medicament for treating solid tumors 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      
                        <template is="dom-if" class="style-scope patent-result"></template>
                        
                        <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/US9956244B2/en"><a id="link" href="#" class="style-scope state-modifier">US9956244B2</a></state-modifier>
                        <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2018-05-01</span>
                    <span class="td style-scope patent-result">Biomarker Hsp90 for predicting effect of a c-Met inhibitor 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      
                        <template is="dom-if" class="style-scope patent-result"></template>
                        
                        <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/US9850537B2/en"><a id="link" href="#" class="style-scope state-modifier">US9850537B2</a></state-modifier>
                        <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2017-12-26</span>
                    <span class="td style-scope patent-result">Biomarker TFF1 for predicting effect of C-MET inhibitor 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      
                        <template is="dom-if" class="style-scope patent-result"></template>
                        
                        <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/US10064939B2/en"><a id="link" href="#" class="style-scope state-modifier">US10064939B2</a></state-modifier>
                        <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2018-09-04</span>
                    <span class="td style-scope patent-result">Combination therapy using c-Met inhibitor and IGF-1R inhibitor for c-Met inhibitor resistant cancers 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      
                        <template is="dom-if" class="style-scope patent-result"></template>
                        
                        <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/EP2891884B1/en"><a id="link" href="#" class="style-scope state-modifier">EP2891884B1</a></state-modifier>
                        <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2017-10-25</span>
                    <span class="td style-scope patent-result">IL-8 for predicting or monitoring efficacy of c-MET inhibitor 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      
                        <template is="dom-if" class="style-scope patent-result"></template>
                        
                        <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/US10472682B2/en"><a id="link" href="#" class="style-scope state-modifier">US10472682B2</a></state-modifier>
                        <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2019-11-12</span>
                    <span class="td style-scope patent-result">Prediction of effect of a c-Met inhibitor using mutation of KRAS or BRAF 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      
                        <template is="dom-if" class="style-scope patent-result"></template>
                        
                        <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/US9943596B2/en"><a id="link" href="#" class="style-scope state-modifier">US9943596B2</a></state-modifier>
                        <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2018-04-17</span>
                    <span class="td style-scope patent-result">Combination therapy using dual inhibitor of c-MET and EGFR and IGF-1R inhibitor 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      
                        <template is="dom-if" class="style-scope patent-result"></template>
                        
                        <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/EP2824113B1/en"><a id="link" href="#" class="style-scope state-modifier">EP2824113B1</a></state-modifier>
                        <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2017-05-03</span>
                    <span class="td style-scope patent-result">Biomarker for selecting a subject for application of an anti-c-met antibody 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      
                        <template is="dom-if" class="style-scope patent-result"></template>
                        
                        <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/US10578621B2/en"><a id="link" href="#" class="style-scope state-modifier">US10578621B2</a></state-modifier>
                        <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2020-03-03</span>
                    <span class="td style-scope patent-result">Biomarker PNCK for predicting effect of a dual-targeting agent 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      
                        <template is="dom-if" class="style-scope patent-result"></template>
                        
                        <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/JP2023508826A/en"><a id="link" href="#" class="style-scope state-modifier">JP2023508826A</a></state-modifier>
                        <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2023-03-06</span>
                    <span class="td style-scope patent-result">
  HUMANIZED ANTI-CA IX ANTIBODY, AND METHODS OF USING SAME
 
     </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      
                        <template is="dom-if" class="style-scope patent-result"></template>
                        
                        <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/JP7494245B2/en"><a id="link" href="#" class="style-scope state-modifier">JP7494245B2</a></state-modifier>
                        <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2024-06-03</span>
                    <span class="td style-scope patent-result">
  Dual targeting of CD47 and EGFR for cancer therapy
 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      
                        <template is="dom-if" class="style-scope patent-result"></template>
                        
                        <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/US9869668B2/en"><a id="link" href="#" class="style-scope state-modifier">US9869668B2</a></state-modifier>
                        <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2018-01-16</span>
                    <span class="td style-scope patent-result">PDGF as a biomarker for predicting resistance or effect of c-Met targeting drugs 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      
                        <template is="dom-if" class="style-scope patent-result"></template>
                        
                        <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/WO2024015463A1/en"><a id="link" href="#" class="style-scope state-modifier">WO2024015463A1</a></state-modifier>
                        <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2024-01-18</span>
                    <span class="td style-scope patent-result">Combination therapy 
       </span>
                  </div>
                  <template is="dom-repeat" class="style-scope patent-result"></template>
                </div>
              </div>
            </div>
            <template is="dom-if" class="style-scope patent-result"></template>

            
            <h3 id="relatedApplications" class="scroll-target style-scope patent-result">Priority And Related Applications</h3>

            <template is="dom-if" class="style-scope patent-result"></template>

            <template is="dom-if" class="style-scope patent-result"></template>

            <template is="dom-if" class="style-scope patent-result"></template>

            
            <h3 id="appsClaimingPriority" class="scroll-target style-scope patent-result">
              Applications Claiming Priority (2)
              <a href="#title" class="style-scope patent-result"><iron-icon icon="arrow-drop-up" class="style-scope patent-result x-scope iron-icon-0"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M7 14l5-5 5 5z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon></a>
            </h3>
            <div class="responsive-table style-scope patent-result">
              <div class="table style-scope patent-result">
                <div class="thead style-scope patent-result">
                  <div class="tr style-scope patent-result">
                    <span class="th style-scope patent-result">Application</span>
                    <span class="th style-scope patent-result">Filing date</span>
                    <span class="th style-scope patent-result">Title</span>
                  </div>
                </div>
                <div class="tbody style-scope patent-result">
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                        <template is="dom-if" class="style-scope patent-result"></template>
                        KR20140001799<template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td nowrap style-scope patent-result">2014-01-07</span>
                    <span class="td style-scope patent-result"></span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                        <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/KR102272788B1/en"><a id="link" href="#" class="style-scope state-modifier">KR1020150000956A</a></state-modifier><template is="dom-if" class="style-scope patent-result"></template>
                        <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td nowrap style-scope patent-result">2015-01-06</span>
                    <span class="td style-scope patent-result">Biomarker for predicting or monitoring effect of a c-Met inhibitor 
       </span>
                  </div>
                  <template is="dom-repeat" class="style-scope patent-result"></template>
                </div>
              </div>
            </div>
            <template is="dom-if" class="style-scope patent-result"></template>

            <template is="dom-if" class="style-scope patent-result"></template>

            
            <h3 id="legalEvents" class="scroll-target style-scope patent-result">
              Legal Events
              <a href="#title" class="style-scope patent-result"><iron-icon icon="arrow-drop-up" class="style-scope patent-result x-scope iron-icon-0"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M7 14l5-5 5 5z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon></a>
            </h3>
            <div class="responsive-table style-scope patent-result">
              <div class="table style-scope patent-result">
                <div class="thead style-scope patent-result">
                  <div class="tr style-scope patent-result">
                    <span class="th style-scope patent-result">Date</span>
                    <span class="th style-scope patent-result">Code</span>
                    <span class="th style-scope patent-result">Title</span>
                    <span class="th style-scope patent-result">Description</span>
                  </div>
                </div>
                <div class="tbody style-scope patent-result">
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">2015-07-07</span>
                    <span class="td nowrap style-scope patent-result">PUAI</span>
                    <span class="td nowrap style-scope patent-result">Public reference made under article 153(3) epc to a published international application that has entered the european phase</span>
                    <span class="td style-scope patent-result">
                      
                      <p class="style-scope patent-result"><strong class="style-scope patent-result">Free format text</strong>: ORIGINAL CODE: 0009012</p>
                      <template is="dom-repeat" as="attr" class="style-scope patent-result"></template>
                    </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">2015-07-08</span>
                    <span class="td nowrap style-scope patent-result">17P</span>
                    <span class="td nowrap style-scope patent-result">Request for examination filed</span>
                    <span class="td style-scope patent-result">
                      
                      <p class="style-scope patent-result"><strong class="style-scope patent-result">Effective date</strong>: 20150107</p>
                      <template is="dom-repeat" as="attr" class="style-scope patent-result"></template>
                    </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">2015-07-08</span>
                    <span class="td nowrap style-scope patent-result">AK</span>
                    <span class="td nowrap style-scope patent-result">Designated contracting states</span>
                    <span class="td style-scope patent-result">
                      
                      <p class="style-scope patent-result"><strong class="style-scope patent-result">Kind code of ref document</strong>: A2</p>
                      
                      <p class="style-scope patent-result"><strong class="style-scope patent-result">Designated state(s)</strong>: AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR</p>
                      <template is="dom-repeat" as="attr" class="style-scope patent-result"></template>
                    </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">2015-07-08</span>
                    <span class="td nowrap style-scope patent-result">AX</span>
                    <span class="td nowrap style-scope patent-result">Request for extension of the european patent</span>
                    <span class="td style-scope patent-result">
                      
                      <p class="style-scope patent-result"><strong class="style-scope patent-result">Extension  state</strong>: BA ME</p>
                      <template is="dom-repeat" as="attr" class="style-scope patent-result"></template>
                    </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">2015-09-11</span>
                    <span class="td nowrap style-scope patent-result">PUAL</span>
                    <span class="td nowrap style-scope patent-result">Search report despatched</span>
                    <span class="td style-scope patent-result">
                      
                      <p class="style-scope patent-result"><strong class="style-scope patent-result">Free format text</strong>: ORIGINAL CODE: 0009013</p>
                      <template is="dom-repeat" as="attr" class="style-scope patent-result"></template>
                    </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">2015-10-14</span>
                    <span class="td nowrap style-scope patent-result">AK</span>
                    <span class="td nowrap style-scope patent-result">Designated contracting states</span>
                    <span class="td style-scope patent-result">
                      
                      <p class="style-scope patent-result"><strong class="style-scope patent-result">Kind code of ref document</strong>: A3</p>
                      
                      <p class="style-scope patent-result"><strong class="style-scope patent-result">Designated state(s)</strong>: AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR</p>
                      <template is="dom-repeat" as="attr" class="style-scope patent-result"></template>
                    </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">2015-10-14</span>
                    <span class="td nowrap style-scope patent-result">AX</span>
                    <span class="td nowrap style-scope patent-result">Request for extension of the european patent</span>
                    <span class="td style-scope patent-result">
                      
                      <p class="style-scope patent-result"><strong class="style-scope patent-result">Extension  state</strong>: BA ME</p>
                      <template is="dom-repeat" as="attr" class="style-scope patent-result"></template>
                    </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">2015-10-14</span>
                    <span class="td nowrap style-scope patent-result">RIC1</span>
                    <span class="td nowrap style-scope patent-result">Information provided on ipc code assigned before grant</span>
                    <span class="td style-scope patent-result">
                      
                      <p class="style-scope patent-result"><strong class="style-scope patent-result">Ipc</strong>: G01N  33/574       20060101AFI20150909BHEP</p>
                      <template is="dom-repeat" as="attr" class="style-scope patent-result"></template>
                    </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">2016-05-25</span>
                    <span class="td nowrap style-scope patent-result">R17P</span>
                    <span class="td nowrap style-scope patent-result">Request for examination filed (corrected)</span>
                    <span class="td style-scope patent-result">
                      
                      <p class="style-scope patent-result"><strong class="style-scope patent-result">Effective date</strong>: 20160414</p>
                      <template is="dom-repeat" as="attr" class="style-scope patent-result"></template>
                    </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">2016-05-25</span>
                    <span class="td nowrap style-scope patent-result">RBV</span>
                    <span class="td nowrap style-scope patent-result">Designated contracting states (corrected)</span>
                    <span class="td style-scope patent-result">
                      
                      <p class="style-scope patent-result"><strong class="style-scope patent-result">Designated state(s)</strong>: AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR</p>
                      <template is="dom-repeat" as="attr" class="style-scope patent-result"></template>
                    </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">2016-08-03</span>
                    <span class="td nowrap style-scope patent-result">17Q</span>
                    <span class="td nowrap style-scope patent-result">First examination report despatched</span>
                    <span class="td style-scope patent-result">
                      
                      <p class="style-scope patent-result"><strong class="style-scope patent-result">Effective date</strong>: 20160705</p>
                      <template is="dom-repeat" as="attr" class="style-scope patent-result"></template>
                    </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">2017-06-15</span>
                    <span class="td nowrap style-scope patent-result">GRAP</span>
                    <span class="td nowrap style-scope patent-result">Despatch of communication of intention to grant a patent</span>
                    <span class="td style-scope patent-result">
                      
                      <p class="style-scope patent-result"><strong class="style-scope patent-result">Free format text</strong>: ORIGINAL CODE: EPIDOSNIGR1</p>
                      <template is="dom-repeat" as="attr" class="style-scope patent-result"></template>
                    </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">2017-07-05</span>
                    <span class="td nowrap style-scope patent-result">INTG</span>
                    <span class="td nowrap style-scope patent-result">Intention to grant announced</span>
                    <span class="td style-scope patent-result">
                      
                      <p class="style-scope patent-result"><strong class="style-scope patent-result">Effective date</strong>: 20170612</p>
                      <template is="dom-repeat" as="attr" class="style-scope patent-result"></template>
                    </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">2017-09-19</span>
                    <span class="td nowrap style-scope patent-result">GRAS</span>
                    <span class="td nowrap style-scope patent-result">Grant fee paid</span>
                    <span class="td style-scope patent-result">
                      
                      <p class="style-scope patent-result"><strong class="style-scope patent-result">Free format text</strong>: ORIGINAL CODE: EPIDOSNIGR3</p>
                      <template is="dom-repeat" as="attr" class="style-scope patent-result"></template>
                    </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">2017-09-22</span>
                    <span class="td nowrap style-scope patent-result">GRAA</span>
                    <span class="td nowrap style-scope patent-result">(expected) grant</span>
                    <span class="td style-scope patent-result">
                      
                      <p class="style-scope patent-result"><strong class="style-scope patent-result">Free format text</strong>: ORIGINAL CODE: 0009210</p>
                      <template is="dom-repeat" as="attr" class="style-scope patent-result"></template>
                    </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">2017-10-25</span>
                    <span class="td nowrap style-scope patent-result">AK</span>
                    <span class="td nowrap style-scope patent-result">Designated contracting states</span>
                    <span class="td style-scope patent-result">
                      
                      <p class="style-scope patent-result"><strong class="style-scope patent-result">Kind code of ref document</strong>: B1</p>
                      
                      <p class="style-scope patent-result"><strong class="style-scope patent-result">Designated state(s)</strong>: AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR</p>
                      <template is="dom-repeat" as="attr" class="style-scope patent-result"></template>
                    </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">2017-10-25</span>
                    <span class="td nowrap style-scope patent-result">REG</span>
                    <span class="td nowrap style-scope patent-result">Reference to a national code</span>
                    <span class="td style-scope patent-result">
                      
                      <p class="style-scope patent-result"><strong class="style-scope patent-result">Ref country code</strong>: GB</p>
                      
                      <p class="style-scope patent-result"><strong class="style-scope patent-result">Ref legal event code</strong>: FG4D</p>
                      <template is="dom-repeat" as="attr" class="style-scope patent-result"></template>
                    </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">2017-10-31</span>
                    <span class="td nowrap style-scope patent-result">REG</span>
                    <span class="td nowrap style-scope patent-result">Reference to a national code</span>
                    <span class="td style-scope patent-result">
                      
                      <p class="style-scope patent-result"><strong class="style-scope patent-result">Ref country code</strong>: CH</p>
                      
                      <p class="style-scope patent-result"><strong class="style-scope patent-result">Ref legal event code</strong>: EP</p>
                      <template is="dom-repeat" as="attr" class="style-scope patent-result"></template>
                    </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">2017-11-15</span>
                    <span class="td nowrap style-scope patent-result">REG</span>
                    <span class="td nowrap style-scope patent-result">Reference to a national code</span>
                    <span class="td style-scope patent-result">
                      
                      <p class="style-scope patent-result"><strong class="style-scope patent-result">Ref country code</strong>: AT</p>
                      
                      <p class="style-scope patent-result"><strong class="style-scope patent-result">Ref legal event code</strong>: REF</p>
                      
                      <p class="style-scope patent-result"><strong class="style-scope patent-result">Ref document number</strong>: 940400</p>
                      
                      <p class="style-scope patent-result"><strong class="style-scope patent-result">Country of ref document</strong>: AT</p>
                      
                      <p class="style-scope patent-result"><strong class="style-scope patent-result">Kind code of ref document</strong>: T</p>
                      
                      <p class="style-scope patent-result"><strong class="style-scope patent-result">Effective date</strong>: 20171115</p>
                      <template is="dom-repeat" as="attr" class="style-scope patent-result"></template>
                    </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">2017-11-29</span>
                    <span class="td nowrap style-scope patent-result">REG</span>
                    <span class="td nowrap style-scope patent-result">Reference to a national code</span>
                    <span class="td style-scope patent-result">
                      
                      <p class="style-scope patent-result"><strong class="style-scope patent-result">Ref country code</strong>: IE</p>
                      
                      <p class="style-scope patent-result"><strong class="style-scope patent-result">Ref legal event code</strong>: FG4D</p>
                      <template is="dom-repeat" as="attr" class="style-scope patent-result"></template>
                    </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">2017-12-07</span>
                    <span class="td nowrap style-scope patent-result">REG</span>
                    <span class="td nowrap style-scope patent-result">Reference to a national code</span>
                    <span class="td style-scope patent-result">
                      
                      <p class="style-scope patent-result"><strong class="style-scope patent-result">Ref country code</strong>: DE</p>
                      
                      <p class="style-scope patent-result"><strong class="style-scope patent-result">Ref legal event code</strong>: R096</p>
                      
                      <p class="style-scope patent-result"><strong class="style-scope patent-result">Ref document number</strong>: 602015005490</p>
                      
                      <p class="style-scope patent-result"><strong class="style-scope patent-result">Country of ref document</strong>: DE</p>
                      <template is="dom-repeat" as="attr" class="style-scope patent-result"></template>
                    </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">2018-01-22</span>
                    <span class="td nowrap style-scope patent-result">REG</span>
                    <span class="td nowrap style-scope patent-result">Reference to a national code</span>
                    <span class="td style-scope patent-result">
                      
                      <p class="style-scope patent-result"><strong class="style-scope patent-result">Ref country code</strong>: FR</p>
                      
                      <p class="style-scope patent-result"><strong class="style-scope patent-result">Ref legal event code</strong>: PLFP</p>
                      
                      <p class="style-scope patent-result"><strong class="style-scope patent-result">Year of fee payment</strong>: 4</p>
                      <template is="dom-repeat" as="attr" class="style-scope patent-result"></template>
                    </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">2018-02-28</span>
                    <span class="td nowrap style-scope patent-result">REG</span>
                    <span class="td nowrap style-scope patent-result">Reference to a national code</span>
                    <span class="td style-scope patent-result">
                      
                      <p class="style-scope patent-result"><strong class="style-scope patent-result">Ref country code</strong>: NL</p>
                      
                      <p class="style-scope patent-result"><strong class="style-scope patent-result">Ref legal event code</strong>: MP</p>
                      
                      <p class="style-scope patent-result"><strong class="style-scope patent-result">Effective date</strong>: 20171025</p>
                      <template is="dom-repeat" as="attr" class="style-scope patent-result"></template>
                    </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">2018-03-12</span>
                    <span class="td nowrap style-scope patent-result">REG</span>
                    <span class="td nowrap style-scope patent-result">Reference to a national code</span>
                    <span class="td style-scope patent-result">
                      
                      <p class="style-scope patent-result"><strong class="style-scope patent-result">Ref country code</strong>: LT</p>
                      
                      <p class="style-scope patent-result"><strong class="style-scope patent-result">Ref legal event code</strong>: MG4D</p>
                      <template is="dom-repeat" as="attr" class="style-scope patent-result"></template>
                    </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">2018-03-15</span>
                    <span class="td nowrap style-scope patent-result">REG</span>
                    <span class="td nowrap style-scope patent-result">Reference to a national code</span>
                    <span class="td style-scope patent-result">
                      
                      <p class="style-scope patent-result"><strong class="style-scope patent-result">Ref country code</strong>: AT</p>
                      
                      <p class="style-scope patent-result"><strong class="style-scope patent-result">Ref legal event code</strong>: MK05</p>
                      
                      <p class="style-scope patent-result"><strong class="style-scope patent-result">Ref document number</strong>: 940400</p>
                      
                      <p class="style-scope patent-result"><strong class="style-scope patent-result">Country of ref document</strong>: AT</p>
                      
                      <p class="style-scope patent-result"><strong class="style-scope patent-result">Kind code of ref document</strong>: T</p>
                      
                      <p class="style-scope patent-result"><strong class="style-scope patent-result">Effective date</strong>: 20171025</p>
                      <template is="dom-repeat" as="attr" class="style-scope patent-result"></template>
                    </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">2018-03-30</span>
                    <span class="td nowrap style-scope patent-result">PG25</span>
                    <span class="td nowrap style-scope patent-result">Lapsed in a contracting state [announced via postgrant information from national office to epo]</span>
                    <span class="td style-scope patent-result">
                      
                      <p class="style-scope patent-result"><strong class="style-scope patent-result">Ref country code</strong>: NL</p>
                      
                      <p class="style-scope patent-result"><strong class="style-scope patent-result">Free format text</strong>: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT</p>
                      
                      <p class="style-scope patent-result"><strong class="style-scope patent-result">Effective date</strong>: 20171025</p>
                      <template is="dom-repeat" as="attr" class="style-scope patent-result"></template>
                    </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">2018-04-30</span>
                    <span class="td nowrap style-scope patent-result">PG25</span>
                    <span class="td nowrap style-scope patent-result">Lapsed in a contracting state [announced via postgrant information from national office to epo]</span>
                    <span class="td style-scope patent-result">
                      
                      <p class="style-scope patent-result"><strong class="style-scope patent-result">Ref country code</strong>: ES</p>
                      
                      <p class="style-scope patent-result"><strong class="style-scope patent-result">Free format text</strong>: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT</p>
                      
                      <p class="style-scope patent-result"><strong class="style-scope patent-result">Effective date</strong>: 20171025</p>
                      
                      <p class="style-scope patent-result"><strong class="style-scope patent-result">Ref country code</strong>: FI</p>
                      
                      <p class="style-scope patent-result"><strong class="style-scope patent-result">Free format text</strong>: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT</p>
                      
                      <p class="style-scope patent-result"><strong class="style-scope patent-result">Effective date</strong>: 20171025</p>
                      
                      <p class="style-scope patent-result"><strong class="style-scope patent-result">Ref country code</strong>: SE</p>
                      
                      <p class="style-scope patent-result"><strong class="style-scope patent-result">Free format text</strong>: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT</p>
                      
                      <p class="style-scope patent-result"><strong class="style-scope patent-result">Effective date</strong>: 20171025</p>
                      
                      <p class="style-scope patent-result"><strong class="style-scope patent-result">Ref country code</strong>: LT</p>
                      
                      <p class="style-scope patent-result"><strong class="style-scope patent-result">Free format text</strong>: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT</p>
                      
                      <p class="style-scope patent-result"><strong class="style-scope patent-result">Effective date</strong>: 20171025</p>
                      
                      <p class="style-scope patent-result"><strong class="style-scope patent-result">Ref country code</strong>: NO</p>
                      
                      <p class="style-scope patent-result"><strong class="style-scope patent-result">Free format text</strong>: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT</p>
                      
                      <p class="style-scope patent-result"><strong class="style-scope patent-result">Effective date</strong>: 20180125</p>
                      <template is="dom-repeat" as="attr" class="style-scope patent-result"></template>
                    </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">2018-05-31</span>
                    <span class="td nowrap style-scope patent-result">PG25</span>
                    <span class="td nowrap style-scope patent-result">Lapsed in a contracting state [announced via postgrant information from national office to epo]</span>
                    <span class="td style-scope patent-result">
                      
                      <p class="style-scope patent-result"><strong class="style-scope patent-result">Ref country code</strong>: LV</p>
                      
                      <p class="style-scope patent-result"><strong class="style-scope patent-result">Free format text</strong>: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT</p>
                      
                      <p class="style-scope patent-result"><strong class="style-scope patent-result">Effective date</strong>: 20171025</p>
                      
                      <p class="style-scope patent-result"><strong class="style-scope patent-result">Ref country code</strong>: GR</p>
                      
                      <p class="style-scope patent-result"><strong class="style-scope patent-result">Free format text</strong>: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT</p>
                      
                      <p class="style-scope patent-result"><strong class="style-scope patent-result">Effective date</strong>: 20180126</p>
                      
                      <p class="style-scope patent-result"><strong class="style-scope patent-result">Ref country code</strong>: RS</p>
                      
                      <p class="style-scope patent-result"><strong class="style-scope patent-result">Free format text</strong>: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT</p>
                      
                      <p class="style-scope patent-result"><strong class="style-scope patent-result">Effective date</strong>: 20171025</p>
                      
                      <p class="style-scope patent-result"><strong class="style-scope patent-result">Ref country code</strong>: AT</p>
                      
                      <p class="style-scope patent-result"><strong class="style-scope patent-result">Free format text</strong>: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT</p>
                      
                      <p class="style-scope patent-result"><strong class="style-scope patent-result">Effective date</strong>: 20171025</p>
                      
                      <p class="style-scope patent-result"><strong class="style-scope patent-result">Ref country code</strong>: BG</p>
                      
                      <p class="style-scope patent-result"><strong class="style-scope patent-result">Free format text</strong>: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT</p>
                      
                      <p class="style-scope patent-result"><strong class="style-scope patent-result">Effective date</strong>: 20180125</p>
                      
                      <p class="style-scope patent-result"><strong class="style-scope patent-result">Ref country code</strong>: IS</p>
                      
                      <p class="style-scope patent-result"><strong class="style-scope patent-result">Free format text</strong>: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT</p>
                      
                      <p class="style-scope patent-result"><strong class="style-scope patent-result">Effective date</strong>: 20180225</p>
                      
                      <p class="style-scope patent-result"><strong class="style-scope patent-result">Ref country code</strong>: HR</p>
                      
                      <p class="style-scope patent-result"><strong class="style-scope patent-result">Free format text</strong>: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT</p>
                      
                      <p class="style-scope patent-result"><strong class="style-scope patent-result">Effective date</strong>: 20171025</p>
                      <template is="dom-repeat" as="attr" class="style-scope patent-result"></template>
                    </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">2018-07-26</span>
                    <span class="td nowrap style-scope patent-result">REG</span>
                    <span class="td nowrap style-scope patent-result">Reference to a national code</span>
                    <span class="td style-scope patent-result">
                      
                      <p class="style-scope patent-result"><strong class="style-scope patent-result">Ref country code</strong>: DE</p>
                      
                      <p class="style-scope patent-result"><strong class="style-scope patent-result">Ref legal event code</strong>: R097</p>
                      
                      <p class="style-scope patent-result"><strong class="style-scope patent-result">Ref document number</strong>: 602015005490</p>
                      
                      <p class="style-scope patent-result"><strong class="style-scope patent-result">Country of ref document</strong>: DE</p>
                      <template is="dom-repeat" as="attr" class="style-scope patent-result"></template>
                    </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">2018-07-31</span>
                    <span class="td nowrap style-scope patent-result">PG25</span>
                    <span class="td nowrap style-scope patent-result">Lapsed in a contracting state [announced via postgrant information from national office to epo]</span>
                    <span class="td style-scope patent-result">
                      
                      <p class="style-scope patent-result"><strong class="style-scope patent-result">Ref country code</strong>: SK</p>
                      
                      <p class="style-scope patent-result"><strong class="style-scope patent-result">Free format text</strong>: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT</p>
                      
                      <p class="style-scope patent-result"><strong class="style-scope patent-result">Effective date</strong>: 20171025</p>
                      
                      <p class="style-scope patent-result"><strong class="style-scope patent-result">Ref country code</strong>: DK</p>
                      
                      <p class="style-scope patent-result"><strong class="style-scope patent-result">Free format text</strong>: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT</p>
                      
                      <p class="style-scope patent-result"><strong class="style-scope patent-result">Effective date</strong>: 20171025</p>
                      
                      <p class="style-scope patent-result"><strong class="style-scope patent-result">Ref country code</strong>: CY</p>
                      
                      <p class="style-scope patent-result"><strong class="style-scope patent-result">Free format text</strong>: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT</p>
                      
                      <p class="style-scope patent-result"><strong class="style-scope patent-result">Effective date</strong>: 20171025</p>
                      
                      <p class="style-scope patent-result"><strong class="style-scope patent-result">Ref country code</strong>: EE</p>
                      
                      <p class="style-scope patent-result"><strong class="style-scope patent-result">Free format text</strong>: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT</p>
                      
                      <p class="style-scope patent-result"><strong class="style-scope patent-result">Effective date</strong>: 20171025</p>
                      
                      <p class="style-scope patent-result"><strong class="style-scope patent-result">Ref country code</strong>: CZ</p>
                      
                      <p class="style-scope patent-result"><strong class="style-scope patent-result">Free format text</strong>: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT</p>
                      
                      <p class="style-scope patent-result"><strong class="style-scope patent-result">Effective date</strong>: 20171025</p>
                      <template is="dom-repeat" as="attr" class="style-scope patent-result"></template>
                    </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">2018-08-31</span>
                    <span class="td nowrap style-scope patent-result">PG25</span>
                    <span class="td nowrap style-scope patent-result">Lapsed in a contracting state [announced via postgrant information from national office to epo]</span>
                    <span class="td style-scope patent-result">
                      
                      <p class="style-scope patent-result"><strong class="style-scope patent-result">Ref country code</strong>: IT</p>
                      
                      <p class="style-scope patent-result"><strong class="style-scope patent-result">Free format text</strong>: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT</p>
                      
                      <p class="style-scope patent-result"><strong class="style-scope patent-result">Effective date</strong>: 20171025</p>
                      
                      <p class="style-scope patent-result"><strong class="style-scope patent-result">Ref country code</strong>: PL</p>
                      
                      <p class="style-scope patent-result"><strong class="style-scope patent-result">Free format text</strong>: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT</p>
                      
                      <p class="style-scope patent-result"><strong class="style-scope patent-result">Effective date</strong>: 20171025</p>
                      
                      <p class="style-scope patent-result"><strong class="style-scope patent-result">Ref country code</strong>: SM</p>
                      
                      <p class="style-scope patent-result"><strong class="style-scope patent-result">Free format text</strong>: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT</p>
                      
                      <p class="style-scope patent-result"><strong class="style-scope patent-result">Effective date</strong>: 20171025</p>
                      
                      <p class="style-scope patent-result"><strong class="style-scope patent-result">Ref country code</strong>: RO</p>
                      
                      <p class="style-scope patent-result"><strong class="style-scope patent-result">Free format text</strong>: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT</p>
                      
                      <p class="style-scope patent-result"><strong class="style-scope patent-result">Effective date</strong>: 20171025</p>
                      <template is="dom-repeat" as="attr" class="style-scope patent-result"></template>
                    </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">2018-08-31</span>
                    <span class="td nowrap style-scope patent-result">PLBE</span>
                    <span class="td nowrap style-scope patent-result">No opposition filed within time limit</span>
                    <span class="td style-scope patent-result">
                      
                      <p class="style-scope patent-result"><strong class="style-scope patent-result">Free format text</strong>: ORIGINAL CODE: 0009261</p>
                      <template is="dom-repeat" as="attr" class="style-scope patent-result"></template>
                    </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">2018-08-31</span>
                    <span class="td nowrap style-scope patent-result">REG</span>
                    <span class="td nowrap style-scope patent-result">Reference to a national code</span>
                    <span class="td style-scope patent-result">
                      
                      <p class="style-scope patent-result"><strong class="style-scope patent-result">Ref country code</strong>: CH</p>
                      
                      <p class="style-scope patent-result"><strong class="style-scope patent-result">Ref legal event code</strong>: PL</p>
                      <template is="dom-repeat" as="attr" class="style-scope patent-result"></template>
                    </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">2018-08-31</span>
                    <span class="td nowrap style-scope patent-result">STAA</span>
                    <span class="td nowrap style-scope patent-result">Information on the status of an ep patent application or granted ep patent</span>
                    <span class="td style-scope patent-result">
                      
                      <p class="style-scope patent-result"><strong class="style-scope patent-result">Free format text</strong>: STATUS: NO OPPOSITION FILED WITHIN TIME LIMIT</p>
                      <template is="dom-repeat" as="attr" class="style-scope patent-result"></template>
                    </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">2018-10-03</span>
                    <span class="td nowrap style-scope patent-result">26N</span>
                    <span class="td nowrap style-scope patent-result">No opposition filed</span>
                    <span class="td style-scope patent-result">
                      
                      <p class="style-scope patent-result"><strong class="style-scope patent-result">Effective date</strong>: 20180726</p>
                      <template is="dom-repeat" as="attr" class="style-scope patent-result"></template>
                    </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">2018-10-31</span>
                    <span class="td nowrap style-scope patent-result">PG25</span>
                    <span class="td nowrap style-scope patent-result">Lapsed in a contracting state [announced via postgrant information from national office to epo]</span>
                    <span class="td style-scope patent-result">
                      
                      <p class="style-scope patent-result"><strong class="style-scope patent-result">Ref country code</strong>: LU</p>
                      
                      <p class="style-scope patent-result"><strong class="style-scope patent-result">Free format text</strong>: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES</p>
                      
                      <p class="style-scope patent-result"><strong class="style-scope patent-result">Effective date</strong>: 20180107</p>
                      <template is="dom-repeat" as="attr" class="style-scope patent-result"></template>
                    </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">2018-10-31</span>
                    <span class="td nowrap style-scope patent-result">REG</span>
                    <span class="td nowrap style-scope patent-result">Reference to a national code</span>
                    <span class="td style-scope patent-result">
                      
                      <p class="style-scope patent-result"><strong class="style-scope patent-result">Ref country code</strong>: IE</p>
                      
                      <p class="style-scope patent-result"><strong class="style-scope patent-result">Ref legal event code</strong>: MM4A</p>
                      <template is="dom-repeat" as="attr" class="style-scope patent-result"></template>
                    </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">2018-11-08</span>
                    <span class="td nowrap style-scope patent-result">REG</span>
                    <span class="td nowrap style-scope patent-result">Reference to a national code</span>
                    <span class="td style-scope patent-result">
                      
                      <p class="style-scope patent-result"><strong class="style-scope patent-result">Ref country code</strong>: BE</p>
                      
                      <p class="style-scope patent-result"><strong class="style-scope patent-result">Ref legal event code</strong>: MM</p>
                      
                      <p class="style-scope patent-result"><strong class="style-scope patent-result">Effective date</strong>: 20180131</p>
                      <template is="dom-repeat" as="attr" class="style-scope patent-result"></template>
                    </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">2018-11-30</span>
                    <span class="td nowrap style-scope patent-result">PG25</span>
                    <span class="td nowrap style-scope patent-result">Lapsed in a contracting state [announced via postgrant information from national office to epo]</span>
                    <span class="td style-scope patent-result">
                      
                      <p class="style-scope patent-result"><strong class="style-scope patent-result">Ref country code</strong>: CH</p>
                      
                      <p class="style-scope patent-result"><strong class="style-scope patent-result">Free format text</strong>: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES</p>
                      
                      <p class="style-scope patent-result"><strong class="style-scope patent-result">Effective date</strong>: 20180131</p>
                      
                      <p class="style-scope patent-result"><strong class="style-scope patent-result">Ref country code</strong>: LI</p>
                      
                      <p class="style-scope patent-result"><strong class="style-scope patent-result">Free format text</strong>: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES</p>
                      
                      <p class="style-scope patent-result"><strong class="style-scope patent-result">Effective date</strong>: 20180131</p>
                      
                      <p class="style-scope patent-result"><strong class="style-scope patent-result">Ref country code</strong>: SI</p>
                      
                      <p class="style-scope patent-result"><strong class="style-scope patent-result">Free format text</strong>: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT</p>
                      
                      <p class="style-scope patent-result"><strong class="style-scope patent-result">Effective date</strong>: 20171025</p>
                      
                      <p class="style-scope patent-result"><strong class="style-scope patent-result">Ref country code</strong>: BE</p>
                      
                      <p class="style-scope patent-result"><strong class="style-scope patent-result">Free format text</strong>: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES</p>
                      
                      <p class="style-scope patent-result"><strong class="style-scope patent-result">Effective date</strong>: 20180131</p>
                      <template is="dom-repeat" as="attr" class="style-scope patent-result"></template>
                    </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">2019-01-31</span>
                    <span class="td nowrap style-scope patent-result">PG25</span>
                    <span class="td nowrap style-scope patent-result">Lapsed in a contracting state [announced via postgrant information from national office to epo]</span>
                    <span class="td style-scope patent-result">
                      
                      <p class="style-scope patent-result"><strong class="style-scope patent-result">Ref country code</strong>: IE</p>
                      
                      <p class="style-scope patent-result"><strong class="style-scope patent-result">Free format text</strong>: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES</p>
                      
                      <p class="style-scope patent-result"><strong class="style-scope patent-result">Effective date</strong>: 20180107</p>
                      <template is="dom-repeat" as="attr" class="style-scope patent-result"></template>
                    </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">2019-06-28</span>
                    <span class="td nowrap style-scope patent-result">PG25</span>
                    <span class="td nowrap style-scope patent-result">Lapsed in a contracting state [announced via postgrant information from national office to epo]</span>
                    <span class="td style-scope patent-result">
                      
                      <p class="style-scope patent-result"><strong class="style-scope patent-result">Ref country code</strong>: MC</p>
                      
                      <p class="style-scope patent-result"><strong class="style-scope patent-result">Free format text</strong>: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT</p>
                      
                      <p class="style-scope patent-result"><strong class="style-scope patent-result">Effective date</strong>: 20171025</p>
                      <template is="dom-repeat" as="attr" class="style-scope patent-result"></template>
                    </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">2020-01-31</span>
                    <span class="td nowrap style-scope patent-result">PG25</span>
                    <span class="td nowrap style-scope patent-result">Lapsed in a contracting state [announced via postgrant information from national office to epo]</span>
                    <span class="td style-scope patent-result">
                      
                      <p class="style-scope patent-result"><strong class="style-scope patent-result">Ref country code</strong>: MT</p>
                      
                      <p class="style-scope patent-result"><strong class="style-scope patent-result">Free format text</strong>: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES</p>
                      
                      <p class="style-scope patent-result"><strong class="style-scope patent-result">Effective date</strong>: 20180107</p>
                      <template is="dom-repeat" as="attr" class="style-scope patent-result"></template>
                    </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">2020-03-31</span>
                    <span class="td nowrap style-scope patent-result">PG25</span>
                    <span class="td nowrap style-scope patent-result">Lapsed in a contracting state [announced via postgrant information from national office to epo]</span>
                    <span class="td style-scope patent-result">
                      
                      <p class="style-scope patent-result"><strong class="style-scope patent-result">Ref country code</strong>: TR</p>
                      
                      <p class="style-scope patent-result"><strong class="style-scope patent-result">Free format text</strong>: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT</p>
                      
                      <p class="style-scope patent-result"><strong class="style-scope patent-result">Effective date</strong>: 20171025</p>
                      <template is="dom-repeat" as="attr" class="style-scope patent-result"></template>
                    </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">2020-05-29</span>
                    <span class="td nowrap style-scope patent-result">PG25</span>
                    <span class="td nowrap style-scope patent-result">Lapsed in a contracting state [announced via postgrant information from national office to epo]</span>
                    <span class="td style-scope patent-result">
                      
                      <p class="style-scope patent-result"><strong class="style-scope patent-result">Ref country code</strong>: PT</p>
                      
                      <p class="style-scope patent-result"><strong class="style-scope patent-result">Free format text</strong>: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT</p>
                      
                      <p class="style-scope patent-result"><strong class="style-scope patent-result">Effective date</strong>: 20171025</p>
                      <template is="dom-repeat" as="attr" class="style-scope patent-result"></template>
                    </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">2020-06-30</span>
                    <span class="td nowrap style-scope patent-result">PG25</span>
                    <span class="td nowrap style-scope patent-result">Lapsed in a contracting state [announced via postgrant information from national office to epo]</span>
                    <span class="td style-scope patent-result">
                      
                      <p class="style-scope patent-result"><strong class="style-scope patent-result">Ref country code</strong>: MK</p>
                      
                      <p class="style-scope patent-result"><strong class="style-scope patent-result">Free format text</strong>: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES</p>
                      
                      <p class="style-scope patent-result"><strong class="style-scope patent-result">Effective date</strong>: 20171025</p>
                      
                      <p class="style-scope patent-result"><strong class="style-scope patent-result">Ref country code</strong>: HU</p>
                      
                      <p class="style-scope patent-result"><strong class="style-scope patent-result">Free format text</strong>: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT; INVALID AB INITIO</p>
                      
                      <p class="style-scope patent-result"><strong class="style-scope patent-result">Effective date</strong>: 20150107</p>
                      <template is="dom-repeat" as="attr" class="style-scope patent-result"></template>
                    </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">2020-07-31</span>
                    <span class="td nowrap style-scope patent-result">PG25</span>
                    <span class="td nowrap style-scope patent-result">Lapsed in a contracting state [announced via postgrant information from national office to epo]</span>
                    <span class="td style-scope patent-result">
                      
                      <p class="style-scope patent-result"><strong class="style-scope patent-result">Ref country code</strong>: AL</p>
                      
                      <p class="style-scope patent-result"><strong class="style-scope patent-result">Free format text</strong>: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT</p>
                      
                      <p class="style-scope patent-result"><strong class="style-scope patent-result">Effective date</strong>: 20171025</p>
                      <template is="dom-repeat" as="attr" class="style-scope patent-result"></template>
                    </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">2023-06-28</span>
                    <span class="td nowrap style-scope patent-result">P01</span>
                    <span class="td nowrap style-scope patent-result">Opt-out of the competence of the unified patent court (upc) registered</span>
                    <span class="td style-scope patent-result">
                      
                      <p class="style-scope patent-result"><strong class="style-scope patent-result">Effective date</strong>: 20230520</p>
                      <template is="dom-repeat" as="attr" class="style-scope patent-result"></template>
                    </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">2024-01-18</span>
                    <span class="td nowrap style-scope patent-result">PGFP</span>
                    <span class="td nowrap style-scope patent-result">Annual fee paid to national office [announced via postgrant information from national office to epo]</span>
                    <span class="td style-scope patent-result">
                      
                      <p class="style-scope patent-result"><strong class="style-scope patent-result">Ref country code</strong>: GB</p>
                      
                      <p class="style-scope patent-result"><strong class="style-scope patent-result">Payment date</strong>: 20231220</p>
                      
                      <p class="style-scope patent-result"><strong class="style-scope patent-result">Year of fee payment</strong>: 10</p>
                      <template is="dom-repeat" as="attr" class="style-scope patent-result"></template>
                    </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">2024-01-31</span>
                    <span class="td nowrap style-scope patent-result">PGFP</span>
                    <span class="td nowrap style-scope patent-result">Annual fee paid to national office [announced via postgrant information from national office to epo]</span>
                    <span class="td style-scope patent-result">
                      
                      <p class="style-scope patent-result"><strong class="style-scope patent-result">Ref country code</strong>: FR</p>
                      
                      <p class="style-scope patent-result"><strong class="style-scope patent-result">Payment date</strong>: 20231222</p>
                      
                      <p class="style-scope patent-result"><strong class="style-scope patent-result">Year of fee payment</strong>: 10</p>
                      <template is="dom-repeat" as="attr" class="style-scope patent-result"></template>
                    </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">2024-04-30</span>
                    <span class="td nowrap style-scope patent-result">PGFP</span>
                    <span class="td nowrap style-scope patent-result">Annual fee paid to national office [announced via postgrant information from national office to epo]</span>
                    <span class="td style-scope patent-result">
                      
                      <p class="style-scope patent-result"><strong class="style-scope patent-result">Ref country code</strong>: DE</p>
                      
                      <p class="style-scope patent-result"><strong class="style-scope patent-result">Payment date</strong>: 20231220</p>
                      
                      <p class="style-scope patent-result"><strong class="style-scope patent-result">Year of fee payment</strong>: 10</p>
                      <template is="dom-repeat" as="attr" class="style-scope patent-result"></template>
                    </span>
                  </div>
                  <template is="dom-repeat" class="style-scope patent-result"></template>
                </div>
              </div>
            </div>
            <template is="dom-if" class="style-scope patent-result"></template>

            
              <h3 id="concepts" class="scroll-target layout horizontal style-scope patent-result">
                <div class="flex style-scope patent-result">Concepts</div>
                <a href="#title" class="style-scope patent-result"><iron-icon icon="arrow-drop-up" class="style-scope patent-result x-scope iron-icon-0"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M7 14l5-5 5 5z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon></a>
              </h3>
              <div class="layout horizontal style-scope patent-result">
                <div class="flex style-scope patent-result">
                  <span id="conceptsWarning" class="righthead tooltip-hint style-scope patent-result">machine-extracted</span>
                  <overlay-tooltip positioning-target="#conceptsWarning" direction="bottom" class="style-scope patent-result" style="display: none;">
    
    <div id="arrow" class="style-scope overlay-tooltip" hidden=""></div>
    <div class="style-scope overlay-tooltip">
      The concepts are extracted by a computer and may be incomplete or incorrect.
    </div>
  </overlay-tooltip>
                </div>
                <span class="headerButton style-scope patent-result"><a href="#" target="_blank" style="display: inline-block;" class="style-scope patent-result"><iron-icon icon="icons:file-download" class="style-scope patent-result x-scope iron-icon-0"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M19 9h-4V3H9v6H5l7 7 7-7zM5 18v2h14v-2H5z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon> Download</a></span>
                <span class="style-scope patent-result">
                  <dropdown-menu multi="true" label="Filter table" show-label="true" change-action="RESULT_CONCEPT_MENU" class="style-scope patent-result">
    
    <span class="label style-scope dropdown-menu">
      <span class="style-scope dropdown-menu">Filter table</span>
      <span id="selected" class="style-scope dropdown-menu" hidden="">
        <span style="margin: 0 4px 0 2px" class="style-scope dropdown-menu"></span>
        <span class="style-scope dropdown-menu"></span>
      </span>
      <iron-icon icon="icons:arrow-drop-down" class="style-scope dropdown-menu x-scope iron-icon-0"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M7 10l5 5 5-5z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon><iron-icon icon="icons:arrow-drop-up" class="style-scope dropdown-menu x-scope iron-icon-0" hidden=""><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M7 14l5-5 5 5z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
    </span>
    <iron-dropdown allow-outside-scroll="" horizontal-align="left" vertical-align="top" class="style-scope dropdown-menu" aria-disabled="false" aria-hidden="true" style="outline: none; display: none;">
    

    <div id="contentWrapper" class="style-scope iron-dropdown">
      <div class="dropdown-content style-scope dropdown-menu" slot="dropdown-content" id="menu" multi="">
        <div class="style-scope dropdown-menu">
          
            <div class="item style-scope dropdown-menu">Anatomy</div>
          
            <div class="item style-scope dropdown-menu">Chemical class</div>
          
            <div class="item style-scope dropdown-menu">Chemical compound</div>
          
            <div class="item style-scope dropdown-menu">Chemical group</div>
          
            <div class="item style-scope dropdown-menu">Diseases</div>
          
            <div class="item style-scope dropdown-menu">Drugs</div>
          
            <div class="item style-scope dropdown-menu">Effects</div>
          
            <div class="item style-scope dropdown-menu">Human genes</div>
          
            <div class="item style-scope dropdown-menu">Inorganic materials</div>
          
            <div class="item style-scope dropdown-menu">Methods</div>
          
            <div class="item style-scope dropdown-menu">Natural products</div>
          
            <div class="item style-scope dropdown-menu">Nutrition</div>
          
            <div class="item style-scope dropdown-menu">Polymers</div>
          
            <div class="item style-scope dropdown-menu">Proteins</div>
          
            <div class="item style-scope dropdown-menu">Species</div>
          
            <div class="item style-scope dropdown-menu">Substances</div>
          
            <div class="item style-scope dropdown-menu">Toxicity</div>
          <template is="dom-repeat" class="style-scope dropdown-menu"></template>
        </div>
      </div>
    </div>
  </iron-dropdown>
  </dropdown-menu>
                </span>
              </div>
              <div class="responsive-table style-scope patent-result">
                <div class="table style-scope patent-result">
                  <div class="thead style-scope patent-result">
                    <div class="tr style-scope patent-result">
                      <span class="th style-scope patent-result">Name</span>
                      <span class="th style-scope patent-result">Image</span>
                      <span class="th style-scope patent-result">Sections</span>
                      <span class="th style-scope patent-result">Count</span>
                      <span class="th style-scope patent-result">Query match</span>
                    </div>
                  </div>
                  <div class="tbody style-scope patent-result">
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Substances style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">inhibitor</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">title,claims,description</span>
                        <span class="td nowrap style-scope patent-result">329</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Proteins style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">Interleukin-8</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">title,claims,description</span>
                        <span class="td nowrap style-scope patent-result">252</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Methods style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">monitoring process</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">title,description</span>
                        <span class="td nowrap style-scope patent-result">44</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Human genes style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">Interleukin-8</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims,description</span>
                        <span class="td nowrap style-scope patent-result">244</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Diseases style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">Neoplasm</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims,description</span>
                        <span class="td nowrap style-scope patent-result">172</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Chemical group style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">alpha amino acid group</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims,description</span>
                        <span class="td nowrap style-scope patent-result">134</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Diseases style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">cancer</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims,description</span>
                        <span class="td nowrap style-scope patent-result">99</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Methods style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">method</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims,description</span>
                        <span class="td nowrap style-scope patent-result">97</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Anatomy style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">serum</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims,description</span>
                        <span class="td nowrap style-scope patent-result">70</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Substances style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">fragment</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims,description</span>
                        <span class="td nowrap style-scope patent-result">47</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Substances style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">antigen</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims,description</span>
                        <span class="td nowrap style-scope patent-result">41</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Proteins style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">antigens</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims,description</span>
                        <span class="td nowrap style-scope patent-result">41</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Human genes style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">antigens</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims,description</span>
                        <span class="td nowrap style-scope patent-result">41</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Proteins style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">Complementarity Determining Regions</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims,description</span>
                        <span class="td nowrap style-scope patent-result">38</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Substances style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">material</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims,description</span>
                        <span class="td nowrap style-scope patent-result">35</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Effects style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">anti-cancer</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims,description</span>
                        <span class="td nowrap style-scope patent-result">31</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Chemical class style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">amino acids</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims,description</span>
                        <span class="td nowrap style-scope patent-result">30</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Proteins style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">Aptamer</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims,description</span>
                        <span class="td nowrap style-scope patent-result">23</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Anatomy style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">blood</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims,description</span>
                        <span class="td nowrap style-scope patent-result">16</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Substances style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">blood</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims,description</span>
                        <span class="td nowrap style-scope patent-result">16</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Chemical compound style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">4-amino-1-[(2r)-6-amino-2-[[(2r)-2-[[(2r)-2-[[(2r)-2-amino-3-phenylpropanoyl]amino]-3-phenylpropanoyl]amino]-4-methylpentanoyl]amino]hexanoyl]piperidine-4-carboxylic acid</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims,description</span>
                        <span class="td nowrap style-scope patent-result">12</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Chemical group style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">amino acid group</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims,description</span>
                        <span class="td nowrap style-scope patent-result">12</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Effects style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">anti-tumor effect</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims,description</span>
                        <span class="td nowrap style-scope patent-result">3</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    <template is="dom-repeat" initial-count="25" class="style-scope patent-result"></template>
                    
                      <div class$="tr layout horizontal conceptDomain" class="style-scope patent-result">
                        <a href="#" class="td flex style-scope patent-result">
                          Show all concepts from the description section
                        </a>
                      </div>
                    <template is="dom-if" class="style-scope patent-result"></template>
                  </div>
                </div>
              </div>
            <template is="dom-if" class="style-scope patent-result"></template>

            <div id="notices" class="vertical layout center style-scope patent-result">
              
                <span class="style-scope patent-result">Data provided by IFI CLAIMS Patent Services</span>
              <template is="dom-if" class="style-scope patent-result"></template>
            </div>
          </div>
          <div class="bottombar style-scope patent-result">
            <bottom-bar class="style-scope patent-result"><template is="dom-if" class="style-scope bottom-bar"></template>
</bottom-bar>
          </div>
        </div>
      </div>
      <template is="dom-if" class="style-scope patent-result"></template>
    </div>
  </patent-result>
    <template is="dom-if" restamp="" class="style-scope result-container"></template>
    <template is="dom-if" restamp="" class="style-scope result-container"></template>
    <template is="dom-if" restamp="" class="style-scope result-container"></template>
  </result-container>
        </div>
      </div>
    
        </div>
      </div>
      <search-footer class="style-scope search-ui">
    
    

    <div id="footer" class="vertical layout center style-scope search-footer">
        <span class="links style-scope search-footer">
          <overlay-tooltip positioning-target="#footerAbout" direction="top" class="style-scope search-footer" style="display: none;">
    
    <div id="arrow" class="style-scope overlay-tooltip" hidden=""></div>
    <div class="style-scope overlay-tooltip">
      Learn more about data coverage, search syntax and other features.
    </div>
  </overlay-tooltip>
          <a id="footerAbout" data-proto="ABOUT" href="https://support.google.com/faqs/answer/6390996" target="_blank" class="style-scope search-footer">About</a>
          <overlay-tooltip positioning-target="#footerFeedback" direction="top" class="style-scope search-footer" style="display: none;">
    
    <div id="arrow" class="style-scope overlay-tooltip" hidden=""></div>
    <div class="style-scope overlay-tooltip">
      Send feedback about technical issues or feature requests for Google Patents.
    </div>
  </overlay-tooltip>
          <a id="footerFeedback" data-proto="SEND_FEEDBACK" href="#" onclick="sendFeedback();" class="style-scope search-footer">Send Feedback</a>
          <a data-proto="PUBLIC_DATASETS" href="https://console.cloud.google.com/marketplace/product/google_patents_public_datasets/google-patents-public-data" target="_blank" class="style-scope search-footer">Public Datasets</a>
          <a data-proto="TERMS" href="https://www.google.com/policies/terms/" target="_blank" class="style-scope search-footer">Terms</a>
          <a data-proto="PRIVACY_POLICY" href="https://www.google.com/privacy/privacy-policy.html" target="blank" class="style-scope search-footer">Privacy Policy</a>
          <a data-proto="SEARCH_HELP" href="https://support.google.com/websearch/" target="_blank" class="style-scope search-footer">Help</a>
        </span>
    </div>
  </search-footer>
    </div>

  </search-ui>
  </search-result>
    <template is="dom-if" restamp="" class="style-scope search-app"></template>
    <template is="dom-if" restamp="" class="style-scope search-app"></template>
    <template is="dom-if" restamp="" class="style-scope search-app"></template>
    <paper-toast id="toast" duration="3000" class="style-scope search-app x-scope paper-toast-0" aria-hidden="true" style="outline: none; display: none;">
    

    <span id="label" class="style-scope paper-toast"></span>
    
      <div id="noticeContent" class="style-scope search-app"></div>
    
  </paper-toast>
  </search-app>
    <script type="text/javascript" src="//www.gstatic.com/feedback/api.js"></script>
    <script type="text/javascript" src="//www.gstatic.com/feedback/js/help/prod/service/lazy.min.js"></script>
    <script type="text/javascript">
      if (window.help && window.help.service) {
        helpApi = window.help.service.Lazy.create(0, {apiKey: 'AIzaSyDTEI_0tLX4varJ7bwK8aT-eOI5qr3BmyI', locale: 'en-US'});
        window.requestedSurveys = new Set();
        window.requestSurvey = function(triggerId) {
          if (window.requestedSurveys.has(triggerId)) {
            return;
          }
          window.requestedSurveys.add(triggerId);
          helpApi.requestSurvey({
            triggerId: triggerId,
            enableTestingMode: false,
            callback: (requestSurveyCallbackParam) => {
              if (!requestSurveyCallbackParam.surveyData) {
                return;
              }
              helpApi.presentSurvey({
                productData: {
                  productVersion: window.version,
                  customData: {
                    "experiments": "",
                  },
                },
                surveyData: requestSurveyCallbackParam.surveyData,
                colorScheme: 1,
                customZIndex: 10000,
              });
            }
          });
        };

        window.requestSurvey('YXTwAsvoW0kedxbuTdH0RArc9VhT');
      }
    </script>
    <script src="/sw/null_loader.js"></script>
  

<iframe id="apiproxyddf475d63cd8173a637a287407211e3c7614fb050.1497666446" name="apiproxyddf475d63cd8173a637a287407211e3c7614fb050.1497666446" style="width: 1px; height: 1px; position: absolute; top: -100px; display: none;" src="https://scone-pa.clients6.google.com/static/proxy.html?usegapi=1&amp;jsh=m%3B%2F_%2Fscs%2Fabc-static%2F_%2Fjs%2Fk%3Dgapi.lb.en.IKZeRvoAYNY.O%2Fam%3DAAAQ%2Fd%3D1%2Frs%3DAHpOoo-SMWTzMRJrTty6iE5dL_aWGYOnuw%2Fm%3D__features__#parent=https%3A%2F%2Fpatents.google.com&amp;rpctoken=600140869" tabindex="-1" aria-hidden="true"></iframe><iron-a11y-announcer>
    
    <div class="style-scope iron-a11y-announcer" aria-live="polite"></div>
  </iron-a11y-announcer></body></html>